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INTRODUCTION 
I. Introduction 
I.1. Infection, immunity and cytokines 
Multicellular organisms are constantly threatened by the invasion of microorganisms. 
The arms race between the host trying to prevent infection and eliminate the invaders and 
the pathogen seeking to exploit the host and to counteract its defence mechanisms led to 
the evolution of a complex, multilayered immune defence. The immune system has 
traditionally been divided into innate and adaptive components. The innate immune 
system predates the adaptive immune response evolutionary (Medzhitov 1997). Even 
single-cell organisms have heritable defence mechanisms, and every multicellular 
organism appears to have a complex innate immune system, whereas adaptive immunity 
is found only in vertebrates (Beutler 2004; Medzhitov 1997). The innate response 
includes both constitutive and inducible mediators and produces generic receptors that 
recognise conserved pathogen-associated molecular patterns (PAMPs) to trigger an 
inflammatory response that limits pathogen invasion (Janeway 2002). Specific adaptive 
immunity, by contrast, depends upon somatic diversification of antigen-receptor genes to 
generate a vast repertoire of lymphocytes, each expressing a different antigen receptor. 
Recognition of specific antigenic pathogen compounds by these cell-surface receptors 
triggers clonal amplification, cellular differentiation and production of secreted receptors 
with the same antigen binding specificity (Burnet 1959). In the vertebrate immune 
system innate and adaptive components synergise in the clearance of pathogens. The 
innate response is crucial in limiting the early replication and spread of infectious agents. 
By contrast, the generation of an adaptive immune response involves considerable lag 
time but culminates in the production of specialised effector mechanisms that are highly 
efficient in eliminating the pathogen and in the formation of an immunological memory 
(Le Bon 2002). In addition to these complementary activities, there is a fundamental 
connection and extensive crosstalk between innate and adaptive immunity. Namely, the 
magnitude and quality of the adaptive immune response is dependent on signals derived 
from the innate response to infection (Medzhitov 1997). Besides cell-cell interactions a 
central mode of communication within the immune system is via cytokines produced by 
hematopoietic and non-hematopoietic cells. Among the cytokines, interferons play a 
complex and central immunomodulatory role mediating host resistance to pathogens 
(reviewed in (Boehm 1997; Stark 1998; Young 2007)). 
 
I .2. Interferons  
Interferons (IFNs) were originally discovered as agents that interfere with viral 
replication (Isaacs 1957a; Isaacs 1957b). Beside their antiviral activity, IFNs exhibit 
growth-inhibitory effects and have important roles in immunosurveillance for malignant 
cells and in immunomodulation. The importance of interferons is apparent from mice 
that lack expression of IFNγ or its receptor due to targeted deletions and consequently are 
susceptible to many infectious agents (Dalton 1993; Huang 1993; Janssen 2002; 
Jouanguy 1999a; Jouanguy 1999b; Orange 1995; Ottenhoff 2002; Scharton-Kersten 
1996) (see Table 1). Humans with naturally occurring mutations in their IFNγ receptor 
genes, however, exhibit a severe, profound and selective susceptibility to weakly virulent 
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mycobacteria only (Doffinger 2002; Jouanguy 1997). IFNs are induced either directly by 
infection and tissue damage or by immune and inflammatory stimuli. IFNs are classified 
into type I, type II and type III according to sequence homology, cellular sources and 
receptor specificity.  
 
Figure 1 Interferon signalling pathways. Type I and type II interferons bind to their respective receptors 
activating related, partially overlapping but distinct signalling pathways of the Janus kinase family (Jak)–
signal transducer and activator of transcription (STAT) type. These signalling cascades activate the 
expression of genes containing GAS (gamma-activated sequence) and ISRE (IFN-stimulated response 
element) elements in their promoter. Type III IFNs (λ-IFNs) signal through the same Jak/STAT pathway as 
type I IFNs driving expression of a common set of genes but engage a distinct heterodimeric receptor 
(IFNLR1/IL10R2) (not shown). The transcriptional response to IFNs includes numerous factors 
participating in the host immune response to viral and microbial pathogens. Protein kinase R (PKR), 2‘-5‘-
oligoadenylate synthetase (2‘-5‘ OAS), adenosine deaminase acting on RNA (ADAR), Mx and guanylate-
binding proteins (GBPs) have been implicated in viral resistance, whereas indoleamine 2,3-dioxygenase 
(IDO), nitric oxide synthase 2 (NOS2), phagocyte oxidase (phox), natural resistance-associated 
macrophage protein 1 (NRAMP1) and immunity-related GTPases (IRGs, p47 GTPases) all have been 
reported to inhibit the replication of bacteria, protozoa and viruses. Other proteins that are inducible by 
IFNs include MHC proteins and transcription factors IRF-1, IRF-9 and CIITA (modified from (Shtrichman 
2001)). 
Type I interferons are comprised of multiple IFNα subtypes (14-20 depending on 
species) (Pestka 1987; van Pesch 2004), IFNβ  (Mogensen 1999), IFNδ (Lefevre 1998), 
IFNε (Conklin 2002; Pestka 2004), IFNκ (LaFleur 2001), IFNτ (Bazer 1997; Martal 
1998), IFNυ (Samarajiwa 2006; Uze 2007), IFNω  (Hauptmann 1985) and limitin/IFNζ 
(Oritani 2000). IFNα and IFNβ are secreted by almost all cell types upon virus infection 
and by activated immune cells such as dendritic cells and macrophages. The other type I 
IFNs are not necessarily present in all mammalian species or expressed upon viral 
infection. For example, mice have no orthologues of IFNυ, IFNκ is constitutively 
expressed by keratinocytes, secretion of IFNτ has only been reported in ungulate 
ruminants and has a specific function in maternal recognition of pregnancy (reviewed in 
(Schroder 2004)). Type I IFN family members bind a common heterodimeric cell-surface 
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receptor, the IFNα receptor (IFNRA), which consists of IFNAR1 and IFNAR2 chains 
and is activated by ligand-induced dimerisation (Darnell 1994; Stark 1998) (Figure 1). 
Each receptor subunit binds constitutively to a single specific member of the Janus 
kinase (Jak) family: IFNAR1 to tyrosine kinase 2 (Tyk2) and IFNAR2 to Jak1. Ligand 
binding induces the phosphorylation of Jak1, Tyk2, intracellular tyrosine residues of the 
IFNA receptor chains and the signal transducers and activators of transcription 1 and 2 
(STAT1 and STAT2). Together with IFN-regulatory factor 9 (IRF9) phosphorylated 
STAT1 and STAT2 form a transcriptional complex called IFN-stimulated gene factor 3 
(ISGF3), which translocates into the nucleus and binds to IFN-stimulated response 
elements (ISREs) present in the promoters of many IFN-regulated genes (Stark 1998).  
Although the three type III IFNs or λ-IFNs (IFNλ1-3 or IL-28A/IL-28A/IL-29) 
differ genetically from type I IFNs, they exhibit similar biological antiviral, antitumour 
and antiproliferative activity and their expression is regulated in a similar fashion 
(Kotenko 2003; Osterlund 2007; Sheppard 2003; Uze 2007). Furthermore, they signal 
through the same Jak/STAT signalling pathway driving expression of a common set of 
genes. Importantly, however, λ-IFNs bind to a distinct membrane receptor composed of 
the IFNLR1 and IL10R2 receptor chains. This specific receptor usage suggests that this 
cytokine family does not merely replicate the type I IFN system and justifies its 
designation as type III IFN. 
Ιnterferon gamma (IFNγ) is the sole type II IFN and is synthesised only by certain 
activated effector cells of the innate and adaptive immune systems including natural 
killer (NK) cells (Bancroft 1993), T lymphocytes (Mosmann 1989), macrophages 
(Gessani 1998; Munder 1998) and dendritic cells (DCs) (Ohteki 1999). Although 
originally defined as an agent with direct antiviral activity, the properties of IFNγ include 
regulation of several aspects of the immune response, stimulation of bactericidal activity 
of phagocytes, stimulation of antigen presentation through class I and class II major 
histocompatibility complex (MHC) molecules, orchestration of leukocyte-endothelium 
interactions, effects on cell proliferation and apoptosis, as well as the stimulation and 
repression of a variety of genes. The two chains of the IFNγ receptor, IFNGR1 and 
IFNGR2, heterodimerise upon binding of an IFNγ homodimer leading to the activation of 
the respective receptor associated Janus kinases, Jak1 and Jak2 (Figure 1) (Darnell 1994; 
Stark 1998). The subsequent tyrosine phosphorylation cascade results in phosphorylated 
and activated STAT1. Upon phosphorylation STAT1 forms a homodimer termed gamma 
activated factor (GAF), translocates into the nucleus and initiates transcription by binding 
to gamma activated sequences (GAS) in the promoters of IFNγ inducible genes (Stark 
1998).  
Thus, binding of IFNs to their specific cell surface receptors leads to the 
activation of distinct but related components of the signal transduction and 
transcriptional activation machinery, resulting in the stimulation of the transcription of 
more than thousand genes belonging to partially overlapping sets (Boehm 1997; Darnell 
1994; Der 1998; Ehrt 2001; Stark 1998; Takaoka 2000; Valente 1992) (Figure 1). Among 
these are a wide range of mediators that undermine the ability of pathogens to survive in 
host cells, contributing to organismal and cellular resistance involving both the innate 
and adaptive immune system (Boehm 1997). 
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I .3. IFN-mediated cell autonomous resistance 
It has become clear over the last decades that the resistance against pathogens does not 
solely rely on specialised immune cells like lymphocytes or macrophages that patrol 
through the body. To counteract intracellular pathogens every single body cell is 
equipped with multiple defence mechanisms that are independent of specialised immune 
cells. Many of the molecular players of this so-called cell autonomous resistance are 
induced by interferons and therefore strictly speaking not completely independent of 
other cells. Still, apart from the need of a ‘danger signal’ to induce cell autonomous 
immunity, the process of pathogen counteraction and clearance is independent from the 
world outside the cell boundaries.  
The list of proteins implicated in cell autonomous immunity is long and still 
growing and includes factors active against all kinds of pathogens. The antiviral factors 
include double stranded (ds)RNA-dependent protein kinase (PKR) (Garcia 2007; Lee 
1993; Meurs 1992; Stojdl 2000; Yang 1995), 2’-5’ oligoadenylate synthetase (2’-5’ 
OAS)/RNase L (Chebath 1987; Chebath 1983; Samuel 2001), dsRNA adenosine 
deaminase (ADAR1) (Jayan 2002; Wong 2002), ISG20 (interferon stimulated 3'-5' 
exonuclease gene 20kDa) (Degols 2007; Espert 2003), promyelocytic leukemia protein 
(PML/TRIM19) (Chee 2003; Chelbi-Alix 1998; Everett 2007; Regad 2001), zinc-finger 
antiviral protein (ZAP) (Gao 2002; Guo 2007), APOBEC3G/CEM15 (apolipoprotein B 
mRNA-editing enzyme, catalytic polypeptide-like 3G) (Harris 2003; Harris 2004; 
Mangeat 2003; Sheehy 2002; Turelli 2004) and tripartite motif protein 5 alpha (TRIM5α) 
(Nisole 2005; Stremlau 2004; Stremlau 2006). Natural resistance-associated macrophage 
protein 1 (NRAMP1) (Atkinson 1997; Barton 1999; Bradley 1979; Gros 1981; Hackam 
1998; Plant 1976; Vidal 1993) mediates resistance against bacterial and protozoal 
pathogens. A number of resistance molecules have been reported to counteract bacterial 
and protozoal as well as viral pathogens. Indoleamine 2,3-dioxygenase (IDO) (Bodaghi 
1999; Murray 1989; Pantoja 2000; Pfefferkorn 1984; Pfefferkorn 1986) and the 
phagocyte oxidase (phox) complex (Jackson 1995; Vazquez-Torres 2001) belong to this 
group. Inducible nitric oxide synthase (iNOS/NOS2) has an even broader field of action, 
displaying cytostatic or cytotoxic activity against viruses, bacteria, fungi, protozoa, 
helminths and tumour cells (Bogdan 2001; Kapur 1999; MacMicking 1997; Turco 1986; 
Vazquez-Torres 2001). The underlying resistance mechanisms range from inhibition of 
mRNA translation (PKR), degradation of RNA (OAS, ISG20, ZAP), RNA deamination 
(ADAR1, APOBEC3G) and binding and premature disassembly of viral capsids 
(TRIM5α) to depletion of divalent cations, tryptophan and arginine (NRAMP1, IDO and 
iNOS respectively) and cytostatic or cytotoxic effects mediated by nitric oxide (iNOS) 
and reactive oxygen species (ROS) (phox). Among this ever growing group of cell 
autonomous resistance factors are numerous members of the superfamily of large, 
interferon-inducible GTPases. 
 
I .4. Guanosine triphosphatases (GTPases) 
Guanosine triphosphatases (GTPases) are a diverse family of proteins that carry out 
various cellular functions, including membrane trafficking (Rab, dynamin), cell 
signalling and migration (Ras, Rho, Gα), nuclear transport (Ran), translation and protein 
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translocation (EF-Tu, EF-G, signal recognition particle (SRP)) (Leipe 2002) and cell 
autonomous resistance against intracellular pathogens (Mx, IRGs) (Martens 2006). 
Guanine nucleotide binding is essential for protein function and is mediated by five 
motifs termed G1–G5, of which the G1 (GX4GKS/T), G3 (DXXG), and G4 
(N/TQ/KXD) are more or less universally conserved (Bourne 1991; Dever 1987). The 
G1 motif or P-loop interacts with the phosphate groups of the nucleotide, the G3 motif 
binds the magnesium ion and makes contact to the γ-phosphate and the G4 motif confers 
specificity by contacting the base of the guanine nucleotide (Bourne 1990; Bourne 1991). 
 
Figure 2 The GTPase cycle. Simplified depiction of a model GTPase cycle. The GDP-bound form of the 
GTP-binding protein is considered inactive, whereas the GTP-bound form represents the active form 
mediating effector functions. For many GTPases the transition between the GDP- and GTP-bound states is 
regulated by other proteins. Guanine nucleotide dissociation inhibitors (GDIs) prevent dissociation of 
GDP, keeping the GTPase in the inactive form. Guanine nucleotide exchange factors (GEFs) release the 
bound GDP from the GTPase enabling GTPase reactivation by GTP-binding. GTPase activating proteins 
(GAPs), in contrast, trigger GTP hydrolysis, restoring the inactive GDP-bound form.  
All GTPases analysed to date share a nucleotide-binding domain with a common 
structural fold (Leipe 2002) and cycle between two alternative conformations induced by 
binding of guanosine diphosphate (GDP) and triphosphate (GTP), respectively, often 
functioning as molecular switches (Bourne 1990; Bourne 1991) (Figure 2). The GDP-
bound form of the GTP-binding protein is considered inactive, whereas the GTP-bound 
form represents the active form mediating effector functions. GTPases associate with 
different regulator and effector molecules depending on their position in the nucleotide 
hydrolysis and exchange cycle. For many GTPases the transition between the GDP- and 
GTP-bound states is regulated by other proteins. Three classes of regulatory proteins are 
distinguished. Guanine nucleotide dissociation inhibitors (GDIs) prevent dissociation of 
GDP, keeping the GTPase in the inactive form. Guanine nucleotide exchange factors 
(GEFs) release the bound GDP from the GTPase. This enables GTPase reactivation by 
GTP-binding due to the higher intracellular concentrations of GTP than GDP and the 
higher affinity for GTP of most GTPases. GTPase activating proteins (GAPs), in 
contrast, trigger GTP hydrolysis, restoring the inactive GDP-bound form (Vetter 2001). 
The GAP activity essential for GTP-hydrolysis in many GTPases can be provided from a 
separate GAP protein, as known from the GAP proteins of H-Ras that insert a catalytic 
arginine side chain (the so called arginine finger) into the active site of the GTPase 
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(Sprang 1997) and from the exceptional Rap1Gap that provides a catalytic asparagine 
(Daumke 2004). Alternatively, GTPases can provide their own GAP activity, either in cis 
from a separate protein domain as it is the case with Gα proteins (Sprang 1997) or in 
trans by self-association as seen in dynamins (Tuma 1994) and large IFN-inducible 
GTPases (Irga6 (Uthaiah 2003) and Pawlowski unpublished results; hGBP1 (Ghosh 
2006)).  
 
I .4.1. Dynamin 
Dynamins are GTPases of about 100 kDa molecular weight found in animals, 
plants and yeast that exert various functions including vesicle formation, vesicle 
transport, organelle division, and cytokinesis (Praefcke 2004b). Dynamins also regulate 
membrane dynamics in the context of cell motility (Kruchten 2006) and have been 
shown to interact with the actin cytoskeleton via a large number of actin binding proteins 
(Schafer 2002; Schafer 2004). Dynamin-related proteins have also been reported in 
bacteria (Low 2006; van der Bliek 1999). Mammals possess three dynamin genes each 
coding for various alternative splice forms (Cao 1998; Urrutia 1997). Dynamin I is 
neuronal specific, dynamin II ubiquitously expressed and dynamin III is restricted to 
lung, brain and testis.  
Dynamins contain a large N-terminal nucleotide binding domain (~300 aa) 
followed by the middle domain, a pleckstrin homology (PH) domain, a GTPase effector 
domain (GED) and a C-terminal proline-rich domain (PRD) mediating self-assembly, 
membrane targeting, GAP activity and interaction with other proteins, respectively 
(Praefcke 2004b; Urrutia 1997). In addition to these structural features, dynamin and 
dynamin-related proteins are distinguished from small GTPases by their oligomerisation-
dependent GTPase activation and cooperative GTP hydrolysis, their low nucleotide-
binding affinities in the micromolar range and the ability of many family members to 
interact with and tubulate lipid membranes (reviewed in (Hinshaw 2000; Praefcke 2004b; 
Song 2003).  
Under physiological salt conditions in absence of nucleotide dynamin is in a 
monomer-tetramer equilibrium in vitro (Binns 1999) showing rather high basal GTP 
hydrolysis (Praefcke 2004b) that is further stimulated by self-assembly into ring-like 
oligomers in solution (Hinshaw 1995; Tuma 1994; Tuma 1993) and into ring- and spiral-
like structures on lipid membranes (Marks 2001; Stowell 1999). Within these oligomers, 
dynamin functions as its own GAP (Muhlberg 1997). The presence of lipids massively 
accelerates GTP hydrolysis and enhances nucleotide-dependent oligomerisation and self-
assembly (Song 2003; Tuma 1994). 
Dynamin tubulates membranes in the presence of GTP-analogues in vitro 
(Hinshaw 1995) and in vivo (Marks 2001) whereby vesicle scission requires GTP 
hydrolysis-dependent conformational changes (Marks 2001). The mechanism by which 
dynamin distorts membranes is under debate (Praefcke 2004b; Song 2003). Dynamin 
could either act as a mechanochemical enzyme pinching off vesicles from donor 
membranes (Hinshaw 1995; Marks 2001) or, alternatively, mediating vesicle scission by 
GTP-dependent recruitment of effector proteins to the neck of budding vesicles (Sever 
1999; Stowell 1999; Sweitzer 1998) where dynamin assembles in spiral-like structures in 
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vivo (Hinshaw 1995). Although the classical dynamins do not seem to play roles in IFN-
mediated immune resistance, all known IFN-inducible GTPase families share 
characteristics with the dynamins. 
 
I .4.2. Large, interferon-inducible GTPases 
The expression of four described families of large GTPases is regulated by IFNs: The Mx 
GTPases (Haller 2002), the 65 kDa (p65) guanylate binding proteins (GBPs) (Cheng 
1986; Cheng 1983), the very large inducible GTPases (VLIGs) (Klamp 2003) and the 
immunity-related or 47 kDa (p47) GTPases (IRGs) (Bekpen 2005b; Boehm 1998). The 
large, IFN-inducible GTPases – despite negligible conservation outside the GTPase 
domain - share numerous dynamin-like features that clearly distinguish them from small, 
Ras-like GTPases (Martens 2006; Praefcke 2004b). Among these features are the 
possession of one or more domains in addition to the conserved G-domain, low 
micromolar nucleotide affinities, GTP-dependent oligomerisation leading to cooperative 
GTP hydrolysis, GAP activity provided by self-interaction, binding – and in some cases 
also tubulation – of lipid vesicles in vitro. In addition, these GTPases are all strongly 
induced by interferons and many have been shown to mediate cell autonomous resistance 
against intracellular pathogens. Two families of large, IFN-inducible GTPases, Mx 
proteins and the guanylate binding proteins (GBPs), share conserved domains with and 
belong to the dynamin superfamily of GTPases (Praefcke 2004b).  
 
I.4.2.1. The Mx GTPases  
The 70–80-kD Mx GTPases are strongly induced exclusively by type I (IFNα/β) and 
type III IFNs (IFNλ) (Aebi 1989; Haller 1980; Holzinger 2007; Kotenko 2003; Simon 
1991; Staeheli 1986a). They were initially discovered in an inbred mouse strain (A2G) 
that showed an exceptionally high degree of resistance against infection with influenza A 
viruses (FLUAV) (Lindenmann 1962; Lindenmann 1963). The resistance phenotype was 
inherited as a single autosomal dominant trait, was specific for members of the 
orthomyxovirus family and was dependent on type I IFN (Haller 1979; Lindenmann 
1963; Lindenmann 1964). The single gene responsible for the resistance phenotype was 
termed orthomyxovirus resistance gene 1 (Mx1) (Lindenmann 1963). The Mx1 antiviral 
effect was shown to be cell autonomous as macrophages from A2G mice were resistant 
to FLUAV infection in vitro (Lindenmann 1978) and to be independent of other IFN-
induced factors (Arnheiter 1990; Staeheli 1986b). In contrast to wild mouse species, most 
laboratory inbred mouse strains carry non-functional Mx1 alleles and are highly 
susceptible to mouse adapted FLUAV strains (Haller 1987; Jin 1998; Staeheli 1988a). 
The second IFN-regulated mouse Mx gene, Mx2, (Reeves 1988; Staeheli 1986c; Staeheli 
1988b) was found to be disrupted in all laboratory strains examined (Staeheli 1988b). 
Functional Mx2 was discovered later in Mus musculus musculus and Mus spretus derived 
mouse strains of feral origin (Jin 1999). The widespread absence of functional Mx genes 
in inbred mice strains kept under pathogen free conditions and the fact that Mx1- alleles 
are frequent in wild mice may indicate that possession of functional Mx alleles is linked 
to high evolutionary costs. However, the absence of functional Mx genes from inbred 
mice might be due to a founder effect (Haller 2007b).  
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The mouse Mx1 and Mx2 proteins localise to the nucleus (Dreiding 1985) 
partially colocalising with PML bodies (Engelhardt 2004; Engelhardt 2001) and the 
cytoplasm (Meier 1988) respectively, and display antiviral activities against RNA viruses 
that replicate in these particular subcellular compartments. Thus, Mx1 confers resistance 
to orthomyxoviruses (e.g. FLUAV) and Thogoto viruses, whereas Mx2 provides 
resistance to bunyaviruses (e.g. La Crosse virus) and rhabdoviruses (e.g. vesicular 
stomatitis virus (VSV)) (Haller 1998; Jin 1999; Zurcher 1992b). Humans possess two 
Mx homologues, MxA and MxB (Aebi 1989; Staeheli 1985). MxA was shown to be 
partially soluble and partially associated with the smooth ER in punctate granula (Accola 
2002; Staeheli 1985; Stertz 2006). It displays antiviral activity against a large range of 
RNA viruses in vivo and in vitro, including bunyaviruses, orthomyxoviruses, 
paramyxoviruses, rhabdoviruses, togaviruses, picornaviruses, and hepatitis B virus, a 
DNA virus with an RNA intermediate (Chieux 2001; Haller 1998; Hefti 1999; Landis 
1998; Melen 1996). MxA can function in mice independent of other IFN-inducible 
factors (Hefti 1999) and is active even in mosquito cells (Miura 2001). In contrast, no 
antiviral function could be detected for MxB (Melen 1996; Pavlovic 1990). MxB 
contains a functional NLS at the N-terminus and mainly localises to the nuclear envelope 
in a nucleotide-dependent manner (King 2004; Melen 1996). Recently, MxB has been 
implicated in the regulation of nuclear transport and cell-cycle progression (King 2004). 
As other large GTPases, Mx proteins have a relatively high molecular mass, a 
low affinity for nucleotides, and a high intrinsic rate of GTP hydrolysis (Haller 2007b; 
Richter 1995; Staeheli 1993). Furthermore they show cooperativity in GTP hydrolysis 
and self-assemble into highly ordered homo-oligomers forming ring-like and helical 
structures in vitro in presence of non-hydrolysable GDP and GTP analogues respectively 
(Accola 2002; Kochs 2002a; Melen 1992; Nakayama 1993). Self-assembly seems to be 
critical for GTPase activity, protein stability (Janzen 2000; Schumacher 1998), and 
recognition of viral target structures (Johannes 1997; Kochs 2002b; Zurcher 1992a). 
MxA was shown to bind and tubulate phosphatidyl serine vesicles in vitro in a 
nucleotide-independent manner (Accola 2002). Mx proteins contain an N-terminal 
GTPase (G) domain, a central-interacting domain (CID) in the middle and a C-terminal 
GTPase effector domain (GED) with leucine-zipper (LZ) motifs (Haller 2002; Haller 
2007b; Melen 1992). Interaction of the LZ region of MxA with the G-domain increases 
the GTPase activity (Schwemmle 1995). The GED can function even when supplied in 
trans but the catalytic mechanism remains elusive (Schwemmle 1995). Further intra- or 
intermolecular interactions of Mx domains including interaction of the GED with the 
CID have been proposed (Di Paolo 1999; Janzen 2000; Ponten 1997; Schumacher 1998; 
Schwemmle 1995). Homo-oligomerisation was proposed to result from binding of the LZ 
region of one molecule to the CID of a second neighbouring molecule leading to an 
enhancement of GTPase activity (Janzen 2000; Schumacher 1998). Homomeric MxA 
and MxB interactions were shown to occur in vivo (Melen 1997; Ponten 1997).  
Mx proteins were found to bind to essential viral components and to interfere 
with viral trafficking, assembly, and replication. A physical interaction of MxA with 
viral nucleocapsid proteins was demonstrated for Thogoto virus, La Crosse virus and – 
weakly – for influenza viruses (Kochs 1999a; Kochs 1999b; Kochs 2002b; Kochs 1998; 
Turan 2004). MxA blocked the transport of viral nucleocapsids into the nucleus in case 
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of Thogoto virus and depleted nucleocapsid proteins from the viral replication sites in the 
case of La Crosse virus (Kochs 1999b; Kochs 2002b; Reichelt 2004). Models of MxA 
action propose that the protein forms two types of assemblies in the cell: the first is a 
resting oligomeric pool of MxA occurring in the absence of viral infection, and the 
second is a co-polymer formed from monomeric MxA that breaks away from the 
oligomeric pools to complex with target viral proteins, effectively sequestering and 
inactivating them (Haller 2002; Haller 2007b). Mouse Mx1 inhibits nuclear primary 
transcription of the influenza virus RNA (Pavlovic 1992), possibly via the viral RNA-
dependent RNA polymerase (Huang 1992; Stranden 1993). Cytoplasmic human MxA 
normally inhibits influenza virus replication at a later step, while primary viral 
transcription is unaffected (Pavlovic 1992). However, when artificially targeted to the 
nucleus, MxA also inhibits primary viral transcription (Zurcher 1992b), whereas mouse 
Mx1 has no activity against influenza virus in the cytoplasm (Zurcher 1992c). GTP 
binding is necessary for the antiviral effect of Mx proteins but, surprisingly, 
oligomerisation and GTP hydrolysis seem to be dispensable (Janzen 2000; Pitossi 1993; 
Ponten 1997). The C-terminal domain shows the highest sequence divergence between 
different Mx proteins and is required for virus inhibition, thus, it may determine the 
specificity of the antiviral activity (Johannes 1997; Ko 2002; Kochs 2002b; Ponten 1997; 
Zurcher 1992a).  
IFN-inducible, antivirally active Mx proteins are found in most vertebrate 
species, including pigs, cows, birds and fish (Leong 1998; Watanabe 2007). However, 
several Mx proteins, such as human MxB and rat Mx3, appear devoid of antiviral activity 
(Meier 1990; Pavlovic 1990). Mx genes are polymorphic in most species and the 
resulting amino acid differences were show to account for variations in the antiviral 
activities of the allelic gene products in many cases (Haller 1987; Jin 1999; Nakajima 
2007; Palm 2007; Seyama 2006). Recently, the first invertebrate Mx protein was 
identified in disk abalone (Haliotis discus discus). It shares certain features with fish and 
mammalian Mx proteins and is induced by PolyI:C injection at the message level (De 
Zoysa 2007). 
 
I.4.2.2. The Guanylate Binding Proteins (GBPs)  
The 65-67 kDa guanylate-binding proteins (GBPs) are among the most abundant proteins 
that accumulate in response to IFNγ stimulation (Boehm 1998; Cheng 1985; Cheng 
1986; Cheng 1983; Nguyen 2002). Induction of GBPs, though somewhat weaker, has 
also been reported by type I IFN, interleukin-1 alpha and beta (IL1α/β), tumour necrosis 
factor alpha (TNFα), and lipopolysaccharide (LPS) (Cheng 1986; Guenzi 2001; Guenzi 
2003; Lubeseder-Martellato 2002; Nantais 1996; Tripal 2007; Vestal 1996). 
Furthermore, Listeria monocytogenes infection resulted in IFNγ-dependent induction of 
mGBP2 and mGBP4 expression in mouse liver (Boehm 1998). The GBP family is 
represented by seven genes in human (hGBP1-7) and ten genes in mouse (mGBP1-10) 
(Boehm 1998; Cheng 1991; Degrandi 2007; Fellenberg 2004; Han 1998; Luan 2002; 
Olszewski 2006; Wynn 1991), and is well conserved throughout the vertebrates 
(Robertsen 2006). ISRE and GAS elements have been detected in the putative promoters 
of most GBP genes (Olszewski 2006).  
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Most family members harbour an unusual G4 motif, T(L/V)RD, instead of the 
canonical (N/T)(K/Q)XD (Praefcke 1999), a property shared with the IFN-inducible 
giant GTPase, VLIG-1 (see below) (Klamp 2003). GBPs bind nucleotides with low 
micromolar affinity (Praefcke 1999; Praefcke 2004a; Schwemmle 1994), display GTP-
dependent oligomerisation (Praefcke 1999; Prakash 2000a) and hydrolyse GTP 
cooperatively (Praefcke 2004a; Prakash 2000a). All GBPs analysed to date bind GTP, 
GDP and GMP with similar micromolar affinity (Cheng 1985; Cheng 1983; Praefcke 
1999; Praefcke 2004a; Staeheli 1984). GBPs, in contrast to other GTPases, hydrolyse 
GTP to GDP and GMP in two successive cleavages of orthophosphate rather than by 
pyrophosphate generation (Neun 1996; Praefcke 1999; Schwemmle 1994). Hydrolysis of 
GDP to GMP involves the same catalytic machinery as GTP hydrolysis, whereby the β-
phosphate of the GDP product of the first round of hydrolysis is brought into the position 
of the former γ-phosphate by movement of the phosphate cap (see below; (Ghosh 2006)). 
GMP is the predominant product for hGBP1 at any time of the reaction, whereby the 
product ratio of GDP and GMP for hGBP1 is temperature dependent (Kunzelmann 2006; 
Schwemmle 1994). GDP can be bound from solution but cannot serve as substrate for 
hydrolysis (Neun 1996; Schwemmle 1994). For hGBP2, the main product of hydrolysis 
is GDP (Neun 1996). 
The structure of human GBP1 has been determined by X-ray crystallography 
(Prakash 2000a; Prakash 2000b). The N-terminal GTP-binding domain (G domain), 
associated with an elongated C-terminal helical domain, has several insertions relative to 
the canonical Ras domain (Pai 1989). The insertions include the unique guanine and 
phosphate caps that shield the nucleotide from the solvent (Prakash 2000b). The helical 
domain consists of 5 α-helices in two three helix bundles, representing the middle and 
the GED domain respectively, followed by a long penultimate helix that reaches back to 
and contacts the G-domain and a short C-terminal helix (Prakash 2000a). Recombinant 
human GBP1 is monomeric in the nucleotide free, GMP- and GDP-bound state but forms 
dimers in the GTP-bound state and tetramers in the GDP+AlFx-stabilised transition state 
(Ghosh 2006; Praefcke 2004a; Prakash 2000a; Prakash 2000b). The isolated nucleotide-
binding domain of hGBP1 crystallised as G-domain–G domain dimer in the GTP- and 
GDP-bound forms (Ghosh 2006). No multimers containing more than four GBP 
molecules have been reported. GTP-dependent dimerisation increases the GTP 
hydrolysis rate probably by providing a catalytic arginine, R48, in cis (Ghosh 2006). The 
arginine residue in the P loop (R48) is conserved in most GBPs (GxxRxGKS) and 
mutation inhibits GTP-hydrolysis but not nucleotide binding (Praefcke 2004a). 
Human and mouse GBP1, -2 and -5 contain a C-terminal CaaX motif (Olszewski 
2006), defined by a cysteine (C) residue, followed by two small, generally aliphatic (a) 
residues, and the X residue, which can be many amino acids (Clarke 1988). This 
sequence enables posttranslational modification by covalent, irreversible attachment of 
an isoprenoid lipid catalysed by one of three protein prenyltransferases: protein 
farnesyltransferase (FTase), protein geranylgeranyltransferase type I (GGTase-I) and 
type II (GGTase-II or Rab GGTase) (Lane 2006). FTase and GGTase-I transfer a 
farnesyl (C15) or geranylgeranyl (C20) isoprenoid, respectively, to the cysteine of a C-
terminal CaaX motif. The specificity is determined by the X residue with a general 
preference of the FTase for methionine, serine, glutamine, or alanine and of the GGTase-
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I for leucine or phenylalanine in that position (Lane 2006). After covalent attachment of 
the isoprenoid in the cytoplasm, most CaaX proteins undergo two further prenylation-
dependent processing steps at the endoplasmic reticulum: proteolytic removal of the aaX 
tripeptide by endopeptidases and carboxymethylation of the prenylcysteine residue by 
carboxyl methyltransferases (Clarke 1992; Schafer 1992). These modifications are 
thought to facilitate membrane binding and certain protein-protein interactions. Judging 
from the sequence of their CaaX motifs, hGBP1 and mGBP5 should be farnesylated 
whereas hGBP2, hGBP5, mGBP1 and mGBP2 are predicted to be geranylgeranylated 
(Olszewski 2006). Prenylation in vivo has been demonstrated for rat GBP (Vestal 1996), 
mGBP1 (Stickney 2000), mGBP2 (Vestal 1998) and hGBP1 (Nantais 1996).  
In subcellular fractionations, hGBP1, mGBP1 and mGBP2 were largely cytosolic 
(Modiano 2005; Nantais 1996; Stickney 2000; Vestal 1998; Vestal 2000). A punctate 
cytoplasmic localisation in vesicle-like structures was observed for endogenous mGBP2 
not colocalising with a variety of organellar markers (Gorbacheva 2002; Vestal 2000). 
Neither GTP binding nor other IFNγ-induced factors but an intact CaaX box were 
required for this localisation (Gorbacheva 2002; Vestal 2000). In contrast, N-terminally 
tagged mGBP1 was diffusely distributed throughout the cytoplasm and not in puncta 
(Vestal 2000). GFP-tagged hGBP1, hGBP3, and hGBP5 were exclusively detected in the 
cytoplasm, whereas hGBP-2 and hGBP4 were also detected in the nucleus of endothelial 
cells (Tripal 2007). Treatment with aluminium fluoride, which can trap GTPases in the 
transition state (Combeau 1988), led to relocalisation of hGBP1 and hGBP2 but not of 
hGBP3 and hGBP4 to the Golgi apparatus (Modiano 2005; Tripal 2007). This required 
IFN induction of the cells and for hGBP1 also GTP binding and a functional 
isoprenylation motif. Human GBP5 was detected at the Golgi independent of IFN and 
AlFx treatment (Tripal 2007). 
Several distinct, apparently unrelated functions have been reported for GBPs. For 
hGBP1 and -2 a weak antiviral effect against VSV and encephalomyocarditis virus 
(ECMV) has been reported in cultured cells and hGBP1 also mediated a similar effect on 
hepatitis C virus (HCV) (Anderson 1999; Carter 2005; Itsui 2006). Furthermore, mGBP1 
and hGBP1 have been implicated in the regulation of angiogenesis by proinflammatory 
cytokines (Guenzi 2001; Guenzi 2003). Hereby hGBP1 is thought to inhibit angiogenesis 
by downregulating the expression of the matrix metalloproteinase-1 in vascular 
endothelia cells (Guenzi 2003). In addition, the C-terminal helical domain of hGBP1 was 
reported to mediate anti-proliferative effects of proinflammatory cytokines on vascular 
endothelial cells independent of the GTPase activity and isoprenylation of the molecule 
(Guenzi 2001). In contrast, mGBP2 was reported to mediate IFNγ-induced enhanced 
proliferation of murine fibroblasts in a nucleotide-binding dependent manner even in 
absence of IFNγ (Gorbacheva 2002). Thus, the current picture of GBP function is 
incomplete and controversial. Furthermore, none of the reported effects provides a 
conclusive explanation for the striking dependence of the GBPs on IFNγ induction in all 
cell types, their high intracellular concentrations, and their unique mechanism of GTP 
hydrolysis. Only very recently a study reported the involvment of several murine GBPs 
in the response to Toxoplasma gondii (Degrandi 2007) (see discussion for details). 
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I.4.2.3. Very large inducible GTPases (VLIGs) 
The very large inducible GTPases (VLIGs) are a family of giant GTP binding proteins 
with a molecular weight of approximately 280 kDa. The family is represented in mouse 
by 6 members on chromosome 7 (Klamp 2003) and in humans by a single conserved 
homologue encoded on chromosome 11. Mouse VLIG-1 was massively induced by IFNγ 
and less strongly by IFNβ in cultured cells and by infection with Listeria monocytogenes 
in different mouse strains. VLIG-1 is a soluble protein found in the cytosol and nucleus. 
The open reading frame of VLIG-1 is encoded on a single very large exon and there is 
evidence that VLIG-1 is polymorphic in mice of different genetic backgrounds. The 
greatest part of the protein sequence does not show significant relationship to other 
known protein families. However, VLIG-1 possesses canonical G1 and G3 GTP-binding 
motifs embedded in a local sequence environment that resembles the nucleotide binding 
domains of the other IFN-inducible GTPase families, especially of the GBPs. The 
relation of VLIG-1 to other GTPase superfamily members is more distant. VLIG-1 is 
indeed a guanine nucleotide-binding protein as it was shown to bind strongly to GDP-
agarose and very weakly, if at all, to GTP- and GMP-agarose. Recently a VLIG-1 related 
sequence was reported in a proteomic analysis of rat microglia cells (Zhou 2005) and 
infectious bursal disease virus (IBDV) was shown to induce a VLIG-1 homologue in 
chicken fibroblasts (Wong 2007). Sequence similarity of the central part of VLIG-1 with 
both caspase recruitment domain protein 6 (CARD6) and up-regulated gene 4 (URG4) 
has been reported in a region that is predicted to be an inosine 5’-monophosphate 
dehydrogenase/GMP reductase domain in those proteins (Dufner 2006). This domain 
family forms a triose-phosphate isomerase (TIM) barrel structure and is involved in 
biosynthesis of guanosine nucleotide (Andrews 1988; Collart 1988; Sintchak 2000). 
CARD6 has been reported to associate with microtubules and to modulate NFκB activity 
while URG4 enhances cell proliferation and both proteins contain a caspase recruitment 
domain (Dufner 2006). The relevance of these observations remains to be determined 
experimentally. VLIG function remains elusive but the IFN-inducibility of VLIG-1 in 
mice and the sequence relationship to other large, IFN-inducible GTPases suggest a role 
in cell autonomous resistance to intracellular pathogens.  
 
I.4.2.4. The immunity-related GTPases (IRGs) 
The immunity-related GTPases (IRGs) or p47 GTPases are guanine nucleotide binding 
proteins with a molecular weight of approximately 47 kDa but no sequence homology to 
any other known GTPase family outside the G-domain (Boehm 1998) (Figure 3). At the 
beginning of this study six mouse IRG genes had been described, namely Irgd (IRG-47) 
(Gilly 1992), Irgm1 (LRG-47) (Sorace 1995), Irgb6 (TGTP/Mg21) (Carlow 1995; Carlow 
1998; Lafuse 1995), Irgm3 (IGTP) (Taylor 1996; Taylor 1997), Irga6 (IIGP) and Irgm2 
(GTPI) (Boehm 1998) and no homologues from other species had been reported (for 
details about the nomenclature of IRG genes and the newly identified genes see results 
section (III.1.1) and (Bekpen 2005b)). Three of the mouse IRG proteins, Irgm1-3, have 
the non-canonical sequence GX4GMS in place of the otherwise universally conserved 
GX4GKS in the first nucleotide-binding motif (G1) correlating with other sequence 
features to define the GMS (IRGM) and GKS subfamilies respectively (Bekpen 2005b; 
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Boehm 1998) (Figure 3). In the course of this study the number of IRG genes in Mus 
musculus domesticus was extended to a total of 21 genes falling into 25 coding units (see 
results section (III.1.2) and (Bekpen 2005b).  
 
Figure 3 Amino acid alignment of six IRG proteins. Manual alignment of amino acid sequences of Irgd 
(IRG-47), Irgb6 (Mg21/TGTP), Irga6 (IIGP), Irgm1 (LRG-47), Irgm3 (IGTP) and Irgm2 (GTPI). Positions 
where at least four sequences share the same residue are shaded. The N- and C-terminal domains show low 
sequence homology between the family members whereas the core G-domain of the proteins is conserved. 
The consensus sequences of the conserved GTP binding motifs are shown below the sequence. Three of the 
proteins contain an unusual methionine instead of the otherwise universally conserved lysine in the first 
nucleotide binding motif (G1) (from (Boehm 1998). 
 
I.4.2.4.1. Expression of the IRG proteins 
The IRG proteins are typically encoded on a single long exon and the promoters contain 
GAS and ISRE motifs mediating IFN-responsiveness but no other recurrent promoter 
motifs (Bekpen 2005b; Gilly 1996). In the mouse, 14 IRG genes have been shown to be 
inducible by IFNγ in fibroblasts. The mouse Irgc is a notable exception in that it lacks 
IFN regulation but is expressed exclusively in haploid spermatids in the mature testis 
(Bekpen 2005b; Rhode 2007). IRG protein expression is rapidly and strongly induced by 
IFNγ in a STAT1-dependent manner in vivo and in vitro in all cell types analysed 
(Boehm 1998; Collazo 2002; Gavrilescu 2004; Gilly 1992; Lafuse 1995; MacMicking 
2003; Sorace 1995; Taylor 1996). IFNα/β also triggers expression, albeit to a lesser 
extent, as does lipopolysaccharide indirectly by stimulating type I IFN (Bafica 2007; 
Carlow 1998; Lafuse 1995; Lapaque 2006; Sorace 1995; Taylor 1996; Zerrahn 2002). 
Other cytokines tested have little effect on expression (Boehm 1998; Lafuse 1995; 
Sorace 1995). In mice, IRG proteins are expressed at modest levels in absence of 
infection in tissues with a significant leukocyte contribution such as thymus and spleen 
(Collazo 2001; Taylor 1996) and in bone marrow derived haematopoietic stem cells 
(Advani 2004; Terskikh 2001; Venezia 2004). A developmentally regulated burst of IFN 
synthesis may be responsible for this expression. Infection induces strong IRG 
expression in most tissues by triggering IFN production (Boehm 1998; Collazo 2001; 
Feng 2004; MacMicking 2003; Taylor 2000; Zerrahn 2002). IRG protein expression in 
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the documented absence of IFN signalling has only been reported for Irga6, which shows 
a high constitutive expression in hepatic parenchymal cells (Zeng 2007, Parvanova 
2005). This expression persists in mice deficient in STAT1 and both the type I and II IFN 
receptors and is driven by a second independent promoter containing numerous binding 
sites for liver-enriched transcription factors of the hepatocyte nuclear factor group 
(HNFs) (Bekpen 2005b, Zeng 2007, Parvanova 2005) known to mediate liver specific 
expression (Costa 2003; Schrem 2002). 
 
I.4.2.4.2. Biochemical properties of the IRG GTPases 
GTPase activity was first documented in vitro for Irgm3 immunoprecitated from IFNγ-
induced cells and for recombinant Irgm3 (Taylor 1996). Furthermore, radiolabelled GTP 
rather than GDP co-immunoprecipitated with Irgm3 from cells (Taylor 1997). As neither 
the affinities of the protein for the different nucleotides nor the hydrolysis rate are known 
and the assay does not detect nucleotide free protein, one can conclude only that Irgm3 is 
capable of binding GTP in IFNγ-induced cells. Subsequently, also recombinant Irgb6 
was shown to hydrolyse GTP to GDP in vitro (Carlow 1998). To date, only Irga6 has 
been systematically characterised biochemically (Ghosh 2004; Uthaiah 2003). Irga6 
hydrolyses GTP to GDP cooperatively with a maximum rate of 2 per minute, 
oligomerises in the presence of GTP, and the oligomers resolve upon GTP hydrolysis 
(Uthaiah 2003). The oligomer is probably the site of rapid hydrolysis as the addition of 
aluminium fluoride to trap the transition state stabilises the oligomers (Ghosh 2004; 
Uthaiah 2003). Thus, Irga6 is a self-activating GTPase, and to date no exogenous 
regulators of its activity have been described. Irga6 has a low nucleotide affinity, which 
is higher for GDP (1 µM) than for GTP (15 µM). Therefore, Irga6 should be 
predominantly GDP bound at cellular concentrations of 300 µM GTP and 100 µM GDP 
(Kleineke 1979) though GTP may be captured in oligomeric complexes in vivo 
(Pawlowski, unpublished data). Irga6 apoprotein and GDP-bound forms both crystallised 
as rotationally symmetrical dimers with identical contact interfaces (Ghosh 2004) (Figure 
4). The G-domain is essentially Ras-like (Pai 1989), and lies between a three-helix 
bundle in the N-terminus, and a complex series of helices and loops in the C-terminus 
(Ghosh 2004). A destabilising mutation in the crystal dimer interface (M173A) yielded a 
monomeric Irga6 crystal with the non-hydrolysable GTP analogue GppNHp (Ghosh 
2004) displaying only small structural changes relative to the GDP-bound structure. It is 
not clear whether the monomeric Irga6(M173A):GppNHp structure accurately reflects 
the actual GTP structure. Mutations in the dimer interface reduced oligomerisation and 
cooperative GTP hydrolysis but none eliminate the activity completely ((Ghosh 2004); 
Pawlowski unpublished data). This and the lack of strong conservation of the dimer 
contact residues between IRG family members (Bekpen 2005b; Ghosh 2004) suggests 
that the crystal dimer interface is not identical to one of the two interfaces needed for 
oligomerisation. Recent mutational analysis defined the primary interface as a G-domain-
G domain interaction involving bound nucleotides (Pawlowski unpublished data). 
Formation of this contact is thought to induce large conformational changes exposing the 
putative second interface.  
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Figure 4 Crystal structure of Irga6 in the GDP bound form. (A) One molecule of the Irga6-GDP dimer 
is shown in ribbon presentation. The N-terminal domain (cyan) is composed of three α-helices and is 
followed by the Ras-like GTP binding domain (light blue). The helical C-terminal domain (dark blue) is 
connected to the G-domain by the linker helix αE (grey). The helices in Irgm1, Irgm2 and Irgm3 
correlating to αK mediate membrane targeting of these proteins (see main text). GDP and Mg2+ are shown 
as atomic stick figure and yellow sphere respectively. The first 13 amino acids of Irga6 are not resolved in 
the structure. (B) Structure of the Irga6-GDP dimer. The subdomains are colour coded as in A. Secondary 
structure elements involved in the dimer interfaces I and II are labelled. The two-fold noncrystallographic 
symmetry axis is shown (from (Ghosh 2004).  
 
I.4.2.4.3. Intracellular localisation of IRG proteins 
IRG proteins associate with distinct subcellular membrane compartments by different 
targeting mechanisms. Irga6 concentrates at the endoplasmic reticulum (ER) (Martens 
2004a) and at least in some cells also at the Golgi apparatus (Kaiser 2004; Zerrahn 2002) 
and contains a myristoylation sequence at the N-terminus (MGQLFSS) (Martens 2004a; 
Uthaiah 2003). The consensus sequence for this lipid modification is 
MG{EDRHPFYW}X2[STAGCNDEF]{P} (Maurer-Stroh 2002), whereby the curly 
brackets indicate non-permissive amino acids, the square brackets essential amino acids, 
X any amino acid. Serine is favoured at position five of the motif, thus, most 
myristoylation motifs can be simplified as MGXXXS. In the myristoylation process a 
methionyl aminopeptidase first removes the initiator methionine (Farazi 2001) before the 
N-myristoyl transferase (NMT) catalyses the covalent attachment of the 14-carbon fatty 
acid myristate to the now N-terminal glycine residue (Casey 1995; Farazi 2001; Johnson 
1994; Rajala 2000). This cotranslational modification is generally regarded as a 
constitutive process, has only been observed in eukaryotes and appears to be irreversible 
(Johnson 1994) though removal of the lipid from mature protein has been reported in 
Dictyostelium (da Silva 1990). Mutations that convert the glycine at position two to 
alanine (G2A) completely abolish myristoylation (Rajala 2000). Myristoylation is critical 
for mediating protein-protein and/or protein-membrane interactions for some proteins 
(Johnson 1994). For others, interactions with cell membranes require accessory factors or 
other covalent modification. In addition, an attached myristoyl can also serve a structural 
role in proteins (Ames 1994; Zheng 1993). An N-terminal peptide of mouse Irga2 (in that 
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study misleadingly called human homolog of IIGP) was myristoylated in an in vitro 
assay (Maurer-Stroh 2004) and Irga6 is efficiently N-terminally myristoylated in vivo 
(Martens 2004b). Furthermore, the N-terminal 68 amino acids of Irga6 targeted EGFP to 
endomembranes in a myristoylation dependent manner (Martens 2004b). In contrast, 
lipid modification is largely dispensable for the membrane association of full length 
Irga6. Thus, Irga6 must employ other, yet unclarified, mechanisms for membrane 
association in uninfected cells. Ten other mouse IRG proteins also contain myristoylation 
sequences (see Table 7 in result section) but their subcellular localisation and 
myristoylation in vivo have not yet been explored. Irgm1 localises to the Golgi as a 
consequence of an amphipathic helix in its C-terminus (αK in the Irga6 crystal structure, 
Figure 4) (Martens 2004b) and Irgm2 and Irgm3 to the Golgi and ER, respectively, 
through the analogous helix, which in these cases lacks amphipathic character (Martens 
2006; Martens 2004b; Taylor 1997). Irgm3 further localised to circular, vesicle-like 
cytoplasmic structures of unknown origin (Taylor 1997). The degree of membrane 
association varies among the IRG proteins. Irgm1 and Irgm3 are both >90% membrane 
bound, while Irga6, Irgb6 and Irgd are 60–70%, 20–30% and <10% membrane bound, 
respectively (Martens 2004b). The precise subcellular localisation of the non-cytosolic 
fraction of Irgb6 and Irgd remains to be determined.  
 
I.4.2.4.4. Function of the IRG proteins 
Only two interaction partners of IRG proteins have been reported to date. First, Irga6 
interaction with the microtubule motor–binding protein, Hook-3, was detected in a yeast 
two hybrid (Y2H) screen and in cell lysates (Kaiser 2004). The interaction was abolished 
with the Irga6(S83N) mutant, which was assumed to be nucleotide-binding deficient by 
analogy to Irgm3(S98N) (Taylor 1997). Thus, the Irga6-Hook3 interaction is nucleotide 
dependent. The abrogation of the co-immunoprecipitation of Irga6 with Hook3 from 
IFNγ-induced cells by GDPβS (Kaiser 2004) strongly argues for GTP as the relevant 
nucleotide. It was proposed that Irga6 might influence cytoskeleton-based membrane 
trafficking via this route. Second, the rat homologue of Irgd was shown to interact with 
adipocyte differentiation-related protein (ADRP) in Y2H, a fatty acid binding protein that 
coats lipid droplets and is involved in their formation and in lipid uptake (Yamaguchi 
2006). The interaction was confirmed in glutathione-S-transferase (GST)-pulldown and 
mapped to the C-terminal half of Irgd (aa 246-420). Thus, Irgd might be involved in 
cellular lipid homeostasis, though the interaction remains to be confirmed in mammalian 
cells.  
Over the last years a number of IRG proteins have been implicated in resistance 
to intracellular protozoal and bacterial pathogens mainly by studying mice with targeted 
deletions of single family members (Table 1). Irgm1-deficient mice were highly 
susceptible to infection with Toxoplasma gondii (Collazo 2001), Leishmania major 
(Taylor 2004), Trypanosomas cruzi (Santiago 2005), Chlamydia trachomatis (Coers 
manuscript in preperation), Listeria monocytogenes (Collazo 2001), Salmonella 
typhimurium (Taylor 2007; Taylor 2004), Mycobacterium tuberculosis (MacMicking 
2003) and M. avium (Feng 2004). In most cases, Irgm1-/- mice succumbed to infection 
with kinetics similar to that of IFNγ-deficient mice. The other IRG proteins tested so far 
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have a narrower pathogen specificity. Irgm3-deficient mice lost resistance against 
Leishmania major (Taylor 2004), Toxoplasma gondii (Taylor 2000), Chlamydia 
trachomatis (Coers manuscript in preparation) and C. psittaci (Miyairi 2007). Irgm3 was 
shown to be required in hematopoietic as well as non-hematopoietic cells for resistance 
to Toxoplasma in vivo (Collazo 2002). Irgd, in contrast, displayed only a partial loss of 
resistance to T. gondii in the chronic phase of the infection (Collazo 2001). IRG function 
in pathogen resistance is non redundant since Irgm3, Irgd and Irgm1 all independently 
contribute to the resistance of mice to the protozoan parasite Toxoplasma gondii.  
 
Table 1 IFNγ and IRG proteins in pathogen resistance. Summary of the susceptibility phenotypes of 
mice or cells (indicated in subscript) genetically (ko) or experimentally deficient for the indicated genes. 
ND: not determined; S: susceptible; R: resistant; strain: susceptible mouse strains; MΦ: macrophages; 
MEFs: mouse embryonic fibroblasts; astroc: astrocytes; MECs: mouse oviduct epithelial cells; RNAi: 
expression suppressed by RNA interference; * in the chronic phase only; # in hematopoietic and non-
hematopoietic cells in vivo: Note: weak antiviral effects observed in cellular overexpression studies for 
Irgm3 and Irgb6 in cellular are not listed here. See main text for more information and for references.  
Recently, two studies linked mouse strain specific differences in resistance to 
Chlamydia trachomatis and C. psittaci to differential expression of Irgb10 (Bernstein-
Hanley 2006; Miyairi 2007). In the case of C. psittaci Irgm2 was also involved in 
determining the resistance differences (Miyairi 2007). Irga6-deficient mice developed 
cerebral malaria with higher incidence than wild type mice following infection with 
Plasmodium berghei but displayed normal resistance to Chlamydia trachomatis and 
Toxoplasma gondii infection as well as to various other pathogens tested (Coers 
manuscript in preparation)(Martens 2006; Martens 2005; Parvanova 2005). In most 
cases, there is a strong correlation between loss of resistance in IRG-deficient mice and 
loss of IFNγ mediated pathogen control in cultured host cells, indicating that regulation 
of innate pathogen killing is a cell autonomous function of the IRG proteins. Thus, Irgm1 
and Irgm3 are required for control of T. gondii, Salmonella typhimurium and Legionella 
growth in macrophages (Butcher 2005; Ling 2006; Taylor 2007; Taylor 2004)(Coers and 
Dietrich personal communication), Irgm3 and Irga6 for control of T. gondii in astrocytes 
(Halonen 2001; Martens 2005), Irgm1 for control of M. tuberculosis and T. cruzi in 
macrophages (MacMicking 2003; Santiago 2005), Irgm3 for control of Chlamydia 
trachomatis in fibroblasts (Bernstein-Hanley 2006) and Irgd for control of T. cruzi in 
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macrophages (Koga 2006) (Table 1). Thus, Irga6 contributes to the cell autonomous 
resistance against T. gondii although Irga6-deficient mice were not significantly more 
susceptible than wild type mice (Martens 2005). Irga6 was reported to participate in C. 
trachomatis resistance in mouse oviduct epithelial cells (Nelson 2005) but was 
dispensable in mouse embryonic fibroblasts (MEFs) (Coers manuscript in preparation).  
Few studies have been performed trying to elucidate the mechanisms by which 
IRGs mediate their non-redundant function in pathogen resistance on a cellular level. 
Irgm1 and Irgm3 have been shown to localise rapidly to phagosomes containing latex 
beads in activated macrophages as the vacuoles form and remain associated as the 
vacuoles mature (Butcher 2005; Martens 2005). The mechanism by which the proteins 
move from their resting localisation at the ER/Golgi or in the cytoplasm to the vacuole is 
not clear but was shown to require a functional GTP binding domain in the case of Irgm1 
(Martens 2004b). Furthermore, defective killing of Mycobacterium tuberculosis in IFNγ-
activated Irgm1-deficient macrophages was associated with impaired maturation of 
bacteria-containing phagosomes that otherwise recruited Irgm1 in wild-type cells 
(MacMicking 2003). Autophagy has subsequently been implicated in the Irgm1-mediated 
enhanced maturation of M. tuberculosis containing phagosomes (Gutierrez 2004). Five 
IRG proteins (Irga6, Irgb6, Irgm2, Irgm3 and Irgd) have been shown to concentrate at the 
parasitophorous vacuolar membrane in IFN-induced, T. gondii–infected primary 
astrocytes and macrophages (Ling 2006; Martens 2005). Irgm1, however, does not seem 
to localise to the T. gondii vacuole (Butcher 2005; Martens 2005), yet it is essential to 
eradicate the pathogen. The molecular mechanisms by which IRG proteins promote T. 
gondii destruction are not clear though both Irga6 and Irgm3 have been shown to 
contribute to the vesiculation and disruption of the parasitophorous vacuolar membrane 
(PVM) and the parasite itself (Ling 2006; Martens 2005). Subsequent engulfment of the 
parasite into an autophagosome-like vacuole ultimately fusing with lysosomes seems to 
be involved in either the killing or the disposal of the dead parasite (Ling 2006). It is not 
clear yet whether IRG proteins play a direct role in the disruption and the associated 
membrane vesiculation. In addition to controlling the fate of pathogens in IFNγ activated 
hosts cells, Irgm1 has also been implicated in the regulation of haematopoiesis following 
chronic infection. Irgm1-deficient mice infected with M. tuberculosis developed 
profound lymphopenia, anaemia and thrombocytopenia that coincided with increased 
bacterial burdens and ultimately decreased survival (Feng 2004). Similarly, infection 
with M. avium resulted in a decreased expansion of haematopoietic progenitors (Taylor 
2007) and T. cruzi infection led to a profound lymphopenia and bone marrow failure in 
Irgm1-deficient mice (Santiago 2005). The mechanism by which the absence of Irgm1 
affects haematopoiesis has not been defined and the molecular basis for the heightened 
susceptibility has not been disentangled. 
At present, the role of the IRG GTPases in viral resistance is not as clear as their 
roles in protozoan and bacterial resistance. Two in vitro studies suggest that Irgb6 and 
Irgm3 may have antiviral properties: Overexpression of Irgb6 in mouse fibroblasts 
decreased vesicular stomatitis virus- but not herpes simplex virus-induced cell lysis 
(Carlow 1998), while overexpression of Irgm3 in HeLa cells diminished coxsackie virus-
induced lysis (Zhang 2003). In the latter study, it was suggested that Irgm3 mediates its 
antiviral effect by both directly blocking viral induced lysis, and modulating viral-
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induced apoptosis (Zhang 2003). Currently, there is no data supporting a function of IRG 
proteins in viral resistance in vivo. Resistance of Irgm1-, Irgm3- and Irgd-deficient mice 
to murine cytomegalovirus (Collazo 2001; Taylor 2000) and of Irgm3-deficinet mice to 
Ebola virus was normal (Taylor 2000).  
In summary, multiple IRG proteins have been implicated in the cell autonomous 
resistance to a wide variety of intracellular bacterial and protozoal pathogens. Yet, the 
resistance to only one pathogen, Toxoplasma gondii, involved all IRG family members 
tested thus far. Hence, it is of central importance to understand the biology of this 
protozoan to gain further insight into the antimircobial effects mediated by the IRGs.  
 
I .5. Toxoplasma gondii 
Suppression of both the acute and chronic phase of Toxoplasma gondii infection in vivo, 
as well as in cultured cells, requires IFNγ-induced responses (Yap 1999b) and all IRG 
proteins analysed so far contribute to pathogen resistance (Martens 2006). Hence, this is 
an excellent system to assess IRG protein function. Toxoplasma gondii is a unicellular, 
obligate intracellular protozoan parasite belonging to the phylum Apicomplexa, many 
members of which are human or animal pathogens (Levine 1988). T. gondii exhibits an 
extremely broad host range, capable of infecting most nucleated cells of virtually any 
warm blooded animal (Black 2000; Sibley 2003). Apicomplexan parasites are bounded 
by the pellicle, a composite structure consisting of the plasma membrane and the closely 
apposed inner membrane complex, which is comprised of two layers of flattened vesicles 
(Figure 5). They contain, in addition to the nucleus, mitochondria, Golgi and ER, a 
unique set of apical organelles called the apical complex and a chloroplast-like organelle, 
the apicoplast (reviewed in (Binder 2004; Black 2000; Vaishnava 2006). The apical 
complex consists of conoid, rhoptries and micronemes and is essential for invasion and 
proliferation. The role of the apicoplast is uncertain but recent results indicate synthesis 
of lipids, heme and isoprenoids as possibilities.  
 
Figure 5 Transmission electron micrograph of a T. gondii tachyzoite (RH strain) within a host cell. T. 
gondii tachyzoites are polarised cells with organelles common to all eukaryotes (mitochondria, nucleus and 
Golgi complex). The micronemes, rhoptries and dense granules are secretory organelles specific to the 
phylum Apicomplexa. Sequential release of organellar contents is thought to be essential for host cell 
invasion. The triple membrane surrounding the parasite is composed of a plasma membrane and two 
membranes that form vesicular structures called the inner membrane complex. The parasite lives within a 
parasitophorous vacuole that is lined with host mitochondria and ER. The vacuole is modified by secreted 
contents of rhoptries and dense granules. The conoid is a cytoskeletal structure at the apex of the tachyzoite 
(from (Binder 2004)). 
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The life cycle of Toxoplasma is unusual in that the organism is capable of 
indefinite replication using either sexual or asexual subcycles (Boothroyd 2002). The 
asexual cycle can occur in any infected animal and consists of two stages, the rapidly 
multiplying tachyzoites and the more slowly dividing bradyzoites, which can encyst in 
brain, heart and other tissues. Acute infection, associated with the tachyzoite stage, is 
normally controlled in the immunocompetent host (Lieberman 2002; Suzuki 1988). 
However, in the chronic phase of infection the cysts in which the bradyzoite state can 
persist are apparently refractory to the robust immune response induced by tachyzoites 
(Sims 1989; Weiss 2000). Persistent bradyzoites can initiate a new infection upon 
ingestion of bradyzoite-infected tissue by a predator or scavenger. Suppression of both 
acute and chronic phase of infection in vivo, as well as in cultured cells, requires IFNγ-
induced responses (Yap 1999a).  
Sexual reproduction of Toxoplasma occurs only in feline species. It includes full 
gametogenesis and mating within the intestinal epithelium and culminates in the 
generation of millions of extremely stable and highly infectious oocysts containing 
haploid sporozoites that are shed in the faeces (Boothroyd 2002). Genetic exchange 
between different strains can occur only in the rare event of a feline becoming infected 
simultaneously with more than one strain. There is no predetermined mating type and a 
single organism can complete the entire life cycle (Pfefferkorn 1977).  
 
 
Figure 6 Toxoplasma gondii host cell invasion and intracellular replication. Invasion is a rapid process 
that is accompanied by sequential secretion of micronemes (green), rhoptries (orange) and dense granules 
(dark blue). (1) Recognition of and attachment to the host cell surface by the parasite is mediated by 
secreted microneme proteins. (2) Rhoptry neck and rhoptry protein secretion. MIC and RON proteins form 
a moving junction, seen as a constriction in the parasite as it enters host cells, that is thought to exclude 
host proteins from the nascent parasitophorous vacuole. (3) Entry of the parasite using its actin-myosin 
motor invaginating the host cell plasma membrane to form the PV. Microneme proteins are excluded form 
the PV. (4) Dense granule secretion occurs after parasite entry is complete. The parasite remodels the 
intracellular vacuole inhibiting lysosomal fusion and recruiting host mitochondria and portions of the host 
ER probably to secure energy and nutrition supply. (5) The parasites undergo several rounds of replication 
by endodyogeny inside the PV before lytic egress from the host cell (not shown). The released parasites 
quickly invade neighbouring cells completing the cycle. Note that the figure is not to scale.  
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Several studies have concluded that, in Europe and North America, the majority 
of T. gondii strains comprises three distinct clonal lineages now known as types I, II and 
III, respectively (Grigg 2001; Howe 1995; Sibley 1992) that differ genetically by 1% or 
less (Saeij 2005; Su 2003). Detailed genetic analysis showed that within type variation is 
extremely rare (Fazaeli 2000; Grigg 2001; Lehmann 2000), except at the highly 
polymorphic microsatellite markers (Ajzenberg 2002; Blackston 2001). Hence, it is clear 
that these three lines have emerged relatively recently without much opportunity for 
genetic drift. Population genetic analyses suggest that recombination(s) between two 
discrete ancestral gene pools produced recombinant progeny, of which a small number 
have recently come to dominate over most other strains in many parts of the world. As a 
result, only two alleles exist for a majority of genes in a majority of strains.  
In mice, T. gondii strains differ enormously in their virulence, by up to 4 orders of 
magnitude, with striking mouse strain specific differences (Araujo 1976; Boothroyd 
2002; Howe 1995). Almost all of the virulent strains typified as RH on the basis of the 
well-characterised RH strain originally isolated by Sabin in 1939 (Sabin 1941) are a 
single clonal genotype (type I), whereas the vast majority of the non-virulent lines are 
type II or type III (reviewed in (Howe 1995; Saeij 2005)). Even though association of 
certain T. gondii strains with specific manifestations of toxoplasmosis (like ocular 
toxoplasmosis) has been documented, no equivalent virulence difference of strains can be 
found in human (Boothroyd 2002). 
The process of host cell invasion is an active parasite-mediated process involving 
the parasite’s cytoskeleton and differs from the facilitated endocytosis seen in bacterial or 
viral infections (Dobrowolski 1996). Entry into the host cell is a rapid process completed 
in about 15 to 20 s. During invasion of host cells, T. gondii directs sequential secretion of 
proteins from the three specific types of secretory organelles of the apical complex: the 
micronemes, rhoptries and dense granules (Figure 5, Figure 6) (Binder 2004; Carruthers 
1999). During attachment to the host plasma membrane, microneme proteins (MICs) are 
secreted and mediate recognition of, and attachment to, the host cell and provide the 
force for host plasma membrane invagination (Carruthers 1997; Dobrowolski 1996). 
During invasion, host proteins are largely excluded from the nascent vacuole by 
establishment of a moving junction containing microneme and rhoptry neck proteins 
(RONs) (Alexander 2005; Mordue 1999a). These results in a dramatic remodelling of the 
intracellular vacuole the parasite resides in, termed parasitophorous vacuole (PV), which 
is primarily composed of host cell lipids (Suss-Toby 1996). Upon contact with the host 
cell rhoptry proteins (ROPs) involved in the formation and modification of the nascent 
parasitophorous vacuole are secreted from the club-shaped rhoptries at the apical tip of 
the parasite (Carruthers 1997; Hakansson 2001). ROPs either associate with the PVM or 
are transported across into the host cell cytoplasm (Bradley 2005; Gilbert 2007). 
Recently two rhoptry kinases, ROP16 and ROP18, have been identified as important 
virulence factors accounting at least for part of the tremendous virulence differences of 
Toxoplasma strains, whereby ROP18 seems to function at the PV membrane and ROP16 
in the host cell nucleus (El Hajj 2006; Saeij 2006; Saeij 2007; Taylor 2006). The 
mechanisms by which these kinases enhance pathogen virulence remain to be clarified. 
Once safely inside the host cell, the parasite secretes proteins from dense granules 
(GRAs) that also modify the vacuolar membrane and associate with a vesicular network 
 21
INTRODUCTION 
within the PV (Carruthers 1997; Dubremetz 1993; Sibley 1995). The modification of the 
vacuole by rhoptry contents (e.g. ROP2; (Carey 2004; Nakaar 2003; Sinai 2001) and 
dense granule proteins (e.g. Gra3; (Henriquez 2005)) results in a vacuole that is 
nonfusogenic, not acidified, and associated with host mitochondria and endoplasmic 
reticulum (Jones 1972; Sinai 1997). This prevents degradation of the parasite by host cell 
lysosomes (Mordue 1999b; Mordue 1997) and secures access to host cell nutrients, 
facilitating parasite replication within this protected intracellular niche (Carruthers 1997; 
Hakansson 2001; Sibley 2004; Sinai 2001). Inside the parasitophorous vacuole T. gondii 
replicates by endodyogeny, a unique form of budding, in which daughter cells are 
assembled within a mother cell (Figure 6) (Goldman 1958; Wildfuhr 1966). When the 
daughter cells are fully mature, they bud from the mother, adopting her plasma 
membrane. The cycle is repeated inside the PV until the infected cell eventually bursts 
and tachyzoites are released.  
 
I .6. The aim of this study  
It has been shown that the IRG resistance system is essential for survival in a world rife 
with pathogens. Furthermore, profound host species-specific and pathogen strain-specific 
differences in susceptibility and employed resistance mechanisms against certain 
pathogens like Toxoplasma gondii have been reported (MacKenzie 1999). Thus, a 
systematic phylogenetic analysis was undertaken to clarify the age and distribution of 
IRG genes in the animal kingdom. It was also analysed whether the IRG family 
displayed signs of recent expansion and diversification in any of the analysed species as 
well as contraction in other species – features that are considered to be characteristic for 
multigene families associated with pathogen resistance due to host-pathogen coevolution 
(Angata 2004; Borghans 2004; Delarbre 1992; Hood 1975; Kumar 2000; Leister 2004; 
Mashimo 2003; Noel 1999; Trowsdale 2001)}. 
Though there is much important data underscoring the essential, cell autonomous, 
non-redundant function of mouse immunity-related GTPases in host resistance to 
intracellular pathogens, at the beginning of this study no investigations of the molecular 
bases of the resistance mechanism had been performed. Only one study had analysed the 
effect of a single IRG protein, Irgb6, on pathogen replication, in this case VSV and HSV-
1 (herpes simplex virus type 1), in absence of IFNγ-induction (Carlow 1998). In contrast 
to the complete inhibition of viral replication by MxA in a similar overexpression setting 
(Haller 2007a), the documented effect was small. Furthermore, the observed antiviral 
effect was marginal compared to the resistance phenotypes documented in bacterial and 
protozoal infections (compare (Carlow 1998) to (Collazo 2001)). Most of the more recent 
functional studies were performed with cells derived from IRG-deficient mice, where 
only the influence of the absence of single IRGs can be assessed but not the influence of 
individual family members on pathogens, cellular functions and other IRG members. 
Moreover, no link between the biochemical properties of the IRG proteins and their 
resistance function in vivo has been drawn to date and nothing is known about the 
regulation of IRG GTPase activity and function in cells.  
To elucidate the cell biology and molecular mechanisms of host resistance 
mediated by IRG proteins on a single cell level and to disentangle the effect mediated by 
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single IRG proteins from the rest of the IFNγ response murine fibroblasts, stably and 
hormone-inducibly expressing single IRGs were established. Furthermore, co-expression 
studies were used to reveal possible interplay between family members. Mutants with 
impaired biochemical properties were characterised and used to link GTPase activity to 
protein function in vivo. Toxoplasma gondii was used as a model for infection as all IRG 
proteins analysed so far contributed to resistance against this pathogen (reviewed in 
(Martens 2006)).  
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II. Material and Methods 
II.1. Material 
II.1.1. Mammalian cells and media 
Gs3T3 mouse fibroblasts (Invitrogen; derived from NIH/3T3 cells ((Jainchill 1969) 
ATCC CRL-1658) by stable transfection with pSwitch vector (Invitrogen)) and murine 
embryonic fibroblasts (MEFs) derived from C57/BL6 mice were cultured in high glucose 
DMEM (Gibco BRL). Both media were supplemented with 10% FCS (Sigma-Aldrich), 2 
mM L-glutamine, 1 mM sodium pyruvate, 1x MEM non-essential amino acids, 100 U/ml 
penicillin and 100 µg/ml streptomycin (all Gibco BRL). Human foreskin fibroblasts 
(Hs27, ATCC CRL-1634) were cultured in IMDM supplemented with 5% FCS and 2 
mM L-glutamine. Sterile trypsin/EDTA solution in PBS (10x trypsin/EDTA solution: 
0.05% (w/v) trypsin (1:250, Gibco BRL)/17 mM EDTA/145 mM NaCl)) was used to 
detach adherent cells from culture dishes (TRP) or flasks (Sarstedt). 
 
I I.1.2. Bacterial strains and media 
E. coli strain Genotype Reference 
K-12 DH5α 80dlacZ∆Μ15, recA1, endA1, gyrA96, thi-1, hsdR17 (rB-, mB+), supE44, 
relA1, deoR, ∆(lacZYA-argF)U169) 
(Bachmann 1983; 
Bachmann 1990)  
BL21 (DE3) B, F-, hsdS (rB-, mB-), gal, dcm, ompT, λ(DE3) (Studier 1986) 
For bacterial culture LB (Luria-Bertani) medium (1 % bacto tryptone (w/v), 0.5 % yeast 
extract (v/w), 1 % NaCl (w/v) (Bertani 1951), for plates including 1.5 % (w/v) bacto 
agar) was used. For selection ampicillin or kanamycin were added to the medium at a 
final concentration of 100 µg/ml and 50 µg/ml respectively (all reagents from Roth).  
 
I I.1.3. Yeast strains and media 
Strain Genotype Reference 
PJ69-4A MATa trpl-901 leu2-3,112 ura3-52 his3-200 ga14∆ ga18O ∆ LYSZ::GALl-
HIS3 GAL2-ADE2 met2::GAL7-lacZ 
(James 1996) 
PJ69-4a MATα trpl-901 leu2-3,112 ura3-52 his3-200 ga14∆ ga18O ∆ LYSZ::GALl-
HIS3 GAL2-ADE2 met2::GAL7-lacZ 
(James 1996) 
Yeast cells were either cultured in complete medium (YPD: 1% (w/v) Yeast extract (MP 
Biochemicals), 2% (w/v) Peptone (Roth), 2% (w/v) Glucose (Roth), for plates including 
2% (w/v) Bacto agar (Roth)) or in synthetic defined (SD) medium (Wickerham 1951) 
(2% (w/v) α-D-glucose (Roth), 0.67% (w/v) yeast nitrogen base including ammonium 
sulfate (Difco), 0.11 mM arginine, 0.08 mM isoleucine, 0.27 mM lysine, 0.07 mM 
methionine, 0.36 mM phenylalanine, 0.42 mM L-threonine, 0.36 mM uracil, 0.46 mM L-
leucine, 0.20 mM tryptophan, 0.15 mM adenine and 0.06 mM histidine (all Merck), for 
plates including 2% (w/v) Bacto agar (Roth)). Depending on the required selection 
leucine, tryptophan, adenine and/or histidine were omitted from the medium. SD plates 
lacking histidine were supplemented with 1 mM 3-amino-1,2,4-triazole (Sigma-Aldrich) 
to decrease the leakiness of the HIS3 reporter (Durfee 1993).  
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I I .1.4. Toxoplasma gondii strains 
ME49: type II strain, avirulent, originally isolated from sheep muscle (California, USA) 
in 1965 (Guo 1997). 
RH: type I strain, virulent, originally isolated in 1939 by Albert B. Sabin from a child 
in Ohio (Sabin 1941), stable YFP expressing transgenic RH strain (2F-1 YFP2, 
termed RH-YFP in this study) generated by Gubbels (Gubbels 2003). 
 
I I .1.5. Vectors 
The following expression vectors were used: pSwitch, pGene/V5-HisA (both Invitrogen), 
pGW1H (British Biotech, Oxford, UK) and pEGFP-C3 (Clontech) for mammalian cells, 
pGEX-4T-2 (GE Healthcare Life-Sciences) for bacteria and pGAD-C(x) and pGBD-C(x) 
(James 1996) for yeast cells (see appendix V.2 for vector maps). 
 
II .1.6. Generation of expression constructs 
The coding regions of Irgm1, -m2, -m3, -a6, -d, and Irgb6 were derived from PCR 
amplification of full-length cDNAs from IFN-γ-stimulated mouse embryonic fibroblasts 
according to standard procedures (Boehm 1998). The open reading frame (ORF) of Irgc 
was obtained by PCR from a bacterial artificial chromosome (BAC) (RP23-57J6; Rohde 
diploma thesis) derived genomic fragment. The PCR fragments with added SalI 
restriction sites on both ends and a Kozak consensus sequence (Kozak 1987) upstream of 
the start codon were cloned with restriction enzymes from New England Biolabs into the 
SalI site of the following expression vectors: pGW1H (British Biotech, Oxford, UK), 
pGEX-4T-2 (GE Healthcare Life-Sciences), pEGFP-C3 (BD Biosciences), pGAD and 
pGBD (James 1996) (Table 2-4; for vector maps see appendix V.2). The native open 
reading frames of the IRG genes (appendix V.3) were cloned into pGene/V5-HisA as 
follows: Irgm1 and Irga6 by BamHI-NotI digestion from the pGEX-4T-2-IRG constructs 
and Irgm2, Irgm3, Irgd and Irgb6 by EcoRI-ApaI restriction from the respective pEGFP-
C3 constructs.  
Mutations in the first nucleotide binding motif (G1) and epitope tags were 
introduced by site directed mutagenesis (see II.3.9). The ctag1 C-terminal epitope tag 
replaces the last two residues (RN) of Irga6 with the sequence KLGRLERPHRD 
(formerly IIGP1-m, (Uthaiah 2003). In case of Irgd-ctag1 the same 13 residues were 
added after the last amino acid of the protein. The FLAG-tagged constructs carry the 
sequence DYKDDDDK at the C-terminus. The bacterial expressed Irga6 proteins all 
carry the extension GSPGIPGSTT at the N terminus due to cleavage of the GST fusion 
by thrombin. All constructs were verified by sequencing.  
vector insert N-terminus C-terminus source 
pGex-4T-2 Irga6 GST-LVPRGSPGIPGSTTMGQL CLRN R Uthaiah 
 Irga6(K82A) GST-LVPRGSPGIPGSTTMGQL CLRN R Uthaiah 
 Irga6(S83N) GST-LVPRGSPGIPGSTTMGQL CLRN This study 
Table 2 Bacterial expression constructs. Amino acid sequences derived from the respective ORFs are 
depicted in bold, the fused glutathione S-transferase (GST) protein is indicated in italics and the thrombin 
cleavage site is highlighted in blue. The enzyme cuts between the arginine and the glycine residue. 
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vector insert N-term.. C-terminus source 
pGW1H Irgc MATS SEDK C. Rhode 
 Irgm2 MEEA IPHP U. Böhm 
 Irgm2(S78N) MEEA IPHP N. Schröder 
 Irgm3 MDLV PEIH S. Martens 
 Irgm3(S98N) MDLV PEIH N. Schröder 
 Irgm1 MKPS PPQI S. Martens 
 Irgm1(S90N) MKPS PPQI S. Martens 
 Irga6 MGQ CLRN U. Böhm 
 Irga6-Ctag1 MGQL CLKLGRLERPHRD N. Papic 
 Irga6(K82A) MGQL CLRN R. Uthaiah 
 Irga6(K82A)-Ctag1 MGQL CLKLGRLERPHRD N. Papic 
 Irga6(S83N) MGQL CLRN This study 
 Irga6(S83N)-Ctag1 MGQL CLKLGRLERPHRD This study 
 Irga6(E106R)-Ctag1 MGQL CLKLGRLERPHRD N Pawlowski, N Papic 
 Irga6(173A)-Ctag1 MGQL CLKLGRLERPHRD R. Uthaiah, N. Papic 
 Irga6(K196D)-Ctag1 MGQL CLKLGRLERPHRD N Pawlowski, N Papic 
 Irgd MDQF VNVA Martens, Luetke 
 Irgd-Ctag1 MDQF VNVAKLGRLERPHRD This study 
 Irgb6 MAWA YWEA U. Böhm 
 Irgb6-FLAG MAWA YWEA S. Martens 
 Irgb6(K69A)-FLAG MAWA YWEA S. Martens 
 Irgb6(S70N)-FLAG MAWA YWEA This study 
pGene/V5-HisA Irgc MATS SEDK This study 
 Irgm2 MEEA IPHP This study 
 Irgm3 MDLV PEIH This study 
 Irga6 MGQL CLRN This study 
 Irgd MDQF VNVA This study 
 Irgm1 MKPS- PPQI This study 
 Irgb6 MAWA YWEA This study 
Table 3 Mammalian expression constructs. Amino acid sequences derived from the respective ORFs are 
depicted in bold, epitope tags in regular letters and alterations from the native sequence are highlighted in 
red. 
vector  insert N-terminus C-terminus source 
pGAD-C1 Irgc GAD-IEFPGGSIDVDMATS SEDK C Rhode 
 Irgc (K65A) GAD-IEFPGGSIDVDMATS SEDK This study 
 Irgc (S66N) GAD-IEFPGGSIDVDMATS SEDK This study 
pGAD-C3 Irgm2 GAD-IEFPGDPSMSTTMEEA IPHP This study 
 Irgm2(S78N) GAD-IEFPGDPSMSTTMEEA IPHP This study 
 Irgm3 GAD-IEFPGDPSMSTTMDLV PEIH This study 
 Irgm3(S98N) GAD-IEFPGDPSMSTTMDLV PEIH This study 
 Irgm1 GAD-IEFPGDPSMSTTMKPS PPQI This study 
 Irgm1(S90N) GAD-IEFPGDPSMSTTMKPS PPQI This study 
 Irga6 GAD-IEFPGDPSMSTTMGQL CLRN This study 
 Irga6(K82A) GAD-IEFPGDPSMSTTMGQL CLRN This study 
 Irga6(S83N) GAD-IEFPGDPSMSTTMGQL CLRN This study 
 Irgd GAD-IEFPGDPSMSTTMDQF VNVA This study 
 Irgb6 GAD-IEFPGDPSMSTTMAWA YWEA This study 
 Irgb6(K69A) GAD-IEFPGDPSMSTTMAWA YWEA This study 
 Irgb6(S70N) GAD-IEFPGDPSMSTTMAWA YWEA This study 
pGBD-C1 Irgc GBD-PEFPGGSIDVDMATS SEDK C Rhode 
 Irgc (K65A) GBD-PEFPGGSIDVDMATS SEDK This study 
 Irgc (S66N) GBD-PEFPGGSIDVDMATS SEDK This study 
pGBD-C3 Irgm2 GBD-PEFPGDPSMSTTMEEA IPHP This study 
 Irgm2(S78N) GBD-PEFPGDPSMSTTMEEA IPHP This study 
 Irgm3 GBD-PEFPGDPSMSTTMDLV PEIH This study 
 Irgm3(S98N) GBD-PEFPGDPSMSTTMDLV PEIH This study 
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vector  insert N-terminus C-terminus source 
 Irgm1 GBD-PEFPGDPSMSTTMKPS- -PPQI This study 
 Irgm1(S90N) GBD-PEFPGDPSMSTTMKPS- -PPQI This study 
 Irga6 GBD-PEFPGDPSMSTTMGQL- -CLRN This study 
 Irga6(K82A) GBD-PEFPGDPSMSTTMGQL- -CLRN This study 
 Irga6(S83N) GBD-PEFPGDPSMSTTMGQL- -CLRN This study 
 Irgd GBD-PEFPGDPSMSTTMDQF- -VNVA This study 
 Irgb6 GBD-PEFPGDPSMSTTMAWA- -YWEA This study 
 Irgb6(K69A) GBD-PEFPGDPSMSTTMAWA- -YWEA This study 
 Irgb6(S70N) GBD-PEFPGDPSMSTTMAWA- -YWEA This study 
Table 4 Yeast expression constructs. Amino acid sequences derived from the respective ORFs are 
depicted in bold, the fused Gal4 activation (AD) and DNA binding domains (BD) are indicated in italics.  
 
I I .1.7. Primers 
side directed mutagenesis (SDM) primers (name/ 5’-3’ sequence) 
Irga6(S83N) SDM fwd ggagacgggatcagggaagAAcagcttcatcaataccctg 
Irga6(S83N) SDM rev cagggtattgatgaagctgTTcttccctgatcccgtctcc 
Irgc(K65A) SDM fwd gagtcgggagccggcGCgtcctccctcatcaatgc 
Irgc(K65A) SDM rev gcattgatgagggaggacGCgccggctcccgactc 
Irgc(S66N) SDM fwd gagtcgggagccggcaagAActccctcatcaatgc 
Irgc(S66N) SDM rev gcattgatgagggagTTcttgccggctcccgactc 
Irgb6(K69A) SDM fwd ggaaacaggcgcagggGCgtccactttcatcaatacc 
Irgb6(K69A) SDM rev ggtattgatgaaagtggacGCccctgcgcctgtttcc 
Irgb6(S70N) SDM fwd ggaaacaggcgcagggaagAAcactttcatcaatacc 
Irgb6(S70N) SDM rev ggtattgatgaaagtgTTcttccctgcgcctgtttcc 
Irgd-ctag1 SDM fwd gaaacagtaaatgttgccaaactaggccgactcgagcggccgcatcgtgactgagtggtcgacctgcagg 
Irgd-ctag1 SDM rev cctgcaggtcgaccactcagtcacgatgcggccgctcgagtcggcctagtttggcaacatttactgtttc 
Irgm1(S90N) SDM fwd gggactctggcaatggcatgAATtctttcatcaatgcacttcg 
Irgm1(S90N) SDM rev cgaagtgcattgatgaaagaATTcatgccattgccagagtccc 
Irgm2(S78N)/ 
Irgm3(S98N) SDM fwd 
gggactctggcaatggcatgAATtctttcatcaatgcccttagg 
Irgm2(S78N)/ 
Irgm3(S98N) SDM 
gggactctggcaatggcatgAATtctttcatcaatgcccttagg 
sequencing primers (name/ 5’-3’ sequence) 
pGW1H-5’ (British Biotech) ctttccatgggtcttttctg 
pGW1H-3’ (British Biotech) tcagggggaggtgtgggagg 
pGene Forward Primer (Invitrogen) ctgctattctgctcaacct 
pcDNA3.1/BGH Reverse Primer (Invitrogen) tagaaggcacagtcgagg 
IS837 (pGAD fwd primer) ccactgtcacctggttggacgg 
IS838 (pGAD/BD rev primer) cacagttgaagtgaacttgcggg 
KU1012 (pGBD fwd primer) gtgcgacatcatcatcggaag 
Table 5 List of primers. Primers were from Operon. Fwd: forward primer, rev: reverse primer. The 
sequences of the ctag1 epitope tag is highlighted in red and mutations introduced in the G1 motive of the 
IRGs are depicted in capital letters. 
 
I I.1.8. Primary immunoreagents 
name recognised antigen type dilution source 
39/3° mouse Irgc peptides LVEKRSTGE-
GTSEEA; YILDSWKRRD LSEDK 
rabbit 
polyclonal 
WB 1:10000 
IF 1:500 
Eurogentec 
αIGTP 
clone 7 
mouse Irgm3 (aa283-423) mouse 
monoclonal 
WB 1:2000  
IF 1:250 
BD Transduction 
Laboratories 
165 recombinant mouse Irga6 rabbit 
polyclonal 
WB 1:25000 
IF 1:8000 
(Martens 2004a; 
Uthaiah 2003)  
10D7 recombinant mouse Irga6 mouse WB 1:2000  Jens Zerrahn, Berlin 
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name recognised antigen type dilution source 
(4.3 mg/ml) monoclonal IF 1:500 (Martens 2005; 
Zerrahn 2002) 
10E7 recombinant mouse Irga6  
(2.6 mg/ml) 
mouse 
monoclonal 
WB 1:1000
IF 1:200 
J. Zerrahn, Berlin 
(Martens 2005; 
Zerrahn 2002) 
2078 mouse Irgd peptides CKTPYQHPK-
YPKVIF; CDAKHLLRKIETVNVA 
rabbit 
polyclonal 
WB 1:1000 
IF 1:500 
Eurogentec 
L115 B0 mouse Irgm1 peptides QTGSSRLP-
EVSRSTE, NESLKNSLGVRDDD 
rabbit 
polyclonal 
WB 1:2000 Eurogentec 
A19 mouse Irgm1 N-terminal peptide goat 
polyclonal 
WB 1:200 
IF 1:100 
Santa Cruz 
Biotechnology 
A20 mouse Irgb6 N-terminal peptide goat 
polyclonal 
WB 1:500 
IF: 1:200 
Santa Cruz 
Biotechnology 
H53 mouse Irgm2 N-term. peptide 
MEEAVESPEVKEFEY 
rabbit 
polyclonal 
WB 1:1000 
IF 1:1000 
Eurogentec 
αIrgb10 mouse Irgb10 C-terminal peptide 
LKKKVFLQDSVDSE 
rabbit 
polyclonal 
WB 1:4000 
IF 1:2000 
(Miyairi 2007); Coers, 
Harvard, Boston 
2600 ctag1 peptide KLGRLERPHRD rabbit 
polyclonal 
WB 1:12000 
IF 1:5000 
Eurogentec 
SPA-865 canine Calnexin N-terminal peptide rabbit 
polyclonal 
WB 1:5000 
IF 1:250 
StressGene 
G65120 C-terminus of rat GM130 mouse 
monoclonal 
IF 1:1000 BD Transduction 
Laboratories 
αGiantin human Giantin mouse 
monoclonal 
IF 1:1000 H. P. Hauri, Basel 
FK2 Ubiquitin mouse 
monoclonal 
WB 1:1000 BioTrend 
αToxo-
plasma 
Toxoplasma gondii (strain C56) rabbit 
polyclonal 
IF 1:1000 BioGenex 
αGRA7 5–
241–178 
Toxoplasma gondii protein GRA7 mouse 
monoclonal 
IF 1:3000 R. Ziemann, Abbott 
Laboratories, USA 
αSAG1 Toxoplasma gondii p30 protein 
(SAG1) 
mouse 
monoclonal 
IF 1:4000 Biodesign 
M2 FLAG-epitope (DTKDDDDK) mouse 
monoclonal 
IF 1:4000 Sigma Aldrich 
GAL-TA 
(C-10) 
GAL4 activation domain (aa768-
881) 
mouse 
monoclonal 
WB 1:500 Santa Cruz 
Biotechnology 
GAL4 DBD 
(RK5C1) 
GAL4 DNA binding domain (aa94-
147) 
mouse 
monoclonal 
WB 1:1000 Santa Cruz 
Biotechnology 
Table 6 Primary immunoreagents. (WB: Western blot; IF: immunofluorescence) 
 
I I.1.9. Secondary immunoreagents 
The following secondary immunoreagents were used: goat anti-mouse Alexa 488 and 
546, goat anti-rabbit Alexa 488 and -546, donkey anti-goat Alexa 350, -488 and -546, 
donkey anti-mouse Alexa 488 and -555, donkey anti-rabbit Alexa 488 and -555 (all 
Molecular Probes; all used 1:1000 for immunofluorescence), donkey anti-rabbit HRP 
(Amersham Bioscience), donkey anti-goat HRP (Santa Cruz) and goat anti-mouse HRP 
(PIERCE) (all horse radish peroxidase (HRP)-coupled sera were used 1:5000 for 
immunodetection of Western blots). 4',6-Diamidine-2'-phenylindole dihydrochloride 
(DAPI, Roche) was used for nuclear counterstaining at a final concentration of 0.5 µg/ml. 
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I I .2. Methods: Phylogenetic analysis 
II.2.1. Use of database resources 
All available public databases (Ensembl (http://www.ensembl.org); NCBI (National 
Centre for Biotechnology Information; http://www.ncbi.nlm.nih.gov)) were extensively 
screened by BLAST (basic local alignment search tool) and related searches for 
sequences belonging to the IRG family. In the case of the mouse, transcript sequences 
derived from the C57BL/6 strain were given preference over sequences of other and 
undefined strain origin, and compared with genomic sequence available (Ensembl mouse 
genome v28.33d.1, February 2005). Newly identified IRG sequences were confirmed 
wherever possible by multiple sequence comparisons at transcriptional and genomic 
levels. The obtained sequences were analysed using DNA Strider v1.3 alignment and 
matrix functions (Marck 1988). Chromosomal locations and synteny analyses of 
chromosomes was initiated through the Ensembl genome browser. The translated open 
reading frames of the IRG family members identified and used in this paper are given in 
the appendix (chapter V.13). 
 
I I.2.2. Generation of multisequence alignment and phylogenetic trees 
Multisequence alignments were performed with ClustalW via the EBI server 
(http://www.ebi.ac.uk/clustalw) using the default settings and edited with SeaView 
(Galtier 1996). Shading of alignments was performed with Genedoc (Nicholas 1997). 
Phylogenetic trees were generated with PhyML (Guindon 2003) and edited with MEGA 
v3.1 (Kumar 2004). The appropriate model of protein evolution was determined with 
ProtTest (Abascal 2005) and is indicated in the respective figure legends.  
 
I I .3. Methods: Mutagenesis and cloning 
II.3.1. Preparation of chemical competent bacteria 
A single colony of E. coli strain DH5α was grown over night in LB medium with 20 mM 
MgSO4 and 10 mM KCl at 37°C. The culture was diluted 1:100 in fresh aforementioned 
medium and grown at 37°C to an OD600 of 0.45. Cultures were incubated on ice for 10 
min, cells were pelleted (2800 g, 4°C, 5 min), resuspended in cold TFB I (30 mM 
KOAc/50 mM MnCl2/100 mM RbCl/10 mM CaCl2/15% (v/v) Glycerol (pH 5.8); 30 
ml/100 ml culture) and incubated on ice for 5 min. The bacteria were pelleted (2800 g, 
4°C, 5 min), resuspended in cold TBF II (10 mM NaMOPS pH 7, 75 mM CaCl2, 10 mM 
RbCl, 15% (v/v) Glycerol (pH 5.8); 4 ml/100 ml culture), shock frozen and stored at –
80°C. 
 
I I.3.2. Transformation of competent bacteria 
Competent cells were incubated with plasmid DNA or ligation mix (see below) for 30 
min on ice. After a heat shock at 42°C for 30 sec followed by a 2 min incubation on ice, 
400 µl of LB medium were added and the mixture was shaken for 30 min at 37°C. 
Different amounts of the transformation were plated on agar dishes containing antibiotics 
(ampicillin 100 µg/ml or kanamycin 50µg/ml) and grown overnight at 37°C.  
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I I.3.3. Plasmid DNA isolation 
For small-scale isolation of plasmid DNA from bacteria, overnight cultures were pelleted 
by centrifugation at room temperature (RT) with 23000 g for 1 min. The pelleted bacteria 
were resuspended in 100 µl P1 (50 mM Tris pH 8, 10 mM EDTA, 100 µg/ml RNase A). 
After addition of 100 µl P2 (200 mM NaOH, 1% SDS), samples were gently mixed and 
incubated for 5 min at RT. 140 µl of P3 (3 M KAc pH 5.5) were added and the reaction 
was spun for 15 min at 23000 g. The supernatant was transferred into a new tube, the 
DNA was precipitated by addition of two volumes of 100% ethanol (EtOH) and pelleted 
for 15 min at 23000 g. The DNA pellet was washed with 70% EtOH, air-dried and 
resuspended in 10 mM Tris pH 8. For preparation of large amounts of plasmid DNA the 
Qiagen Midi Plasmid Preparation Kit were used according to the manufacture’s 
instructions.  
 
I I.3.4. Agarose gel electrophoresis 
DNA was analysed by agarose gel electrophoresis in 40 mM Tris/0.5 mM EDTA (pH 
7.5). Migration of the samples in the electric field was visualised by bromphenol blue. 
Fragment size was determined in comparison to the 1 kb ladder for agarose gels (Gibco). 
The DNA was visualised by use of ethidium bromide (0.3 µg/ml gel) and UV light. 
 
I I.3.5. Purification of DNA fragments from agarose gel 
DNA fragments obtained by restriction endonuclease digest and separated on agarose 
gels were cut out of the gel. The DNA fragments were eluted from the gel blocks using 
the Rapid PCR Product Purification Kit (Boehringer) according to the manufacturer’s 
protocol. Purity and yield of DNA was determined using the spectrophotometer 
measuring the optical density at 260 and 280 nm (concentration = OD260nm* 50 
µg/ml*dilution factor). 
 
I I.3.6. Restriction digest 
All restriction endonucleases were purchased from New England Biolabs and used 
according to the manufacturer’s advice. Double digests were either performed 
simultaneously in the advised NEB buffer or subsequently with adjustment of the salt 
concentration after the first digest. 
 
I I.3.7. Ligation 
Purified insert DNA was ligated into pre-cut, de-phosphorylated (with shrimp alkaline 
phosphatase (Amersham Bioscience)), purified vector in a molar ratio of 3:1 using T4 
DNA ligase (NEB) according to the manufacturer’s instructions at 16°C overnight.  
 
I I.3.8. Sequencing 
All constructs were verified by sequencing using the BigDye Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystems), which is based on the didesoxy-chain termination 
method of sequencing developed by Sanger (Sanger 1977). In a total volume of 10 µl, 0.5 
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µg of template DNA, 10 pmol of the respective primer and 0.5 µl BigDye Terminator 
Ready Reaction Mix were mixed and PCR was carried out with the following program: 5 
min 96°C, 25 cycles of 30 sec 96°C/15 sec 50°C/4 min 60°C. The DNA was precipitated 
with 70% EtOH/300 mM sodium acetate and pelleted with 23000 g at 4°C for 15 min. 
The pellet was washed with 70% ethanol, air-dried and rehydrated for sequencing on the 
ABI 3730 sequencer at the Cologne Centre of Genomics. 
 
I I.3.9. Site directed mutagenesis 
Site directed mutagenesis was carried out using a modification of the protocol supplied 
with “QuikChangeTM XL Site-Directed Mutagenesis” Kit from Stratagene. The 
amplification was carried out using 20 ng plasmid as template, 125 ng of the sense and 
antisense primers and 2.5 U of Pfu-polymerase (Promega) in a total volume of 50 µl. The 
following PCR program was used: 1x 30 sec 95°C; 25x (30 sec 95°C/1 min 55°C/2 
min/kb of plasmid length 72°C); 1x 15 min, 72°C. The template DNA of bacterial origin 
was digested with the dam methylation sensitive restriction enzyme DpnI (NEB) for 1 
hrs at 37°C. 5 µl of the reaction were used to transform competent DH5α cells.  
 
I I .4. Methods: Protein Biochemistry 
II.4.1. Expression and purification of recombinant protein 
pGEX-4T-2-Irga6 (Uthaiah 2003), -Irga6(K82A), and –Irga6(S83N) were transformed 
into E. coli strain BL-21. Cells were grown at 37 °C in LB medium (Bertani 1951) to an 
OD600nm of 0.8. Irga6 proteins were expressed as N-terminal GST fusions upon overnight 
induction with 0.1 mM isopropyl-β-D thiogalactoside (IPTG) at 18 °C. The cells were 
harvested (5000 g, 15 min, 4°C), frozen at –20°C, resuspended in PBS/2 mM DTT 
containing “complete mini protease inhibitors, EDTA free” (Roche) and lysed using a 
microfluidiser (EmulsiFlex-C5, Avestin) at a pressure of 150000 kilopascals. The lysate 
was cleared by sequential centrifugation at 4°C with 50000 g for 15 min and 75600 g for 
30 min. The soluble fraction was purified on a glutathione Sepharose affinity column 
(GSTrap FF 5ml, GE Healthcare Life-Sciences) equilibrated with PBS/2 mM DTT. GST 
was cleaved off by overnight incubation of the resin with 5 units/ml thrombin (Serva) at 
4 °C. Free Irga6 was eluted with PBS/2 mM DTT. Protein containing fractions were 
analysed by SDS-PAGE and visualised by Coomassie staining (de St. Groth 1963). Irga6 
containing fractions were pooled and subjected to size exclusion chromatography on a 
Superdex 75 column (GE Healthcare Life-Sciences) equilibrated in 50 mM Tris/HCl pH 
7.4/5 mM MgCl2/2 mM DTT. The fractions were analysed by SDS-PAGE, and those 
containing Irga6 were concentrated by a centrifugal concentrator (Vivaspin 20, Sartorius, 
10 kDa cut-off). Aliquots were shock-frozen in liquid nitrogen and stored at -80 °C. The 
concentration of Irga6 was determined by UV spectrophotometry at 280 nm (Gill 1989). 
The purified proteins carry the extension GSPGIPGSTT at the N terminus due to 
digestion of the GST fusion with thrombin (see Table 2). 
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I I.4.2. Guanine nucleotide binding parameters 
The nucleotide binding affinities of Irga6, Irga6(K82A) and Irga6(S83N) for 2'(3')-O-
methylanthraniloyl (mant) GDP (mGDP) and mGTPγS, a nonhydrolysable analogue of 
GTP (both from Jena Bioscience) were determined by equilibrium titration as described 
in Uthaiah et al 2003. In short Irga6 proteins were titrated in a range from 0 to 100 µM 
against 0.5 µM mant nucleotides in 50 mM Tris/HCl pH7.4/5 mM MgCl2/2 mM DTT. 
The mant nucleotides were excited at 355 nm, and the fluorescence was monitored at 448 
nm (Aminco-Bowman 2 Luminescence Spectrometer; SLM Instruments). The increase in 
fluorescence upon the stepwise addition of the protein was measured, and each value was 
averaged over 30 sec. The equilibrium dissociation constants, Kd, were obtained by 
fitting a quadratic function to the data as described in (Herrmann 1996) by using the 
Sigma Plot program (Systat). To determine whether the nucleotide binding of Irga6 
depended on the presence of magnesium, the equilibrium titration was also carried out in 
absence of MgCl2 and presence of 10 mM EDTA.  
 
I I.4.3. GTP hydrolysis assay 
Irga6 wild type and mutant recombinant proteins (80 µM) were incubated with 10 mM 
GTP (Sigma-Aldrich) containing traces of αP32-labeled GTP (GE Healthcare Life-
Sciences) at 37°C in 50 mM Tris/HCl pH7.4/5 mM MgCl2/2 mM DTT. At the indicated 
time points aliquots of the reaction were spotted onto PEI Cellulose F thin layer 
chromatography (TCL) plates (Merck). Dried plates were run in 1 M acetic acid/0.8 M 
LiCl. Signals were detected by use of the BAS 1000 phosphoimager analysis system 
(Fujifilm) and quantified with the AIDA Image Analyser v3 software (Raytest). 
 
I I.4.4. Analysis of protein oligomerisation by light scattering  
Oligomerisation behaviour of Irga6 and the Irga6 mutants K82A and S83N was 
determined by conventional and dynamic light scattering. Light scattering of 80 µM 
protein in the presence of 10 mM GDP and GTP respectively (Sigma-Aldrich) in 50 mM 
Tris/HCl pH7.4/5 mM MgCl2/2 mM DTT was analysed at 37°C. Samples were cleared 
by ultracentrifugation prior to addition of nucleotides. In conventional light scattering, 
samples were excited at 350 nm and scattered light was detected at the same wavelength 
in an Olis DM45 Spectrofluorimeter (Olis) at a fixed angle of 90°. Dynamic light 
scattering (DLS) was performed using a DynaPro molecular sizing instrument equipped 
with a MircoSampler temperature control unit (MSTC800, Protein Solutions, Wyatt 
Technologies). The scattering of light with 650 nm wavelength by the sample was 
measured at 37°C for 30 min in a Quartz cuvette (acquisition time 10 sec). Data were 
obtained and analysed using the DYNAMICS software (v.5). The hydrodynamic radius 
(RH) was calculated from the translational diffusion coefficient (DT), obtained by 
autocorrelation of the data, using the Stokes-Einstein Equation (RH = kb T/6πηDT; kb: 
Boltzmann constant, T: absolute temperature in Kelvin, η: solvent viscosity). The 
molecular weight (MW) was estimated from the hydrodynamic radius RH using the 
standard curve of MW versus RH for globular proteins (MW = (RH factor * RH)Power, for 
globular proteins RH factor = 1.68, Power = 2.3398). 
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I I .5. Methods: mammalian cells 
II.5.1. Freezing and thawing of mammalian cells 
Cells were harvested, pelleted at 400 g for 5 min, resuspended in ice-cold sterile 
FCS/10% DMSO (v/v) (4*106 cells/ml), frozen slowly in cryotubes (Greiner) and 
transferred to liquid nitrogen for long-term storage. Cells were thawn at 37°C, 
immediately transferred into a large volume of medium, pelleted and plated in fresh 
medium.  
 
I I.5.2. Transfection of mammalian cells 
FuGENE6 transfection reagent (Roche) was used for transient transfections of the 
indicated amounts of DNA according to the manufacturer’s instruction using a FuGENE 
to DNA ration of 3:1. For stable transfection calcium phosphate co-precipitation was 
used (Graham 1973). Cells were plated on 10 cm dishes to be 50-80% confluent on the 
day of transfection. The medium was changed at least 2 hrs prior to transfection (9 
ml/plate). DNA solutions (0.1 µg - 5 µg) were prepared in 500 µl of 250 mM CaCl2, 
pipetted drop wise into 500 µl of 2xHBS (280 mM NaCl, 50 mM HEPES, 1.5 mM 
Na2HPO4/H2O, pH 7.1) while shaking vigorously. The mix was incubated for 20 min at 
RT and added drop wise to the cells while shaking the plates cautiously. The medium 
was exchanged 24 hrs later with fresh medium containing selection agents. 
 
II .5.3. Hormone-inducible mammalian expression system (GeneSwitch) 
The hormone-inducible mammalian expression system used in this study (GeneSwitch, 
Invitrogen) (Wang 1994)) is based on two plasmids. The pSwitch vector expresses a 
hybrid regulatory protein, the so called GeneSwitch protein, containing the yeast GAL4 
DNA binding domain (GAL4-DBD), a truncated human progesterone receptor ligand 
binding domain (hPR-LBD) and the p65 activation domain (p65-AD) from human NF-
κB under the control of a hybrid promoter consisting of yeast GAL4 upstream activating 
sequences (UAS) (Giniger 1985; Wang 1994) linked to a minimal promoter from the 
Herpes Simplex Virus thymidine kinase (TK) gene. The pGene/V5-His plasmid 
inducibly expressing the gene of interest, is controlled by a hybrid promoter consisting of 
yeast GAL4 upstream activating sequences linked to the TATA box sequence from the 
adenovirus major late E1b gene (Lillie 1989). 
In the absence of the synthetic progesterone antagonist Mifepristone, low basal 
transcription of the GeneSwitch gene from pSwitch occurs from the minimal TK 
promoter. Once translated, the GeneSwitch protein is predominantly localised in the 
nucleus in an inactive form. Upon addition, Mifepristone binds with high affinity to the 
truncated hPR-LBD (Vegeto 1992) and causes a conformational change of this domain 
resulting in dimerisation and activation of the GeneSwitch protein. The ligand-bound 
homodimer then interacts with the GAL4-UASs of both pGene/V5-His and pSwitch and 
activates transcription of both the gene of interest and the GeneSwitch gene, resulting in 
a positive feedback loop (Figure 7) (Marmorstein 1992; Wang 1994) (for vector maps 
see appendix V.2). 
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Figure 7 GeneSwitch system for inducible expression. The GeneSwitch hybrid regulatory protein is 
expressed constitutively at low level from the minimal thymidine kinase promoter. Upon binding of the 
synthetic steroid Mifepristone the GeneSwitch protein undergoes a conformational change resulting in 
dimerisation and activation. The ligand-bound homodimer then interacts with the GAL4-binding sites in 
the GAL4 UAS of both pGene/V5-His and pSwitch activating the transcription of both the gene of interest 
from the E1b TATA box and the regulatory fusion gene itself. (GAL4-UAS: yeast upstream activating 
sequences with binding sites for GAL4 transcription factor; E1bTATA: TATA box sequence from 
adenovirus major late E1b gene; PTk: herpes simplex virus thymidine kinase minimal promoter; GAL4-
DBD: yeast GAL4 DNA binding domain; hPR-LBD: truncated human progesterone receptor ligand 
binding domain; p65-AD: activation domain of human NFκB; GeneSwitch protein: GAL4-DBD/hPR-
LBD/p65-AD regulatory fusion protein; Mif: Mifepristone).  
 
I I.5.4. Generation of stable inducible cell lines  
Following transfection by calcium phosphate precipitation with single pGeneA-IRG 
constructs, cells were kept under selection (50µg/ml Hygromycin and 200 µg/ml Zeocin, 
both Cayla) on 10 cm culture dishes until larger clones were visible. Cells were 
trypsinised, counted in a Neubauer chamber and cloned by limiting dilution. Single 
clones were expanded and expression of the respective gene after 24 hrs induction with 
Mifepristone was determined by immunofluorescence and Western Blot. Clones with 
Mifepristone-induced IRG expression levels comparable to IFN-induced one and no 
detectable background expression were subcloned and used for further experiments.  
 
I I.5.5. Induction with IFNγ and Mifepristone 
Cells were supplemented with fresh medium containing the desired amount of inducer 
(200 U/ml recombinant murine IFNγ (Cell Concepts) and 10-7 to 10-10 M Mifepristone 
(Invitrogen)) and incubated for 24 hrs unless noted otherwise.  
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I I.5.6. Immunofluorescence 
Cells were grown on heat-sterilised cover slips, induced with IFNγ (Cell Concepts) or 
Mifepristone (Invitrogen) for 24 hrs, transfected or left untreated and fixed with PBS/3% 
(w/v) paraformaldehyde for 20 min at RT. Subsequently cells were washed four times 
with PBS, permeabilised with washing buffer (PBS/0,1% (w/v) Saponin) for 10 min at 
RT and blocked with PBS/0,1% (w/v) Saponin/3% (w/v) BSA (blocking buffer) for 1 hr 
at RT. Incubation with the primary antibodies diluted in blocking buffer was performed 
in a humid chamber for 1 hr at RT or over night (o.n.) at 4°C. Cover slips were washed 
with washing buffer (3x5 min) followed by incubation with the secondary antibodies and 
DAPI (0.5 µg/ml) diluted in blocking buffer for 30 min at RT. After washing 3x5 min 
with washing buffer, cover slips were mounted on slides with ProLong Gold antifade 
reagent (Invitrogen) and sealed with nail polish. Images were made on a Zeiss Axioplan 
II fluorescence microscope equipped with an AxioCam MRm camera (Zeiss) using the 
Metamorph (Universal Imaging Corporation) and Axiovision (v4; Zeiss) software. 
 
I I.5.7. Cell proliferation assay 
For analysis of proliferation 1000 cells/well were plated onto 96well plates and kept 
under induction with either IFNγ (200 U/ml) or Mifepristone (10-9 M) for the indicated 
length of time. Each day cell proliferation was evaluated using the CellTiter 96 AQueous 
non-radioactive cell proliferation assay (Promega) according to the manufacturer’s 
instructions. The absorption of the bioreduced form (formazan) of a substrate (MTS) 
generated by metabolically active cells during incubation at 37°C for 4 hrs was measured 
in an ELISA reader (Vmax, Molecular Devices) at 490 nm (Barltrop 1991; Cory 1991; 
Mosmann 1983). The quantity of formazan product is directly proportional to the number 
of living cells in the culture.  
 
I I.5.8. Cell cycle assay 
Single cell suspensions in PBS (1*106 cells/ml) were fixed with 70% (v/v) ethanol for 30 
min on ice. Cells harvested by centrifugation were resuspended in PBS and passed 
through a 25-gauge syringe needle. Cells were incubated with 100 µg/ml RNase A and 
40 µg/ml propidium iodide for 30 min at 37°C and analysed using a FACSCan flow 
cytometer and the CellQuest Pro 4.0.2 software (both BD Bioscience).  
 
I I .6. Methods: Analysis of cellular protein 
II.6.1. Generation of cell lysates for SDS-PAGE 
If not mentioned otherwise, cells were harvested by scraping in cold PBS (Cellscraper; 
Sarstedt), pelleted at 500 g and 4°C for 5 min and resuspended in PBS/1% Triton X-100 
(Sigma-Aldrich)/“Complete Mini Protease inhibitor Cocktail” (Roche) (200µl/3*105 
cells). Samples were incubated 30 min on ice and nuclei were pelleted for 30 min at 
23.000 g and 4°C. The supernatant was analysed directly in immunoblot while the pellet 
was boiled in protein loading buffer (50 mM Tris/HCl pH 6.8/0.7 % β-ME/1% SDS/5 % 
glycerol/0.0025 % (w/v) bromephenol blue) to detect aggregated protein. 
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I I.6.2. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
For the analysis of proteins, discontinuous one-dimensional gel electrophoresis (Laemmli 
1970) was carried out under denaturing conditions in the presence of 1% SDS on 7.5-
12% polyacrylamide gels (separating gel; stacking gel: 5%). The protein samples were 
boiled for 10 min in protein loading buffer (50 mM Tris/HCl pH 6.8/0.7 % β-ME/1% 
SDS/5 % glycerol/0.0025 % (w/v) bromephenol blue (Sigma-Aldrich)) prior to loading. 
Small gels were run for several hours at RT and large gels over night at 4°C in 
electrophoresis buffer (25 mM Tris/190 mM glycine/0.1 % SDS). Wide range protein 
standard marker (Sigma-Aldrich) was used for size determination of protein bands. 
 
I I.6.3. Western Blotting and Ponceau S staining 
After SDS-PAGE proteins were transferred to nitro-cellulose membranes (Protan 0.45 
µm, Schleicher & Schuell) by electro-blotting in transfer buffer (15 mM Tris/190 mM 
glycine) for 1 hr at RT and 0.5 A in a blotting chamber (Ideal Scientific Company). 
Ponceau S staining (0.1% Ponceau S (w/v) in 5% acetic acid) was used to locate proteins 
on the membrane after Western blotting. Membranes were blocked with PBS/5% skim 
milk powder/0.1% Tween 20 for 1 hr at RT, washed twice for 20 min with PBS/0.1% 
Tween 20 and incubated with the appropriate primary antibodies diluted in PBS/1% FCS 
(1.5 hrs at RT or o.n. at 4°C). After washing the blots 3x10 min with PBS/0.1% Tween 
20, they were incubated for 30 min at RT with the respective secondary HRP-coupled 
antisera and washed with PBS/0.3% Tween 20 (3x10 min). Bound primary antibodies 
were detected using HRP-coupled secondary reagents and visualised by 
chemiluminescence (100 mM Tris/HCl pH 8.5, 12.5 mM 3-aminophthalhydrazide, 200 
µM p-coumaric acid, 0.01% H2O2) using a Super RX film (Fujifilm). 
 
I I.6.4. Sequential Triton X-114 partitioning assay 
24 hrs after transient transfection with 2 µg pGW1H-IIGP and/ or induction with 
200U/ml IFNγ and/or 10-10 M Mifepristone, 3*105 gs3T3 cells/sample were harvested by 
scarping and lysed in 400 µl ice cold PBS/1% Triton X-114 (Sigma)/“CompleteMini 
protease inhibitor cocktail, EDTA free” (Roche) for 1 hr on ice. Lysates were centrifuged 
for 15 min at 3000 g and 4°C to remove nuclei. Supernatants were incubated for 5 min at 
RT to induce phase separation seen as cloudiness of the solution and centrifuged for 1 
min at 23.000 g at RT. The detergent phase was adjusted to the same volume as the 
aqueous phase with PBS and stored on ice. The aqueous phase was subjected to a 
subsequent round of partitioning by adding ice cold 10% Triton X-114 to a final 
concentration of 1% Triton X-114. The samples were incubated on ice until the solution 
became clear again and were then shifted to RT to induce phase separation. The samples 
were further treated as described above. In total four subsequent partitionings were 
performed. Equal volumes (40 µl) of all collected fractions were used for SDS-PAGE 
and immunoblot with 165 anti-Irga6 serum. 
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I I.6.5. Co-Immunoprecipitation  
IFNγ-induced (24 h, 200U/ml) and untreated gs3T3 cells were lysed in lysis buffer 
(PBS/0.1% Thesit (Sigma-Aldrich)/3 mM MgCl2/“CompleteMini protease inhibitor 
cocktail, EDTA free” (Roche)) either in absence of nucleotide or in presence of 0.5 mM 
GDP and 0.5 mM GTPγS respectively (both Sigma-Aldrich). Lysates were cleared by 
high-speed centrifugation (30 min, 23000 g, 4°C). The Irga6 specific 165 serum (Uthaiah 
2003) was coupled to protein A Sepharose CL-4B (GE Healthcare Life-Sciences) (14 µl 
antibody/50 µl dry beads). Beads were washed extensively and bound immunglobulins 
were crosslinked to the protein A Sepharose using 20 mM dimethyl pimelimidate (DMP) 
(Sigma-Aldrich) (Harlow 1988). Coupled beads were washed with PBS and lysis buffer 
and incubated with the cell lysates for 2 hrs at 4°C. Beads were washed twice with lysis 
buffer and twice with PBS/3 mM MgCl2. Bound proteins were eluted by incubation with 
100 mM Tris pH 8.5/0.5% SDS for 30 min at room temperature (RT). Residual beads 
were removed by centrifugation and filtration (filter tubes, pore size 0.45 µM; Millipore). 
Eluates were supplemented with SDS-PAGE protein loading buffer, boiled for 5 min and 
subjected to SDS PAGE. For the co-immunoprecipitation of Irgm3 with Irga6 one 
quarter of the eluate was used for detection with anti-Irga6 antibody 10D7 and three 
quarters were used for detection with the anti-IGTP (Irgm3) antibody clone 7. For the 
immunoprecipitation performed to detect ubiquitinated Irga6 equal amounts of 
precipitate were analysed by SDS-PAGE and detected with the anti-Irga6 antibody 10D7 
and the anti-ubiquitin antibody FK2 respectively. 
 
I I .6.6. Pull down 
Irga6 and Irga6(S83N) GST fusion proteins were expressed and harvested as described 
above (chapter II.4.1). Cleared bacterial lysates were incubated with glutathione 
Sepharose (High Performance, GE Healthcare Life-Sciences) for 2 hrs at 4°C. Beads 
were washed 10 times with PBS/2 mM DTT, pelleted by centrifugation (2 min, 2000 g) 
and resuspended in the same buffer. To control protein binding, beads were boiled in 
protein loading buffer and the supernatant was subjected to SDS-PAGE followed by 
Coomassie staining (de St. Groth 1963). The protein bound glutathione Sepharose was 
washed once with PBS/5 mM MgCl2/1 mM DTT and preincubated with or without 1 mM 
nucleotide (GDP, GTPγS or mGDP (both Sigma-Aldrich) or a combination of 100 µM 
GDP plus 300 µM GTPγS) or 10 mM EDTA in PBS/5 mM MgCl2/1 mM DTT buffer for 
1 h at RT. Beads were washed with lysis buffer (PBS/0.1% Thesit/3 mM 
MgCl2/“CompleteMini protease inhibitor cocktail, EDTA free”) containing 10 µM of the 
respective nucleotide. Gs3T3 cells were induced for 24 hrs with 200 U/ml IFNγ and 10-9 
M Mifepristone respectively, harvested and lysed in lysis buffer containing 0.5 mM of 
the respective nucleotides or 100 µM GDP plus 300 µM GTPγS or 10 mM EDTA for 1 
hr at 4°C. The lysates were cleared by centrifugation (23000 g 30 min 4°C), mixed with 
the nucleotide pre-treated protein-glutathione Sepharose and incubated at 4°C o.n. Beads 
were washed twice with lysis buffer and twice with PBS/3 mM MgCl2. Cellular proteins 
bound to the beads were eluted with 100 mM Tris pH 8.5/0.5% SDS for 30 min at RT, 
supplemented with protein loading buffer and boiled for 5 min. The samples were 
separated by SDS-PAGE and subjected to Western blot. Input of recombinant protein 
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was monitored by Ponceau S staining. Immunodetection of Irgm3 was performed with 
αIGTP monoclonal antibody (clone 7) over night at 4°C. 
 
I I.6.7. Coomassie staining  
For unspecific detection of all proteins, SDS-PAGE gels were stained with (0.1% (w/v) 
Coomassie Brilliant Blue R-250 (Serva)/40% (v/v) ethanol/10% (v/v) acetic acid (de St. 
Groth 1963) shaking 20 min at RT. Excess staining was removed by incubation in 40% 
(v/v) ethanol/10% (v/v acetic acid) at RT for 1 hr. Gels were washed o.n. with H2O and 
dried under vacuum pressure at 80°C for 2 hours. 
 
I I.6.8. Analytical size exclusion chromatography of cellular IRG GTPases 
Gs3T3 cells (1x106 cells/sample) were induced with 200 U/ml IFNγ of 10-9 M 
Mifepristone respectively for 24 hrs and lysed for 1 hr at 4°C in 500 µl PBS/0.1% 
Thesit/”CompleteMini protease inhibitor cocktail, EDTA free” (Roche). Postnuclear 
supernatants cleared by ultracentrifugation (45000 g, 30 min, 4°C) were separated on a 
Superose 6 HR 10/30 size exclusion column (Amersham Bioscience) in PBS/0.1% Thesit 
with a flow rate of 0.2 ml/min on an ÄKTA fast protein liquid chromatography (FPLC) 
(monitor UPC-900, pump P-920, fraction collector Frac-950, valves INV-907; 
Amersham Bioscience) using the Unicorn 5.01 software. The column was calibrated with 
carbonic anhydrase (29 kDa), bovine serum albumin (BSA; 66 kDa), alcoholic 
dehydrogenease (150 kDa), β-amylase (200 kDa). 0.2 ml fractions were collected and 
analysed for their IRG protein content in SDS-PAGE followed by immunoblot with 
specific immunoreagents. Thesit was used for cell lysis, as the low UV absorption of this 
non-ionic detergent did not interfere with the monitoring of protein elution during 
chromatography at 280 nm.  
 
I I .7. Methods: Infection assays 
II.7.1. In vitro passage of Toxoplasma gondii 
Tachyzoites from T. gondii strains ME49 and RH-YFP (Gubbels 2003) were maintained 
by serial passage in confluent monolayers of human foreskin fibroblasts (Hs27, ATCC 
number CRL-1634) cultured in 25 cm2 flasks with IMDM/5% FCS/2 mM L-glutamine. 
Following inoculation of fibroblasts with 2x106 and 0.5x106 parasites respectively, 
parasites actively invade the host cells, replicate intracellularly and egress from their host 
cells approximately 3 days later. Extracellular parasites were harvested from the 
supernatant and purified from host cell debris by differential centrifugation (5 min at 100 
g, 15 min at 500 g). Parasites were resuspended in medium, counted using a Neubauer 
chamber and immediately used for inoculation of host cells. RH-YFP parasites were 
propagated in presence of Chloramphenicol (3.2 µg/ml, Sigma-Aldrich) to counter select 
for loss of the stable integrated YFP expression plasmid containing a Chloramphenicol 
acetyltransferase selectable marker (Gubbels 2003). 
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I I.7.2. Infection of murine cells with Toxoplasma gondii  
Murine fibroblasts seeded onto cover slips were stimulated with 200 U/ml IFNγ (Cell 
Concepts) and/or 10-9 M Mifepristone (Invitrogen) and/or transfected with the indicated 
expression constructs using FuGENE6 reagent (Roche) for 24 hrs or were left untreated. 
The cells were then inoculated with T. gondii ME49 or RH-YFP tachyzoites for 2 hrs at 
37°C at a multiplicity of infection (MOI) of 4 to 6. Infection was synchronised by 
centrifugation. Extracellular parasites were removed by washing 3x with medium and 
once with PBS. The infected cells were fixed for 20 min with PBS/3% paraformaldehyde 
at RT and processed further for immunofluorescence staining as described above. 
Parasites were visualised either by T. gondii specific immunoreagents (see above, Table 
6) or by detection of YFP fluorescence (RH-YFP). Intracellular parasites were either 
identified in phase contrast or by immunostaining for the T. gondii dense granule protein 
GRA7, a 29 kDa-predicted transmembrane protein that is released into the 
parasitophorous vacuole by intracellular parasites shortly after invasion and associates 
with the PV membrane (Bonhomme 1998; Fischer 1998). 
 
I I.7.3. Quantification of IRG signals on T. gondii parasitophorous vacuoles 
The intensities of IRG specific signals on T. gondii parasitophorous vacuoles were 
quantified using the ImageJ software (Wayne Rasband, NIH). Two to three intensity 
profiles orthogonal to each other were generated per vacuole followed by subtraction of 
the background fluorescence and averaging of the 4 (6) peak values obtained for each 
vacuole. The average pixel intensity of each vacuole was plotted for each IRG protein in 
a scatter plot using Excel (Microsoft).  
 
I I .8. Methods: Yeast 2 Hybrid 
II.8.1. Lithium acetate transformation of Saccharomyces cerevisiae 
Fresh yeast colonies (strain PJ69-4a-a or -α) were washed once with 100 mM LiAc. The 
pellet was resuspended in 100 mM LiAc/33% (w/v) polyethylenglycol 3350 (Sigma-
Aldrich)/25 µg calf thymus DNA (Sigma-Aldrich)/1 µg of pGAD/BD expression 
construct), incubated 30 min at 37°C and heat shocked for 20 min at 42°C. The lithium 
acetate transformed yeast cells (Gietz 1995) were pelleted and plated on selection 
medium (SD lacking leucine (SD-L) and tryptophan (SD-T) respectively). After 2-3 days 
incubation at 30°C colonies were picked and replated on SD-L or –T. Transformed 
strains were frozen in 15% glycerol at –80°C for storage.  
 
I I.8.2. Analysis of protein interaction by yeast two-hybrid (Y2H) 
The complete coding regions of the IRG proteins studied were expressed constitutively at 
low level as N-terminal fusions with the Gal4 DNA-binding (BD) and Gal4 activation 
domain (AD) in haploid yeast reporter strains of opposite mating types (PJ69-4a-α and 
PJ69-4a-a) using tryptophan and leucine selection respectively (SD-T, SD-L) (James 
1996) (Figure 8). PJ69-4a-a-pGAD-IRG and PJ69-4a-α-pGBD-IRG yeast cells were 
mated with each other on YPD plates and selected for diploid cells on SD-L-T medium. 
Single colonies were assayed for protein-protein interaction driving expression of the 
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pyrophosphate-aminoimidazole carboxylase and the imidazoleglycerolphosphate 
dehydratase reporter genes involved in adenine and histidine biosynthesis (Stotz 1993), 
respectively, by growth on SD-L-T also lacking adenine and/or histidine. 1 mM 3-amino-
1,2,4-triazole (Sigma-Aldrich) was used to inhibit autoactivation of the HIS3 reporter 
(Durfee 1993). At least two independent crossings were performed for each interaction. 
 
Figure 8 Classical yeast-two hybrid assays using yeast mating. Classical yeast-two hybrid assays using 
yeast mating. Constructs encoding putative interacting proteins (X and Y) fused to the DNA-binding (BD) 
and transcription activation (AD) domains, respectively, are transformed separately into yeast strains of 
opposite mating type (a and α). After mating, both constructs are present in the same yeast cell and, if 
proteins X and Y interact, reporter gene activity is detected (modified from (Causier 2002)). 
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III. Results 
III.1. Genomic organisation, synteny and phylogenetic relationship 
of IRG GTPases  
At the beginning of this study only six IRG genes from mouse, namely Irgd (IRG-47) 
(Gilly 1992), Irgm1 (LRG-47) (Sorace 1995), Irgb6 (TGTP/Mg21) (Carlow 1995; 
Carlow 1998; Lafuse 1995), Irgm3 (IGTP) (Taylor 1996; Taylor 1997), Irga6 (IIGP) and 
Irgm2 (GTPI) (Boehm 1998), were published but evidence for the presence of additional 
family members was accumulating from analyses of genomic bacterial artificial 
chromosome (BAC) clones and expressed sequence tags (ESTs) available in the public 
databases (identification of several Irga6-like genes, (Parvanova 2005)). Upon 
completion of the mouse genome project , a thorough analysis of all p47 GTPase genes 
in C57BL/6 strain was feasible. Hence, BLAST (Basic Local Alignment Search Tool; 
(Altschul 1990; Altschul 1997)) and SSAHA (Sequence Search and Alignment by 
Hashing Algorithm; (Ning 2001)) searches with the known IRG genes were performed. 
The relevant parts of the genome containing homologues were extracted and analysed 
further for gene order, orientation and homology to the published IRGs using DNA 
Strider v1.3 (Marck 1988). Where ambiguities persisted in the mouse genomic map, 
especially on chromosome 18 in the region of Irga6-Irga8 (Mb 60.878-60.958) and on 
chromosome 11 in the region from PA28βψ to Irgb7ψ (Mb 57.570-57.700), primary 
BAC and cosmid sequences were used to reach a consensus view (positions refer to the 
Ensembl mouse genome release v28.33d.1, February 2005 ). Additionally, transcript 
sequences, preferentially from C57BL/6 strain, were compared with the genomic 
sequences available via Ensembl. Subsequently the search for and analysis of IRG 
homologues was extended to other species in order to shed light onto the phylogenetic 
relationship, age and evolutionary history of this family of large GTPases. 
 
I II.1.1. Nomenclature 
Altogether over 180 novel p47 GTPases from 33 different species were identified during 
this study (summarised in Table 7). The protein sequences of all the genes are listed in 
the appendix (chapter V.13). To assure a consistent naming of new family members, a 
general nomenclature based on phylogenetic principles using the stem IRG (immunity-
related GTPase) was introduced. This terminology not only allows the priority in 
nomenclature to IRG-47 as the first IRG gene identified (Gilly 1992). It also intentionally 
does not refer to IFN-inducibility since the highly conserved IRGC genes of mammals 
are clearly related phylogenetically to the IFN-inducible immunity genes but are 
definitely not IFN-inducible (see below). The stem IRG is followed by a single-letter 
suffix each identifying an individual deep monophyletic clade in the phylogenetic trees 
of IRGs (e.g. IRGM or IRGA, see Figure 14 and Figure 13). Individual genes in one 
clade are distinguished by consecutive numbering (e.g. Irga6). To date nine IRG suffixes 
based on the phylogenetic analyses were defined (A-H and Q) (Figure 14, Figure 22). It 
has to be noted that some of the suffix defining clades are less deep than others in a broad 
phylogenetic comparison, especially in case of IRGA, IRGB and IRGD (Figure 22). Still 
these clades are very well defined in the mammals, thus justifying the distinction (Figure 
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14, Figure 18). The analysis of more fish sequences is essential to clarify whether the 
distinction between IRGG and IRGE genes is justified or if those genes rather belong to 
one joint clade (Figure 22).  
Table 7 IRG GTPases in the animal kingdom. List of all the IRG genes identified in the public databases 
during this study. The number of genes belonging to certain IRG clades is given in brackets for the GKS 
genes. Conservative substitutions present in the G1 motif of two GMS GTPases are specified in brackets. 
Some of the listed genes are represented only by fragments due to the premature state of many of the 
databases used (for references of the used databases see main text and material and methods section; for 
sequences see appendix V.13). Note that there are 12 IRGB sequences in the mouse genome, that represent 
8 genes four of which are tandem genes with two IRG sequences as coding exons. The GMS genes of the 
higher primates (*) are considerably shorter than all other IRG genes and shorter than H-Ras-1 terminating 
shortly before the G5 motif. Grey highlighting marks genes with a single intron situated between the G4 
and G5 motif.  
As the nomenclature of IRG genes is based on their phylogenetic relationship, an 
adequate naming of newly identified sequences requires a thorough phylogenetic 
analysis. Novel genes were provisionally named applying the following principles: 
Firstly each gene name starts with a two-letter prefix for the species of origin (e.g. RN 
for Rattus norvegicus, see appendix V.4 for details); secondly the name of the IRG 
subfamily the respective sequence belongs to (GKS or GMS, see below) was added; 
thirdly the genes were numbered in order of discovery (e.g. LA_GMS1 for the first 
elephant (Loxodonta africana) GMS sequence identified). In order to avoid repeated 
renaming, the provisional names were given up in favour of the general nomenclature 
only upon complete and unambiguous phylogenetic characterisation. The IRG 
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nomenclature using different forms for mouse (Irg), human (IRG), dog (IRG) and 
zebrafish (irg) (see below) has been accepted by the gene nomenclature committees of 
human and mouse, and by the zebrafish sequencing project. As is customary, the same 
nomenclature rules were used for mice and rat (Irg) 
(http://www.informatics.jax.org/mgihome/nomen/gene.shtml). For all other mammals the 
capitalised form (IRG) was used. The principles of zebrafish gene nomenclature were 
applied to all fish, amphibian and reptile sequences as suggested by others 
(http://genome.jgi-psf.org/Xentr4/docs/Xenopus_gene_naming.pdf). 
The nomenclature of the 'quasi IRG' proteins (IRGQ) departs from the 
phylogenetic principle. The original IRGQ nomenclature published in Bekpen et al. 2005 
(Bekpen 2005b) grouped all IRG homologous sequences that are devoid of GTPase 
function due to modifications in the GTP-binding site together, though they clearly 
represent a polyphyletic group. However, further analysis revealed that the mammalian 
genes highly conserved with the radically modified murine Irgq (also known as 
FKSG27) form a monophyletic group distant from the other IRG clades (Figure 20). It 
was decided to keep the Irgq nomenclature for these genes. Other mammalian IRG genes 
with disrupted GTPase motifs possess otherwise conserved clade specific features 
(Figure 18-19). Therefore, it was decided to allocate them to the respective clade adding 
the suffix “q” to the name (e.g. EE_ GKS2/IRGBQ1) thereby departing from the original 
principles (Bekpen 2005b) to accommodate more information about the phylogenetic 
origin of the respective sequence. As it is rather difficult to predict whether a distinct 
substitution in the nucleotide-binding site renders a GTPases non-functional, only a clear 
disruption of the universally conserved G1 motif/P-loop was considered sufficient to 
qualify an IRG member for the suffix “q”. The GMS GTPases are excluded from this 
rule despite the unusual methionine in the G1 motif since they have been shown to be 
functional in vivo (Collazo 2001; Taylor 2000; Taylor 1997). All IRG sequences with 
non-canonical substitutions in the G1, G2 and G3 motifs are listed in Table 8. At least 
some of the IRGs with modified G3 or G4 motifs only will surely also prove to lack 
GTPase function upon experimental analysis. The quasi IRGs, which are neither 
orthologous to murine Irgq nor can be assigned to a defined phylogenetic clade of IRG 
genes, will be preliminary named IRGXQ (e.g. DR_irgxq1, formally termed irgq1). The 
entire IRGQ nomenclature should be considered provisional. 
 
II I.1.2. IRG genes of the C57BL/6 mouse 
The C57BL/6 mouse (Mus musculus domesticus) possesses 26 p47 GTPase (IRG) 
related sequences, including the six previously described members of the family (Boehm 
1998), localised in four clusters on chromosomes 7 (band A2), chromosome 11 (bands 
B1.2 and B2) and chromosome 18 (band D2) (mouse genome release v28.33d.1, 
February 2005 ) (Figure 9, Figure 10). Twenty-five of the sequences contain all the 
features typical for the IRG family while one sequence is more distantly related and 
contains drastic alterations in the GTPase domain (Irgq, see below, Table 8). The 26 
sequences represent 21 genes, as four of the IRG coding units on chromosome 11 are 
apparently only transcribed in tandem with a second coding unit, thus giving rise to a 
protein twice the size of a typical immunity-related GTPase (see below). Chromosome 7 
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contains two IRG genes in close proximity, termed Irgc or CINEMA and Irgq (also 
known as FKSG27) (Figure 9, Figure 15), while chromosome 18 contains 8 closely 
related genes in a stretch of 220 Mb, (Figure 9, Figure 10). Chromosome 11 carries 16 
IRG-related sequences in two clusters of 230 and 32 Mb separated by 65 Mb (Figure 9, 
Figure 10).  
Figure 9 Chromosomal location of the IRG GTPase in Mus musculus domesticus. Disposition of the 
IRG sequences on the mouse karyotype (mouse genome Ensembl release v28.33d.1, February 2005). 
Individual IRG genes are listed in correct gene order in each cluster. In the most recent Ensembl database 
version, the cluster on chromosome 7 lies in band A3 (v43.36d, Feb. 2007). The location of the other 
sequences is unaltered. 
The protein sequences encoded by the identified IRG genes were aligned based 
on the crystal structures of Irga6 (IIGP) (Ghosh 2004) using ClustalW ((Higgins 1994), 
http://www.ebi.ac.uk/Tools/clustalw) (Figure 11). The G-domains were further aligned 
on the structure of H-Ras-1 (Pai 1990; Wittinghofer 1991). As in Irga6, Irgb6 and Irgd 
(Boehm 1998; Ghosh 2004), four classical GTPase motifs (Bourne 1991) are conserved 
in most newly identified murine IRG proteins: the P-loop or G1 motif (Gx4GKS/T), the 
G3 motif (DxxG), the G4 motif (N/T/SxxD), and the G5 motif (SAK/L in small 
GTPases, most commonly SNF in the IRGs). The IRG proteins are typically 400-450 
amino acids in length. In contrast, the murine ‘quasi’ IRG protein Irgq is extended 
amino-terminally relative to other IRG GTPases by about 180 residues encoded on a 
single exon preceded by two untranslated upstream exons. The remaining 407 residues, 
encoded on a single long exon, are clearly homologous to and collinear with the other 
IRG proteins (Figure 13, see also (Bekpen 2005b)), especially in the amino- and 
carboxyl-terminal parts of the main exon. The region of lowest similarity is in the G-
domain, and conserved GTP-binding motifs are lacking (Table 8, Figure 13, Figure 14; 
see also DNA matrix Irgq vs. Irgc in (Bekpen 2005b)). Thus, Irgq is not a GTPase 
despite its phylogenetic relationship to the other IRG proteins. Irgq is closely linked to 
Irgc in mouse, humans, chimpanzee, rat and dog and probably also in other mammals 
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(Figure 15-17). As the IRGQ genes diverge so much from the classical IRG genes and 
form an isolated, conserved group in the phylogenetic analysis (Figure 20), it can be 
questioned whether they truly belong to the family of IRG GTPases. Contrariwise, IRGQ 
genes clearly carry sequence features that are characteristic for the IRG family, especially 
outside of the GTPase domain where IRGs are most divergent from other GTPases 
(Figure 13, Figure 14). Furthermore, IRGQ genes are easily recovered from public 
databases by classical TBLASTN searches with the sequences of classical IRG family 
members. The expectation values for the resulting alignments are low, indicating 
significance (e.g. 1.1-36 for the alignment of mouse Irgc with mouse Irgq). The 
expectation values for pairwise alignments of divergent members of the classical IRG 
proteins are comparable (e.g. 7.5-41 for Irgc with Irgm1) though the values are 
significantly lower for more closely related family members (already 1.9-85 for Irgc with 
Irgd). Members of other GTPase families do not constitute significant hits in these 
BLAST searches. Together with the close spatial linkage to IRGC genes, this argues for 
the IRGQ genes as legitimate, though distantly related, members of the IRG family. 
Nevertheless, on grounds of the profound differences to the classical IRGs, it is unlikely 
that IRGQ proteins are functionally related to the other IRG proteins. 
 
Figure 10 Genomic positioning of mouse IRG GTPases (Mus musculus domesticus). Positioning and 
orientation of the murine IRG genes in the chromosome 11 and 18 clusters. Positions of genes refer to the 
location in mouse genome release v28.33d.1 (February 2005)  of the first G of the second glycine codon of 
the G1 motif (Gx4GKS or GMS) of each gene. The segments of the chromosome 11 cluster indicated with 
square brackets are regions of uncertain structure. Gene orientation is given by black arrows. The shaded 
region of the chromosome 11 maps might represent a duplication introduced in the Ensemble mouse 
genome in an attempt to resolve a region of high ambiguity indicated by the longer square bracket. Though 
BAC sequence analysis indicated a misalignment of genomic sequences, the existence of independent 
transcripts reflecting the two distinct copies of Irgb6 suggests a recent genomic duplication with little time 
to diverge by genetic drift. The independent existence of the two sibling sequences Irgb3 and Irgb4 is 
proved by the proximity of the PA28βΨ retropositioned pseudogene to Irgb3 but not to Irgb4, in addition 
to consistent sequence differences. (*) Indicates recently duplicated genes with not or only minor sequence 
differences to their sibling genes.  
*
In Irgm1, Irgm2 and Irgm3, the otherwise universally conserved Gx4GKS/T 
sequence in the P loop is replaced by Gx4GMS (Figure 11). This striking difference 
correlates with other sequence features to define the GMS subgroup of the IRG GTPases, 
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which form a distinct clade in the phylogenetic analysis of both nucleotide and amino 
acid sequences (Figure 11, Figure 12; (Boehm 1998)). From alignment of Irga6, Irgb6, 
Irgd, Irgm1, Irgm2 and Irgm3 alone it was not predictable which of the (partially) 
conserved threonines corresponding to positions 102, 107 or 108 in the switch I region of 
Irga6 functions as G2 motif (Ghosh 2004). The alignment in Figure 11 reveals that only 
Thr108 is conserved in all murine IRG proteins. Furthermore, the threonine residue at 
this position is highly conserved in IRG proteins throughout the euchordates (Figure 13, 
Figure 19, Figure 23) making it a good candidate as potential equivalent of the G2 motif 
Thr35 in H-Ras (Wittinghofer 1991). However, in the GppNHp-bound crystal structure 
of Irga6 neither Thr102 nor Thr108 are involved in Mg2+- or γ-phosphate coordination 
(Ghosh 2004). IRG specific sequence features that are absent from H-Ras are apparent 
over the complete length of the proteins, though the N- and C-terminal parts are clearly 
more divergent than the GTPase domain (Figure 11). For eleven members of the IRGA 
and IRGB group a potential myristoylation motif was identified at the N-terminus (Table 
9; MGQLFSS in Irga6, for consensus sequence see figure legend). 
 
Table 8 IRG GTPases with modified GTPase motifs. List of all IRG proteins with non-canonical 
substitutions in one or more of the GTPase motifs. Only the altered motifs are given. Consensus residues 
are printed in bold. X: irrelevant residues. As MM_Irga5Ψ and MM_Irgb7Ψ terminate before the G1 motif 
due to premature stop codons they are not considered to be ‘quasi’ IRGs but pseudogenes.  
All the IRGs on chromosome 18 show closest sequence homology to Irga6 (IIGP) 
and cluster together in phylogenetic analysis (Figure 11, Figure 12). The members of this 
subfamily (IRGA) were subsequently termed Irga1 to -a8 (Figure 10). The two clusters 
of IRG genes on chromosome 11 include Irgd (IRG-47) and the 3 GMS GTPases Irgm1 
(LRG-47), Irgm2 (GTPI) and Irgm3 (IGTP) (Figure 10, Figure 11, Figure 12). The 
remaining 12 IRG sequences belong to the IRGB group and are most similar to Irgb6 
(TGTP) (Figure 12). Three of these sequences, Irgb4, Irgb5 and Irgb6, seem to have 
been duplicated in conjunction giving rise to a second, closely related block of three 
IRGB sequences: Irgb3 differing by only 11 nucleotides (resulting in six amino acid 
exchanges) from Irgb4, a second identical copy of Irgb5 (Irgb5*) and Irgb6*, which 
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differs from Irgb6 by four nucleotides but is unaltered at the amino acid level (square 
brackets in Figure 10) (see appendix V.6 and V.7). As these two regions are also highly 
similar in the intragenic space, two explanations are conceivable for their origin. This 
stretch of DNA might either represent a misalignment of sequences during the assembly 
of the mouse genome in a region of high ambiguity and therefore an artificial duplication 
in silico or a very recent genomic duplication with little time to diverge. BAC sequence 
analysis made the first hypothesis favourable, especially as the region is rich in repetitive 
elements and contains a large number of closely homologous IRG genes. In earlier 
versions of the mouse genome assembly, this region and the area of chromosome 18 
carrying the IRGA genes were subjected to extended changes and rearrangements, 
frequently leading to the loss or duplication of one or the other IRG gene from the 
database for months. The independent existence of Irgb3 and Irgb4, however, is proved 
by the proximity of the PA28βΨ retropositioned pseudogene to Irgb3 but not to Irgb4, in 
addition to consistent sequence differences (Figure 10, appendix V.7). Furthermore, 
recent detailed analysis of novel ESTs and cDNA sequences available in the public 
databases confirms the existence of the two independent versions of Irgb6 
distinguishable by 4 non-coding substitutions in the ORF and a few additional exchanges 
in the untranslated regions (UTRs) (Irga6* (AK163978, BE632518), Irga6 (L38444); 
Table 10, appendix V.6). Taken together, this supports the presence of both sequence 
blocks in the mouse genome.  
Our understanding of the situation will grow as new versions of the mouse 
genome, transcript databases and detailed experimental data become available as nicely 
exemplified by the history of Irgb10. This gene was thought to be truncated at the C-
terminus due to a premature stop codon right after the G5 motif based on the version of 
the Ensembl mouse genome release used for analysis (v28.33d.1, February 2005), despite 
its IFNγ-inducibility in murine fibroblasts (Bekpen 2005a; Bekpen 2005b). However, 
Frank Kaiser identified full length Irgb10 (“cIGP_9”, XM_137576) as an interaction 
partner of Irga6 (IIGP) in a yeast two hybrid screen (Kaiser 2005). Furthermore 
Bernstein-Hanley and colleagues revealed that Irgb10 is an intact gene functional in 
resistance against Chlamydia trachomatis (Bernstein-Hanley 2006). Recently, Irgb10 
was also implicated in resistance to Chlamydia psittaci (Miyairi 2007). In the latest 
version of the mouse genome, Irgb10 is represented as an intact gene on chromosome 11 
at bp 58,004,193 (first base of the glycine codon of the G1 motif; mouse genome 
Ensembl release v43.36d, Feb 2007). 
Figure 11 Amino acid alignment of the mouse IRG GTPases (see next pages). Amino acid sequences of 
23 mouse IRG sequences showing the close homology extending to the carboxyl-terminus, aligned on the 
known secondary structure of Irga6 (indicated in blue above sequence alignment). The sequences of 
notional products of the two pseudogenes Irga5 and Irgb7 have been partially reconstructed; premature 
terminations are indicated by red highlighting. In the C57BL/6 mouse the sequence of the Irga8 gene is 
damaged by an adenine insertion, indicated by the red highlighted N at position 204. The sequence given 
after this point is derived by correcting the frame shift. Irga8 from Mus musculus musculus (CZECHII) 
lacks the extra adenine (BC023105). The turquoise-highlighted M in Irgm1 and Irgm2 are initiation codons 
that are dependent on alternative splicing; the unusual methionine residues in the G1 motif of GMS 
proteins are highlighted in green. The blue background Q residue of Irgb5, Irgb2 and Irgb8 indicate the 
point where tandem splicing occurs to Irgb4/b3, Irgb1 and Irgb9, respectively. Canonical GTPase motifs 
are indicated by red boxes. Note that the C-terminal part of Irgb10 is missing due to a premature stop 
codon in previous versions of the Ensembl mouse genome (v28.33d, Feb 2005) (see main text below; for 
alignment of the full length Irgb10 protein see Figure 13). (The figure was kindly provided by Cemalettin 
Bekpen and modified slightly; (Bekpen 2005b)) 
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The open reading frame of an IRG gene is typically encoded on a single long 3' 
exon behind one or more 5'-untranslated exons with the exception of Irgq (see above) 
and of alternative splice forms of Irgm1 and Irgm2 where the initial methionine is 
encoded on the penultimate exon (Bekpen 2005b). Furthermore, four of the closely 
related IRGB sequences on chromosome 11 (Irgb1, Irgb3, Irgb4 and Irgb8) apparently 
occur only as tandem transcripts in-frame with the respective closely linked upstream 
IRGB sequences (Irgb2, Irgb5*, Irgb5 and Irgb9) (for accession numbers see appendix 
V.5). To date, neither dedicated 5'-untranslated exons nor putative promoters containing 
IFN-inducible elements could be identified for Irgb1, Irgb3, Irgb4 and Irgb8. 
Furthermore, no independent transcripts were detected for these downstream tandem 
domains. Therefore, the downstream parts of the tandems are strictly speaking not genes 
but exons of genes twice the size of typical IRG GTPases. Three of the tandems are 
supported by ESTs in the databases (Irgb2-b1, Irgb5-b4, Irgb9-b8; for accession 
numbers see appendix V.5), though further information is needed to define the 5’ prime 
region of the Irgb9-Irgb8 transcript (AK144287, AK165747, and Li unpublished data). 
The donor and acceptor sites mediating the splicing from the upstream IRGB unit into the 
downstream one are conserved between the three distinct tandems and in different mouse 
subspecies (C57Bl/6 (Mus musculus musculus), Jyg (unidentified Chinese subspecies, 
(Imai 1994)), CZECHII (Mus musculus domesticus) (appendix V.5). The fourth tandem, 
Irgb5*-Irgb3, was postulated in analogy to the other tandem pairs. Indeed, the 60 
nucleotides upstream of the start codon of Irgb3 including the splice acceptor site are 
conserved with the other downstream units of the tandem genes (Figure 13, appendix 
V.13). To date, no ESTs could be identified in the databases representing the Irgb5*-
Irgb3 tandem, but recent experimental analysis confirmed the presence of all four tandem 
transcripts in IFNγ-induced mouse embryonic fibroblasts (Li, unpublished data). 
Furthermore, the upstream tandem elements were detected as independent transcripts, 
indicating that two alternative splice variants exist for the tandem genes – a tandem 
version and a normal sized one. Hence, chromosome 11 contains 12 IRG genes, four 
tandem genes and eight classical, single exon genes. Since the majority of IRG GTPases 
is encoded on one long exon and for simplicity reasons, the individual exons of the 
tandem genes will nevertheless be treated as single units for the phylogenetic analysis.  
Of all CB57BL/6 mouse IRGs, only Irga5 and Irgb7 are unambiguously pseudo-
genes due to premature stop codons before the first GTP-binding motif (Figure 11). The 
remaining 21 classical IRG genes are intact across the GTP-binding domain, although 
Irga1 and Irga8 are carboxyl-terminally truncated relative to the majority, and no 
transcripts of Irga7 have yet been found. In silico analysis revealed that most mouse p47 
GTPases, except for Irgc (CINEMA), Irga7 and those genes transcribed only as the 3’ 
half of a tandem, contain IFN-inducible elements (GAS and ISRE) in their putative 
promoters, and 14 have been shown experimentally to be IFN-inducible (namely Irga2, -
a3, -a4, -a6, -a8, Irgb1, -b2, -b5, -b6, -b10, Irgd, Irgm1, -m2 and -m3) (Bekpen 2005a; 
Bekpen 2005b; Boehm 1998; Gilly 1996). The proximal promoter region of Irgc, which 
was neither infection- nor IFN-induced, is devoid of ISRE or GAS elements but contains 
putative Sox5, Sox17 and NF-Y transcription factor binding sites (Sox: Sry-type high-
mobility-group domain box; (Bekpen 2005b; Rhode 2007)). Sox5 and Sox17 are 
expressed in haploid spermatids but are not testis specific (Wegner 1999) while NF-Y is 
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a universal transcription factor (Mantovani 1999). Irgc is expressed exclusively and 
constitutively in the testis (Bekpen 2005b; Rhode 2007). While their IFN-inducibility 
suggests a function related to immunity for most of the IRG GTPases, the developmental 
regulation paralleling sexual maturity and the expression limited to haploid spermatids 
implicate Irgc in sperm development (Rhode 2007). However, no infertility or other 
phenotype has yet been detected in Irgc-deficient mice (Rhode 2007).  
Figure 12 Phylogenetic relationship of mouse IRG GTPases. (A) Unrooted phylogenetic tree (p-
distance based on neighbour-joining method) of nucleotide sequences of the G-domains of 23 mouse IRG 
GTPases, including the two presumed pseudo-genes Irga5 and Irgb7. The amino acid sequences of all IRG 
sequences are given in the appendix V.13. (B) Phylogenetic tree of the amino acid sequences of the G-
domains of 21 mouse IRG GTPases rooted on the G-domain of H-Ras-1 (accession number: P01112). The 
products of the two presumed pseudo-genes Irga5 and Irgb7 are excluded from the analysis. (The figure 
was kindly provided by Cemalettin Bekpen and modified slightly (Bekpen 2005b)) 
Chromosome 11 contains the most divergent IRG sequences (Figure 10, Figure 
11, Figure 12), including all three GMS (IRGM) GTPases as well as Irgd and the IRGB 
genes (Boehm 1998), suggesting that this cluster is relatively ancient. In contrast, the 
eight IRGA genes on chromosome 18 cluster phylogenetically, suggesting more recent 
divergence, probably from a translocated member of the IRGB cluster on chromosome 
11. The isolated IRG gene on chromosome 7, Irgc, is an ancient root with no obvious 
systematic relationship to the other subfamilies. Within the chromosomal clusters, more 
recent duplication events are apparent (see also above). The downstream elements of the 
tandem genes, Irgb1, Irgb3, Irgb4, and Irgb8, cluster phylogenetically and appear to 
have been duplicated in tandem with the likewise clustered upstream units, Irgb2, 
Irgb5*, Irgb5 and Irgb9, respectively (Figure 10, Figure 12). The pattern of divergence 
in the mouse IRG tree suggests an old gene family that has undergone a succession of 
duplication-divergence cycles over time, a pattern of evolution that is still ongoing in 
several of the subfamilies. 
A systematic study of polymorphism has not yet been completed but it is already 
clear that nearly all IRG sequences derived from the CZECHII cDNA libraries (Mus 
musculus musculus) differ from C57BL/6 sequences. These differences make allocation 
of many CZECHII sequences to individual clade members of the C57BL/6 mouse 
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problematic. A thorough analysis of the IRG gene content of the south-eastern Asian 
mouse (Mus musculus castaneus) is currently under way (Li unpublished data). 
Homology searches revealed that the rat (Rattus norvegicus) genome contains a 
comparable complex set of IRG genes, whereas the representation of the IRG family is 
radically different in human.  
 
I II.1.3. Human IRG genes and their synteny relationship to mouse IRGs 
Only three IRG sequences, all transcribed, are present in human, two (IRGC and 
IRGQ) on chromosome 19 (19q13.31) and one (IRGM) on chromosome 5 (5q33.1). 
Human IRGC is more than 85% identical at the nucleotide level and 90% at the amino 
acid level to the isolated mouse gene Irgc on chromosome 7 (Figure 13). Human IRGQ is 
over 80% identical to mouse Irgq on the amino acid level and is likewise radically 
modified in all GTPase motifs but contains an insertion absent from the mouse protein 
(Table 6, Figure 13. appendix V.9). IRGM encodes an amino- and carboxyl-terminally 
truncated G-domain homologous to the IRGM (GMS) subfamily of mouse p47 GTPases 
(Figure 13, Figure 14). Human IRGM protein is 183 amino acids in length, as opposed to 
around 400 residues for the mouse IRGM proteins, and is 54%, 53% and 51% identical 
to mouse Irgm1, Irgm2 and Irgm3, respectively. Hence, human IRGM is not significantly 
closer related to Irgm1 in sequence than to the other two mouse GMS proteins, though 
this has occasionally been implied in the literature (Deretic 2006; Miyairi 2007; Singh 
2006). Phylogenetic analysis confirmed that human IRGM is equally distant to all three 
mouse GMS proteins (Figure 14, Figure 21).  
The mouse and human IRGC and IRGQ genes sit in chromosomal regions 
syntenic between chromosomes 7 and 19, respectively (Figure 15 A) and are clearly 
orthologous. The proximal promoter region of human IRGC is largely conserved with 
that of mouse Irgc and contains the same transcription factor binding sites (Sox5, Sox17 
and NF-Y) (Rhode 2007). As in the mouse, no interferon response elements are found 
either in the proximal conserved region or in divergent regions up to 10 kb upstream of 
the transcriptional start (Bekpen 2005b; Rhode 2007). Human IRGC, like mouse Irgc, is 
not inducible in vitro by interferons and is strongly expressed exclusively in adult testis 
(Bekpen 2005b; Rhode 2007). The human genomic segments syntenic to the IRG gene 
containing regions on mouse chromosome 11 and 18 both mapped to human 5q33.1, 
suggesting that the interferon-inducible IRG proteins were once encoded in a single 
block ancestral to the human chromosome 5 region (Figure 15 B). IRGM (150.2 Mb) 
maps only 180 kb upstream and 90 kb downstream of the closest syntenic markers TNIP1 
and DCTN4, respectively (human genome Ensembl release v43.36d, Feb. 2007). 
Figure 13 Alignment Glires and human IRG proteins (see next pages). The sequences of Irga8 and the 
two pseudogenes Irga5 and Irgb7 have been partially reconstructed (see Figure 11). The unusual 
methionine residue in the G1 motif of GMS proteins is highlighted in dark green, conservative exchange to 
isoleucine in yellow. The turquoise-highlighted M in Irgm1 and Irgm2 are initiation codons that are 
dependent on alternative splicing (dark blue). The dark blue shaded residues indicate the positions at which 
splicing from upstream exons or tandem splicing occurs form Irgb5, Irgb2, Irgb9 and Irgb14 to Irgb4/b3, 
Irgb1, Irgb8 and Irgb13, respectively. Disruptive mutations in the G1 motif are marked in pink. CP_GMS1 
represents a hybrid sequence combining IRGM- and IRGB10-like features separated by a frame shift 
causing a premature stop codon (red highlighting). GTPase motifs are indicated by red boxes. Black 
shading: 80%, grey shading: 25% conserved. CP: Cavia porcellus, HS: Homo sapiens, MM: Mus 
musculus, OC: Oryctolagus cuniculus, RN: Rattus norvegicus, ST: Spermophilus tridecemlineatus. 
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Figure 14 Phylogenetic relationship of Glires and human IRG proteins. Maximum likelihood 
consensus bootstrapped tree based on the alignment of Glires and human IRG proteins (see Figure 13) 
rooted on the IRGQ proteins. Only the G-domains were used for the phylogenetic analysis applying the 
JTT+I+G amino acid replacement matrix (Jones 1992). CP_GMS1 represents a hybrid sequence combining 
IRGM- and IRGB10-like features separated by a frame shift causing a premature stop codon right before 
the G3 motif (red highlighting in Figure 13). The red # indicates sequences that are shorter than the 
classical IRG genes. CP: Cavia porcellus, HS: Homo sapiens, MM: Mus musculus, OC: Oryctolagus 
cuniculus, RN: Rattus norvegicus, ST: Spermophilus tridecemlineatus.  
 57
RESULTS 
Figure 15 Synteny relationship between the human and mouse IRG genes. Figures indicate distances 
from the centromere in megabases. The locations of IRG genes are shown in the yellow panels. Positions of 
diagnostic syntenic markers are also indicated. Syntenic blocks are given in full colour, and the rest is 
shaded. A. Synteny between mouse chromosome 7 and human chromosome 19 in the region of the IRGC 
and IRGQ genes. Gene orientation is given by black arrows. B. Complex synteny relationship between 
human chromosome 5 and mouse chromosomes 11 and 18 in the regions containing the mouse IRG genes.  
IRGM is transcribed in unstimulated human tissue culture lines with no increase 
after interferon induction (Bekpen 2005a; Bekpen 2005b). The promoter region 
corresponds to the ERV9 (endogenous retrovirus 9) U3 long terminal repeat (LTR) and 
does not contain any interferon response elements (Bekpen 2005a; Bekpen 2005b; Ling 
2002). Polyadenylated transcripts of IRGM occur with five 3' splicing isoforms, three of 
which are probably subject to rapid RNA degradation by nonsense mediated decay 
(NMD) due to the presence of a stop codon more than 50 bp upstream of an exon-intron 
boundary (Singh 2003). IRGM protein was detected in several human cell lines in 
absence of IFN (Singh 2006). At the protein level the shortest isoform of IRGM is 
shorter than a canonical G-domain, being truncated in the middle of β-strand 6 just 
before the G5 sequence motif, which interacts with the guanine base of the bound 
nucleotide (Figure 19, see Figure 11 for alignment on Irga6 crystal structure, (Bekpen 
2005b; Bourne 1991; Ghosh 2004)). The longer isoforms are terminated by short 
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sequence extensions that are unrelated to known GTPase domains. Hence, all residual 
IRG genes of human lack the character of functional resistance genes.  
In order to clarify whether the situation in the mouse or the human represents the 
exception, the analysis was extended to other species including different orders of 
vertebrates. 
 
I II.1.4. IRG homologues in rodents and lagomorphs (Glires)  
All rodents analysed so far contain numerous divergent IRG GTPases including 
representatives of the GKS as well as GMS subtype (Table 7; mouse: 19 GKS/3 GMS, 
rat: 13 GKS/3 GMS, guinea pig 9 GKS/3 GMS, thirteen-lined ground squirrel 3 GKS/1 
GMS). While the GMS genes as well as Irgd, Irgc, Irgq, Irga5 and Irgb10 are reasonably 
conserved within the Muridae, other IRGA and IRGB genes have diverged to an extent 
that makes clear assignment of rat (Rattus norvegicus) sequences to specific mouse genes 
impossible (Irga11-a16, Irgb13 and Irgb14; Figure 14, see also (Bekpen 2005a); rat 
genome Ensembl release RGSC 3.4 v45.34o, Feb 2006). Analysis of the genomic 
positioning of the rat IRG genes revealed a situation very similar to the mouse. Rat IRG 
genes are found in four clusters on three chromosomes (18, 1 and 10) syntenic to the 
respective regions of mouse chromosome 18, 7 and 11 (Figure 16). Rat chromosome 18 
(18q12.1) carries 7 IRGA genes clustered in a stretch of 230 kb. Rat Irgc and Irgq are 
situated in the band q21 of chromosome 1. Rat chromosome 10 contains two clusters of 
IRG genes separated by 9 Mb, one consisting of Irgm1, Irgb13, Irgb14 and Irgd and the 
other of Irgb10, Irgm3 and Irgm2.  
 
Figure 16 Genomic positioning of rat (Rattus norvegicus) IRG GTPases. Positioning and orientation of 
IRG genes in the rat chromosome 10, 1 and 18 clusters. Positions of genes refer to the location in rat 
genome Ensembl release v45.34o (Aug. 2007); Gene orientation is given by black arrows. Irgb14 and 
Irgb13 are probably expressed as tandem transcript. The closest syntenic markers are indicated in grey. 
Interestingly, one of these IRGB genes, Irgb13, lacks a start codon and is closest 
related to mouse Irgb1, -b3, -b4 and -b8, all of which have been shown to be expressed 
as the downstream half of a tandem transcript (see above and Figure 14, Figure 13). 
Sequence analysis revealed that the 60 nucleotides upstream of the mutated start codon 
including the (putative) splice acceptor site are conserved between rat Irgb13 and the 
downstream parts of the mouse tandems (Figure 13, appendix V.13). Furthermore, a 
second IRGB gene, Irgb14, is situated only 8 kb upstream of Irgb13 in the same 
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orientation (Figure 16). Irgb14 clusters phylogenetically with the upstream units of the 
mouse IRGB tandems (Irgb2, Irgb5*/Irgb5 and Irgb9) (Figure 14) and the splice donor 
site used by the mouse tandems is conserved (see appendix V.13). Thus, Irgb14 and 
Irgb13 are probably expressed as a tandem, though to date no confirming transcripts 
could be identified in the databases. Interestingly, only one IRG gene tandem pair is 
present in the rat genome as opposed to four pairs in the mouse indicating recent 
successive duplication events in the murine line (compare Figure 10 and Figure 16). 
Thus, the only independently transcribed IRGB gene in rat is Irgb10. If one reconsiders 
the mouse situation on this basis, it becomes likely that Irgb6, which is transcribed as a 
single unit, was also derived from a tandem gene. Interestingly, Irgb6 clusters 
phylogenetically with the downstream halves of the known tandem genes (Irgb1, -b8, -b3 
and -b4). Furthermore, the pseudogene Irgb7 is situated only 11 kb upstream of Irgb6 in 
the same orientation. Irgb7Ψ clusters phylogenetically with the upstream halves of the 
IRGB-tandems (Irgb2, -b5/b5* and -b9) and possesses the conserved splice donor site 
used in the other transcripts. This makes it likely that Irgb7 and Irgb6 were originally 
duplicated together from an ancestral tandem gene. While Irgb7 became a pseudogene 
due to insertion of premature stop codons, Irgb6 apparently managed to acquire a 
functional promoter and became an independent gene. 
Between Muridae and Caviidae the sequence divergence of all members besides 
Irgc and Irgq is either too pronounced to identify individual homologous pairs (GMS 
genes) or different genes of the family have duplicated and diversified further (Figure 
14). Irgd and Irgb10, which are single genes in mouse and rat, are represented by three 
and four closely related genes in the guinea pig (Cavia porcellus), respectively (guinea 
pig genome Ensembl release cavPor2 v44.1a, April 2007). Notably, one of the guinea pig 
GMS genes (CP_GMS1) represents a hybrid sequence combining IRGM- and IRGB-like 
features separated by a frame shift causing a premature stop codon right before the G3 
motif Figure 13, appendix V.13). It remains to be analysed whether these features are due 
to incorrect genome assembly or not. To date, no IRGA genes could be detected in the 
guinea pig genome.  
In the thirteen-lined ground squirrel, Spermophilus tridecemlineatus, four GKS 
IRG genes were identified, representing Irgc, Irgq and Irgb10, plus one member of the 
GMS subfamily (Figure 14) (squirrel genome Ensembl release speTri1 v44.1, April 
2007). In the rabbit (Oryctolagus cuniculus), a representative of the Lagomorpha, two 
IRG sequences were identified (rabbit genome Ensembl release RABBIT v44.1b, Apr 
2007). One represents an IRGA gene, the other clearly belongs to the GMS subfamily of 
IRG GTPases (Figure 14) though it has an isoleucine instead of a methionine in the G1 
motif (Figure 13 and see below). Thus, all Glires analysed so far possess multiple and 
divergent full-length IRG genes.  
 
I II.1.5. IRG homologues in the carnivore Canis familiaris 
For the domestic dog (Canis familiaris), as a representative of the Carnivora, 
eleven IRG genes plus the partial sequence of a 12th genes could be recovered from the 
public genome database (Table 7, appendix V.13; dog genome Ensembl release 
CanFam2.0 v44.2b, April 2007). Of these, three are GMS genes (IRGM4, -M5 and -M6) 
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and appear to have diversified independently from the mouse GMS genes (Figure 18, 
Figure 20). One gene clearly represents dog IRGD and four are closely related to murine 
Irgb10 (IRGB11, –B12, CF_GKS1, and CF_GKS2ψ). One of these IRGB10 like 
sequences contains a single frame shift (CF_GKS1) and another one is a pseudogene by a 
number of criteria (CF_GKS2ψ). Two genes are clearly dog IRGC and IRGQ, 
respectively, whereas the partial sequence is novel but most closely related to IRGC 
(CF_IRGC-like) (Figure 18-20). The dog possesses an additional ‘quasi’ IRG gene, 
IRGDQ1, which is clearly related to Irgd and contains several premature stop codons as 
well as a disrupted G1 motif (Qx4RMY) (Figure 18, Figure 19, Table 8). Thus, both 
GMS and GKS genes are represented and representatives of both subgroups are inducible 
by interferon in dog MDCK epithelial cells (IRGM4-6 and IRGB12; (Bekpen 2005a; 
Bekpen 2005b)). As in human and mouse, dog IRGC was not induced by IFNγ in vitro 
(Bekpen 2005a; Bekpen 2005b). The canine IRG genes are situated in separate clusters 
on chromosome 1 (IRGC, IRGQ, IRGC-like), chromosome 10 (IRGM4-6, IRGB11-12, 
CF_GKS1, IRGD, IRGDQ1) and chromosome 29 (CF_GKS2ψ) (Figure 17). The IRG 
genes containing region of dog chromosome 10 is syntenic to the respective regions of 
mouse chromosome 11 and human chromosome 5. The region of canine chromosome 1 
containing the IRGQ and -C genes is syntenic to the respective regions of murine 
chromosome 7 and human chromosome 19. For the isolated pseudogene on chromosome 
29, CF_GKS2ψ, no syntenic linkage to IRG gene containing regions of the human or 
mouse genomes has been reported. Overall, the IRG gene status of the dog clearly 
resembles that of mouse rather than that of humans.  
Figure 17 Genomic positioning of dog (Canis familiaris) IRG GTPases. Positioning and orientation of 
IRG genes in the dog chromosome 10, 1 and 29 clusters. Positions of genes refer to the location in dog 
genome Ensembl release v44.2b (CanFam 2.0 v44.2b April 2007). Gene orientation is given by black 
arrows. The closest syntenic markers are indicated in grey. 
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Figure 18 Phylogenetic relationship of mammalian IRG GTPases. Unrooted maximum likelihood 
consensus bootstrapped tree based on the alignment of the G-domains of mammalian IRG proteins (see 
Figure 19) using the JTT+I+G amino acid replacement matrix (Jones 1992). IRGC proteins and the IRGs 
from non-murine Glires were analysed separately (Figure 14, Figure 20). The nucleotide and amino acid 
sequences of all IRG sequences are given in the appendix (chapter V.13). The red # indicates sequences 
that are shorter than the classical IRG genes. Note that DN_GKS3 and EE_GKS2 are ‘quasi’ IRG proteins 
(DN_IRGBQ2 and EE_IRGBQ1 respectively). BT: Bos taurus, CF: Canis familiaris, DN: Dasypus 
novemcinctus, EC: Equus caballus, EE: Erinaceus europaeus, ET: Echinops telfairi, FC: Felis catus, HS: 
Homo sapiens, LA: Loxodonta africana, MD: Monodelphis domestica, ML: Myotis lucifugus, MM: Mus 
musculus, MN: Macaca mulatta, MU: Microcebus murinus, OA: Ornithorhynchus anatinus, OG: 
Otolemur garnettii, PP: Pongo pygmaeus, PT: Pan troglodytes, SA: Sorex araneus, SS: Sus scrofa. 
 
 
Figure 19 Alignment of mammalian IRG proteins (see following pages). Amino acid alignment of all 
mammalian IRG GTPases identified in this study besides the IRGs from the non-murine Glires, the IRGC 
and the IRGQ proteins (analysed separately, Figure 13, Figure 20). The unusual methionine residue in the 
G1 motif of GMS proteins is highlighted in dark green, the conservative exchange to leucine in yellow. 
The dark blue background Q residues indicate the point where tandem splicing occurs from Irgb5/b5*, 
Irgb2 and Itgb9 to Irgb4/b3, Irgb1 and Irgb8, respectively. Canonical GTPase motifs are indicated by red 
boxes. Black shading: 70% conserved; grey shading: 50% conserved 
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Figure 20 Phylogenetic relationship of mammalian IRGC and IRGQ GTPases. Maximum likelihood 
consensus bootstrapped tree based on the alignment of murine IRG proteins, human IRGM, mammalian 
IRGC and IRGQ proteins rooted on the IRGQ proteins. Only the G-domains were used for the 
phylogenetic analysis applying the JTT+I+G amino acid replacement matrix (Jones 1992). The red # 
indicates sequences that are shorter than the classical IRG genes. Note that the available fragment of 
Spermophilus IRGC is so short that it forms a branch with murine Irgd in the phylogenetic analysis though 
it is clearly an IRGC protein (see alignment appendix V.8). Note that the macaque IRGC sequence was 
reconstructed from a fragment derived from the Macaca mulatta genome and several ESTs from Macaca 
nemestrina (DY750065, EB520540). BT: Bos Taurus, CF: Canis familiaris, CP: Cavia porcellus, DN: 
Dasypus novemcinctus, EC: Equus caballus, EE: Erinaceus europaeus, ET: Echinops telfairi, FC: Felis 
catus, HS: Homo sapiens, LA: Loxodonta africana, MD: Monodelphis domestica, ML: Myotis lucifugus, 
MM: Mus musculus, MN: Macaca mulatta, MU: Microcebus murinus, OA: Ornithorhynchus anatinus, 
OC: Oryctolagus cuniculus, OG: Otolemur garnettii, PP: Pongo pygmaeus, PT: Pan troglodytes, RN: 
Rattus norvegicus, SA: Sorex araneus, SS: Sus scrofa, ST: Spermophilus tridecemlineatus. 
 
I II.1.6. IRG homologues in other mammalian species 
For several other mammalian species including the other carnivore analysed in 
this study, the domestic cat (Felis catus), to date only IRGC- and IRGQ-related 
sequences could be recovered (cat genome Ensembl release CAT, v44.1, April 2007). 
The common shrew (Sorex araneus), the little brown bat (Myotis lucifugus) and the cat 
(Felis catus) possess one gene each that is closely homologous to murine Irgq and Irgc 
and a third gene that is more distantly related to Irgc (IRGC-like) (shrew genome 
Ensembl release sorAra1, version 45, Jun 2007; bat genome Ensembl release myoLuc1, 
v44.1, April 2007). The pig (Sus scrofa) also possesses two IRGC-related sequences 
(IRGC and IRGC-like) but an Irgq orthologue could not be retrieved yet (Sscrofa1, 
http://pre.ensembl.org). Only a single IRGC and IRGQ gene each is present in the horse 
(Equus caballus) genome (EquCab2, http://pre.ensembl.org).  
Figure 21A Phylogenetic tree of the mammalian IRGM proteins. Unrooted maximum likelihood 
consensus bootstrapped tree based on the alignment of the complete IRGM proteins (see B) using the 
JTT+G amino acid replacement matrix (Jones 1992)  
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Figure 21B Alignment of the mammalian IRGM proteins. The turquoise-highlighted M in Irgm1 and 
Irgm2 are initiation codons that are dependent on alternative splicing (highlighted in dark blue). 
Conservative substitutions of the IRGM typical methionine in the G1 motif to leucine or isoleucine are 
highlighted in yellow. Substitutions disrupting the conserved GTPase motifs (indicated with red boxes) are 
highlighted in pink. Red highlighting indicates premature stop codons (*) or frame shifts (X). Red 
highlighted R in the PP_IRGM consensus sequence marks the position of the premature stop codon present 
in the majority of the orang-utan sequences (see appendix V.10). Note that a consensus sequence was used 
for orang-utan IRGM (see main text). Black highlighting: 90% conserved, grey highlighting: 50% 
conserved. CF: Canis familiaris, CP: Cavia porcellus, DN: Dasypus novemcinctus, ET: Echinops telfairi, 
HS: Homo sapiens, LA: Loxodonta africana, MM: Mus musculus, MN: Macaca mulatta, MU: Microcebus 
murinus, OC: Oryctolagus cuniculus, PP: Pongo pygmaeus, PT: Pan troglodytes, RN: Rattus norvegicus, 
ST: Spermophilus tridecemlineatus. 
However, other species in the respective orders, Insectivora, Carnivora and 
Artiodactyla (even-toed ungulates), did posses immune type IRG genes (e.g. tenrec, dog 
and bull; Table 7). It is therefore unlikely that the absence of homologues of the IFN-
inducible mouse IRGs will persist in all cases upon availability of a larger number of 
sequences in the databases. The case of the carnivores has already been discussed above. 
In the ungulate Bos taurus (cattle) four IRGs are present, namely IRGQ, IRGD, IRGC 
and IRGC-like as opposed to the situation in the pig (see above). Two of the three 
insectivore species analysed contained homologues of the IFN-inducible mouse IRG 
genes. The western European hedgehog (Erinaceus europaeus) possesses an IRGQ gene 
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and two members of the IRGB group, one of which clearly belongs to the ‘quasi’ IRGs 
(IRGBQ1: GNF in G1 motif; Table 8, Figure 18, Figure 19). In the lesser hedgehog 
tenrec (Echinops telfairi) eight IRG sequences were identified, IRGC, IRGQ, one IRGA 
gene, one IRGD gene, two IRGB genes and two GMS genes (Table 7, Figure 9, Figure 
10). Interestingly, both the tenrec and the rabbit (see above) possess one GMS related 
gene containing a conservative substitution for the unusual methionine in the G1 motif, 
Gx4GLS and Gx4GIS respectively, while preserving GMS characteristic features 
throughout the sequence, thus suggesting that a large hydrophobic residue in this position 
might not only be permissive but also essential for GMS function (Figure 21, appendix 
V.13).  
Two more species were analysed to cover the deep branches of the Eutheria; the 
African elephant (Loxodonta africana) as a representative of the Proboscidea and the 
nine-banded armadillo (Dasypus novemcinctus) as a representative of the Cingulata. 
They both possess a variety of IRG genes, IRGC, IRGQ, two GMS, two IRGA and two 
IRGD genes in case of the elephant and three IRGB genes and a single GMS, IRGD, 
IRGC and IRGQ gene each in case of the armadillo (Table 7, Figure 18, Figure 19). 
Thus, divergent IRG GTPases are widespread in the Eutheria and at least as old as the 
rapid eutherian radiation 85-100 million years ago (Bininda-Emonds 2007). On this 
ground it was analysed whether the reduced IRG status in humans is representative for 
other primates and where in the evolution of the primate lineage the divergent, immune-
type IRG genes have been lost.  
 
I II.1.7. IRG homologues in non-human primates 
Not only the human but apparently also other higher primates have lost full 
length, IFN-inducible IRG genes. The situation in the chimpanzee is identical to that in 
humans. The chimp IRGM gene is 98% identical to human IRGM and is situated on a 
stretch on chromosome 5 (152,8 Mb) collinear with the syntenic part of human 
chromosome 5 flanked by the same marker genes (DCTN4 and TNIP1) (chimp genome 
Ensembl release PanTro 2.1 v44.21c, April 2007) (Figure 21 B). Also the stretch on 
chromosome 19 harbouring chimp IRGC (49.3 Mb) and IRGQ is syntenic to the 
respective region on human chromosome 19. The genome of the orang-utan (Pongo 
pygmaeus) contains 9 sequences related to human IRGM, most of which are disrupted by 
premature stop codons and/or frame shifts (appendix V.10) (BLAST of the incomplete 
Pongo genome via http://www.ncbi.nlm.nih.gov/sutils/genom_tree.cgi). Alignment of the 
protein sequences revealed that they are all near identical (appendix V.10). Taking into 
account that the orang-utan genome database is still in a premature state, the sequences 
might all represent two IRGM genes, one of which possesses a stop codon immediately 
after the G1 motif. For the phylogenetic analysis, a consensus sequence generated from 
the 9 sequences was used (for sequence see appendix V.13). Further analysis awaits 
database versions with a better sequence coverage of the genome.  
The Rhesus monkey (Macaca mulatta) as a representative of the old world 
monkeys possesses three IRG genes, IRGC, IRGQ and a single IRGM gene 93% identical 
to human IRGM. The Rhesus monkey IRGM gene is situated on chromosome 6 (Mb 
147.3) between the same syntenic markers as the human orthologue with comparable 
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spacing (DCTN4 and TNIP1) (macaque genome Ensembl release MMUL 1.0 v43.10c, 
February 2007) (Figure 18). Interestingly, this gene is clearly damaged in several ways, 
as it contains a frame shift before and a stop codon after the first GTP-binding motif 
(Figure 21 B, appendix V.13). Furthermore, the amino acid sequence of the G1 motif is 
Gx4GMN, a mutation that renders other IRG proteins non-functional ((Taylor 1997) and 
see below, chapter III.2). Despite the absence of confirming transcripts from the 
databases and the preliminary status of the macaque genome project, a tripartite 
disruption is unlikely to be due to sequencing errors alone. Furthermore, an independent 
genomic clone (BV210965) confirms the damaged IRGM sequence.  
Recent genomic analysis of the common marmoset (Callithrix jacchus) as a 
representative of the new world monkeys yielded a similar picture. Despite the 
unfinished status of the genome project, three IRG genes were recovered representing 
IRGC, IRGQ and IRGM (Table 7). As in the Rhesus monkey, the first GTP-binding motif 
of the marmoset IRGM protein is damaged by mutation (Gx4SIS in this case). The 
mutation of the universally conserved glycine residue in the G1 motif was reported to 
interfere with nucleotide binding in H-Ras (Chen 1994; Powers 1989). Thus, all higher 
primates analysed exclusively possess IRGM GTPases that are significantly shorter than 
a typical G-domain and terminate before the G5 motif (Figure 14). In case of the orang-
utan, the rhesus monkey and the marmoset the IRGM genes are even further damaged by 
truncation or mutation.  
Table 9 Myristoylation motifs of IRG GTPases. IRG proteins with intact or disrupted potential 
myristoylation motifs. The consensus sequence is MG{EDRHPFYW}X2[STAGCNDEF]{P} with curly 
brackets indicating non-permissive amino acids and square brackets indicating essential amino acids (X: 
any amino acid) (Maurer-Stroh 2002). Serine (bold) is favoured at position 6. AC: Anolis carolinensis, CF: 
Canis familiaris, CP: Cavia porcellus, DN: Dasypus novemcinctus, EE: Erinaceus europaeus, ET: 
Echinops telfairi, LA: Loxodonta africana, MM: Mus musculus, MU: Microcebus murinus, OC: 
Oryctolagus cuniculus, OG: Otolemur garnettii, RN: Rattus norvegicus, ST: Spermophilus 
tridecemlineatus 
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In contrast, in the lower primate Otolemur garnettii (bushbaby) an IRGA gene 
(OG_GKS1) coding for a full-length protein with a functional myristoylation sequence at 
the N-terminus was found in addition to an IRGC and IRGQ gene (Table 9) despite the 
low coverage of the genome assembly. The IRGA protein has an unusual substitution 
(DxxA instead of DxxG) in the G3 motif but possesses consensus sequences in the other 
GTPase motifs (Table 8). The analogous mutation prevents bound GTP from changing 
the protein conformation in EF-Tu, GSα and H-Ras while affecting the nucleotide 
affinities only moderately (Bourne 1991; Ford 2005; Lee 1992). Thus, it remains to be 
determined whether Otolemur IRGA can function as a GTPase. Further analysis should 
also aim to identify the putative promoter of this gene and clarify whether it contains 
GAS and/or ISRE sites and therefore fulfils the prerequisites for functioning in IFN-
mediated cell autonomous resistance.  
Only shortly before completion of this study, genomic data from another lower 
primate (Strepsirrhini) has become available. Microcebus murinus (grey mouse lemur) 
possesses at least 9 IRG genes, including a single IRGC, IRGQ and IRGD gene each, two 
IRGA, and four full-length GMS genes. Furthermore, four short fragments of IRG genes 
are present, two of which clearly belong to the GMS subfamily. At least one of the IRGA 
genes encodes a protein with a functional myristoylation sequence (Table 9). Thus, 
resistance IRG GTPases must have been lost sometime between the divide of the 
Haplorrhini (tarsier and anthropoids) and the Strepsirrhini (loris and lemurs) perhaps 60 
million years ago and the division of the Hominoidae and the Old World monkeys 
(Catarrhini) from the New World monkeys (Platyrrhini) (30-40 million years ago; for 
phylogenetic tree of the primates see Figure 56). 
To understand why the higher primates could afford to lose a resistance system 
highly active and absolutely essential in rodents might shed light onto important 
differences in innate immune mechanisms of mice and men. 
 
I II.1.8. IRG homologues outside the Eutheria 
To gain further insight into the dynamics of the evolution of the IRG family and 
the phylogenetic age of different subgroups, all available chordate genomes were 
scanned for IRG genes by homology searches. The results are summarised in Table 7. 
Irgc orthologues can be found throughout the mammals right down to the Marsupialia 
(Monodelphis domestica, opossum) and Monotremata (Ornithorhynchus anatinus, 
platypus) and are frequently accompanied by a second, closely related gene (IRGC-like) 
spatially linked to IRGC (see Table 7) (opossum genome Ensembl release MonDom 4.0 
v43.3c, Feb 2007; platypus genome Ensembl release Oana-5.0 v43.1a, Feb 2007). In the 
opossum one fragment representing IRGC, one IRGC-like gene and two IRGD-related 
sequences were detected. The two Irgc-related sequence are situated in a region on 
chromosome 4 syntenic to human chromosome 19 in the vicinity of the genomic marker 
Plaur that is found adjacent to Irgc in other mammals. The N-terminus of the opossum 
IRGC sequence is missing due to a gap in the current genome assembly. Interestingly, the 
opossum IRGC-like gene contains a single intron between the G4 and the G5 motif 
roughly at the same position as the fish IRGF genes (see below; highlighted in Figure 
23). In the platypus IRGC, three genes distantly related to IRGC-like and one IRGB gene 
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could be identified (Figure 20). Notably the IRGC-like genes from platypus and other 
mammals are very divergent compared to the classical IRGCs. It remains to be 
determined whether IRGC-like genes represent another clade of resistance IRGs rather 
than being functionally related to Irgc. Thus, divergent IRG genes are also present in 
marsupials and monotremes but to date no GMS genes could be detected in either group.  
After confirming the presence of IRG GTPases throughout the mammals, species 
from other classes were analysed concerning their IRG gene content. IRG genes were 
detected in most vertebrate genomes including reptiles, amphibians and fish, with 
chicken (Gallus gallus) and zebra finch (Taeniopygia guttata) being the clear exceptions 
(chicken genome Ensembl release WASHUC2 v46.2d, Aug 2007; zebra finch genome, 
http://www.ncbi.nlm.nih.gov/projects/genome/guide/finch). Unfortunately, it still cannot 
be excluded that the absence of IRG genes from the birds rather reflects a poor coverage 
of the genomes than a true deficiency.  
12 IRG sequences were identified in the freshwater pufferfish Tetraodon 
nigroviridis, 9 IRG sequences in the saltwater pufferfish Takifugu rubripes, and 14 
partially clustered IRG genes in the zebrafish Danio rerio (Table 7, zebrafish genome 
Ensembl release Zv7 v 46.7, Aug 2007; Tetraodon genome Ensembl release 
TETRAODON 7 v46.1i, Aug 2007 and Takifugu genome Ensembl release FUGU 4.0 
v46.4g, Aug 2007). The fish IRG genes fall into separate clades from the mammalian 
genes, termed IRGE, IRGF and IRGG (Figure 22). A specific IRGC homologue is not 
immediately apparent. IRGM genes are absent from fish. All the pufferfish sequences are 
closely related and belong to the IRGF group. As the database is still fragmented and rich 
in gaps and misreads, it is difficult to come to a final conclusion concerning the number 
of IRG genes in these species but recurring sequence features support the presence of at 
least three genes in Tetraodon and two in the Fugu (appendix V.11-V.13). The pufferfish 
and the four zebrafish IRGF genes have one intron identically positioned at the end of 
helix 4 of the G-domain (Figure 23; appendix V.13). The six distinct IRGE subfamily 
genes and the single IRGG gene of the Danio are intronless in the open reading frame, 
like the majority of the mammalian IRG genes (Figure 22-23). Neither IRGE nor IRGG 
genes could be detected in the pufferfish genomes. The zebrafish genome additionally 
contains three IRG homologues with modified GTP-binding motifs (irgxq1-irgxq3; 
Figure 22-23, Table 8). Their homology to other IRG genes is stronger than that of IRGQ 
but, as with IRGQ, their function as GTPases is doubtful. The irgxq1 gene is clustered on 
chromosome 16 (26.23-26.67 Mb) with four of the apparently normal IRGE genes 
(irge1-4) and lies immediately downstream of a truncated IRG sequence, irgg, with 
which irgxq1 is transcribed in tandem (accession number: BQ481122). Thus, the 
hypothetical protein product would be a carboxyl-terminally truncated p47 GTPase, 
linked to a similarly truncated IRG homologue probably devoid of GTPase function. 
Though no function for tandem IRG genes has been demonstrated yet, it remains 
intriguing that they appear in such distant species as rat/mouse, zebrafish and Xenopus 
(see below). Irgxq3 is also situated on chromosome 16, 20 megabases downstream of the 
other IRG genes. The two remaining IRGE genes, irge5 and irge6, are both located on an 
unpositioned scaffold (Zv7_NA674) while all the IRGF genes cluster on chromosome 
19. Irgxq2 is an isolated gene on chromosome 15.  
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Figure 22 Phylogenetic relationship of fish, reptile, amphibian and Cephalochordate IRG GTPases. 
Maximum likelihood consensus bootstrapped tree using the WAG+I+G amino acid replacement matrix 
(Whelan 2001) based on the alignment of the G-domains of mouse, fish, amphibian, reptile and 
Cephalochordate IRG proteins rooted on H-Ras-1 (see Figure 23). Red asterisks indicate bootstrap values 
below 20. Red line indicates ambiguous part of the tree with low bootstrap values. AC: Anolis carolinensis, 
AM: Acropora millepora, AT: Ambystoma tigrinum tigrinum, BF: Branchiostoma floridae, DR: Danio 
rerio, MM: Mus musculus 
 73
RESULTS 
Three IRG sequences of cartilaginous fish could be retrieved from the databases: 
two fragments from the shark Squalus acanthias, which are too short for phylogenetic 
analysis (EE884816, EE049107), and one full length sequence from the little skate 
(Leucoraja erinacea), which forms a new deep branch in the phylogenetic tree together 
with Danio irgxq1 and two reptile sequences (see below, Figure 22). However, this part 
of the tree should be considered with care as the bootstrap values are low and the 
positions of the branches are instable. The skate sequence was generated as a consensus 
sequence from five near identical ESTs (DR714243, DR714385, CV221991, DT726565, 
DR783592).  
There are few amphibian IRG sequences available in the databases. One gene 
distantly related to Irgc was found in the eastern tiger salamander (Ambystoma tigrinum 
tigrinum, http://www.ambystoma.org, Tig_NM_019612_Contig_1, EST CN054487) 
(Figure 22) and two IRG sequences transcribed in tandem in the South African clawed 
frog (Xenopus tropicalis) (transcript: DT429555). The 3’ half of the tandem, irgxq4, is 
clearly a ‘quasi’ IRG gene, while the other half is only slightly modified in the G3 motif 
(Table 8). The two Xenopus genes are situated on the same genomic scaffold 
(scaffold:JGI4.1:scaffold_449) with the irgxq4 (XT_GKS1) gene only 4 kb downstream 
of XT_GKS2 (Xenopus genome Ensemble release JGI 4.1 v46.41g, Aug 2007). Neither 
of these two genes falls into one of the known IRG clades. The Xenopus sequences were 
excluded from the phylogenetic analysis displayed in figure 13 as they are rather 
divergent and destabilised parts of the tree when included in the analysis.  
There are at least 10 IRG genes in the lizard Anolis carolinensis, five of which are 
distantly related to Irgc and two form a new clade together with zebrafish irgxq1 and the 
sequence from Leucoraja (Figure 22) (BLAST of Anolis genome via 
http://www.ncbi.nlm.nih.gov/sutils/genom_tree.cgi). As described above, this part of the 
phylogenetic tree (marked by a red line in Figure 22) should be considered provisional. 
The remaining three Anolis genes belong to the IRGE group. The bootstrap values of this 
particular branch of the phylogenetic tree (marked by red asterisks in Figure 22) are low 
because the Anolis sequences are rather divergent and also related to the IRGF genes. 
However, the absence of an intron in these Anolis genes supports their affiliation to the 
likewise intronless IRGE genes. In general, the phylogenetic analysis of IRG genes is 
complicated by the combination of high intra- and inter-species sequence divergence in 
this gene family, resulting in low bootstrap values and instable branches in less well 
defined parts of the phylogenetic trees, though other parts of the trees remain reliable. 
Thus, especially in cases when only few supportive sequences are available, the precise 
positions of these branches in the phylogenetic tree should be considered provisional 
until more IRG sequences become available. 
In summary, IRG genes were identified in many vertebrates, including mammals, 
reptiles, amphibians and fish. IRGC-related sequences are found in all mammalian 
groups, in reptiles and amphibians but the highly conserved classical IRGC gene seems 
to be specific for mammals. Most genomes analysed encode 'quasi' IRG proteins that are 
homologous to the IRG GTPases but almost certainly devoid of GTPases function as 
they are radically modified in the GTP-binding site. IRGQ is represented throughout the 
Eutheria (Figure 20, appendix V.9), however, to date no homologue could be identified 
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from Metatheria, Prototheria and non-mammalian vertebrates. IRGA-related genes are 
found throughout the Eutheria while IRGB and IRGD genes can be also found in the 
Proto- and Metatheria, respectively. IRGF and IRGG genes seem to be specific for fish 
while IRGE genes are also present in reptiles (Figure 22). A new deep branch on the 
phylogenetic tree is formed by two Anolis genes (AC_GKS8, AC_GKS6), zebrafish 
irgxq1 and one sequence from the little skate (Leucoraja erinacea). Myristoylation 
motifs can be found throughout the vertebrates in a subset of the IRGA, -B and -E 
proteins suggesting that myristoylation is an ancient mechanism of membrane attachment 
in IRG proteins (Table 9).  
The only unambiguous IRG homologues outside the vertebrates have been found 
in the Cephalochordate Branchiostoma floridae. More than 14 genes were identified in 
the yet incomplete genome (http://genome.jgi-psf.org/Brafl1/Brafl1.home.html) forming 
an independent clade within the GKS subfamily most closely related to zebrafish irgxq2 
(IRGH, Figure 22). Two possibly related sequences were recovered from the 
Caenorhabditis elegans genome (C46E1.3, W09C5.2), and several groups of putative 
GTPases of unknown function with sequence features reminiscent of IRG GTPases exist 
in bacteria (e.g. BAA10832, BAA18140, BAA18642, BAC08557, BAC08842). These 
sequences are, however, too distantly related for a clear phylogenetic relationship to IRG 
proteins to be established from sequence similarity alone. To date, no IRG family 
members could be identified in the sea urchin and tunicate genomes. A cDNA derived 
from the coral Acropora millepora (DY583583) is closely related to zebrafish irgg1 and 
therefore clearly represents a cross contamination with a fish sequence. 
Thus, while GKS IRG proteins are at least as old as the euchordates, IRGM 
GTPases seem to be specific for Eutheria as they can be found in rodents, lagomorphs, 
insectivores, primates and carnivores but seem to be absent from marsupials, 
monotremes, reptiles, amphibians, fish and Cephalochordates. Hence, IRGM genes must 
have been present in an early eutherian progenitor and therefore must be at least 75 
million years old (Bininda-Emonds 2007).  
Taken together the IRG resistance GTPases are an ancient family that recently 
underwent extensive expansion and diversification (as well as contraction) in the 
euchordates – a feature characteristic for multigene families associated with pathogen 
resistance due to host-pathogen coevolution (Angata 2004; Borghans 2004; Delarbre 
1992; Hood 1975; Klein 1986; Leister 2004; Mashimo 2003; Noel 1999; Trowsdale 
2001). The absence of full length IRGM GTPases and IFN-inducible IRGs in general in 
higher primates indicates that this ancient resistance system, despite its importance for 
the mouse, became – at least largely - dispensable in this linage and was lost during 
divergent evolution of the primates. Consequently, mice and humans must deploy their 
immune resources against vacuolar pathogens in radically different ways. 
Figure 23 Alignment of fish, reptile, amphibian and Cephalochordate IRG proteins (see also next 
page). Alignment of fish, reptile, amphibian and Cephalochordate IRG proteins with representatives of the 
murine IRGs and the opossum IRGC-like protein. The positions of the introns in fish IRGF genes and 
opossum IRGC-like are marked in dark blue. Modifications in the G1 motif of the Danio IRGXQ genes are 
highlighted in pink. GTPase motifs are marked by red boxes. AC: Anolis carolinensis, AT: Ambystoma 
tigrinum tigrinum, BF: Branchiostoma floridae, DR: Danio rerio, MM: Mus musculus, MD: Monodelphis 
domestica. 
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III.2. Regulatory interactions between IRG GTPases controlling 
activation and function  
The exceptional importance of the IFNγ-inducible p47 GTPases in cell 
autonomous resistance has been demonstrated both in vivo (Collazo 2001; MacMicking 
2003; Taylor 2000) and in vitro (Bernstein-Hanley 2006; Feng 2004; Martens 2005; 
Nelson 2005), but next to nothing is known about the molecular and cell biological 
mechanisms mediating these effects. To fill this gap and to disentangle the effect 
mediated by individual IRG GTPases from the residual IFNγ response, stable cell lines 
inducibly expressing single IRGs were established. Inducible expression was chosen 
because an earlier study reported difficulties in obtaining stable clones constitutively 
expressing Irgb6 and observed a reduced growth rate for cells expressing high levels of 
this protein (Carlow 1998). This may indicate that the constitutive expression of single 
IRGs in absence of IFN-induction can be toxic for cells.  
 
I II.2.1. Generation and characterisation of stable cell lines inducibly 
expressing single IRGs  
The GeneSwitch (gs) system, based on the NIH3T3 derived gs3T3 cell line stably 
expressing the GeneSwitch inducer protein (Invitrogen; (Wang 1994)), was used for 
hormone-inducible expression of the IRG proteins. Upon binding of the synthetic steroid, 
Mifepristone, the inducer drives the expression of the protein of interest from the 
pGene/V5-His vector (see material and methods (II.5.3) for details). The complete open 
reading frames of Irga6, Irgb6, Irgc, Irgd, Irgm1, Irgm2 and Irgm3 were cloned into this 
vector and the resulting native constructs were transfected individually into gs3T3 cells. 
Cells with stable integrated IRG expression constructs were selected with Zeocin and 
cloned twice by limiting dilution. The resulting stable cell lines were characterised for 
IRG protein expression following Mifepristone induction, using SDS-PAGE and 
immunoblotting with specific serological reagents (Figure 24). The IRG expression level 
was not adjustable by using different hormone concentrations (Figure 24; shown for 
Irga6 (A), Irgm3 (F) and Irgm1 (G)). No induction was detected with a concentration of 
10-11 M Mifepristone or less, and maximal induction with 10-10 M and more. 
Subsequently, 10-9 M Mifepristone was used for induction unless specified elsewise. 
Clones expressing IRG proteins at comparably high levels following Mifepristone- and 
IFNγ-induction were chosen for further analysis (Figure 24, see also Figure 34). In the 
case of Irgb6, all clones analysed expressed considerably less protein following 
Mifepristone induction than following IFNγ induction (Figure 24 B).  
All IRG proteins migrated in SDS-PAGE at the position expected from their 
calculated molecular weight (MW), which is about 47 kDa for Irga6, Irgb6, Irgd and the 
IRGM proteins but 50 kDa for Irgc. The exception was Irgm1 that had an apparent 
molecular weight in SDS-PAGE of around 37 kDa compare with the calculated MW of ~ 
47 kDa (Figure 24 G). Furthermore, Irgm3 protein migrated as a double band following 
IFNγ induction but only the upper band at 47 kDa was detected following Mifepristone 
induction (Figure 24 F). The second Irgm3 band migrating slightly faster than the 
predominant band was also seen by Taylor et al (Taylor 1996). The difference between 
the two bands could either be due to the use of an alternative methionine 20 amino acids 
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downstream of the primarily used one (as for Irgm1 and Irgm2; see above III.1.2) or 
result from an incomplete covalent protein modification. Yet, no ESTs supporting the use 
of the alternative methionine could be found in the databases.  
 
Figure 24 IRG protein expression in gs3T3-IRG cell lines. Gs3T3-IRG and -wt cells were stimulated 
with Mifepristone (10-7 to 10-13 M) or IFNγ (200 U/ml) for 24 hrs, postnuclear supernatants of PBS/1% 
Triton X-100 cell lysates were separated by SDS-PAGE and Irga6 (A), Irgb6 (B), Irgm2 (C), Irgd (D), Irgc 
(E), Irgm3 (F) and Irgm1 (G) were detected in immunoblot with the specific antibodies 165, A20, H53, 
2078, 39/3°, αIGTP clone 7, and L115/B0 respectively. Detection of Calnexin with the SPA-865 serum 
served as a loading control. (A), (F) and (G) show Mifepristone dose responses for gs3T3-Irga6, -Irgm3 
and –Irgm1 cells respectively. In (B-E) cells were induced with 10-9 M Mifepristone. Black arrowheads 
indicate the respective IRG protein band(s), the asterisks in (A) indicates the additional Irga6 band at 55 
kDa prominent in Mifepristone-induced gs3T3-Irga6 cells, the asterisks in (F) the second Irgm3 band seen 
only in IFNγ-induced cells. The asterisk in (G) indicates an unrelated protein band present in gs3T3 cells, 
the Irgm1 serum (L115/B0) cross-reacted on.  
In the case of Irga6, Mifepristone induction resulted in the expression of two 
forms, one migrating at the same height as the endogenous Irga6 and one form that had 
an apparent molecular weight of approximately 55 kDa (Figure 24 A asterisks and Figure 
25 D red arrowhead). Likewise, transient transfection of an Irga6 expression construct 
into murine fibroblasts in absence of IFNγ induction resulted in formation of two 
predominant Irga6 bands in SDS-PAGE, in this case with an apparent molecular weight 
of about 47 and 48 kDa respectively (Figure 25 C black and green arrowhead 
respectively; see also (Papic 2007)). The lower band correlates with endogenous IFN-
induced Irga6 that migrated predominantly as a single band of 47 kDa (Figure 25 A+B). 
The 55 kDa Irga6 band seen in Mifepristone-induced cells could also be detected in cells 
transiently transfected with Irga6 and sometimes even in IFNγ-induced cells, though the 
signal was much weaker in the last case (Figure 25 A+C+D red arrowhead).  
It was previously shown by Triton X-114 phase partitioning that endogenous 
Irga6 is completely myristoylated at its N-terminal myristoylation site in vivo (Martens 
2004b). In this assay, hydrophobic proteins partition into the detergent phase upon 
temperature shift induced phase separation (Bordier 1981). Irga6 from IFNγ-induced 
L929 cells partitioned roughly equally between the aqueous and the detergent phases in 
consecutive Triton X-114 extractions, indicating complete lipid modification of Irga6 but 
only 50% efficiency of partitioning for this protein (Martens 2004b). This result was 
confirmed with IFNγ-induced gs3T3 and gs3T3-Irga6 cells (Figure 25 A+B). The 47 kDa 
Irga6 band seen in transiently transfected cells behaved like endogenous Irga6 
partitioning equally between the two phases in subsequent rounds of extraction, while the 
48 kDa band was completely aqueous (Figure 25 C; see also (Papic 2007)). The latter 
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band was shown to represent non-myristoylated Irga6 (Papic 2007) behaving like the 
myristoylation mutant Irga6(G2A) (Martens 2004b). It is noteworthy that the 48 kDa 
form of Irga6 was also found in tiny amounts in IFN-induced cells (Figure 25 A, A4, 
green arrow). This indicates that lipid modification of Irga6 by the N-terminal myristoyl 
transferase is carefully balanced and overexpression of Irga6 by transient transfection of 
an expression construct with a strong viral promoter probably overburdened the capacity 
of the myristoylation machinery. In Mifepristone-induced gs3T3-Irga6 cells, both the 47 
and the 55 kDa form of Irga6 behaved like the endogenous protein partitioning roughly 
equally between the aqueous and the detergent phase (Figure 25 D black and red 
arrowhead). Thus, the 55 kDa form of Irga6 is myristoylated and, whatever modification 
leads to the shift in apparent molecular weight, it does not influence the hydrophobicity 
of the protein detectably.  
Figure 25 IFNγ- and Mifepristone-induced Irga6 is completely myristoylated in vivo. Gs3T3 cells (A, 
C) were either induced with IFNγ (200 U/ml) for 24 hrs or transiently transfected with the pGW1H-Irga6 
(2µg) expression vector. Gs3T3-Irga6 cells (B, D) were either induced with IFNγ (200 U/ml) or 
Mifepristone (10-9 M) for 24 hrs. Cell lysates were generated with PBS/1% Triton X-114/3 mM MgCl2 and 
the aqueous and detergent phases were separated by shifting the sample to temperatures above the cloud 
point (22°C) aided by centrifugation. Four subsequent partitionings of aqueous (A1-4) and detergent phase 
(D1-4) were performed by re-adding detergent to the aqueous phase (A1 partitions into A2 and D2 etc.). 
As the Irga6 band at 55 kDa was resistant to reducing and denaturing agents (β-
mercaptoethanol, SDS, boiling), a covalent post-translational modification of the protein 
was likely to be the explanation for the shift of around 8 kDa. This size difference is 
consistent with mono-ubiquitination, as one ubiquitin molecule has a molecular weight of 
8.5 kDa (Schlesinger 1975). To test this possibility, Irga6 was immunoprecipitated from 
lysates of gs3T3-Irga6 cells induced with IFNγ, Mifepristone or both with the specific 
polyclonal serum 165 coupled to protein A Sepharose. Gs3T3 cells and untreated gs3T3-
Irga6 cells served as controls. The immunoprecipitates were analysed in SDS-PAGE 
followed by immunoblot with the monoclonal antibodies 10D7 (Figure 26 A) and FK2 
(Figure 26 B) specific for Irga6 and ubiquitin respectively. The FK2 antibody readily 
detected ubiquitinated proteins in the lysate controls (Figure 26 B, lanes 1-4 and 9-12). 
Furthermore, large amounts of ubiquitin-positive higher molecular weight species were 
detected following Mifepristone induction indicating strong polyubiquitination of Irga6 
(Figure 26 B, lane 7). Upon longer exposure, the higher molecular weight bands were 
also visible in the Irga6 immunoblot (Figure 26 C, lane 7 and 8). The effect was only 
partially reversed by co-induction with IFNγ (Figure 26 B, lane 8) whereas no 
ubiquitination could be detected following IFNγ induction (Figure 26 B, lane 6). The 
immunoprecipitated sample from Mifepristone-induced gs3T3 wild type lacked the 
prominent ladder of bands ranging from 55 to 200 kDa seen in Mifepristone-induced 
gs3T3-Irga6 cells (Figure 26 B, compare lane 15 to lane 7), ruling out unspecific co-
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precipitation of unrelated ubiquitinated proteins. Thus, ectopically expressed Irga6 is 
polyubiquitinated in vivo. This effect was not (or only partially) rescued by parallel 
induction with IFNγ, probably due to the elevated Irga6 expression levels following 
double induction. However, no obvious difference in protein stability was seen between 
endogenous Irga6 protein in MEFs and Mifepristone-induced Irga6 protein in gs3T3-
Irga6 cells (half life in both cases about 16 hrs; T. Steinfeld, unpublished results). A 
prominent but diffuse band at 55 kDa was detected with the anti-ubiquitin antibody in 
immunoprecipitated samples from Mifepristone-induced gs3T3-Irga6 cells (Figure 26 B, 
lane 7). However, the fact that this band is equally intense even in Irga6 negative samples 
argues strongly for a cross-reaction of the ubiquitin antibody with the heavy chain (MW 
~ 50 kDa) of the serum used for immunoprecipitation (Figure 26 B lane 5, 13, 15). Due 
to this technical problem, it could not be determined in this assay whether mono-
ubiquitination was responsible for the observed size shift of Irga6 protein in SDS-PAGE. 
The immunoprecipitation was repeated and the samples were subjected to SDS-PAGE 
under non-reducing conditions (without β-mercaptoethanol) to prevent the separation of 
the disulfide bridge linked heavy and light chains of the used serum. Thereby the 
detected antibody band should shift to a higher molecular weight (~150 kDa). 
Unfortunately, Irga6 did not migrate properly under these conditions (data not shown).  
 
Figure 26 Irga6 is polyubiquitinated in Mifepristone- but not in IFNγ-induced gs3T3-Irga6 cells. 
Gs3T3 wt (lane 1-8) and -Irga6 cells (lane 9-16) were stimulated for 24 hrs with either IFNγ (200 U/ml), 
Mifepristone (10-9 M) or both or were left untreated before lysis in PBS/1% Triton X-100. Irga6 protein 
was immunoprecipitated from the postnuclear supernatants with 165 antiserum coupled to protein A 
Sepharose beads. 2% of the original lysates (lanes 1-4 and 9-12) and 50% of immunoprecipitates (lane 5-8 
and 13-16) were analysed in two parallel immunoblots with the monoclonal antibodies directed against (A, 
C) Irga6 (10D7) and (B) ubiquitin (FK2). (C) Represents a longer exposure of the immunoblot displayed in 
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(A) in order to make the ubiquitinated higher molecular weight bands visible (γ: induced with IFNγ; M: 
induced with Mifepristone, M+γ: induced with both IFNγ and Mifepristone, no: untreated). Black 
arrowheads indicate the heavy chain of the serum used for immunoprecipitation. Irga6 specific band are 
indicated in red: red arrowheads indicate the 47 and 55 kDa forms of Irga6 and red asterisks indicate 
ubiquitinated Irga6.  
In order to determine the type of protein modification found on the 55 kDa form 
of Irga6, the protein was immunoprecipitated from Mifepristone-induced cells and 
separated by SDS-PAGE. The band at 55 kDa was cut from the Coomassie stained gel 
and was sent for matrix assisted laser desorption/ionisation mass spectrometry (MALDI-
MS) analysis (U. Roth, Bioanalytical Laboratory of the CMMC, Cologne). Even though 
Irga6 derived peptides could be identified, the contamination with the heavy chain of the 
antibody used for immunoprecipitation resulted in a largely reduced coverage making the 
identification of a protein modification impossible (data not shown). Also separation of 
Irga6 by two-dimensional gel electrophoresis failed to yield any further insights as the 
protein did not focus in the separation by isoelectric point (data not shown). 
 
I II.2.2. Influence of IRG expression cell proliferation and survival 
Prompted by the previous report on the negative influence of stable ectopic expression of 
Irgb6 on cell survival and proliferation (Carlow 1998), the growth behaviour of the 
inducible gs3T3-IRG cell lines was monitored over a period of 10 days using a 
colorimetric cell proliferation assay (CellTiter96, Promega). Several clones were 
analysed for each IRG protein in at least two independent experiments. Results of single 
representative experiments are shown. Gs3T3 wt cells induced with Mifepristone 
proliferated slightly but repeatedly slower than both untreated and IFNγ-induced cells 
(Figure 27 B). This effect could not be documented with NIH3T3 cells not containing the 
inducer plasmid, suggesting that the expression of the GeneSwitch protein might be 
responsible for the reduction in growth rate (Figure 27 A). On the other hand, NIH3T3 
cell growth rate was slightly reduced following IFNγ-induction indicating some general 
differences between the NIH3T3 and gs3T3 cells used. When induced with Mifepristone, 
gs3T3-Irga6, -Irgm1, -Irgm2, -Irgm3 and -Irgc cells reproducibly displayed a minor 
growth retardation compared to non-induced cells in the same range as the effect seen in 
the wild type gs3T3 cells (Figure 27 C-G). No additional growth inhibitory effect 
mediated by the expressed proteins could be detected. In contrast to the other cell lines 
tested, gs3T3 cells expressing Irgd or Irgb6 following Mifepristone induction showed a 
dramatic growth arrest over the whole course of the experiment (Figure 27 H, I). 
Microscopically monitoring of the cells during the assay confirmed a lack of proliferation 
and revealed increasing cell death over time. All gs3T3-Irga6 and -Irgd clones analysed 
were growth inhibited following Mifepristone induction (3 clones for Irgd and 5 clones 
for Irgb6; data not shown). As induction of endogenous Irgb6 and Irgd in the context of 
the IFNγ response did not show a negative effect on cell proliferation (Figure 27 B, K, I), 
it was hypothesised that in Mifepristone-induced cells an IFNγ-induced regulatory factor 
is missing that normally prevents growth inhibition by these proteins. To test this 
possibility, double inductions with Mifepristone and IFNγ were performed, inducing 
either simultaneously or preinducing 24 hrs with one inducer before adding the other one. 
Unexpectedly, neither of these treatments resulted in a rescue of the complete growth 
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inhibition (Figure 27 K, I). In the case of Irgd that could be explained by overexpression 
of the protein as a result of double induction. As the Irgb6 expression induced by 
Mifepristone was hardly detectable in Western blot and drastically lower than following 
induction with IFNγ, such a stoichiometric effect is highly unlikely for Irgb6.  
Figure 27 Influence of IRG expression on cell proliferation. Equal numbers of cells from the indicated 
cell lines (1000/well) plated onto 96well plates in quadruplicates were induced with either IFNγ (200 
U/ml), Mifepristone (10-9 M) or a combination of both for the indicated time. Cell proliferation was 
measured in a colorimetric assay detecting the formazan product of a tetrazolium salt bioreduced by living 
cells at 490 nm (empty squares: non-treated; red triangles: IFNγ-induced; blue circles: Mifepristone-
induced; green diamonds: Mifepristone + IFNγ; blue crosses: 24 hrs preinduction with IFNγ followed by 
double induction; pink asterisks: 24 hrs preinduction with Mifepristone followed by double induction). The 
small differences in kinetics between the cell lines and individual experiments can be largely attributed to 
variations in cell number at the beginning of the experiment due to counting errors, as cells grew slower 
when plated at a lower density. Kinks in the curves were due to disturbance of the cells during feeding. 
One representative of two performed experiments is displayed. 
To determine whether the observed growth inhibition was due to a cell cycle 
arrest, the DNA content of untreated, IFNγ- and Mifepristone-induced gs3T3 wt and -
Irgb6 cells was determined (Figure 28). Independent of treatment, wild type cells 
displayed a DNA profile typical for proliferating cells (Figure 28 A), and so did non-
induced gs3T3-Irgb6 cells (Figure 28 B upper panel). By contrast, gs3T3-Irgb6 cells 
were blocked in cell cycle progression before reaching the G2/M phase as early as 24 hrs 
after Mifepristone induction (Figure 28 B lower panel).  
In order to exclude that the site of chromosomal integration of the Irgb6 
expression construct was responsible for the observed growth inhibition and cell cycle 
arrest, the stable transfection was repeated and the growth behaviour of newly generated 
clones was determined. While the clone BB6 was also completely growth inhibited 
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following both Mifepristone and double induction (Figure 27 K), another clone, AC3, 
was only partially inhibited (Figure 27 L). Thus, further experiments need to be 
performed to confirm the specificity of the observed growth inhibitory effects, to analyse 
the suggested effect of Irga6 (and probably also Irgd) on the cell cycle and to establish 
whether apoptosis or necrosis is induced in cells expressing these proteins. Consequently, 
only short-term experiments were performed when expressing Irgb6 or Irgd in absence of 
IFNγ induction.  
 
Figure 28 Influence of Irgb6 expression on cell cycle progression. Cell cycle progression of gs3T3 wt 
(A) and -Irgb6 cells (B) was monitored by analysing the cellular DNA content using propidium iodide (PI) 
staining of ethanol fixed cells and flow cytometry. Non-induced cells were compared with 24 hrs 
Mifepristone (10-9 M) and IFNγ (200 U/ml) induced ones. Single cells were gated (R1 in small inlay; cell 
size (forward scatter, FSC) is plotted against cell granularity (side scatter, SSC) and the DNA content 
measured by intensity of PI fluorescence was plotted against cell counts. The duplication of the cellular 
DNA content during the S phase can be see as an increase in PI fluorescence. The different phases of the 
cell cycle are indicated above the peaks. Percentage of gated cells in the G2/M phase is given. 
 
I II.2.3. Influence of IFNγ on the subcellular localisation of Irgm1-3, Irgc, 
Irgd and Irga6 
The subcellular localisation of single IRG proteins induced by Mifepristone and 
IFNγ, respectively, was examined in gs3T3 mouse fibroblasts by immunofluorescence 
using specific immunoreagents. Of the three IRGM proteins, Irgm3 has been reported to 
localise to the endoplasmic reticulum and to undefined circular cytoplasmic structures 
(Taylor 1997). Irgm1 is found at a high intensity on Golgi membranes (Martens 2004b), 
and on the endolysosomal system (Zhao unpublished results), while Irgm2 is localised 
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rather precisely to Golgi membranes (Martens 2006). All three of these distinctive 
localisations were accurately reproduced in IFNγ-induced gs3T3 cells as seen by partial 
colocalisation with the organellar markers calnexin (ER), giantin and GM130 (both 
Golgi) (A-C of Figure 29-31. Furthermore, individual IRGM proteins expressed in 
absence of IFN by Mifepristone induction in the respective gs3T3-IRG cells (D-F of 
Figure 29-31) or by transient transfection of gs3T3 cells with single cDNA expression 
constructs (G-I of Figure 29-31; see also (Taylor 1997) (Irgm3) and (Martens 2004b) 
(Irgm1)) displayed the same localisation. Taylor and colleagues showed that the G1 
mutant of Irgm3, S98N, did not bind GTP in vivo and localised normally to the ER when 
transfected as a GFP fusion into HeLa cells not stimulated with interferon (Taylor 1997). 
A similar result has been reported in transfected mouse L cells for the homologous 
mutant, Irgm1(S90N), in an otherwise native construct (Martens 2004b). These 
observations were both confirmed in gs3T3 fibroblasts transfected with cDNA 
expression constructs of the mutant GTPases singly (J-L of Figure 29, Figure 31) and 
were extended to include Irgm2(S78N), which is also correctly localised in uninduced 
gs3T3 fibroblasts (Figure 30 J-L). The localisation of the three GMS GTPases is thus 
independent of IFNγ stimulation, the presence of other IRG proteins and GTP binding.  
Mifepristone-induced Irgc (CINEMA) in gs3T3-Irgc cells localised in a 
distributed reticular pattern both in absence (Figure 32 A) and presence of IFNγ (Figure 
32 B-C). This is consistent with the primarily cytosolic localisation indicated by the 
predominant presence of Irgc in the supernatant of hypotonic lysates of seminiferous 
tubules from murine testes (Rhode 2007). Direct comparison of the subcellular 
localisation of hormone-induced Irgc in fibroblasts with endogenous Irgc was not 
possible, as Irgc is exclusively expressed in haploid spermatids in vivo (Rhode 2007). 
There are no immortalised cell lines that adequately represent this cell type and cell lines 
of other origin did not express detectable levels of the protein, either constitutively or 
after induction with interferons (Bekpen 2005b; Rhode 2007). However, endogenous Irgc 
was detected the whole cytoplasm of haploid spermatids with the specific rabbit serum 
39/°3 in testis sections (Rhode 2007), thus arguing that Irgc localisation following 
ectopic expression in gs3T3 cells did not differ radically from the normal subcellular 
localisation. 
The subcellular localisation of endogenous Irgd induced by IFNγ and Irgd 
ectopically expressed by Mifepristone induction could not be determined with absolute 
certainty as the Irgd specific serum 2078 worked poorly in immunofluorescence of 
uninfected cells (Figure 32 D-F). However, a weak, distributed, reticular signal could be 
detected in IFNγ as well as in Mifepristone-induced cells (Figure 32 E-F) but not in 
uninduced cells (Figure 32 D). To ascertain Irgd localisation, gs3T3 cells were 
transiently transfected with an expression construct of Irgd C-terminally tagged with 
ctag1 in presence and in absence of IFNγ. Irgd detected with the ctag1 specific 2600 
antiserum localised in a distributed reticular pattern independent of IFN-induction and 
partially colocalised with Irga6 in IFN-induced cells (Figure 32 G-I). Additionally, Irgd 
was found inside the nucleus, especially in cells expressing high levels of the protein, 
whereas Irga6 was excluded from the nucleus (Figure 32 G-I). These results suggest that 
Irgd is largely cytosolic in vivo, as was indicated by its predominant presence in the 
supernatant of hypotonic lysates from IFNγ-induced fibroblasts (~ 90%; (Martens 
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2004b)), allowing detectable diffusion of the protein into the nucleus through the nuclear 
pores (permeable for proteins smaller than ~60 kDa; (Paine 1975)). In absence of any 
other conspicuous signal, it is likely that the residual membrane associated 10% of the 
endogenous Irgd protein localise to the ER. 
 
Figure 29 Subcellular localisation of Irgm1 is independent of IFNγ and nucleotide binding. (A-F) 
Gs3T3-Irgm1 cells were induced with IFNγ (200 U/ml) (A-C) or Mifepristone (10-9 M) (D-F) for 24 hrs. 
(G-L) Gs3T3 cells were transiently transfected with an (pGW1H, 1µg) expression construct for either 
Irgm1 wt (G-I) or for the G1 motif mutant Irgm1(S90N) (J-L) in absence of IFN. Irgm1 was detected in IF 
with the Irgm1 specific antiserum A19 (red in A, D; green in G, J) and the Golgi protein GM130 with 
G65120 monoclonal antibody (green in B, E; red in H, K). Overlay with the nuclear counterstain (DAPI, 
blue) is shown in C, F, I and L. The magnification is 400x in A-F and 630x in G-L. 
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Figure 30 Subcellular localisation of Irgm2 is independent of IFNγ and nucleotide binding. (A-F) 
Gs3T3-Irgm2 cells were induced with IFNγ (200 U/ml) (A-C) or Mifepristone (10-9 M) (D-F) for 24 hrs. 
(G-L) Gs3T3 cells were transiently transfected with an (pGW1H, 1µg) expression construct for either 
Irgm2 wt (G-I) or for the G1 motif mutant Irgm2(S78N) (J-L) in absence of IFN. Irgm2 was detected with 
in IF with the Irgm2 specific antiserum H53 (red in A, D; green in G, J) and the Golgi protein Giantin with 
αGiantin monoclonal antibody ((green in B, E; red in H, K). Overlay with the nuclear counterstain (DAPI, 
blue) is shown in C, F, I and L. The magnification is 630x. 
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Figure 31 Subcellular localisation of Irgm3 is independent of IFNγ and nucleotide binding. (A-F) 
Gs3T3-Irgm3 cells were induced with IFNγ (200 U/ml) (A-C) or Mifepristone (10-9 M) (D-F) for 24 hrs. 
(G-L) Gs3T3 cells were transiently transfected with an (pGW1H, 1µg) expression construct for either 
Irgm3 wt (G-I) or for the G1 motif mutant Irgm3(S98N) (J-L) in absence of IFN. Irgm3 was detected with 
in IF with the Irgm3 monoclonal antibody αIGTP clone 7 (red in A and D; green in G and I) and the ER 
protein Calnexin with SPA-865 antiserum (green in B, E; red in H, K). Nuclei/cellular DNA was stained 
with DAPI (blue). The magnification is 400x in A-F and 630x in G-L. 
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Figure 32 Subcellular localisation of Irgc and Irgd are independent of IFNγ. Gs3T3-Irgc cells were 
induced with (A) (10-9 M) Mifepristone alone (A) or together with (200 U/ml) IFNγ (B-C) for 24 hrs and 
stained with Irgc specific antiserum 39/3° (red in A and B). IFN-induced cells were counterstained for 
Irga6 with 10E7 monoclonal antibody (green in C). (D-F) Gs3T3-Irgd cells were either stimulated with 
IFNγ (E) or Mifepristone (F) as described above or left untreated (D), and stained with the Irgd specific 
antiserum 2078 (green) and DAPI for nuclear counter staining (blue). (G-I) Gs3T3 cells were transiently 
transfected with an (pGW1H, 1µg) expression construct for Irgc-ctag1 in the absence (G) or presence of 
IFNγ (H-I). Irgd was detected with the ctag1-specific serum 2600 (green in G-I). 10E7 monoclonal 
antibody was used for Irga6 counterstaining (red in I). The magnification is 400x in A-C and 630x in D-F. 
Irga6 expressed in absence of IFNγ by transient transfection of a cDNA 
expression construct (Martens 2004b) or by Mifepristone-induction of gs3T3-Irga6 cells 
departed significantly from the typical dispersed ER distribution of endogenous, IFN-
induced Irga6 (Figure 33 A) forming small cytoplasmic aggregates (Figure 33 B). Thus, 
this mislocalisation behaviour was not an artefact of the transient transfection protocol 
and it was also not due to over-expression, since gs3T3 cells expressed Irga6 at 
comparable levels following interferon and Mifepristone induction (Figure 34). When 
gs3T3-Irga6 cells were treated simultaneously with IFNγ and Mifepristone the wild-type 
localisation of Irga6 was largely restored (Figure 33 C). Hence, subcellular localisation 
of Irga6 was dependent on other IFN-inducible factors. The presence of residual 
aggregates in some cells suggest that this regulatory effect is close to stoichiometric and 
slightly overburdened in cells expressing twice the normal amount of Irga6 (see also 
Figure 33 M-R). 
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Figure 33 Subcellular localisation of Irga6 is dependent on IFNγ. Gs3T3-Irga6 cells were induced with 
(A) 200 U/ml IFNγ, (B) 10-9 M Mifepristone or (C) both for 24 hrs and Irga6 was detected in 
immunofluorescence with the 10E7 monoclonal antibody (green).  
Since Irga6 was shown to form GTP-dependent homo-oligomers in vitro, it was 
conceivable that the Irga6 aggregates seen in vivo in absence of IFNγ represent GTP-
bound oligomers. Thus, the monoclonal Irga6 antibody 10D7 that was shown to 
exclusively recognise the active, GTP-bound conformation of Irga6 in 
immunofluorescence (Papic 2007) was used to determine the nucleotide status of Irga6 
protein in vivo. The polyclonal rabbit serum 165 (Figure 35 A, D, G, J, M, P) and the 
monoclonal antibody 10E7 directed against Irga6 both recognised Irga6 in 
immunofluorescence independent of the expression conditions (Figure 35 B, H, N). The 
monoclonal antibody 10D7, by contrast, failed to detected endogenous Irga6 in IFN-
induced cells (Figure 35 E) but efficiently bound to the Irga6 aggregates formed 
following ectopic expression by Mifepristone induction of gs3T3-Irga6 cells (Figure 35 
K). Upon co-induction with IFNγ and restoration of the wild type localisation, both the 
ectopic expressed and the endogenous Irga6 protein became undetectable for 10D7 
(Figure 35 Q). Only residual aggregates were stained by 10D7. Thus, Irga6 is in the 
inactive, GDP-bound conformation in IFNγ-induced cells and in the active, GTP-bound 
conformation when expressed in absence of IFNγ. To further ascertain the nucleotide-
dependence of Irga6 mislocalisation in vivo, the biochemical properties of two mutants of 
the first guanine nucleotide-binding motif, Irga6(K82A) and Irga6(S83N), were 
characterised in vitro and analysed respecting their subcellular localisation.  
Figure 34 Comparable Irga6 expression levels following IFNγ-and Mifepristone-induction. Gs3T3 wt 
(A) and gs3T3-Irga6 cells (B) were stimulated with 200 U/ml IFNγ or 10-9 M Mifepristone for 24 hrs or 
left untreated. Postnuclear supernatants of PBS/1% Triton X-100 lysates from 1.5, 3 and 6*104 cells (1.5x, 
3x, 6x) were separated by SDS-PAGE. Irga6 was detected in immunoblot with the 165 serum. Note the 
presence of the 48 kDa band of Irga6 protein in both IFN- and Mifepristone-induced cells.  
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Figure 35 Irga6 conformation is dependent on the presence IFNγ (see previous page). Gs3T3-Irga6 
cells were induced with 200 U/ml IFNγ (A-F), 10-9 M Mifepristone (G-L) or both (M-R) for 24 hrs and 
Irga6 was detected in immunofluorescence with the polyclonal rabbit serum 165 (A, D, G, J, M, P; green) 
and in parallel with either 10E7 (B, H, N; red) or 10D7 monoclonal antibodies (E, K, Q; red). Overlay of 
both channels with DAPI used for nuclear staining (blue) is shown in C, F, I, L, O and R. 10D7 is specific 
for the GTP-bound active conformation of Irga6 in immunofluorescence while 165 and 10E7 are not 
conformation sensitive. 
I II.2.4. Biochemical properties of Irga6 G1 mutants 
For the biochemical analysis, Irga6(K82A) and Irga6(S83N) were expressed as N-
terminal GST-fusions in bacteria and purified via a glutathione Sepharose affinity 
column followed by size exclusion chromatography (for documentation see appendix 
V.1). K82 is homologous to K16 of p21 Ras and mutations of this P-loop residue have 
been shown in several GTPases to be deficient in GTP binding (Pitossi 1993; Praefcke 
2004a; Sigal 1986). Irga6(K82A) was previously reported to have wild type affinity for 
mant-(m)GDP but its interaction with mGTPγS has not been detected (Uthaiah 2002). 
Unexpectedly, Irga6(K82A) had essentially wild type affinity for mGTPγS as measured 
in equilibrium titration (Figure 36 A, C), but with an unusually weak signal on mant-
nucleotide binding (red arrow in Figure 36 A). The increase in the intensity of the 
fluorescence signal from the mant group normally observed upon binding of labelled 
nucleotides to GTPases is due to reduced quenching by exclusion of solvent from the 
binding grove (Rojas 2003). Thus, a decreased change in fluorescence presumably 
reflects some restructuring of the nucleotide-binding site leading to a more open 
conformation. As previously reported, the affinity of Irga6(K82A) for mGDP was also 
wild-type (Figure 36 B, C; (Uthaiah 2002)). Unlike wild-type protein, however, 
Irga6(K82A) had no detectable GTPase activity over a large protein concentration range 
(Figure 36 E-F) while wt Irga6 showed cooperative hydrolysis of αP32-GTP as 
documented before (Figure 36 F; (Uthaiah 2003)). These surprising results implicate 
Irga6 lysine 82 not in nucleotide binding as in H-Ras (Sigal 1986) but rather in 
nucleotide hydrolysis alone. Wild-type Irga6 rapidly forms oligomers in vitro on addition 
of GTP that resolve as GTP is hydrolysed. Oligomerisation can be monitored by 
conventional (LS) and dynamic light scattering (DLS) (Figure 36 G-H) (Uthaiah 2003). 
Irga6(K82A), in contrast, slowly and continuously formed GTP-dependent oligomers 
that, consistent with its failure to hydrolyse GTP, did not resolve over the time-course of 
the experiment. Thus Irga6(K82A) is biochemically constitutively active, locked into the 
GTP-bound state. 
Figure 36 Biochemical properties of Irga6 wt, Irga6(K82A) and Irga6(S83N) (see next page). (A-D) 
Nucleotide affinities of wt Irga6, Irga6(K82A) and Irga6(S83N) measured by equilibrium titration with 0.5 
µM mant nucleotides and protein concentrations of 0-100 µM. (A) Equilibrium titration with mGTPγS. (B) 
Equilibrium titration with mGDP. (C) Average dissociation constants (Kd) from 2 independent 
experiments. (D) Effect of magnesium ion depletion with 10 mM EDTA on the nucleotide affinities of wt 
Irga6 protein. (E) Kinetics of α32P-GTP hydrolysis by Irga6 and Irga6 mutants (80 µM) displayed as ratio 
of the GTP concentration to the starting concentration (10 mM) against time. Similar results were obtained 
with 1 mM GTP and 50 µM protein (data not shown). (F) Specific GTP hydrolysis activity of Irga6wt and 
Irga6(K82A) measured over 30 min in the presence of 10 mM GTP and 20-160 µM protein (for wt see also 
(Uthaiah 2003) (G-H) Nucleotide dependent oligomerisation of 80 µM Irga6 proteins in the presence of 10 
mM nucleotide measured by conventional light scattering at 350 nm (F) and by dynamic light scattering at 
650 nm (G). (a.u.: arbitrary units). 
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The mutation S17N of p21 Ras retains normal affinity for GDP but is unable to 
bind GTP, and is therefore dominant negative, locked in the inactive state (Feig 1988). 
The homologous mutation of Irga6, S83N, generated in this study, however, had greatly 
reduced binding affinities for both nucleotides (Figure 36 A-C), did not hydrolyse αP32-
GTP (Figure 36 E), and did not form GTP-dependent oligomers (Figure 36 G-H). The 
hydrodynamic radius of Irga6(S83N) measured in DLS was consistent with a monomer. 
Irga6(S83N) therefore provided a negative control protein for the documentation of 
nucleotide-dependent processes mediated by Irga6. 
Binding of both GDP and GTP is strongly dependent on the presence of Mg2+ for 
H-Ras (Feuerstein 1987; Hall 1986; John 1988; Tucker 1986) and other small GTPases 
such as RalA (Frech 1990) and nucleotide dependent processes can therefore be easily 
inhibited in vitro. Thus, the influence of Mg2+ depletion by addition of EDTA on 
nucleotide binding of Irga6 was determined in vitro. Surprisingly the binding affinities 
for both mGDP and mGTPγS were only marginally lower in presence than in the absence 
of EDTA (Figure 36 C-D), hence divalent cations are dispensable for nucleotide binding 
by Irga6. A thorough literature search revealed that numerous other GTPases like SRP 
(Shan 2005), ARL3 (Hillig 2000) and the Rho family members Cdc42, Rac1 and RhoA 
(Zhang 2000) have also been reported to bind nucleotide in absence of magnesium ions 
indicating that a priori assumptions for the behaviour of GTPases on the basis of H-Ras 
data should be considered with caution. 
 
I II.2.5. Influence of nucleotide binding on the subcellular localisation of 
Irga6 
Having characterised the Irga6 G1 mutants K82A and S83N as biochemically dominant 
negative and inactive respectively, these mutants were employed to confirm that 
aggregated wild-type Irga6 in cells not treated with IFNγ was trapped in the GTP-bound 
state. Like wt protein, Irga6(K82A)-ctag1 expressed in uninduced murine fibroblasts by 
transient transfection formed cytoplasmic aggregates (Figure 37 A) but unlike 
endogenous and Mifepristone-induced wild type protein (Figure 33 A, B) as well as 
transiently transfected Irga6-ctag1 (data not shown), this mutant made similar aggregates 
in IFNγ-induced cells (Figure 37 B). A similar anomalous localisation of transfected 
Irga6(K82A) was reported earlier in interferon-induced astrocytes (Martens 2005). 
Furthermore, the endogenous Irga6 apparently co-localised in aggregates with the 
transfected Irga6(K82A) protein (Figure 37 C-D). These results suggested that 
cytoplasmic aggregation is a property of GTP-bound Irga6, constitutively in the case of 
the constitutively active protein, and, in the absence of IFNγ, also for the wild type. 
Furthermore it appeared that the constitutively active mutant could capture wild-type 
Irga6, presumably also in the GTP-bound form, in mixed aggregates. The significance of 
nucleotide binding for the formation of Irga6 aggregates was indicated by the failure of 
transfected, ctag1-tagged Irga6(S83N) to form aggregates either in IFN-induced or 
uninduced cells (Figure 37 E-H). Irga6(S83N)-ctag1 protein was distributed smoothly on 
cytoplasmic membranes.  
These results suggest that correct positioning of Irga6 to the ER is prohibited by 
GTP binding. When GTP binding occurs but hydrolysis is inhibited, as in the K82A 
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mutant, Irga6 delocalises and tends to aggregate. However, since the wild-type protein in 
interferon-induced cells localises correctly to the ER, but forms aggregates when 
expressed alone in cells, either following transfection or in the Mifepristone-inducible 
cells, the binding or hydrolysis of GTP in the natural situation must be regulated by other 
interferon-inducible factors. This conclusion was supported by the largely restored 
localisation of Irga6 observed in gs3T3-Irga6 cells induced simultaneously with 
Mifepristone and IFNγ (Figure 33 C, (Figure 35 M-R). It is, however, interesting that, 
despite the obvious normalisation of Irga6 in most doubly induced cells, the correct 
localisation was not completely restored in all cells. This could suggest that the control of 
Irga6 localisation in the interferon-induced cells is nearly limiting, and that the second 
“aliquot” of Irga6 expression due to the Mifepristone induction exceeds the capacity of 
the regulatory system. The behaviour of Irga6(K82A), forming aggregates whether the 
cell is induced with IFNγ or not, suggests that this mutant protein cannot be controlled by 
the regulatory system.  
Figure 37 Subcellular localisation of Irga6 is dependent on nucleotide binding. (A-D) Fibroblasts 
transiently transfected with “dominant negative” Irga6(K82A)-ctag1. (A) Gs3T3 cells not induced with 
IFNγ show typical cytoplasmic aggregates. (B-D) wild type MEFs induced with IFNγ. Irga6 is aggregated 
in IFNγ-induced cells transfected with Irga6(K82A). (E-H) Fibroblasts transiently transfected with inactive 
Irga6(S83N)-ctag1. (E) Gs3T3 cells not induced with IFNγ show essentially wild type, dispersed 
distribution. (F-H) wild type MEFs induced with IFNγ. Irga6 is not aggregated in cells transfected with 
Irga6(S83N). Transfected proteins were detected with anti-ctag1 antiserum 2600 (red in A, B, E, F) and 
total Irga6 with 10E7 monoclonal antibody (green in C, D). 
 
I II.2.6. Influence of IFNγ and nucleotide on the subcellular localisation of 
Irgb6 
Subcellular localisation of Irgb6 in IFNγ and Mifepristone-induced gs3T3-Irgb6 cells 
could not be determined due to the low expression level following Mifepristone 
induction and the fact that the goat anti-Irgb6 antiserum, A20, detected interferon-
induced cellular Irgb6 inefficiently in immunofluorescence (Figure 38 B-D). So an Irgb6 
construct with a C-terminal FLAG-tag was used for subsequent experimentation. This tag 
did not interfere with the properties of Irgb6 in any of the performed analyses (Figure 38 
see below, Figure 51).  
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Wild-type Irgb6, and Irgb6 with a C-terminal FLAG tag, transiently transfected into non-
induced fibroblasts were both even more strikingly mislocalised than Irga6, forming long 
fibre-like cords that surrounded the nucleus and appeared to entangle other cellular 
organelles (Figure 38 A). Irgb6-FLAG transfected into IFNγ-induced gs3T3 fibroblasts 
showed a fine reticular pattern with a few small residual structures (Figure 38 B-D). The 
striking fibre-like cords associated with transfection of Irgb6 into unstimulated cells were 
absent. Unlike the endogenous Irgb6 and the redistributed transfected protein, the 
residual aggregates as well as the severe aggregates observed in absence of IFN could be 
visualised by use of the A20 antiserum (Figure 38 B, C). Thus, like for Irga6 subcellular 
localisation of Irgb6 was dependent on other IFN-inducible factors. The reticular 
distribution seen in IFNγ-induced cells transiently transfected with Irgb6-FLAG 
presumably reflects the subcellular localisation of endogenous Irgb6, which is in 
accordance with the majority of the protein being soluble in hypotonic lysates (Martens 
2004b). In absence of any other conspicuous signal in immunofluorescence, it is likely 
that the membrane-associated part of Irgb6 protein (20-30%) localise to the ER.  
Figure 38 Subcellular localisation of Irgb6 is dependent of IFNγ and nucleotide binding. Gs3T3 cells 
transiently transfected with FLAG-tagged Irgb6 wt and mutant expression constructs (pGW1H, 1 µg). 
Transfected proteins were detected with the anti-FLAG monoclonal antibody M2 (red, A-B, D, E, G, I, K-
L). (A-D) Irga6 wt-FLAG transfected into (A) uninduced and (B-D) IFNγ-induced cells (200U/ml). (C) 
Irgb6 specific A20 antiserum (green) does not detect distributed Irgb6 protein efficiently. (D) Overlay of B 
and D with nuclear counterstain (DAPI). (E-J) Irga6(S70N)-FLAG transfected into (E-F) uninduced and 
(G-J) IFN-induced cells. (F, H) Calnexin staining with SPA-865 serum. (J) Irga6 detected with 165 serum. 
(K-L) Irgb6(K69A)-FLAG transfected into (K) uninduced and (L) IFN-induced cells.  
As with Irga6, the formation of aggregates by Irgb6 in absence of IFNγ was 
dependent on the integrity of the GTP-binding site and hence nucleotide binding. The G1 
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motif mutant Irgb6(S70N) like the corresponding nucleotide binding-deficient Irga6 
mutant, S83N, displayed wild-type localisation, apparently overlapping with Calnexin, 
both in IFNγ-induced (Figure 38 G-H) and uninduced cells (Figure 38 E-F) and with 
Irga6 in induced cells (Figure 38 I-J). The mutant Irgb6(K69A), like the corresponding 
nucleotide-binding but hydrolysis-deficient Irga6 mutant, K82A, formed typical 
aggregates in the absence and presence of IFNγ (Figure 38 K-L).  
 
I II.2.7. Behaviour of IRG proteins in size exclusion chromatography 
Since the IRG proteins displayed such a distinct behaviour in cells their behaviour in 
analytical size exclusion chromatography was determined. Furthermore, it was analysed 
whether the formation of Irga6 and Irgb6 aggregates in absence of IFNγ was reflected in 
a shift of the proteins to higher molecular weight fractions ex vivo. Lysates of IFNγ- or 
Mifepristone-induced gs3T3 and gs3T3-IRG cells were separated over a Superose6 HR 
column and fractions were collected and analysed for the IRG proteins in SDS-PAGE 
followed by Western blot with specific immunoreagents (Figure 39). The analysed 
members of the IRG family displayed a distinct running behaviour following IFNγ 
induction in analytical gel filtration. Irgb6 and Irgd signals were strongest at a size that 
roughly equals a monomer (Figure 39 C+F), while all the IRGM proteins migrated at 
sizes consistent with a dimer or trimer: 70 kDa for Irgm1 (monomer 37 kDa in WB, 
Figure 39 G), 100 kDa for Irgm2 (Figure 39 H, Mifepristone-induced) and 150 kDa for 
Irgm3 (Figure 39 I). Irgm2 was analysed only following Mifepristone-induction, as the 
polyclonal H53 serum did not recognise endogenous, IFN-induced Irgm2 in 
NIH3T3/gs3T3 cells, probably due to a polymorphism present in different mouse strains 
(H53 was generated against a C-terminal peptide from C57BL/6 Irgm2, see material and 
methods II.1.8). Heteromeric interactions cannot formally be excluded for the IRGM 
proteins, though at least for Irgm2 IFN-induced proteins are not involved. Irga6 trailed 
over a large range from the size of a monomer to the size of a tetramer (50-200 kDa) 
(Figure 39 A) indicating that Irga6 is present in different states in the cell.  
Even though Irga6 and Irgb6 formed large, nucleotide-dependent intracellular 
aggregates upon expression in absence of IFNγ, Mifepristone-induced proteins migrated 
identical to IFNγ-induced endogenous proteins in size exclusion chromatography (Figure 
39 B, D, E). The covalently modified 55 kDa form of Irga6 found in Mifepristone-
induced cells also behaved like IFNγ-induced 44 kDa form of Irga6. The two analysed 
gs3T3-Irgb6 clones (AC3 and BB6) that behaved somewhat differently in the cell 
proliferation assays (partially and completely growth inhibited respectively) displayed 
identical elution profiles (Figure 39 D, E). This suggests that in vivo aggregation is 
largely reversible upon cell lysis and that no other IFN-inducible factors participate in 
forming the higher molecular weight fraction of Irga6. To exclude that the aggregated 
pool of Irga6 protein is actually lost by pelleting the nuclei after cell lysis with non-ionic 
detergents, this pellet was solubilised in boiling protein loading buffer and separated in 
SDS-PAGE. As seen in Figure 40, all the Mifepristone-induced Irga6 protein is found in 
the detergent soluble fraction and no protein was found in the pellet fraction.  
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Figure 39 Behaviour of IRG proteins in analytical size exclusion chromatography. Gs3T3 cells 
induced with 200U/ml IFNγ or 10-9 M Mifepristone respectively were lysed in PBS/0.1% Thesit and the 
postnuclear supernatants were subjected to analytical gel filtration on a Superose 6 HR column in the same 
buffer. The eluted fractions were analysed by SDS-PAGE followed by Immunoblot with specific antisera 
((A-B) Irga6 with 10D7, (C-E) Irgb6 with A20, (F) Irgd with 2078, (G) Irgm1 with A19, (H) Irgm2 with 
H53, (I) Irgm3 with αIGTP clone7). (A, C, F, G, I) IFNγ-induced gs3T3-Irga6 cells (B) Mifepristone-
induced gs3T3-Irga6 cells, (D) Mifepristone-induced gs3T3-Irgb6 clone AC3 cells, (E) Mifepristone-
induced gs3T3-Irgb6 clone BB6 cells. (H) Mifepristone-induced gs3T3-Irgm2 cells. The molecular mass 
correlating with a certain elution volume derived from calibration of the column with marker proteins (see 
material and methods) is indicated at the bottom of the figure. 
In contrast to cellular Irga6, non-myristoylated recombinant bacterial Irga6 
(Uthaiah 2002) and recombinant Irga6(G2A) from insect cells (Papic 2007) fractionated 
as a monomer. Myristoylated recombinant Irga6 from insect cells, however, ran at 200-
250 kDa in size exclusion chromatography (Papic 2007). Thus, the high molecular 
weight fraction of Irga6 is dependent on the myristoyl group itself and seems to be 
independent of other cellular proteins. This effect is probably either due to the intrinsic 
properties of the lipid moiety or to myristoyl-induced conformational changes that might 
enhance homomeric interaction. 
 
Figure 40 Irga6 protein from Mifepristone and IFNγ-induced cells is completely detergent soluble. 
Untreated, IFNγ- and Mifepristone-induced gs3T3-Irga6 cells were lysed in PBS/1% Triton X-100. 
Unsolubilised material pelleted by centrifugation and boiled in protein loading buffer (50 mM Tris/HCl pH 
6.8/0.7 % β-ME/1% SDS/5 % glycerol/0.0025 % (w/v) bromephenol blue) as well as the postnuclear 
supernatants were subjected to SDS-PAGE followed by immunoblot with the anti-Irga6 serum 165 and 
calnexin antiserum SPA-865. Both IFN- and Mifepristone-induced Irga6 was completely detergent soluble. 
Similar results were obtained with 0.1% Thesit and fibroblasts transiently transfected with expression 
constructs for Irga6 (Papic unpublished data). 
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I II.2.8. Regulation of Irga6 and Irgb6 positioning by the GMS proteins 
In view of the complex representation of the IRG proteins in the mouse and their 
extensive functional non-redundancy, it was conceivable that IRG proteins themselves 
are the IFNγ-dependent regulators of Irga6 and Irgb6 and interact with each other to 
maintain some kind of functional equilibrium in the interferon-induced cell, reflected in 
the correct ER localisation of these two proteins. To examine this hypothesis directly, the 
5 other IRG GTPases Irgm1, Irgm2, Irgm3, Irgd and Irgb6 were transfected transiently 
into the Mifepristone-inducible gs3T3-Irga6 fibroblasts that normally express 
mislocalised Irga6. After Mifepristone induction, 84% of the cells expressing the other 
IRG proteins showed wild type Irga6 localisation, while 87 % of the control cells 
transfected with EGFP alone showed typical Irga6 aggregates (Figure 41 A). The effect 
of the transfected IRG GTPases on Irga6 localisation correlated positively with the DNA 
amount used for transfection (compare Figure 41 B with D). Not all 5 IRG members were 
necessary to correct the localisation of Irga6. In single transfections, the GKS subfamily 
members Irgd and Irgb6 did not promote the wild type localisation of Irga6, while the 
three GMS proteins Irgm1, Irgm2 and Irgm3 all did so (Figure 41 B, D). Transfection of 
Irgb6 into Mifepristone-induced gs3T3-Irga6 cells caused a further maldistribution of 
Irga6 (Figure 41 B). Irgb6 was itself massively mislocalised in these transfectants (see 
above). Single IRGM GTPases mediated a less pronounced effect than transfection of all 
5 p47 GTPases but all were clearly active (Figure 41 B, D). The deficient normalising 
activity of single IRGM proteins could not be compensated by an increase in the amount 
of DNA transfected (compare Figure 41 B with D). However, simultaneous transient 
transfection of 3 GMS GTPases into Mifepristone-induced gs3T3-Irga6 fibroblasts 
restored wild type Irga6 localisation as efficiently as co-transfection with all 5 additional 
GTPases (Figure 41 A, C and Figure 42 A-C). Hence, intracellular localisation of Irga6 is 
indeed regulated by other IRG proteins, and the regulatory function is specifically a 
property of the three IRGM proteins, working in concert and independently of Irgb6 and 
Irgd. The ability of the IRGM GTPases to rescue Irga6 localisation was dependent on an 
intact G1 motif. When the three IRGM proteins carrying the GMS to GMN mutation in 
the G1 motif of the nucleotide binding site or EGFP were co-transfected into 
Mifepristone-induced gs3T3-Irga6 cells no normalisation of Irga6 localisation was seen 
(Figure 41 A, C, Figure 42 D-F). An intact G1 motif was required in all three IRGM 
proteins for full normalisation of Irga6 localisation but individual GMN mutants had no 
dominant negative effect on the normalisation activity of co-transfected wild-type IRGM 
proteins (data not shown).  
In transient transfection of the 5 IRG proteins Irgm1-3, Irgd and Irgb6 into 
Mifepristone-induced gs3T3-Irga6 fibroblasts, it was already observed that not only that 
Irga6 aggregates were resolved, but also that the transfected Irgb6 was localised in a 
distributed, smooth, cytoplasmic pattern. No cell with Irgb6 fibres was detected in any of 
these experiments. Hence, it was analysed whether the regulatory activity of the IRGM 
proteins could be generalised on Irgb6 as well as Irga6. Aggregate formation in 
uninduced cells by transfected, FLAG-tagged wild type Irgb6 was eliminated by co-
transfection with the 3 GMS proteins (Figure 42 G-I, Figure 43 A) but not by co-
transfection of the 3 GMN mutants or EGFP (Figure 42 J-L, Figure 43 A). As shown 
above for Irga6, GKS proteins (Irgd and Irga6) had no beneficial effect (data not shown) 
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whereas Irgm2 and Irgm3 both partially restored Irgb6 localisation when co-transfected 
one at a time with Irgb6, however Irgm1 alone was ineffective for Irgb6 (Figure 41 B). 
Transfection of Irgm2 and Irgm3 together could not normalise Irgb6 localisation 
completely, and, as with Irga6, only co-transfection of all 3 IRGM proteins was fully 
effective (Figure 41 B). The situation with Irgb6 is thus very similar to that with Irga6. 
Both proteins form distinctive aggregates and mislocalise in the absence of other 
interferon-induced proteins. This mislocalisation is dependent on the integrity of the GTP 
binding site. The mislocalisation can be completely prevented if the 3 IRGM proteins are 
co-expressed, and this normalising activity is in turn dependent on the integrity of the 
GTP binding sites of the IRGM proteins.  
 
Figure 41 Quantification of the effect of other IRG proteins on Irga6 localisation. Irga6 localisation 
was assayed in Mifepristone-induced gs3T3-Irga6 cells transiently transfected with the indicated (pGW1H) 
expression constructs either individually or in pools (see also Figure 42). Effect of presence of GMS 
proteins on resting localisation of Irga6, recorded as smooth reticular (wild type) staining (white), partly 
aggregated (grey) and strongly aggregated (black). 150 cells were counted blind per data point. (A) Cells 
transfected with a pool of (pGW1H) expression constructs of Irgm1, Irgm2, Irgm3, Irgb6 and Irgd (5IRGs; 
400 ng each, total 2 µg) were compared with cells transfected with an EGFP expression vector (2 µg). (B, 
D) Cells were transfected with (pGW1H) expression constructs encoding single IRG proteins: (B) 2 µg 
each, (D) 400 ng each. Each IRGM protein alone showed a significant dose-dependent beneficial effect on 
Irga6 localisation, but this was in all cases incomplete. Similar effects were also seen with cells transfected 
with constructs encoding pairs of GMS proteins (data not shown). Irgd was inactive. Cells transfected with 
the Irgb6 expression construct showed striking Irgb6 aggregates, which largely colocalised with aggregated 
Irga6 (see also Figure 38). (C) Cells transfected with a pool of (pGW1H) expression constructs of the three 
wild type GMS proteins were compared with cells transfected with a similar pool of the three inactive 
GMN mutants (667 ng each).  
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Figure 42 Subcellular localisation of Irga6 and Irgb6 are dependent on the 3 wild-type GMS 
proteins. (A-F) Gs3T3-Irga6 cells were induced for 24 hrs with 10-9 M Mifepristone and transfected 
transiently with other IRG expression constructs (pGW1H). Irga6 (green) was identified in 
immunofluorescence by 10E7 monoclonal antibody and Irgm2 (red) with H53 antiserum. In (C, F) nuclei 
are counterstained with DAPI (blue). (A-C) Cells transiently transfected with 3 expression constructs 
encoding Irgm1, Irgm2 and Irgm3 (667 ng DNA each). Note the diffuse localisation of Irga6 only in cells 
transfected with the 3 functional GMS proteins. (D-F) Cells transiently transfected with 3 expression 
constructs encoding Irgm1(S90N), Irgm2(S78N) and Irgm3(S98N) (667 ng DNA each). (G-L) Uninduced 
gs3T3 wt cells transiently co-transfected with (pGW1H) expression constructs for FLAG-tagged Irgb6 and 
either 3 GMS wt (G-I) or GMN mutant (J-L) proteins (0.5 µg each). Irgb6-FLAG was detected with the 
FLAG-specific monoclonal antibody M2 (red) and Irgm2 (green) was detected with the rabbit serum H53 
(green). In (I, L) nuclei are counterstained with DAPI (blue). 
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Figure 43 Quantification of the effect of GMS proteins on Irgb6 localisation. Quantification of Irgb6 
localisation in gs3T3 wt cells transiently transfected with an Irgb6-FLAG expression construct (0.5 µg) 
recorded as smooth reticular (wild type) staining (white), partly aggregated (grey) and strongly aggregated 
(black). 150 cells were counted blind per data point. (A) Cotransfection of the 3 GMS proteins (0.5 µg 
each), the 3GMN proteins (0.5 µg each) or EGFP (1.5 µg) respectively (see also Figure 42 G-L) (B) 
Cotransfection of single GMS protein expression constructs compared to cotransfection with different 
combinations of these constructs (0.5 µg per construct, adjusted to 1.5 µg of DNA with empty vector).  
 
I II.2.9. Nucleotide-dependent direct interactions of IRG proteins in Y2H 
To determine whether nucleotide-dependent regulation of Irga6 by the IRGM proteins 
involved direct interaction between the proteins, a yeast two-hybrid (Y2H) assay was 
performed. The complete coding regions of the IRG proteins studied were expressed as 
N-terminal fusions with the Gal4 DNA-binding (BD) and Gal4 activation domain (AD) 
in yeast reporter strains (James 1996). Protein-protein interactions were detected by 
growth on selective media (see Materials and Methods for details). The IRG proteins 
showed multiple interactions in this assay system with each family member displaying a 
distinct pattern of behaviour (Figure 44).  
The strong homotypic interaction of Irga6 observed in the Y2H system 
reproduced the in vitro oligomerisation of Irga6 in the presence of GTP (Figure 36, 
(Uthaiah 2003)) strengthening the potential in vivo relevance of this interaction. Very 
strong homotypic interaction was also observed for Irgb6. Furthermore, Irgb6 interacted 
strongly with Irga6 and more weakly with Irgm2. As anticipated, Irga6 displayed a very 
strong interaction with Irgm3 and a rather weak one with Irgm1. Irgm3 interacted with 
Irgm2 and Irgm1 and Irgm1 displayed a weak homotypic interaction. Furthermore, Irgc 
interacted with Irgm3 and Irga6, though the in vivo relevance of these interactions for 
Irgc function in testis remains elusive. As frequently seen in Y2H, some of the observed 
positive interactions were unidirectional, probably as a result of the different structural 
impacts of the AD and BD on the fused protein (Estojak 1995; Van Criekinge 1999).  
 
Figure 44 Nucleotide-dependent interactions of IRG proteins in yeast two hybrid (see next page). 
Interaction behaviour of full-length IRG proteins and mutants observed in a Gal4 based Y2H assay. 
Interactions were measured by growth on selective medium (synthetic defined medium lacking leucine, 
tryptophan, histidine and adenine). (A) Graphic representation of the strengths of the interactions indicated 
in terms of intensity of shades of grey following the key given next to the table. (B) Photographic 
documentation of the observed interactions and the respective mutants controls. ND: not determined. -: no 
interaction. 
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To confirm the specificity of the interactions seen and their relevance to the in 
vivo findings, the Y2H assay was repeated with nucleotide binding site mutants of the 
individual proteins. All Y2H interactions of GMS proteins with other family members 
were completely abolished by the GMS to GMN mutants, Irgm3(S98N), Irgm2(S78N) 
and Irgm1(S90N) (Figure 44). Likewise, Irga6(S83N) was also completely negative for 
all interactions shown by wild-type Irga6 (Figure 44). These results are consistent with 
the essentially passive behaviour displayed by Irga6(S83N) and the GMN mutants in 
fibroblasts (see above III.2.5 and III.2.8). The corresponding mutants of Irgb6(S70N) and 
Irgc(S66N) similarly failed to show any of the interactions observed with the respective 
wt proteins. The constitutively active mutant Irga6(K82A) retained many interactions in 
Y2H (Figure 44) but lost bi-directionality in its interaction with wt Irga6 and interaction 
with Irgb6 and Irgc were completely abolished. This observation is consistent with the 
slightly altered conformation of the mutant protein suggested by the anomalous 
behaviour upon mGTPγS binding (see above III.2.4). The corresponding mutant of Irgb6, 
K69A, preserved its interactions with wt Irgb6 and Irga6, though the latter was weakened 
significantly, and the interactions with the GMS proteins Irgm2 and Irgm3 were lost 
(Figure 44). Similarly, Irgc(K65A) retained its interaction with Irgm3 but failed to bind 
to Irga6. Thus, the multiple interaction between IRG proteins observed in Y2H were all 
sensitive to mutation of the G1 motif in either of the two interaction partners and hence 
presumably nucleotide dependent.  
An independent Y2H study based on N-terminal fusions with the LexA DNA-
binding domain and B42 activation domain also documented multiple interactions within 
the IRG family though nucleotide dependence was not analysed (Kaiser 2005). In 
contrast to the Gal4 system used in this study, which is based on low, constitutive 
expression, the LexA system employs high, inducible expression of the constructs. As 
anticipated from the different properties possessed by the two assay systems (Van 
Criekinge 1999) they highlighted distinct interactions, though the observed interaction 
profile is partially overlapping. Interestingly, both Irgb10, which was not tested in this 
study, and Irgd, which did not show any detectable interaction in the Gal4 system, 
interacted with other IRG family members in the LexA Y2H assay (Kaiser 2005). Since 
the AD- and BD-Irgd proteins were expressed in yeast cells as shown in Western blot 
(data not shown) it is likely that the absence of any interaction of these proteins with 
other IRG family members in the Gal4 based Y2H assay is due to structural constraints 
imposed by the fused Gal4 domains.  
 
I II.2.10. Direct GDP-dependent interaction of cellular Irgm3 with Irga6 
The results shown above document that functionally significant nucleotide-
dependent interactions between Irga6 and the GMS proteins occur in IFNγ-induced cells 
(III.2.8), and the yeast 2-hybrid data suggested that at least some of these interactions 
were likely to be direct (III.2.9). The strongest interaction of Irga6 with a GMS protein in 
yeast 2-hybrid was with Irgm3 and both proteins localise to the ER membrane in IFN-
stimulated cells. Accordingly, co-precipitation between Irga6 and Irgm3 from IFN-
stimulated cells was examined employing the Irga6-specific antiserum 165 coupled to 
protein A Sepharose beads. Clear but weak co-precipitation of Irgm3 with Irga6 was 
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documented in the absence of exogenous nucleotide (Figure 45). In the presence of 
exogenous GDP, the signal was noticeably weakened. The signal observed for Irgm3 was 
markedly sub-stoichiometric compared to the amount of immunoprecipitated Irga6. No 
signal was detected from lysates of uninduced cells. Addition of exogenous GTPγS, 
which favours Irga6 homomeric interaction (see above III.2.4 and (Papic 2007), 
completely abolished interaction of Irga6 with Irgm3. Together with the observation that 
both Irga6(S83N) and the Irgm3(S98N) were inert both in Y2H and in fibroblasts, this 
suggests that the Irga6-Irgm3 interaction requires GDP bound to both interaction 
partners. Thus, in absence of exogenous nucleotide GDP is presumably trapped in the co-
precipitated complex preformed inside the cell. Depletion of divalent cations by addition 
of EDTA did not prevent Irga6-Irgm3 interaction, suggesting that nucleotide binding for 
Irgm3, like for Irga6 (see above, Figure 36), is largely independent of the presence of 
Mg2+. A possible explanation for the noticeable inhibition of the co-immunoprecipitation 
of Irgm3 by exogenous GDP is the complex network of (regulatory) interactions between 
members of the IRG family observed in murine cells and in Y2H, as the lysate from 
IFNγ-induced cells also contains the other IFN-inducible IRG proteins. This might also 
apply to the strong inhibitory effect mediated by GTPγS. Yet, it cannot formally be 
excluded that one of the interaction partners, presumably Irgm3, needs to be in the GTP-
bound state for Irga6-Irgm3 interaction. 
 
Figure 45 Nucleotide dependent interaction of Irga6 with Irgm3 from mammalian cells in co-IP. Co-
immunoprecipitation of Irgm3 with Irga6. Irga6 was immunoprecipitated from IFNγ-induced gs3T3 cells 
lysed in the presence or absence of nucleotide (0.5 mM) using 165 serum. Irga6 and co-
immunoprecipitated Irgm3 were detected in immunoblot with 10D7 and anti-IGTP (Irgm3) antibody 
respectively. Non-induced cells served as negative control. To visualise Irgm3 in the lysate and in the IP 
samples, different exposure times were used (middle row: 10 sec; bottom row: 5 min). Two independent 
experimental are displayed. Loading: 5% of lysates, 25% of IPs for Irga6 blot, 75% for Irgm3 blot. (The 
shadow above the Irgm3 band in the long exposure is derived from the heavy chain of the 165 antibody 
used for IP). 
To confirm the results from the co-immunoprecipitation and to further clarify the 
nucleotide status of the observed interaction, purified bacterially expressed GST-Irga6 
bound to glutathione-Sepharose beads was used to pull-down Irgm3 from lysates of 
interferon-treated gs3T3 fibroblasts. In the absence of nucleotide, a very weak Irgm3 
signal was detected indicating a basal affinity of the two proteins for each other in 
absence of nucleotide. However efficient pull-down of Irgm3 followed the addition of 
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GDP to the binding reaction while GTPγS inhibited the interaction completely 
suppressing even the basal interaction seen in absence of nucleotide (Figure 46 A). 
Similar to the co-immunoprecipitation only a small proportion of the cellular Irgm3 
protein was trapped by a vast excess of recombinant Irga6 protein. When the Irga6 GTP-
binding deficient mutant, Irga6(S83N), was employed in the same assay, no increment in 
Irgm3 pull-down above background was seen on addition of GDP. Thus Irga6 probably 
interacts with Irgm3 in the IFNγ-treated cell in the GDP-bound state. As a mixture of 
GDP and GTPγS reflecting the intracellular concentrations of the nucleotides (100 µM 
GDP + 300 µM GTP; (Kleineke 1979)) completely inhibited Irgm3 precipitation, it 
seems unlikely that Irgm3 needs to be in the GTP-bound state in this interaction. GTP 
labelled with a mant fluorescent group has been shown to interfere with in vitro 
oligomerisation of recombinant Irga6 by sterically hindering the formation of the 
essential G-domain-G-domain interaction interface involving the bound nucleotides 
(Pawlowski, unpublished data). The formation of this interaction interface was crucial for 
substrate-aided hydrolysis of GTP by Irga6. Interestingly, addition of mantGDP to the 
pull down reaction similarly reduced Irga6-Irgm3 interaction to basal levels, implicating 
the same G-domain-G-domain interface in this interaction. 
 
Figure 46 Nucleotide dependent interaction of Irga6 with Irgm3 from mammalian cells in pull-down. 
Pull-down of cellular Irgm3 with recombinant GST-Irga6 and -Irga6(S83N) protein from IFNγ-induced 
gs3T3 cells (A) and from Mifepristone-induced gs3T3-Irgm3 cells (B) lysed in the presence or absence of 
guanine nucleotides (0.5 mM GDP, GTPγS or mGDP; mix: 100 µM GDP + 300 µM GTPγS; EDTA: 10 
mM). GST alone served as negative control. Recombinant fusion protein was visualised by Ponceau S 
staining of Western blot membranes (top row). Irgm3 was detected by immunostaining with anti-IGTP 
(Irgm3) antibody (bottom row). Lys: lysate control (4% of input). Dotted lines indicate positions where 
irrelevant lanes were removed from the image of the original gel. 
That the GDP-dependent interaction between Irga6 and Irgm3 does not depend on 
other IFNγ-induced intermediaries was shown by a similar pull down by Irga6 from 
Mifepristone-induced gs3T3-Irgm3 cell lysates (Figure 46 B). Again, GDP induced a 
strong interaction with wild type Irga6 but not with Irga6(S83N). The identity of the 
nucleotide required by Irgm3 for this interaction with Irga6 is not clear, but seems likely 
also to be GDP in view of the high concentration (0,5 mM) of the nucleotide maintained 
throughout the experiment. Additionally, the failure of Irgm3(S98N) to influence Irga6 
localisation in mammalian cells and to interact with Irga6 in yeast two-hybrid strongly 
argues against a functional interaction in absence of nucleotide. However, Taylor et al 
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reported some years ago that Irgm3 immunoprecipitated from IFNγ-induced cells 
predominantly co-precipitated GTP (Taylor 1997).  
Having documented the direct, regulatory interactions between GKS and GMS 
members of the IRG family governing the nucleotide status and localisation of GKS 
proteins in uninfected cells, the requirement of these interactions for IRG function in 
resistance to Toxoplasma gondii were explored. 
 
I II.2.11. Regulation of Irga6 in Toxoplasma-infected cells 
Data are accumulating that IRG GTPases cause the vesiculation and destruction 
of Toxoplasma gondii parasitophorous vacuole (PV) membranes (Ling 2006; Martens 
2005). At least five members of the family (Irga6, Irgb6, Irgd, Irgm2 and Irgm3) 
accumulate at the PV membrane in interferon-induced astrocytes (Martens 2005), a result 
that was confirmed for IFNγ-induced gs3T3 and mouse embryonic fibroblasts in this 
study (see below). However, nothing is known about the transition from the “resting” 
localisation of IRG proteins in the uninfected, interferon-induced cell to the (presumably) 
active forms that accumulate at the PV membrane shortly after infection. To shed more 
light onto this process, it was investigated whether nucleotide-dependent regulatory 
interactions between IRG proteins, like those required for the resting localisation of Irga6 
and Irgb6, are required for transfer of IRG proteins to the PV membrane.  
Figure 47 Irga6 localisation to the T. gondii PV is IFNγ and GMS protein dependent. Gs3T3-Irga6 
cells were induced for 24h with 200/ml IFNγ or 10-9 M Mifepristone or both or induced with Mifepristone 
and transfected transiently with other IRGs. Subsequently, cells were infected with T. gondii strain ME49 
for 2 hrs (MOI 6). Irga6 was identified by immunofluorescence with 10E7 monoclonal antibody (green) 
and Irgm2 with H53 antiserum. Nuclei were stained with DAPI. Intracellular Toxoplasma identified in 
phase contrast are marked with white arrows (B, D, F, H, J, M). (A-B) IFNγ-induced cells. (C-D) 
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Mifepristone-induced cells. (E-F) Cell induced with both Mifepristone and IFNγ. (G-H) Cells induced with 
Mifepristone and transiently transfected with (pGW1H) expression constructs for 5 IRGs (Irgm1-3, Irgb6, 
Irgd, 400 ng each). Note that the blue channel was used to detect Irgb6 with the A20 antiserum and the 
displayed PV was also Irgb6 positive (data not shown). (I-J) Cells induced with Mifepristone and 
transiently transfected with expression constructs for 3 GMS proteins (667 ng each). (K-L) Cells induced 
with Mifepristone and transiently transfected with expression constructs for the 3 GMN proteins (667 ng 
each). 
 
Figure 48 Influence of the other IRG proteins on the Irga6 signal at the T. gondii PV. (A) Number of 
Irga6 positive T. gondii PVs identified with the 10E7 antibody in gs3T3-Irga6 cells following 24 hrs 
induction with IFNγ (200 U/ml), Mifepristone (10-9 M) or both, or Mifepristone induction and transfection 
with either a pool of expression constructs encoding Irgm1, Irgm2, Irgm3, Irgb6 and Irgd (5IRGs), the 
three GMS proteins or the 3 inactive GMN mutants (in all cases total of 2 µg DNA; see also Figure 47). 
Data are recorded as the percentage of Irga6-positive PVs per 100 intracellular T. gondii. Around 100 
vacuoles per data point were counted blind. (B) Quantification of the mean pixel intensity of the Irga6 
signal observed in gs3T3-Irga6 cells infected with Toxoplasma gondii strain ME49 for 2 hrs at a MOI of 6. 
Cells were induced with IFNγ or with Mifepristone and simultaneously co-transfected with a pool of the 
indicated IRG expression constructs (400 ng each, total of 2 µg DNA; empty vector was used to adjust 
DNA amounts): Irga6, Irgb6, Irgm1, Irgm2 and Irgm3 (5IRGs), Irgm1, Irgm2 and Irgm3 (3GMS), the 3 
GMS plus Irgb6 (3GMS+b6) or the 3 GMS plus Irgd (3GMS+d). Irga6 was detected in 
immunofluorescence with 10E7 antibody. Pixel intensities of the Irga6 signal at the PV at a constant 
exposure time were determined at 6 points across the vacuole with Image J software 
(http://rsb.info.nih.gov/ij/). The average pixel intensity is indicated by black lines (35 vacuoles/treatment). 
Values of 5000 pixels and below cannot be distinguished from the background of the ER signal and can be 
considered as negative. The 3 GMS proteins are not sufficient to enable wild type intensity of Irga6 
accumulation at the PVM. Transfected cells in (A) and (B) were identified by staining for Irgm2 with the 
H53 serum.  
Indeed, in contrast to interferon-induced gs3T3 cells (Figure 47 A-B), Irga6 
expressed alone in cells, either by Mifepristone induction in gs3T3-Irga6 cells (Figure 47 
C-D) or Irga6-ctag1 expressed in fibroblasts transiently by transfection (data not shown) 
failed to accumulate at Toxoplasma gondii parasitophorous vacuoles. If, however, gs3T3-
Irga6 cells were simultaneously induced with IFNγ and Mifepristone, the ability of the 
Irga6 to accumulate at the PV was restored (Figure 47 E-F). The effect of IFNγ on Irga6 
localisation at the PVM was mirrored by transient co-transfection of the 5 other IRG 
GTPases into Mifepristone-treated gs3T3 fibroblasts (Figure 47 G-H) as well as by 
transient co-transfection of the 6 IRG GTPases into untreated gs3T3 fibroblasts (data not 
shown). Under these conditions also all the other IRG proteins except for Irgm1 localised 
to the PVM (Figure 47 G-H and see below, III.2.12). Co-transfection of the 3 IRGM 
GTPases into Mifepristone-induced gs3T3-Irga6 fibroblasts was sufficient to allow 
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accumulation of Irga6 at the PVM (Figure 47 I-J). However fewer Irga6 positive PVs 
were found than in IFNγ-induced cells (Figure 48 A), and the average intensity of the 
Irga6 accumulation at the vacuoles was lower than in interferon-induced cells (Figure 48 
B). This suggested that other IFN-inducible components might affect the efficiency of 
vacuolar accumulation of Irga6. Indeed, co-transfection of one or more further GKS IRG 
proteins along with the 3 GMS proteins (Irgb6 or Irgd or both) increased the average 
intensity of Irga6 on the vacuoles to a level comparable with that in IFNγ-induced cells 
(Figure 48 B). In a similar co-transfection, the 3 GMS to GMN G1 motif mutants of 
Irgm1, Irgm2 and Irgm3 were unable to mediate Irga6 accumulation at the Toxoplasma 
vacuoles (Figure 47 K-L, Figure 48 A), demonstrating nucleotide dependence of this 
process on the side of the IRGM proteins.  
The monoclonal antibody 10D7 that is specific for the active, GTP-bound 
conformation of Irga6 was used to analyse the nucleotide status of Irga6 at the T. gondii 
parasitophorous vacuolar membrane (PVM). As shown above (Figure 35), 10D7 failed to 
detect normally distributed Irga6 at the ER of IFNγ-induced gs3T3 cells (Figure 49 C-D). 
However, 10D7 efficiently recognised the Irga6 protein accumulated at the PVM (Figure 
49 C-D). 10E7, in contrast, recognised both pools of Irga6 efficiently (Figure 49 A-B).  
Figure 49 Irga6 is in the active, GTP-bound conformation at the T. gondii PV. (A-D) IFNγ-induced 
(200U/ml) gs3T3 cells were infected with T. gondii strain ME49 (MOI 8) for 2 hrs and Irga6 was detected 
with the monoclonal antibodies (A-B) 10E7 or (C-D) 10D7 (green). Intracellular parasites were identified 
by containing with anti-Toxoplasma serum (B, D, red). Note that the 10D7 antibody that is specific for 
Irga6 in the active, GTP-bound conformation exclusively recognised the protein at the PV.  
To further explore the nucleotide dependence of Irga6 localisation to the PVM 
embryonic fibroblasts from wt and Irga6 deficient mice (Parvanova 2005) were infected 
with Toxoplasma and transiently transfected with expression constructs of ctag1-tagged 
wt and mutant Irga6 proteins. The Irga6-deficient cells were used to dissect whether 
possible association of the mutants with the PVM were due to inherent properties of the 
mutants or due to interaction with the endogenous wild type protein. C-terminally 
epitope-tagged Irga6-ctag1 transiently transfected into IFNγ-induced Irga6-deficient 
fibroblasts (Parvanova 2005) showed essentially normal resting localisation and 
relocalisation to the T. gondii PVM (Figure 50 A-C) showing that this tag does not 
interfere with normal Irga6 protein function. In contrast, both the biochemically 
dominant active K82A and the inactive S83N mutant of Irga6 failed to relocalise to the 
PVM in IFNγ-induced Irga6-/- MEFs (Figure 50 D-F, G-I). Irga6(S83N) also did not 
accumulate at the PVM in IFNγ-induced wt MEFs nor did it prevent wild-type Irga6 
from doing so (Figure 50 J-L). However, the constitutively active mutant Irga6(K82A), 
itself also impaired in vacuolar targeting in IFN-induced wt MEFs, almost completely 
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prevented the endogenous Irga6 protein from reaching the T. gondii vacuole (Figure 50 
M-O), thus acting functionally as a dominant negative as previously reported for T. 
gondii-infected, IFNγ-induced astrocytes (Martens 2005). 
 
Figure 50 Irga6 localisation to the T. gondii PVM is nucleotide-dependent. Localisation of Irga6 in 
mouse embryonic fibroblasts transiently transfected with ctag1-tagged Irga6 expression constructs 
(pGW1H, 1 µg each) and infected for 2 hrs with T. gondii strain ME49 (MOI 6). White arrows indicate 
intracellular T. gondii identified in phase contrast (Phaco, C, F, I, L, O). Irga6 was detected by 
immunofluorescence with the monoclonal antibody 10E7 (green). Transfected Irga6-ctag1 protein was also 
detected by anti-ctag1 antiserum 2600 (red). (A-I) Embryonic fibroblasts (MEFs) from Irga6-deficient 
mice (A-C) transiently transfected with Irga6-ctag1. One of the three intracellular parasites did not acquire 
Irga6 (white arrowhead), the two other PVs are Irga6 positive and in the process of destruction. Differences 
in coating of individual PVs with IRG proteins seem to be related to the time of infection (Khaminets 
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unpublished data). Irga6-/- MEFs transiently transfected with Irga6(S83N)-ctag1 (D-F) or Irga6(K82A)-
ctag1 (G-I). Wt MEFs transiently transfected with Irga6(S83N)-ctag1 (J-L). . Wild type Irga6 (green in G) 
relocated normally to the T. gondii PVM (white arrows) while the Irga6(S83N) (red in H) fails to transfer 
to the PVM. Irga6 was not aggregated in cells transfected with Irga6(S83N) (see also Figure 37 E-H). Wt 
MEFs transiently transfected with Irga6(K82A)-ctag1 (M-O). The transfected protein (red in E) did not 
transfer to the T. gondii PVM and also inhibited the transfer of the endogenous protein (green in D 
(includes Irga6-ctag1)). The non-transfected cell on the left of the image shows a normal PVM stain with 
endogenous Irga6 (white arrowhead) despite the low expression of Irga6. Irga6 is aggregated in IFNγ-
induced cells transfected with Irga6(K82A) (see also Figure 37 A-D).  
Together these results suggest that cytoplasmic aggregation and failure to reach 
the T. gondii PVM are properties of GTP-bound Irga6, constitutively in the case of the 
constitutively active mutant, and, in the absence of IFNγ, also for the wild-type protein. 
Furthermore it appeared that the constitutively active mutant could capture wild type 
Irga6, presumably also in the GTP-bound form, in mixed aggregates. On these grounds it 
was hypothesised that wild type Irga6 is normally maintained in the cytoplasm in the 
GDP-bound state in IFNγ-induced cells, but accumulates at the T. gondii PVM in the 
active GTP-bound state. In the absence of IFNγ, wild-type Irga6 activates prematurely in 
the cytoplasm and forms “sterile” aggregates that cannot localise to the PVM. 
Constitutively active Irga6(K82A) activates constitutively in the cytoplasm and forms 
ectopic GTP-bound aggregates, which can also capture wild-type Irga6, thus acting as a 
functional dominant negative. Above all, these experiments strongly suggested that the 
nucleotide-binding status of Irga6, and hence its adaptive behaviour in T. gondii 
resistance, is normally regulated by the unusual GMS proteins.  
 
II I.2.12. Regulation of Irgb6, Irgd, Irgm1-3 and Irgc in Toxoplasma-infected 
cells 
In view of the regulation of Irgb6 resting localisation by the GMS proteins, it was 
unexpected that Irgb6 relocated apparently normally - though somewhat less efficiently - 
to the Toxoplasma gondii parasitophorous vacuole the in absence of other IRG proteins 
after transfection into unstimulated gs3T3 fibroblasts (Figure 51 A-B) and in 
Mifepristone-induced gs3T3-Irgb6 cell lines (data not shown). This relocalisation 
occurred even when the majority of the Irgb6 protein was strikingly mislocalised 
elsewhere in the cytoplasm (Figure 51 A-B). Irgb6 was the only IRG family member 
studied whose association with the PV membrane was found to be independent of IFN-
signalling or any other IRG GTPase (see below). The G1 motif mutant Irgb6(S70N), like 
the corresponding S83N mutant of Irga6, failed to associate with T. gondii 
parasitophorous vacuoles in transiently transfected gs3T3 cells (Figure 51 C-F). In 
contrast, Irgb6(K69A), corresponding to Irga6(K82A), was capable of targeting the T. 
gondii PV efficiently in IFNγ-treated but not in untreated cells, despite mislocalisation 
elsewhere in the cell (Figure 51 G-J). The ability of transfected wild-type Irgb6 to 
accumulate on the T. gondii PVM in uninduced cells may suggest that in the absence of 
GMS proteins an equilibrium, perhaps between GTP-bound, aggregated and GDP-bound 
free forms, is slightly more favourable to GDP in the case of Irgb6. In IFNγ-induced 
cells, the by analogy to Irga6(K82A) constitutively active Irgb6(K69A) can perhaps also 
be partially repaired by co-expressed GMS proteins, which push the equilibrium 
sufficiently towards the GDP-bound state. 
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Figure 51 Localisation of Irgb6 to the T. gondii PVM is nucleotide-dependent. Gs3T3 cells were 
transiently transfected with (pGW1H) expression constructs of FLAG-tagged wt and mutant Irgb6 (0.5 
µg/construct) in absence (A-B, C-D, G-H) and presence of 200U/ml IFNγ (G-F, I-J) and infected with T. 
gondii strain ME49 at an MOI of 6 for 2 hrs. Transfected protein was detected with the FLAG-specific 
monoclonal antibody M2 (green). White arrows indicate intracellular T. gondii identified in phase contrast 
(Phaco, B, D, F, H, J). Wild type Irgb6 in uninduced cells (A-B). Irgb6(K69A) in uninduced (C-D) or IFN-
induced (G-F) cells. Irgb6(S70N) in uninduced (G-H) or IFN-induced cells (I-J). 
 
Figure 52 Irgd accumulation at the T. gondii PV is dependent of other IRG proteins. Localisation of 
Irgd detected with 2078 antiserum (red in A, C, E) in gs3T3-Irgd cells infected with T. gondii strain ME49 
at a MOI of 6 for 2 hrs. Note that the serum weakly recognises the distributed Irgd at normal expression 
levels, but efficiently stains Irgd on the PVM. Intracellular parasites are indicated by white arrows. (A-B) 
Cells induced with 10-.9 M Mifepristone. (C-D) cells induced with 200 U/ml IFNγ. Parasites are stained 
with Gra7 antiserum (green in B and D). (E-F) Mifepristone-induced (10-.9 M) cells transiently transfected 
with (pGW1H) expression constructs for Irga6, Irgb6, Irgm1, Irgm2 and Irgm3 (500 ng each). Transfected 
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cells were identified by counterstained for Irga6 with the 10E7 monoclonal antibody (green in B). Note that 
the Irgd positive vacuole also contains Irga6. The Irgd positive vacuole also contains Irga6. Overlay 
together with nuclear counterstain (DAPI, blue) is shown in (C). Intracellular parasites were identified in 
phase contrast (H).  
Figure 53 PVM localisation of Irgm2 and Irgm3 is dependent on other IRG proteins. Cells infected 
with T. gondii strain ME49 at a MOI of 6 for 2 hrs. Parasites were detected with anti-Gra7 monoclonal 
antibody (B, E, green) or T. gondii specific rabbit serum (H, K, red), Irgm2 with H53 serum (A, D, red) 
and Irgm3 with anti-IGTP clone7 mAb (G, J, green). Nuclei are counterstained with DAPI (blue). White 
arrows indicate intracellular T. gondii. (A-C) gs3T3-Irgm2 cells induced with Mifepristone. (D-F) 
Relocalisation of Irgm2 (red) to the PVM in uninduced gs3T3 cells transiently transfected with a pool of 6 
IRG expression plasmids (Irgm1, Irgm2, Irgm3, Irga6, Irgb6, Irgd, total 2 µg of DNA). (G-I) gs3T3-Irgm3 
cells induced with Mifepristone. (J-L) Relocalisation of Irgm3 (green) to the PVM in uninduced gs3T3 
cells transiently transfected with a pool of 6 IRG expression plasmids (Irgm1, Irgm2, Irgm3, Irga6, Irgb6, 
Irgd, total 2 µg of DNA) 
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Unlike Irgm1, both Irgm2 and Irgm3 have been shown to accumulate on the T. 
gondii PVM in IFNγ-induced, infected cells (Martens 2005). Even though the subcellular 
localisation of these two proteins in uninfected cells was independent of IFN (see above, 
Figure 30-31), the accumulation at the PVM did not occur in Mifepristone-induced stable 
Irgm2 and Irgm3 gs3T3 cell lines cells infected with T. gondii in the absence of IFNγ 
(Figure 53 A-C and G-I). Normal localisation of Irgm2 and Irgm3 to the T. gondii PVM 
was, however, seen in cells transfected with Irga6, Irgb6 and Irgd in addition to the three 
GMS proteins (Figure 53 D-F and J-L). Furthermore, the ability of Irgm2 and Irgm3 to 
accumulate on the PVM was dependent on the integrity of the G1 motif (data not shown). 
Thus, correct localisation of Irgm2 and Irgm3 to the PV was dependent on the presence 
of other IRG proteins and nucleotide binding.  
Surprisingly, Irgc expressed by Mifepristone induction in gs3T3-Irgc fibroblasts 
accumulated at the Toxoplasma PVM in an IFNγ dependent manner (Figure 54 A-D). 
Transient cotransfection of the IRG proteins Irgm1, Irgm2, Irgm3, Irga6, Irgb6 and Irgd 
also promoted Irgc association with the PVM (Figure 54 E-F) and so did the 3 GMS 
proteins alone, though markedly less efficiently (Figure 54 G-H). These features are 
reminiscent of the behaviour of Irga6 in Toxoplasma infected cells. Whether and how the 
localisation of Irgc to the PVM relates to the in vivo function of the protein is unclear.  
Figure 54 Irgc accumulates at the PVM in the presence of other IRG proteins. Irgc localisation was 
detected by the 39°3 serum (red in A-D, E, G) in cells infected with T. gondii strain ME49 for 2 hrs at a 
MOI of 6. Intracellular parasites identified in phase contrast (not shown) are marked with white arrows. 
(A-B) gs3T3-Irgc cells induced with10-.9 M Mifepristone alone (A-B) or together with IFNγ (200 U/ml) 
(C-D). Parasites were counterstained with Gra7 antibody (green in B and C). (E-F) gs3T3-Irgc cells 
induced with Mifepristone (10-.9 M) and transiently transfected with (pGW1H) expression constructs for 
the 3 GMS proteins (667 ng each). Transfected cells were identified by co-staining with anti-Irgm3 
antibody (green in F). (G-H) gs3T3-Irgd cells induced with Mifepristone (10-.9 M) and transiently 
transfected with (pGW1H) expression constructs for Irga6, Irgb6, Irgd, Irgm1, Irgm2 and Irgm3 (333 ng 
each). Cells were counterstained for Irgb6 with the A20 antiserum (blue in H). 
 
III.2.13. Virulent T. gondii counteract IRG protein accumulation at the PVM 
As IRG proteins are essential resistance factors in mouse active against Toxoplasma 
gondii, it was asked whether virulent strains of the parasite evolved mechanisms to 
counteract IRG proteins. Indeed, accumulation of Irgb6 on the PVM of virulent YFP-
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labelled RH strain parasite was strongly impaired (Figure 55). Only 8 % of the PVs from 
containing RH T. gondii accumulated detectable amounts of Irgb6 protein as opposed to 
60-70 % in case of the avirulent ME49 strain (Figure 55 E). The accumulation of other 
IRG proteins at the PVM was also diminished in the case of the virulent strain, but the 
effect was much less pronounced (Figure 55 E, shown for Irga6 and Irgd). There was 
only a reduction of ~15% in the number of detectably Irga6 positive PVs, yet the amount 
of Irga6 protein found on the vacuoles was largely reduced (Figure 55 F, white arrows in 
A-D). Interestingly, only those vacuoles containing large amounts of Irgb6 also acquired 
Irga6 efficiently (Figure 55 A-D, white arrow head) while the Irgb6 negative PVs were 
Irga6 dim (Figure 55 A-D, white arrows). Thus, virulent Toxoplasma possess a 
mechanism to counteract IRG protein accumulation on the parasitophorous vacuole that 
presumably targets Irgb6. As data are accumulating that Irgb6 is a pioneer in the 
colonisation of the PV and necessary for efficient vacuolar recruitment of other IRG 
proteins (Figure 55, Figure 51 and Könen-Waismann, Khaminets unpublished data), the 
effect on the other IRG proteins is presumably secondary. The mechanism by which 
virulent T. gondii inhibits Irgb6 remains to be determined.  
Figure 55 Accumulation of IRG proteins on the PVM is hindered by virulent T. gondii. IFNγ-induced 
(200 U/ml) gs3T3 cells were infected with the T. gondii strains ME49 or RH-YFP for 2 hrs at a MOI of 6. 
Irgb6 (A, blue) and Irga6 (B, red) were detected in immunofluorescence with the A20 serum and the 10E7 
monoclonal antibody respectively. Intracellular, yellow fluorescent parasites (green in C) identified in 
phase contrast (D) are indicated by white arrows heads (strongly IRG positive) and arrow (weakly IRG 
positive). (E-F) Quantification of data displayed in (A-D). (E) Number of IRG protein positive PVs per 100 
intracellular parasites (grey bars: ME49 strain; black bars: RH-YFP strain). 50 intracellular parasites were 
counted blind per data set. (F) Mean pixel intensities of the Irga6 and Irgb6 signal at the PVM quantified as 
described in Figure 48. The red line marks the approximate visible threshold. 35 PVs were per data set 
were quantified blind. 
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IV. Discussion 
The immunity-related GTPases are a large family of essential, cell autonomous resistance 
factors in the mouse against intracellular pathogens with diverse life styles. All family 
members identified thus far contribute in a unique way to this resistance, mediating the 
immune control of distinct pathogens in different phases of the infection by – at least 
partially - different mechanisms. Thus, newly identified family members are promising 
candidates for an important innate immune function. Furthermore, analysis of their role 
in resistance will help to elucidate common mechanisms and to understand the IRG 
resistance system as such. This study identified the complete set of IRG genes present in 
the mouse and also in other animal species. Phylogenetic analyses of the large set of 
newly identified genes (more than 180 in over 30 species) allowed insights into the 
dynamics of evolution in the IRG family, which underwent rapid expansion, 
diversification and contraction in euchordates, presumably driven by host-pathogen 
interactions.  
Furthermore, the cellular properties, regulation and function of seven mouse IRG 
proteins were analysed to shed light onto the molecular mechanism of IRG resistance 
function and the reasons for the high degree of genetic diversity and plasticity in the 
evolution of the IRG family. Six of the analysed IRG proteins localise to the 
parasitophorous vacuole upon infection with avirulent Toxoplasma gondii. This 
behaviour is dependent on nucleotide binding and on a complex network of direct 
nucleotide-dependent regulatory interactions between IRG family members. Irga6 and 
Irgb6 self-interaction leads to activation and formation of oligomers on the PVM. In 
contrast, Irga6/Irgb6-GMS protein interaction is inhibitory, keeping the GKS proteins in 
the GDP-bound state and preventing premature activation prior to infection. The 
necessity of complex patterns of regulatory interactions within the IRG family for normal 
function of the proteins delivers an explanation for the pronounced functional non-
redundancy of the IRGs. 
 
IV.1. Signs for divergent evolution of the IRG genes in rodents 
The IRG family constitutes an essential, cell autonomous resistance system against 
intracellular bacterial and protozoal pathogens in the mouse involving all of the six 
previously published IRG proteins (Irga6, Irgb6, Irgd, Irgm1, Irgm2, Irgm3) (Martens 
2006; Miyairi 2007). In the course of this study, 15 additional murine IRG genes were 
identified and mapped in the mouse genome to four clusters on three chromosomes 
(Figure 9-10). One of the newly identified genes, Irgb10, was subsequently shown to be 
involved in resistance against Chlamydia species (Bernstein-Hanley 2006; Miyairi 2007). 
This strongly suggests that also other newly identified family members contribute to 
pathogen resistance. The IRG genes in the individual clusters display various degrees of 
sequence conservation arguing for different evolutionary ages of the underlying 
duplication events (Figure 11-12). The eight Irga6-related genes (IRGA clade) clustered 
on chromosome 18 and seven of the Irgb6-like genes (IRGB clade) clustered on 
chromosome 11 show the least divergence amongst each other and therefore presumably 
originate from a more recent gene duplication. The entire amino acid sequence of IRG 
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proteins is typically encoded on a single long exon. Four of the IRGB genes, however, 
consist of 2 IRG coding units transcribed in tandem and thus give rise to proteins twice 
the size of a usual IRG (appendix V.5). The fact that IRG proteins form functionally 
relevant dimers and oligomers in vitro (Figure 36, (Uthaiah 2003)) and in vivo (Figure 
44-45, (Papic 2007)), suggests that these tandems may actually have their interaction 
partners covalently linked.  
Irgc, Irgd, Irgb10, Irgm1, Irgm2 and Irgm3 are all more divergent than the other 
IRG members proposing that these genes are phylogenetically older (Figure 12). 
Comparison with the IRG genes from rat confirmed this interpretation. The 15 rat IRG 
coding units are situated on three chromosomes in four clusters, which are syntenic to the 
respective mouse chromosomal clusters. Rat Irgc, Irgd, Irgb10, Irgm1, Irgm2 and Irgm3 
are clearly orthologous to the respective mouse genes. For the seven closely related 
IRGA genes, however, no clear mouse orthologues could be identified with the exception 
of Irga5 (Figure 14). The set of IRGB genes in the proximal cluster on rat chromosome 
10 is reduced relative to the mouse (Figure 16). Only two coding units, probably 
representing a single tandem gene, are present (Irgb14-Irgb13). Therefore, the numerous 
mouse IRGB genes must either represent a very recent gene duplication of an ancestral 
IRGB tandem gene or alternatively the rat must have lost the rest of the IRGB genes. The 
presence of the mouse IRGB coding units in pairs of two, which cluster phylogenetically 
with the rat tandem pair, and the high degree of sequence conservation in the intergenic 
spaces between the mouse IRGBs favour the first hypothesis. Interestingly, one of the 
first mouse IRG genes identified, Irgb6 (TGTP) (Carlow 1995), is absent from the rat and 
is the only IRGB sequence in the cluster, which is not part of a tandem.  
The Irgc genes exclusively expressed in haploid spermatids in the testis (Rhode 
2007) as well as the distantly related IRG gene with the radically modified GTPase 
domain sequence, Irgq, are both highly conserved between rat and mouse, arguing for a 
housekeeping rather than an immune function. This view is supported by the high degree 
of conservation of Irgc and Irgq throughout the mammals and the Eutheria, respectively 
(Figure 20). Despite their phylogenetic relationship to the classical IRG proteins, IRGQ 
proteins probably lack nucleotide binding and hydrolysis function owing to the absence 
of conserved GTP-binding motifs and the low degree of sequence conservation in the G-
domain (Table 6, Figure 20).  
 
IV.2. Divergent IRG genes are found throughout the mammals 
IRG genes were detected in all mammalian orders, indicating that this family of GTPases 
was widely distributed at the origin of the mammalian radiation. There is, however, 
plenty of evidence for diversifying evolution in the mammalian IRG proteins.  
Interestingly, all IRGB genes identified in mammals other than rat and mouse 
cluster phylogenetically with the isolated mouse Irgb10 gene (Figure 14, Figure 18). 
Together with the chromosomal positioning of Irgb10 in mouse and rat in a separated 
cluster with Irgm2 and Irgm3, this suggests that an ancestral Irgb10-like gene probably 
gave rise to the second cluster of IRGB genes in rat and mouse by gene duplication 
(Figure 10, Figure 16). The association of the Irgb10 gene cluster with Irgm2 and Irgm3 
and of the other IRGB gene cluster with Irgm1 suggests that an ancestral Irgb10-like 
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gene in close proximity to a single IRGM gene gave rise to these two IRG gene clusters 
by a series of gene duplication followed by diversification.  
In agreement with this, all dog IRGM and IRGB genes (except for one 
pseudogene on chromosome 29) are grouped together in one cluster of only 400 kb on 
chromosome 10 (Figure 17). This cluster also contains two IRGD-related genes, one of 
which possesses a drastically damaged G1 motif. Thus, the common mammalian 
ancestor must have possessed at least a single copy of an IRGM, IRGD and IRGB10-like 
gene each. The absence of IRGA genes from the dog seems to be a specific loss in this 
lineage as not only rodents and rabbits but also primates, insectivores and elephants 
possess IRGA genes. Dog IRGB12 and the three dog IRGM genes have been shown to 
be IFNγ-inducible in vitro (Bekpen 2005a; Bekpen 2005b), classifying them also 
experimentally as immune-type IRGs.  
IRGC, IRGB and IRGD genes were found in all mammalian groups, whereas 
IRGQ, IRGM and IRGA genes were only detected in the Eutheria. All the clades 
originally defined on the basis of a phylogenetic comparison of mouse and dog IRG 
sequences alone (Bekpen 2005b), are well defined throughout the mammals. 
Interestingly, in two of the newly identified members of the IRGM subfamily, the 
unusual methionine in the first GTP-binding motif was exchanged for a leucine or 
isoleucine, respectively. This conservative exchange suggests that a large hydrophobic 
residue at this position might be essential for the function of the proteins. Though the 
mutation of the conserved P loop lysine interferes with nucleotide binding and hydrolysis 
in many GTPases (e.g. hGBP1, H-Ras and Mx1/MxA (Pitossi 1993; Praefcke 2004a; 
Sigal 1986)), the analogous lysine to methionine substitution in the ATPase shikimate 
kinase has been reported to increase the ATP affinity of the protein (Krell 2001). 
However, nucleotide hydrolysis was abolished and the organisation of the P loop 
flanking regions of the protein was disturbed. Biochemical analysis of recombinant 
IRGM proteins is therefore essential to gain insight into the role of the P loop methionine 
in the activity of these unusual GTPases.  
 The IRGM genes of different mammalian species have either been 
duplicated independently or have diversified so much, that clear orthologues of 
individual genes can not be identified (Figure 18, Figure 20). Different clades of the IRG 
gene family have expanded in different mammalian species. Dog, hedgehog, armadillo, 
guinea pig and tenrec contain several IRGB10-related genes, while the other IRGB genes 
represent a rodent specific expansion (Figure 18, Figure 14). IRGA genes have been 
massively expanded in mouse and rat whereas the guinea pig possesses multiple IRGD 
genes. This indicates that the immune-type IRG genes are under strong diversifying 
selection, probably due to host-parasite coevolution.  
Another sign of diversity in the IRG family is the presence of a single, IRGC-
related gene (IRGC-like) in numerous but not all mammals. The IRGC-like was found in 
shrew, bat, cat, dog, bull, pig as well as in opossum (Table 7). It is phylogenetically 
related to and spatially closely linked to IRGC (Figure 17, Figure 20). The IRGC-like 
genes are highly divergent suggesting an immune function. Apart from IRGQ, which 
contains an N-terminal extension encoded on a separate upstream exon, IRGC-like is the 
only mammalian IRG gene that contains an intron (see also below).  
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IV.3. Loss of IRG resistance system in the anthropoids 
From the essential role of IRG proteins in pathogen resistance of mice and the presence 
of immune-type divergent IRG proteins (IRGA, IRGB, IRGD and IRGM clades) in many 
mammalian orders, it was surprising to find that the IRG resistance system has 
apparently been lost in the human (Table 7, Figure 15). The argument for the absence of 
the IRG resistance system in humans relies on several findings. The system is reduced 
from 22 genes in mouse to two full-length genes plus a transcribed G-domain in humans, 
and the residual genes lack the character of functional resistance genes. Thus, IRGC is 
highly conserved in mammals (Figure 20), is not interferon or infection inducible, and is 
expressed constitutively in mature testis (Bekpen 2005b; Rhode 2007). IRGQ is also 
highly conserved in mammals plus it contains a radically modified G-domain (Table 8). 
IRGM, although clearly derived from a typical GMS subfamily resistance gene, is 
transcribed constitutively from an endogenous retroviral LTR, is unresponsive to 
interferon (Bekpen 2005b), and is structurally damaged by truncation and loss of the fifth 
GTP-binding motif (). 
Similarly, all anthropoids (old world monkeys, new world monkeys and 
hominoids; Figure 56) contain the reduced set of IRG genes (IRGC, IRGQ and IRGM). 
Interestingly, the IRGM protein of both macaque and marmoset possess a damaged first 
GTP-binding motif, Gx4GMN and Gx4SIS respectively (Table 8). In analogy to H-Ras, 
the loss of the universally conserved glycine in the marmoset IRGM is expected interfere 
with nucleotide binding (Chen 1994; Powers 1989). The serine to asparagine mutation 
occurring in the macaque has been reported to interfere with nucleotide binding in Irgm3 
(Taylor 1997) and rendered all IRG proteins analysed in this study (and other GTPases; 
(Feig 1988; Nuoffer 1994; Praefcke 2004a; Stenmark 1994)) non-functional in vivo 
(Figure 42, 44, 47, 50 and 51). The macaque IRGM gene additionally contains a 
premature stop codon shortly after the G1 motif (Figure 21). Thus, it seems very unlikely 
that any of these primate IRG proteins carries out an immune function. Consequently, 
effective resistance to vacuolar pathogens in the anthropoids must be organised on 
radically different principles than in the mouse. Recently, however, the human IRGM 
protein has been implicated in resistance to Mycobacterium tuberculosis by induction of 
autophagy (Singh 2006). However, the observed effect was small and the data are not 
conclusive. In particular, no explanation is provided for how an IRG protein with an 
incomplete G-domain that lacks the complete N- or C-terminal helical domains and is 
constitutively expressed under the control of the long terminal repeat of the endogenous 
retrovirus ERV9 (Bekpen 2005b), should mediate an immune function. The involvement 
of IRGM in autophagy-mediated mycobactericidal activity has been analysed in analogy 
to that observed for the murine Irgm1 protein (Gutierrez 2004). Irgm1, however, is part 
of the highly interactive IRG resistance system (III.2.11, III.2.12 and see below) and at 
least its function in resistance to Toxoplasma gondii is dependent on an intact nucleotide-
binding site (Figure 47-48). Human IRGM was recently identified as a susceptibility 
locus associated with Crohn’s disease (Jacobs 2007; WTCCC 2007). Both the suggested 
involvement of IRGM in Mycobacterial resistance and in Crohn’s disease requires 
further experimental analysis.  
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Since lower primates (lemurs and bushbabies, Strepsirrhini) possess diverse IRG 
genes belonging to the IRGD and IRGA clade as well as full-length GMS subfamily 
genes, it is clear that the IRG resistance system has been lost from the higher primates. 
This loss happened after the divide of the Haplorrhini from the Strepsirrhini around 60 
million years ago and before the split of the old world monkeys about 30-40 million 
years ago (Figure 56). It will be of interest to analyse the tarsier genome (Tarsius 
syrichta, currently being sequenced; http://genome.wustl.edu, Genome Sequencing 
Centre) to further pinpoint the loss of divergent IRG genes in the primate lineage (Figure 
56).  
The IRG resistance system seems to have been lost independently also from some 
other species outside the primates. For cat, pig, bat and shrew only IRGC and IRGQ 
genes were detected in the database, while other species belonging to the same orders of 
mammals (e.g. dog as a carnivore, tenrec and hedgehog as insectivores) were shown to 
possess immune-type IRG genes (Table 7). Unless the absence of divergent IRGs from 
the listed species reflects a failure of the databases, the IRG resistance system has been 
repeatedly lost during the evolution of the mammals, suggesting a balance between the 
benefit of immunity against intracellular pathogens and the evolutionary cost of 
possessing the IRG system. Strikingly, in the cat as the primary host of Toxoplasma 
gondii, the IRG resistance system seems to be absent, possibly allowing unrestricted 
replication. A very recent sequence analysis, however, discovered a fragment of a GMS 
gene closely related to dog IRGM4 in the cat genome database. Thus, more immune type 
IRG genes may remain to be discovered in the growing databases.  
 
Figure 56 Schematic phylogenetic tree of the primates. Phylogenetic relationships between species are 
based on (Shoshani 1996). Species analysed for IRG genes are indicated in red (human (Homo sapiens), 
chimpanzee (Pan troglodytes), orang-utan (Pongo pygmaeus), marmoset (Callithrix jacchus), Rhesus 
monkey (Macaca mulatta), grey mouse lemur (Microcebus murinus), bushbaby (Otolemur garnettii). Note 
that the Tarsius syrichta genome database is not available yet. Primates with a reduced set of IRG proteins 
are highlighted in yellow, those with immune type IRGs in light blue.  
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In line with the argument above, the frequent presence of IRG genes with altered 
nucleotide binding motifs may reflect the evolutionary pressure to lose redundant gene 
copies. This is reminiscent of the balanced frequency of minus over wild type alleles of 
Mx1 in mice (Haller 1987; Jin 1998; Staeheli 1988a). Alternatively, IRG proteins that 
have lost their GTPase activity by mutation might function as regulators of intact IRG 
proteins by forming regulatory heterodimers influencing the interaction equilibria 
between other family members (see below). A case of a GTPase-like protein regulating 
the activity of a functional GTPase has recently been reported. The GTPase-activating 
protein of the small GTPase, Rap1, is itself probably derived from a GTPase ancestor and 
retains the G-domain structure but not the sequence to reveal its origin (Daumke 2004). 
 
IV.4. The IRG family is ancient and present in euchordates 
IRG genes are not only represented in the mammals but in all vertebrate classes 
except for the birds. Whether this represents another, yet even more complete loss of the 
IRG system or is rather due to incompleteness of the available databases remains to be 
determined. Analysis of IRG genes in zebrafish and the anole lizard revealed an array of 
complexity comparable to the mouse situation (Figure 22, Table 7) and zebrafish IRG 
genes have been shown to be IFN-inducible (D. Sieger, C. Stein personal 
communication). IRG genes were also recovered from cartilaginous fish and amphibians 
(Table 7). Most of the non-mammalian IRG genes formed new, independent clades in the 
phylogenetic analyses (Figure 22; IRGF, IRGE, IRGG). Myristoylation seems to be an 
ancient mechanism of membrane attachment in IRG proteins as myristoylation motifs 
can be found in subsets of the IRGA, -B and -E proteins throughout the vertebrates 
(Table 9). IRGF genes were exclusively detected in the bony fish, and the zebrafish 
genes diverged independently from the pufferfish ones, following the same principle 
already observed in mammals (see above). The IRGE clade contains zebrafish and anole 
genes and also here no clear orthologues can be identified. To decide whether the 
zebrafish irgg gene is really characteristic for an independent clade or rather represents a 
divergent IRGE gene, more fish sequence need to be analysed. One sequence from 
salamander and several anole sequences cluster phylogenetically with the IRGC-
like/IRGC genes, suggesting a common ancestor for these proteins. Similar to the 
mammalian IRGC-like genes, the anole sequences show a high degree of divergence but 
by contrast they are encoded on a single exon. IRGF genes, however, contain a single 
intron situated between the G4 and the G5 motif of the G-domain, roughly at the same 
position as the intron of the mammalian IRGC-like genes (Figure 23, appendix V.13). 
Furthermore, the IRGF genes are more closely related to the IRGC-like genes and the 
other mammalian IRGs than to the IRGE group. Thus, one can hypothesise that an 
intron-containing common ancestor of the IRGF and IRGC-like genes has given rise to 
the divergent sets of IRG genes in mammals, reptiles, amphibians and fish.  
Interestingly, ‘quasi’ IRG proteins with modified GTP-binding motifs were 
detected in both fish and amphibians. Thus, loss of GTPase activity from members of the 
IRG family has taken place repeatedly during evolution also outside the mammals. 
Strikingly, the Xenopus irgxq4 gene is transcribed in tandem with an other IRG gene that 
might have retained GTPase activity. Similarly, in zebrafish the canonical irgg gene, is 
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apparently expressed in tandem with the adjacent downstream gene irgxq1, which is a 
modified quasi-GTPase gene (Table 8). Thus, IRG genes that occur in pairs in a head-to-
tail arrangement, are transcribed in tandem and are presumably expressed as dimeric 
proteins, are not a sole invention of the rodents but have occurred repeatedly and 
probably independently during vertebrate evolution. The basic unit of IRG protein 
function may therefore be a dimer. This conclusion is consistent with the G-domain-G-
domain homodimer shown to be essential for GTP-dependent oligomerisation and 
cooperative hydrolysis Irga6 (Pawlowski unpublished data), and the regulatory, GDP 
dependent Irga6-Irgm3 interaction documented in this study (chapters III.2.10 and 
III.2.11). Unlike the observed homodimer of Irga6, the products of the tandem genes are 
heterodimers, implying that the two IRG subunits serve distinct functions in the protein. 
In the cases of zebrafish and Xenopus the parts of the tandems without functional G-
domains may be regulatory for the canonical IRG domains. Other ‘quasi’ IRG proteins 
may also be regulators of IRG proteins, interacting with the functional IRG proteins 
presumably via the G-domain-G domain interface used by the activating Irga6 self 
interaction (Pawlowski unpublished data) and the inhibitory Irga6-Irgm3 interaction 
(Figure 45). Thus, ‘quasi’ IRG proteins would coevolve with IRG proteins. Curiously, a 
rat transcript that codes for a triple IRG protein constituted of Irgb10, Irgm3 and Irgm2 is 
present in the databases (AY321344; see (Bekpen 2005a)). It is unclear whether that 
protein is functional in vivo or whether the transcript represents an anomalous splicing 
event occasionally occurring for these genes closely clustered on rat chromosome 10 
(within 33 kb; Figure 16).  
Multiple divergent IRG genes forming an independent phylogenetic clade 
(IRGH) were identified in the lancet fish. Thus, the IRG resistance system is at least as 
old as the cephalochordates (>550 million years; (Khalturin 2004; Kumar 1998)) and 
therefore pre-dates the development of an adaptive immune system in jawless and jawed 
vertebrates (Cooper 2006; Flajnik 2001). This argues against the proposed role in 
lymphomyeloid development (Feng 2004; Santiago 2005) being the primary function of 
IRGs proteins (see also below).  
There are no convincing IRG homologues in tunicates, sea urchins or other 
invertebrates. Two IRG similar sequences recovered from Caenorhabditis elegans miss 
many of the IRG protein characteristic features including some of the conserved GTP-
binding motifs (accession numbers: W09C5, C46E1.3; for alignment see (Bekpen 
2005a)). Several groups of 45-50 kDa putative GTPases of unknown function with 
sequence features reminiscent of IRG GTPases, however, exist in bacteria (e.g. 
Cyanobacteria, see also (Bekpen 2005b; Martens 2006)). These bacterial enzymes show 
a plausible homology to the chordate IRGs in the G-domain, which is located within the 
proteins at roughly the same, characteristic position. Secondary structure predictions 
analysis indicated that the bacterial IRG-like proteins have a secondary structure similar 
to Irga6 (Howard unpublished data; (Ghosh 2004)). These observations raise the 
possibility that the IRG genes in the euchordates may originate from horizontal transfer 
of bacterial IRG-like genes. Biochemical or structural studies are, however, necessary to 
clarify the validity of the bacterial genes as members of the IRG family.  
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In summary, GKS IRG proteins are an ancient family at least as old as the 
euchordates (>550 million years; (Khalturin 2004; Kumar 1998)), while GMS (IRGM) 
GTPases seem to be specific for the Eutheria. Hence, IRGM genes must have already 
been present in an early eutherian progenitor some 75 million years ago (Bininda-
Emonds 2007). The IRG resistance GTPases underwent rapid expansion and 
diversification as well as contraction in the euchordates probably due to host-pathogen 
coevolution. This feature has frequently been documented in multigene families 
associated with pathogen resistance in both animals and plants (Angata 2004; Borghans 
2004; Delarbre 1992; Hood 1975; Klein 1986; Leister 2004; Mashimo 2003; Noel 1999; 
Trowsdale 2001). In these cases, however, the resistance mechanism itself has been 
retained as its protein mediators have evolved or even, in case of the natural killer cell 
receptor case, been replaced by a different molecular species (Barten 2001). The IRG 
case may be different because here the resistance mechanism itself has apparently been 
lost during primate evolution. It is a key question, why this ancient resistance system 
became dispensable and was lost during divergent evolution of the primate lineage, 
despite its importance for mouse resistance against pathogens infecting both rodents and 
primates. 
 
Figure 57 Phylogenetic tree of mouse GBPs, Mx proteins, dynamins, and selected IRGs. Unrooted 
maximum likelihood phylogenetic tree generated with Treepuzzle (www.tree-puzzle.de) based on a full 
length protein alignment generated with ClustalW (Thompson 1994). Branch lengths are measured relative 
to the estimated number of substitutions. Note that the IRG proteins display a markedly higher degree of 
sequence divergence than the other GTPases (from (Degrandi 2007)). 
 Since some of the murine GBP proteins have very recently been shown to target 
the Toxoplasma gondii parasitophorous vacuole similarly to the IRG proteins (Degrandi 
2007) and the GBP family is conserved in humans, one could argue that the GBPs fulfil 
the resistance function of IRG proteins in humans. This hypothesis surely deserves 
experimental testing. It has, however to be noted, that the sequence divergence among 
the GBP family is much lower than within the IRG family (Boehm 1998; Degrandi 2007; 
Olszewski 2006) (Figure 57). Thus, the IRG family is either older or more rapidly 
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evolving than the GBP family or both. In view of this, it seems less likely that the GBPs 
are involved in direct interaction with pathogen-derived components and that they target 
a comparably broad pathogen range. Better understanding of the mechanism of action 
and regulation of the IRG proteins is needed before their complex evolutionary history 
can be put in context.  
 
IV.5. IRG proteins in cell proliferation and survival 
Most of the IRG proteins (Irga6, Irgc, Irgm1, Irgm2 and Irgm3) did not alter cell 
proliferation and survival when expressed in the absence of IFN (Figure 27). In contrast, 
both Irgb6 and Irgd expression resulted in a severe growth arrest and cell death. In the 
case of Irgb6, cells were shown to be blocked in cell cycle progression before the G2/M 
phase (Figure 28). A simple integration effect as explanation for these effects was ruled 
out by the repetition of the stable transfection of Irgb6. Thus, this study documents at 
least three independent events of IRG protein mediated inhibition of cell proliferation 
(two stable transfections for Irgb6, one for Irgd). Furthermore, similar effects were 
observed by Carlow and colleagues for Irgb6 (Carlow 1998). They reported problems in 
generating stable clones constitutively expressing Irgb6 and the few clones obtained 
showed a reduced growth rate and lost expression over time. It is easily imaginable how 
the severe fibre-like Irgb6 aggregates that entangle many cellular organelles in absence 
of IFNγ would negatively influence cell proliferation and survival. Yet, co-induction with 
IFNγ did resolve the majority of these aggregates (Figure 38) but did not lead to a rescue 
of the growth inhibition in any way (Figure 27). Saturation of the IFN system by 
overexpression of Irgb6 following double induction is unlikely to play a role, since 
Mifepristone-induced Irgb6 expression levels were very low (Figure 24). Irgd expressed 
in absence of IFNγ showed no signs of mislocalisation (Figure 32) but the expressing 
cells were completely growth inhibited. As for Irgb6, no beneficial effect of co-induction 
with IFNγ could be observed. In this case, however, expression of twice the normal 
amount of Irgd following double induction could play a role.  
Taken together, the phenomenon of growth inhibition by Irgb6 and Irgd remains 
obscure. But given the number of independent events in which this effect has been 
observed and the absence of any other proposed mechanism of action for these two 
proteins, it is conceivable that Irgb6 and Irgd function by inducing the death of infected 
cells, killing the pathogen together with the host cell. Recent data indicate that death of 
Toxoplasma gondii infected, IFN-induced murine fibroblasts is indeed involved in 
elimination of the parasites (Zhao unpublished data). 
 
IV.6. Covalent protein modification of Irga6 
Upon expression of Irga6 in absence of IFNγ in mouse fibroblasts, a proportion of the 
protein is covalently modified by a yet unidentified moiety, indicated by a shift of about 
8 kDa in apparent molecular weight  (Figure 24). The observed protein modification did 
neither alter the hydrophobicity of Irga6 (Figure 25) nor the behaviour in size exclusion 
chromatography (Figure 39 see below). Both the modified 55 kDa (Figure 25) and the 
endogenous 47 kDa form of Irga6 were completely myristoylated in vivo (Figure 25, 
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(Martens 2004b)). Transient transfection of Irga6, in contrast, gave rise to considerable 
amounts of unmyristoylated protein, presumably due to overburdening of the cellular 
myristoyl transferase by overexpression (Figure 25, see also (Papic 2007)). Thus, 
efficient myristoylation of Irga6 is independent of IFNγ but dependent on the expression 
level of the protein. Additional modifications altering the protein hydrophobicity can be 
excluded to be responsible for the shift in apparent molecular weight of Irga6. 
The same modified form of Irga6 was present to a somewhat lesser extent upon 
co-induction of ectopically Irga6 expressing cells with IFNγ and was observed only in 
trace amounts for endogenous protein in IFNγ-induced cells (Figure 25). Irga6 is 
predominantly aggregated in the GTP-bound, active state when expressed ectopically in 
absence of IFNγ and partially so in the presence of IFNγ, whereas endogenous, IFN-
induced Irga6 is predominantly in the GDP-bound, inactive conformation due to negative 
regulation by the three GMS proteins (Figure 35). Furthermore, Irga6 accumulating at the 
parasitophorous vacuolar membrane of Toxoplasma gondii in infected cells is also GTP-
bound (Figure 49). One could therefore hypothesise that the protein modification is 
linked to Irga6 activation and might function in resistance, for instance by facilitating 
translocation to the parasitophorous vacuole either directly by influencing Irga6 
trafficking or indirectly by shifting the ER-cytoplasm equilibrium of Irga6 more towards 
the soluble state (Figure 58). Consistent with this idea, the modification did not occur on 
the nucleotide binding deficient, inactive mutant Irga6(S83N) (Figure 36; (Kaiser 2005)). 
The protein modification might prevent negative regulation of Irga6 by the GMS proteins 
upon infection-induced activation by directly or indirectly hindering interaction of these 
proteins. This hypothesis would also explain why Irga6 and two of its negative 
regulators, Irgm2 and Irgm3, can co-exist on the PV (see below) and still exert their 
function in pathogen resistance. An alternative explanation for this phenomenon would 
be that GKS protein accumulation at the PV precedes the arrival of the GMS proteins. 
Recent analysis, however, showed that both Irga6 and Irgm2 accumulation can occur 
within minutes of infection but the relative timing of these events has not been explored 
(Zhao unpublished data). The IRG resistance system could then be switched back to the 
inactive state by removal of the protein modification on Irga6 (and maybe also other 
GKS IRG proteins) allowing access of the GMS proteins that are tightly packed together 
with Irga6 on 30-40% of the PVs. Alternatively, the reaction could of course be 
terminated by degradation of the IRG proteins accumulated at the PV together with the 
parasite by autophagy or related mechanisms (Ling 2006). Thus, the covalent 
modification of Irga6 documented here could be of central importance in pathogen 
resistance mediated by IRG proteins. Therefore, it is of great interest to identify the type 
of modification and to analyse whether this modification also accompanies Irga6 
activation in the context of Toxoplasma gondii infection. Ubiquitin and ubiquitin-like 
proteins such as SUMO (small ubiquitin-related modifier), ISG15 (interferon-stimulated 
gene 15), NEDD8 (neural precursor cell expressed, developmentally down-regulated 8) 
and FAT10 (HLA-F adjacent transcript 10) (Welchman 2005) are possible candidates as 
they are all between 6 and 18 kDa in size and thus could induce a shift in apparent 
molecular weight in SDS-PAGE in the same range as was observed experimentally for 
modified Irga6.  
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Monoubiquitination as a candidate for modification of the 55 kDa form of Irga6 
was tested experimentally. For technical reasons, this modification could unfortunately 
neither be confirmed nor be ruled out. Considerable amounts of ubiquitin positive, high 
molecular weight species were, however, detected in immunoprecipitation of Irga6 from 
Mifepristone- but not from IFNγ-induced gs3T3-Irga6 cells in absence of proteasome 
inhibitors (Figure 26). At least a part of the ubiquitinated protein was shown to be Irga6. 
Thus, Irga6 is ubiquitinated when it is in the GTP bound state in absence of IFNγ, though 
co-immunoprecipitation of a tightly bound ubiquitinated interaction partner of Irga6 may 
contribute to the observed ubiquitin signal. IFNγ-induction in parallel with ectopic 
expression of Irga6 reduced the amount of ubiquitinated protein somewhat (Figure 26). 
This is consistent with the incomplete restoration of the GDP-bound state and wild type 
intracellular localisation under these conditions (Figure 35). Interestingly, a subset of the 
GTP-bound Irga6 aggregates, formed due to ectopic expression, was found to be positive 
for ubiquitin in immunofluorescence (Kaiser 2005). Despite ubiquitination of ectopically 
expressed Irga6 in Mifepristone-induced gs3T3-Irga6 cells, the protein half-life was 
comparable to that observed for endogenous Irga6 in IFNγ-induced mouse embryonic 
fibroblasts (~16 hrs; Steinfeld unpublished data). Thus, Irga6 might be subject either to 
monoubiquitination at multiple lysine residues or to lysine 63-linked polyubiquitination, 
both of which modulate protein function rather than mediate degradation (Pickart 2004). 
Whether mono- or polyubiquitination plays a role in the regulation of endogenous, IFN-
induced Irga6 protein during infection remains to be determined. Interestingly, proteins 
with deubiquitinating activity have been identified in several virus families including the 
Herpesviridae, in pathogenic bacteria like Chlamydia trachomatis, Salmonella 
typhimurium and Yersinia as well as in eukaryotic pathogens such as Plasmodium 
falciparum and Toxoplasma gondii (Love 2007). In many cases these enzymes have been 
implicated in host cell manipulation and immune evasion, not least because the 
machinery for ubiquitin conjugation is missing from non-eukaryotic pathogens.  
 
IV.7. IRG localisation is regulated by IFN and nucleotide 
The intracellular behaviour of the seven IRG proteins analysed in this study is 
summarised in Table 10. The three GMS proteins Irgm1, Irgm2 and Irgm3 localised to 
the Golgi plus endolysosomes, Golgi and ER, respectively, in IFNγ-induced cells (Figure 
29-31, (Martens 2006; Martens 2004b; Taylor 1997), Zhao unpublished data). These 
localisations were independent of other IFN-inducible factors and nucleotide binding in 
gs3T3 cells (Figure 29-31), as described previously for Irgm3-GFP in HeLa cells (Taylor 
1997) and for native Irgm1 in L929 fibroblasts (Martens 2004b).  
Intracellular localisation of Irgc and Irgd was determined in immunofluorescence 
for the first time in this study. As for Irgd no appropriate immunoreagent was available 
and Irgc was exclusively expressed in haploid spermatids, the localisation was analysed 
in mouse fibroblasts ectopically expressing ctag1-tagged Irgd and native Irgc, 
respectively. Endogenous Irgc and Irgd are predominantly cytosolic and only partially 
membrane associated according to analysis of hypotonic lysates of mouse fibroblasts and 
seminiferous tubules, respectively (Martens 2004b; Rhode 2007). Consistent with this 
observation, both Irgc and Irgd displayed a distributed reticular staining in 
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immunofluorescence when expressed by transient transfection (Figure 32). In absence of 
any other conspicuous signal, it is likely that the membrane-associated part of the 
proteins locates to the ER. This interpretation was supported by partial colocalisation of 
the Irgd and Irgc with the ER localised Irga6 protein in IFN-induced cells (Figure 32). 
The presence of Irgd in the nucleus of transfected cells is consistent with the diffusion of 
the largely soluble protein through the nuclear pores, which are permeable for proteins 
smaller than 60 kDa (Paine 1975). Both Irgc and Irgd localisation were independent of 
IFNγ-induction (Figure 32). 
Irga6 localised in a distributed reticular pattern in IFNγ-induced cells (Figure 33, 
Figure 35), and is largely ER associated (Martens 2004b). Localisation of endogenous 
Irgb6 could not be determined due to the lack of an appropriate immunoreagent but 
analysis of hypotonic lysates suggested that the protein is predominantly cytosolic 
(Martens 2004b). Native Irga6 and FLAG-tagged Irgb6 expressed in absence of IFNγ 
resulted in the formation of large intracellular aggregates (Figure 33, Figure 38). The 
formation of aggregates was due to the absence of IFN-induced regulatory factors, as 
costimulation of cells ectopically expressing the IRG proteins with IFNγ largely restored 
the wild type localisation of Irga6 (Figure 33, Figure 35). Similarly, Irgb6-FLAG 
localised in a distributed reticular pattern under these conditions, presumably reflecting 
the wild type localisation of endogenous Irgb6 (Figure 38). The beneficial effect of 
interferon was clearly dose dependent, as the redistribution of Irga6 was much more 
complete for Mifepristone-induced gs3T3-Irga6 cells (Figure 33, Figure 35) than 
following transient transfection, which results in a much higher expression level in most 
of the cells (Papic 2007). In transient transfection, Irga6 wild type localisation was 
observed only in cells expressing relatively low amounts of the protein (Papic 2007).  
 
Table 10 Summary of the intracellular behaviour of IRG proteins. Table summarising the intracellular 
behaviour of the seven IRG proteins analysed in this study in uninfected and Toxoplasma gondii (strain 
ME49) infected cells (nd: not determined, dep: dependent, nucl: nucleotide). 
Irga6 expressed in absence of IFN did not accumulate in aggresomes, a place in 
the cell where misfolded proteins accumulate, as the observed aggregates neither fulfil 
the morphological critera nor the characteristic of detergent insolubility (TritonX-100 
(Figure 40), Thesit (Papic 2007) and NP-40 (Kaiser 2005)) (Garcia-Mata 1999; Garcia-
Mata 2002; Johnston 1998). The absence of Irga6 (and Irgb6) aggregates upon 
coinduction with IFNγ despite the expression of twice the amount of Irga6 protein further 
argued against the involvement of aggresomes (Figure 33, Figure 35, Figure 38). In an 
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independent study (Kaiser 2005), Irga6 aggregates following ectopic expression were 
shown also to lack other characteristic of aggresomes, including association with the 
microtubule organisation centre and restructuring of the intermediate filament 
cytoskeleton (Garcia-Mata 1999; Garcia-Mata 2002; Johnston 1998). The morphology of 
Irgb6 aggregates formed upon ectopic expression was also not consistent with 
localisation in aggresomes (Figure 38). The vimentin containing intermediate filaments 
were shown to form cage-like structures in HeLa cells expressing high amounts of Irgb6-
FLAG following transient transfection but Irgb6 itself was not aggregated inside these 
cages where aggresomes would be localised (Martens 2004a).  
 
IV.8. Irga6 and Irgb6 aggregates formed in absence of IFNγ represent 
GTP-bound homomers  
Irga6 – and by analogy probably also Irgb6 – self-activates by GTP-dependent 
oligomerisation in vitro (Figure 36, (Uthaiah 2003)). Thus, it was conceivable that the 
Irga6 and Irgb6 aggregates observed in cells in the absence of IFNγ represented GTP-
bound homo-oligomers. Indeed, the formation of the intracellular aggregates was 
nucleotide dependent, as the nucleotide binding deficient mutants of Irga6(S83N) and 
Irgb6(S70N) did not aggregate in absence of IFN (Figure 37-38). By contrast, the 
Irga6(K82A) mutant, which is probably locked in the GTP-bound, active state (as it 
binds but cannot hydrolyse GTP (Figure 36)), and the analogous Irgb6(K69A) mutant 
developed aggregates even in IFNγ-induced cells (Figure 37-38). IFNγ failed to resolve 
the aggregates formed by the two Gx4GAS mutants either because incipient 
oligomerisation events cannot be terminated by GTP hydrolysis or because GMS 
proteins are unable to interact normally with the mutants, as indicated by the altered 
interaction profile in yeast 2-hybrid assays (Figure 44).  
That the aggregated Irga6 protein in absence of IFNγ-induction was in the GTP-
bound, active conformation was confirmed by immunofluorescence with the 10D7 
monoclonal antibody specific for this conformation (Figure 35, for proof of 10D7 
conformation specificity see (Papic 2007)). Irga6 expressed in absence of IFNγ was 
efficiently recognised by this antibody, while endogenous, IFN-induced Irga6 as well as 
Mifepristone-induced Irga6 localised normally due to co-induction with IFNγ were not 
detected (Figure 35). Only the residual aggregates present due to the expression of a 
double dose of Irga6 that exceeds the normalising capacity of the IFN-induced GMS 
proteins, were 10D7 positive (Figure 35). Thus, Irga6 is in the active, GTP-bound 
conformation in absence of IFNγ but in the inactive conformation in IFN-induced cells. 
In the latter case Irga6 is presumably bound to GDP due to the protein’s higher affinity 
for GDP than for GTP (~7-15 fold, Figure 36, (Uthaiah 2003)) and the cellular 
concentration of the respective nucleotides (300 µM GTP and 100 mM GDP (Kleineke 
1979)). Consistent with this idea, addition of aluminium fluoride, which traps Irga6 
oligomers in vitro by stabilising the transition state of GTP-hydrolysis, trapped Irga6 
homodimers in cells expressing Irga6 in absence but not in presence of IFNγ (Papic 
2007).  
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IV.9. GTP-bound homomeric Irga6 and Irgb6 complexes dissociate 
ex vivo 
Aggregate formation of Irga6 and Irgb6 protein in absence of IFNγ was not 
reflected in an altered running behaviour in analytical size exclusion chromatography 
(Figure 39 A-E). Furthermore, the aggregates were completely soluble in several non-
ionic detergents (TritonX-100 (Figure 40), NP-40 and Thesit (Kaiser 2005; Papic 2007)). 
Thus, the GTP-dependent homomeric complexes formed in vivo (Figure 33 B, Figure 38 
A) dissociated in cell lysates ex vivo, presumably due to hydrolysis of GTP (Figure 36). 
Irgb6 and Irgd behaved as a monomer in size exclusion chromatography (Figure 39 C-F). 
The elution profiles of the GMS proteins were consistent with the formation of dimeric 
complexes probably representing homodimers, as the elution profiles of the three GMS 
proteins did not overlap completely (Figure 39 G-I). Furthermore, at least for Irgm2, the 
complexes were formed in absence of other IFN-inducible proteins. Interactions with 
other, non-IFN-inducible factors cannot be formally excluded.  
The apparent molecular weight range (50-200 kDa) displayed by cellular Irga6 in 
gel filtration independent of IFNγ (Figure 39 A-B) suggested that the protein was in 
equilibrium between the monomeric and the tetrameric state. The high molecular weight 
species of the protein were also observed for recombinant protein and were dependent on 
the presence of myristoyl modification (Papic 2007; Uthaiah 2002). Thus, the myristoyl 
group apparently induces major conformational changes that either strongly influence the 
apparent molecular weight of the protein or favour homomeric interaction.  
 
IV.10. The three GMS proteins negatively regulate Irga6 and Irgb6  
In view of the complex representation of the IRG proteins in the mouse (Figure 
12), their extensive functional non-redundancy in pathogen resistance (Martens 2006) 
and their massive expression following IFN-induction (Bekpen 2005b; Boehm 1998; 
Martens 2004b), it was conceivable that IRG proteins themselves are the IFNγ-dependent 
regulators of Irga6 and Irgb6. Coexpression of the three GMS proteins, indeed, restored 
the wild type localisation of Irga6 and Irgb6 in over 80-90% of the cells (Figure 41-43). 
The GKS proteins tested (Irgd and Irgb6 or Irga6) did not mediate any normalising effect 
(Figure 42 and data not shown). Except for Irgm1 in the case of Irgb6, each of the three 
GMS proteins partially restored the wild type localisation of Irga6 and Irgb6, but only the 
coexpression of all three GMS proteins together mediated an efficient relocalisation 
(Figure 41, Figure 43). Thus, the GMS proteins cooperatively mediate normal 
localisation of Irga6 and Irgb6. There are two possible explanations for this 
cooperativity. Either the individual GMS proteins regulate Irga6 and Irgb6 at different 
subcellular compartments or the formation of heteromeric IRG protein complexes is 
necessary for efficient control of Irga6 and Irgb6 (Irgm2 and Irgm1 both mainly localise 
to the Golgi while Irgm3 is predominantly ER associated, (Figure 29-31). The role of 
Irgm1 in regulation of Irgb6 is difficult to interpret in absence of more data concerning 
the interactions of IRG proteins, as Irgm1 alone was inert but had an either beneficial or 
negative effect when coexpressed with Irgm2 or Irgm3, respectively (Figure 43). The 
formation of competing heteromeric interactions, however, is clearly one possible 
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explanation, supported by distinct interaction profiles of the four involved IRG proteins 
with other family members in Y2H (Figure 44).  
The normalising effects of Irgm1, Irgm2 and Irgm3 were strictly nucleotide 
dependent, as the three GMS to GMN mutants failed to influence Irga6 and Irgb6 
localisation (Figure 41-43). The P loop serine to asparagine mutant of Irgm3 (S98N), like 
Irga6(S83N) (Figure 36) and many other GTPases (Feig 1988; Nuoffer 1994; Praefcke 
2004a; Stenmark 1994), was shown to be deficient in nucleotide binding (Taylor 1997). 
Thus, the analogous mutants of the other two GMS proteins are probably also nucleotide 
free (Irgm1(S90N), Irgm2(S78N)).  
The beneficial effect of the GMS proteins was clearly dose dependent. 
Transfection of larger DNA amounts of GMS protein expression constructs had a 
stronger effect on Irga6 relocalisation (Figure 34). In the case of Irgb6, the beneficial 
effect of IFN-induction was much smaller (data not shown) than the effect of 
cotransfecting the three GMS proteins together with Irgb6-FLAG, which leads to a 
uniformly high expression of all the transfected proteins. Thus, the expression levels of 
all the involved IRG proteins have to be balanced to prevent Irga6 and Irgb6 aggregation. 
Consistent with these data, Irga6 and Irgb6 were aggregated in Irgm1-deficient mouse 
embryonic fibroblasts (Könen-Waisman unpublished data).  
These findings have important implications for the interpretations of the 
susceptibility phenotypes of GMS-deficient mice. Since the regulation of Irga6 and Irg6 
by the three GMS proteins is carefully balanced and the IRG proteins seem to function in 
a complex network of nucleotide-dependent homo- and heteromeric interactions that 
presumably compete with each other (Figure 44-46), the system might be put completely 
out of balance by depletion of one family member. The GMS proteins are probably 
especially vulnerable to such an effect considering their extraordinary importance in 
regulation of Irga6 and Irgb6 and the presence of only three GMS genes as opposed to 16 
intact, immune-type GKS coding units, including six Irga6- and eight Irgb6-related 
sequence (Figure 12). The non-redundancy of IRG proteins in pathogen resistance 
observed in mice and cells deficient for single members of the IRG family might 
therefore actually reflect an unbalancing of the whole IRG resistance system. Thus, the 
observed susceptibility phenotypes may not necessarily be due to the non-redundant 
activity of single IRG members. In agreement with this, the two GMS-deficient mice 
analysed thus far displayed the broadest range of susceptibilities (Table 1). One could 
even postulate that GMS proteins are solely regulators in the IRG resistance system, 
while the GKS proteins constitute the – partially redundant (Martens 2005) - effector 
molecules. Consequently, all pathogen susceptibilities identified to date only for GMS-
deficient mice would be attributable to certain GKS proteins not yet tested for 
involvement in resistance to these particular pathogens.  
 
IV.11. Direct, nucleotide-dependent interactions of IRG proteins 
Functional interactions of IRG family members take place in vivo since the three 
GMS GTPases were both necessary and sufficient to regulate the nucleotide status and 
the intracellular localisation of Irga6 and Irgb6 (Figure 35, 37, 38, 41-43). A Y2H 
analysis performed with the IRG proteins revealed that numerous of these interactions 
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are direct. Strong homomeric interactions were documented for Irga6 and Irgb6 (Figure 
44) in line with the biochemical and cell biological data presented and discussed above. 
Furthermore, Irga6 interacted with Irgb6, which fits nicely with the observation that 
Irga6 colocalised with severe Irgb6 aggregates when the two proteins were expressed 
together in mouse fibroblasts in absence of IFNγ (data not shown). GMS-GMS protein 
interactions were also observed, namely Irgm1-Irgm3, Irgm2-Irgm3 and Irgm1 
homomeric interaction. Furthermore, two of the GKS-GMS regulatory interactions 
observed in mammalian cells were reflected in Y2H: Irgb6 interacted with Irgm2 and 
Irga6 with Irgm3. Interestingly, all the interactions documented for Irga6 in Y2H were 
independent of the myristoyl group, since the N-terminal fusion with the Gal4 AD and 
BD obliterates the myristoylation motif. This is in line with the G-domains forming the 
interaction interface for Irga6 homomeric (Pawlowski unpublished data) as well as for 
regulatory GKS-GMS interactions (Figure 46). 
All the observed interactions were strictly nucleotide dependent as they were 
completely abolished if one of the interaction partners carried the G1 motif serine to 
asparagine mutation interfering with nucleotide binding. As the Irga6(S83N) mutant 
loses affinity for both nucleotides, while Irga6(K82A) preserved wt affinity in both cases, 
GTP- and GDP-dependent processes could not be distinguished in the Y2H system 
(Figure 36). Mutants exclusively binding GDP were not identified thus far (Pawlowski 
unpublished data). In case of the Gx4GKS to Gx4GAS mutants of Irga6 and Irgb6, some 
of the interactions observed for the wild type proteins were preserved while others were 
lost, again suggesting that the two mutants possess an altered conformation that may 
hinder interaction with other proteins. Potential formation of homo-oligomers inside the 
yeast cells might also effectively reduce the free pool of these two mutants available for 
interaction with other proteins. Furthermore, the interactions observed in Y2H were 
independent of membrane association, as activation of the reporter genes requires 
translocation of the interacting proteins into the nucleus as well as binding to the 
respective promoters. Together with the data from mouse fibroblasts, this may suggest 
that interactions between IRG proteins are not restricted by conformational changes 
induced by membrane association in the uninfected cell but rather by spatial exclusion of 
certain interactions due to distinct subcellular localisations of the involved proteins.  
One of the limitations of the yeast two-hybrid approach used is that heteromeric 
complexes formed by more than two proteins cannot be detected (McAlister-Henn 1999). 
This could be one of the reasons why Irgm1 showed only rather weak interactions in 
Y2H and Irgd non at all (Figure 44). Another likely explanation for these effects is the 
structural constraints imposed on the IRG proteins by N-terminal fusion to the Gal4 
DNA binding and activating domains. Altered behaviour of tagged and fusion constructs 
of the IRG proteins has been observed previously in mammalian cells as well as with 
recombinant protein in vitro (Martens unpublished data (Martens 2004a; Uthaiah 2002)). 
Furthermore, hybrid proteins may not efficiently move into the nucleus and may not 
carry post-translational modifications necessary for proper function (McAlister-Henn 
1999).  
 An independent Y2H study of the wild type IRG proteins based on the LexA 
DNA-binding domain and the B42 activation domain documented partially overlapping 
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but not identical interactions, including Irgd-Irgm2 and -Irgb6 interaction (Kaiser 2005). 
Interestingly, one of the newly identified IRG genes, Irgb10, was shown to interact with 
Irgm2, Irga6 and Irgd in that Y2H assay (termed cIGP9 in that study (Kaiser 2005)). 
Thus, different expression conditions highlight distinct interactions as reported in the 
literature (Van Criekinge 1999). Together this suggests that the nucleotide dependent, 
direct interactions documented by Y2H in this study probably represent a solid basis, 
while more interactions within the IRG family remain to be discovered.  
 
IV.12. Direct, GDP-dependent interaction of Irga6 with Irgm3 occurs 
via the G-domain 
As a representative of the documented direct, nucleotide-dependent regulatory 
GKS-GMS protein interactions, Irga6 interaction with Irgm3 was confirmed by 
coimmunoprecipitation from IFNγ-induced mouse fibroblasts. Irgm3 co-precipitated with 
Irga6 in absence of exogenous nucleotides (Figure 45). As the regulatory effect observed 
in fibroblasts as well as the interaction of Irga6 with Irgm3 seen in Y2H were nucleotide-
dependent (for both partners in case of the Y2H), this presumably reflects the pre-
existence of heterodimeric complexes in vivo containing trapped nucleotides. The 
amount of co-immunoprecipitated Irgm3 was markedly sub-stoichiometric relative to 
Irga6. This might indicate the transient nature of the Irga6-Irgm3 interaction in vivo with 
only a minor proportion of Irga6 bound to Irgm3 at any given time. Alternatively, the 
complex could be of limited stability, so that only a minor proportion of the Irgm3 
associated with Irga6 inside the cells would still be present at the end of the 
immunoprecipitation procedure. Since depletion of bivalent cations by addition of EDTA 
did not prevent Irga6-Irgm3 interaction, nucleotide binding for Irgm3, as shown for Irga6 
in vitro (Figure 36), must also be largely independent of Mg2+ (Figure 55). Addition of 
exogenous GTPγS to the reaction, which was shown to favour homomeric interactions of 
cellular Irga6 ex vivo in a similar setup (Papic 2007), abolished the co-precipitation of 
Irgm3. This suggests that both partners are in the GDP-bound state in the Irga6-Irgm3 
interaction. The amount of co-immunoprecipitated Irgm3 was, however, noticeably 
decreased upon addition of exogenous GDP. This could be either due to the fact that one 
of the interaction partners, presumably Irgm3, has to be in the GTP-bound state or to 
competing hetero- and homomeric interactions with other IRG proteins present in the cell 
lysate.  
 The nucleotide status of the Irga6-Irgm3 interaction was further clarified in pull 
down experiments employing purified GST-Irga6 to capture cellular Irgm3. A weak but 
specific nucleotide independent affinity of Irgm3 for Irga6 was observed that was not 
detected with GST protein alone (Figure 46). The absence of an efficient Irga6-Irgm3 
interaction without exogenous nucleotide in pull down as opposed to co-
immunoprecipitation supports the presence of preformed cellular Irgm3-Irga6 complexes 
with trapped nucleotide in the latter case. Efficient Irgm3 pull down from IFNγ-induced 
cells as well as from cells ectopically expressing Irgm3 in absence of IFN was obtained 
only in the presence of GDP. Thus, the Irgm3-Irga6 interaction is independent of other 
IFN-induced factors and probably requires both proteins to be GDP bound, though it 
cannot be formally excluded that endogenous GTP was trapped in the cellular Irgm3 
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protein. It has been reported that Irgm3 immunoprecipitated from cells predominantly 
coprecipitated GTP (Taylor 1997). However, considering the high concentrations of 
exogenous GDP present, it seems unlikely that Irgm3 could retain GTP. Furthermore, 
exogenous GTPγS as well as a mixture of GDP and GTPγS reflecting physiological 
concentrations (Kleineke 1979) both did not promote Irga6-Irgm3 interaction. The GDP-
dependent precipitation of Irga6 was abolished when the Irga6(S83N) mutant was used. 
Thus, Irgm3 and Irga6 interact in cells and cell lysates whereby Irga6 and most likely 
also Irgm3 are GDP bound.  
Several non-Ras GTPases have recently been shown to accelerate GTP hydrolysis 
by G-domain-G-domain dimerisation (Egea 2004; Focia 2004; Ghosh 2004; Scrima 
2006; Smith 2002; Sun 2002), the two G-domains functioning effectively as GAP 
proteins for each other. Such mutually activating GTPase pairs may be heterodimeric as 
for members of the signal recognition particle (SRP) family (Focia 2004) or 
homodimeric as shown for hGBP1 (Ghosh 2006) and Irga6 (Pawlowski unpublished 
data). Mant-labelled GTP interferes with oligomerisation of Irga6 in vitro by sterically 
hindering the formation of the essential G-domain-G-domain interaction interface that 
normally involves the bound nucleotides (Pawlowski unpublished data). The G-domain-
G-domain interaction interface was shown here to be essential for the Irga6-Irgm3 
interaction as well, since addition of mGDP to the pull down reaction reduced the 
interaction to the basal level (Figure 46). 
Thus, Irgm3 may negatively regulate Irga6 via GDP-dependent, heterodimeric G-
domain-G-domain interaction by successful competition with other Irga6 molecules for 
this interaction interface and by hindering GTP uptake, thus acting in this sense as 
guanine nucleotide dissociation inhibitor (GDI). The same principles may apply for the 
other GMS proteins and Irgb6.  
 
IV.13. Regulatory IRG interactions in Toxoplasma infection 
All IRG proteins analysed so far, namely Irga6, Irgb6, Irgd, Irgm1 and Irgm3, were 
shown to contribute to the IFN-mediated resistance to the protozoan parasite Toxoplasma 
gondii whereby the two GMS proteins play a much more important role than the tested 
GKS proteins (reviewed in (Martens 2006; Taylor 2007), Martens, Parvanova 
unpublished data). The mediated resistance was shown to be cell autonomous for Irgm1, 
Irgm3 and Irga6 (Butcher 2005; Halonen 2001; Ling 2006; Martens 2005). The 
mechanism of the anti-Toxoplasma activity conferred by the IRG proteins is poorly 
understood but involves disruption of the membrane of both the parasitophorous vacuole 
and the parasite by vesiculation (Ling 2006; Martens 2005). Both Irga6 and Irgm3 as 
well as subsequent autophagic events have been implicated in this process (Ling 2006; 
Martens 2005). Five IRG proteins (Irga6, Irgb6, Irgd, Irgm2 and Irgm3) were previously 
shown to accumulate at the parasitophorous vacuole in Toxoplasma gondii infected 
IFNγ-induced primary astrocytes (Martens 2005). For Irgm3, the vacuolar localisation 
was confirmed in primary macrophages (Ling 2006). Irgm1 association with the 
Toxoplasma PVM could not be detected (Butcher 2005; Martens 2005).  
In this study, the accumulation of Irga6, Irgb6, Irgd, Irgm2 and Irgm3 at the 
Toxoplasma PVM was generalised to mouse fibroblasts and was shown to be dependent 
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on IFNγ for all but one of these IRG proteins (Figure 47-53). Despite massive 
aggregation in the cell, ectopically expressed Irgb6 translocated to the PVM in absence 
of IFN (Figure 51), though somewhat less efficiently than in IFNγ-induced cells. Thus, 
accumulation of Irgb6 in the active, GTP-bound state in homooligomers in absence of the 
negative regulation of the GMS proteins still allows localisation to the vacuole. In 
contrast, Irga6 aggregated due to the lack of negative regulation by the GMS proteins 
was incapable of associating with the PV (Figure 47-48). Thus, activation of Irga6 prior 
to infection prevents PV association of the protein. This paradoxical difference between 
Irga6 and Irgb6 allows several interpretations.  
First, Irga6 might be completely in the GTP-bound, oligomeric state following 
ectopic expression while a part of the Irgb6 protein might remain nucleotide free or GDP 
bound. This might be due to the larger cytosolic pool of Irgb6 and the therefore lower 
local concentration of the protein. Alternatively, Irgb6 could possess different 
biochemical properties than Irga6 (e.g. lower affinity for GTP or higher GTP-hydrolysis 
rate). However, the similar behaviour of the two proteins in most analyses rather suggests 
the contrary. Second, Irgb6 could be a pioneer in colonisation of the parasitophorous 
vacuole directly recognising features of and binding to the PVM (see also chapter IV.15), 
while other family members might require the presence of Irgb6 at the vacuole to 
efficiently accumulate there. The second hypothesis is consistent with the observation 
that cotransfection of Irgb6, Irgd, Irgm1, Irgm2 and Irgm3 but not of the three GMS 
proteins alone efficiently restored the vacuolar localisation of Irga6 expressed in absence 
of IFNγ (Figure 47-48). Furthermore, the percentage of Irga6 positive vacuoles was 
reduced by roughly one third relative to IFNγ-induced cells in the latter case, while the 
average intensity of Irga6 signal at the PVM was four fold reduced (Figure 48). Thus, 
efficient association of Irga6 (and presumably also other IRGs) with the PVM seems to 
require Irgb6 at the vacuole probably as initiator of an activating interaction promoting 
Irga6 oligomerisation. Coexpression of Irgd with Irga6 and the three GMS proteins also 
resulted in Irga6 amounts on the PVM similar to those following IFN-induction, 
suggesting that Irgd might be able to fulfil a similar function for Irga6. Thus, the 
presence of GMS proteins is sufficient to allow vacuolar association of Irga6 but other 
GKS proteins seem to be necessary for its efficient accumulation at the PVM. Alternative 
interpretations of that data are discussed in the next chapter (IV.15). As observed for 
Irga6 regulation in uninfected cells, the beneficial effect of the three GMS proteins on 
Irga6 was completely abolished for the three GMN mutants and is thus nucleotide 
dependent.  
The Irga6 protein accumulating at the PVM was shown to be in the active, GTP-
bound conformation by use of the conformation-specific 10D7 antibody (Figure 49). 
Furthermore, the association of Irga6 with the PVM required nucleotide binding, as 
Irga6(S83N) was incapable of doing so even in the presence of IFNγ (Figure 50). The 
lack of vacuolar association of Irga6(S83N) was observed in both Irga6-deficient as well 
as in wild type mouse embryonic fibroblasts. In the latter, the endogenous wild type 
Irga6 localised normally to the PVM. Thus, consistent with the documented inability of 
Irga6(S83N) to interact with wild type Irga6 in Y2H (Figure 44, confirmed in 
coimmunoprecipitation (Papic 2007)), the mutant did not function as a dominant 
negative. The Irga6(K82A) mutant failed to localise to the parasitophorous vacuole in 
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IFN-induced Irga6-deficient MEFs and was strongly impaired in doing so in IFN-
induced wild type MEFs (Figure 50). Furthermore, this mutant acted as a dominant 
negative, almost completely preventing endogenous Irga6 from reaching the vacuole 
(Figure 50). Irga6(S83N) is not able to localise to the PVM, presumably due to its 
inability to bind GTP. In contrast, both wild type Irga6 and Irga6(K82A) were not able to 
relocalise to the PVM in absence of IFNγ and the latter also not in presence of IFN, 
probably due to the binding of GTP leading to activation and homooligomer formation 
prior to infection. Thus, Irga6 has to be in the inactive (presumably) GDP-bound state 
prior to infection and then needs to bind GTP in order to be able to form oligomers at the 
PVM. This process is regulated by competing activating (e.g. Irga6-Irga6) and inhibiting 
interactions (e.g. Irga6-Irgm3) of IRG family members with each other. That vacuolar 
localisation of Irga6(K82A) is not promoted by IFNγ induction suggests that this mutant 
cannot be regulated by the GMS proteins. On the one hand, this could be due to the 
altered conformation of the mutant protein, indicated by its changed interaction 
properties in Y2H as well as the anomalous binding of mant-GTP and the slow GTP-
dependent oligomerisation in vitro (Figure 36, Figure 44). On the other hand, the 
inability of the mutant to hydrolyse GTP (Figure 36), trapping the protein in GTP-
dependent G-domain-G-domain homodimers that cannot be resolved, might be the 
reason. As the activating self-interaction as well as the inhibitory Irga6-Irgm3 interaction 
relies on the same interface that includes the bound nucleotide, Irgm3 might only be able 
to compete with the Irga6 self-interaction upon dissociation following GTP hydrolysis. 
That Irga6(K82A) forms severe aggregates even in presence of IFN supports this latter 
hypothesis (Figure 37). As the endogenous Irga6 protein was found in aggregates 
together with Irga6(K82A) and the two forms of the protein interacted with each other in 
Y2H (Figure 44), Irga6(K82A) presumably exerts its dominant negative function by 
trapping wild type Irga6 protein in such inert complexes locked in the GTP-bound state.  
Together, these results suggest that Irga6 has to be held in the inactive, GDP-
bound conformation by interaction with the GMS proteins prior to infection and that 
Irga6 is activated upon T. gondii infection, accumulating at the PVM in the GTP-bound 
oligomeric form. The biochemical data as well as the Y2H analysis and the requirement 
of other GKS proteins for efficient Irga6 accumulation at the PV suggest that 
homooligomers as well as heterooligomers with other GKS proteins are probably formed 
at the vacuole. GTP-dependent interactions with other GKS proteins already present at 
the PV might be necessary to initiate efficient Irga6 homooligomerisation at the vacuole. 
Irgb6 is the prime candidate for such a pioneering oligomerisation-initiator, as the protein 
is able to translocate to the PV in absence of other IRG proteins (Figure 51). Irgb6 
localisation to the PVM was nucleotide dependent. Similar to the respective Irga6 
mutant, Irga6(S70N) did not accumulate at the vacuole (Figure 51). Irgb6(K69A), 
however, was still able to accumulate at the PVM rather efficiently in presence of IFNγ, 
but in contrast to the wild type protein did not do so in absence of IFNγ (Figure 51). 
Thus, Irgb6(K69A) cannot reach the vacuole autonomously. In view of the preserved 
interaction of this mutant with wild type Irgb6 and Irga6 documented in Y2H, 
Irgb6(K69A) might reach the vacuole by interaction with these proteins.  
Irgd required the presence of IFNγ or the other five IRG proteins (Irgb6 Irga6, 
Irgm1, Irgm2 and Irgm3) for localisation to the PV, whereas the three GMS proteins 
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were not sufficient (Figure 52). Vacuolar localisation of both Irgm2 and Irgm3 depends 
on the presence of the five other IRG proteins and on nucleotide binding since the GMN 
mutants did not accumulate at the PVM (Figure 53 and data not shown). In case of Irgd, 
Irgm2 and Irgm3 the minimal requirements for vacuolar localisation were not analysed.  
Taken together, these data indicate that the complicated network of nucleotide-
dependent interactions observed in Y2H is of functional relevance for the IRG proteins in 
infected cells. Considering the complexity of the IRG system and the lack of data 
available concerning the molecular mechanisms of IRG function thus far, it is difficult to 
interpret many of the obtained results.  
 
IV.14. Irgc – a protein in search of a function 
Despite extensive analysis no phenotype could be documented for mice genetically 
deficient for Irgc r (Rhode 2007). Testis and sperm morphology as well as fertility were 
not impaired. In a Y2H screen, two potential interaction partners of Irgc, the elongation 
release factor 1 (eRF1) and a testis specific splice variant of the Golgi reassembly and 
stacking protein 2 (tsvGORASP2), were identified (Rhode 2007). The interactions were 
dependent on an intact nucleotide-binding site, but the functional implications of these 
potential interactions remain unclear.  
Thus, the unexpected, IFNγ-dependent relocalisation of Irgc ectopically expressed 
in mouse fibroblasts to the T. gondii parasitophorous vacuole is, to date, the only 
documented ‘function’ of this protein (Figure 54). The six IRG proteins Irgm1, Irgm2, 
Irgm3, Irgd, Irga6 and Irgb6 were sufficient to mediate vacuolar localisation of Irgc, and 
so were the three GMS proteins alone, though with markedly lower efficiency in the 
latter case (Figure 54). The other IRG proteins probably mediate Irgc translocation to the 
PVM via direct nucleotide dependent interaction, as Irgc interacted with both Irga6 and 
Irgm3 in Y2H and intact nucleotide binding sites were required on both sides of the 
interaction (Figure 44). As the G-domains display the highest sequence conservation 
within the IRG family, it is conceivable that Irgc interaction with other IRG proteins 
occurs via the G-domain-G domain interface involved in Irga6 homomeric (Pawlowski 
unpublished data) and Irga6-Irgm3 heteromeric interaction (Figure 46, see also chapter 
IV.12). Whether the Irgc translocation to the Toxoplasma PVM reflects an in vivo 
function of Irgc in resistance or only documents conserved interaction properties within 
the IRG family remains to be determined by infection of Irgc-deficient mice with 
Toxoplasma gondii. Interestingly, both virulent and avirulent T. gondii strains were 
reported to disseminate efficiently and rapidly (within 4-5 days) to the testis and to 
replicate there in high numbers following intraperitoneal infection of BALB/c and 
C57BL/6 mice (Hitziger 2005). Despite the obvious need for immunity against 
Toxoplasma in the testis, several facts argue against Irgc functioning as a host resistance 
factor in this immunoprivileged region. First, Irgc is not inducible by interferons but is 
developmentally regulated paralleling sexual maturity (Rhode 2007). Second, Irgc is only 
expressed in haploid spermatids (Rhode 2007) and thus would leave the majority of the 
testis tissue unprotected. Third, the Irgc gene is highly conserved throughout the 
mammals (Figure 20) arguing for a conserved function rather than a function in innate 
immunity. Fourth, Irgc translocation to the T. gondii PVM was dependent on the 
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presence of other, IFN-inducible IRG proteins that are clearly absent from higher 
primates and maybe other animals like the pig (Table 7). Then again, one could argue 
that the GBP family of IFN-inducible GTPases which are conserved in humans and have 
recently been implicated in Toxoplasma resistance in mouse (Degrandi 2007), might 
facilitate Irgc vacuolar localisation in species where immune type IRG proteins are 
absent. A conclusion about Irgc function awaits further experimental evidence.  
 
IV.15. Virulent Toxoplasma gondii inhibit IRG proteins  
While at least 6 IRG proteins accumulated efficiently at the parasitophorous vacuoles 
containing Toxoplasma gondii of the avirulent ME49 strain, the PVs generated by the 
virulent RH strain were largely devoid of IRG proteins (Figure 55). The most drastic 
effect was observed for Irgb6 with a nearly 10-fold reduction in percentage of detectibly 
positive PVs, while the reduction for the other IRGs (Irga6, Irgd, Irgm2 and Irgm3) was 
much less pronounced (Figure 55 and data not shown). There was, however, a much 
stronger effect on the quantity of Irga6 protein accumulating at the PVM. Only the few 
remaining Irgb6 positive vacuoles (8%) acquired normal amounts of Irga6 protein, while 
most of the Irga6 positive vacuoles acquired only small amounts of protein (Figure 55). 
Thus, virulent Toxoplasma possess a yet unidentified mechanism to efficiently inhibit the 
accumulation of IRG proteins at the PVM. As the effect was most drastic for Irgb6, the 
pathogen presumably targets this IRG protein and the effects on the other IRG proteins 
are secondary. This hypothesis is supported by fact that Irgb6 is the only IRG protein that 
was able to target the PVM independent of other IRGs (Figure 51). Furthermore, a 
striking inclusion relationship was observed for IRG protein accumulation at the PV of 
avirulent T. gondii: all of the Irgm3 positive vacuoles were also positive for Irgm2, all of 
which were positive for Irgd, followed by Irga6 and Irgb6 (Könen-Waisman unpublished 
data. These results, together with the restoration of efficient Irga6 PVM localisation in 
cells expressing Irga6 and the three GMS proteins by the presence of Irgb6 (Figure 48, 
see also chapter IV.13), strongly argue for a pioneer role of Irgb6 in vacuolar targeting. 
The presence of Irgb6 at the parasitophorous vacuole would then promote association of 
other IRG proteins presumably by GTP-dependent heteromeric interactions.  
Surprising in this context was, however, the observation that also the presence of 
Irgd enhanced the amount of Irga6 accumulation at the PVM in cells coexpressing Irga6 
and the three GMS proteins (Figure 48). A possible explanation for this effect is that the 
addition of Irgd in this setup indirectly releases Irga6 from a too strong inhibition by the 
GMS proteins by competing with Irga6 for the interaction with these proteins. As the 
inhibitory effect of the GMS proteins was dose dependent in uninfected cells (Figure 41), 
it is conceivable that overexpression of the 3 GMS by transient transfection in cells 
expressing normal amounts of Irga6 following Mifepristone induction might lock the 
majority of the Irga6 protein in the inactive form. Consequently, transient transfection of 
the 3 GMS proteins into IFNγ-induced cells should inhibit Irga6 accumulation at the 
PVM. This could indeed be the case, since Bernstein-Hanley and colleagues (Bernstein-
Hanley 2006) observed that absence as well as overexpression of Irgm3 reduced cellular 
resistance to Chlamydia trachomatis. The same argumentation made for Irgd could of 
 139
DISCUSSION 
course also apply to Irgb6; however, the additional data listed above strongly support the 
pioneer role of Irgb6 in vacuolar colonisation.  
Recent experiments generalised the IRG protein accumulation at the PVM to 
other avirulent strains, and the inhibition of Irgb6 and Irga6 accumulation to other 
virulent strains of Toxoplasma (Khaminets unpublished data). The inhibition of Irgb6 
accumulation at the parasitophorous vacuole by virulent Toxoplasma gondii was shown 
to function locally in coinfection with virulent and avirulent strains (Khaminets 
unpublished data) but the mechanism remains unknown. Masking of potential target 
structures on the PVM and modulation of the nucleotide status of Irgb6 either directly or 
indirectly by unbalancing the complicated regulatory network of IRG protein interactions 
is, however, conceivable. Two rhoptry kinases, ROP16 and ROP18, have been identified 
as important virulence factors, accounting at least for part of the tremendous virulence 
differences of Toxoplasma strains (El Hajj 2006; Saeij 2006; Saeij 2007; Taylor 2006), 
and are therefore potential candidates for inhibitors of the IRG proteins. 
Very recently, mGBP1, -2, -3, -6, -7 and -9 have also been shown to localise to 
the PV of avirulent T. gondii, while mGBP5 could not be detected at the vacuole. As for 
the IRG proteins, mGBP1 and mGBP2 accumulation at the PVM was inhibited by the 
virulent BK strain (Degrandi 2007). This adds another six large, IFN-inducible GTPases 
potentially cooperating in resistance to the already crowded vacuole.  
 
IV.16. Model of IRG function in uninfected and infected cells 
In view of the complex pattern of activating as well as inhibitory interactions between 
IRG family members, it is difficult to draw a conclusive picture about the molecular 
mechanisms governing individual IRG proteins in uninfected and T. gondii infected cells. 
Based on the data generated in this study, however, it is for the first time possible to 
formulate a model of how the IRG resistance system might function as an entity (Figure 
58). In view of the complexity of the situation this model is primarily based on the data 
obtained for Irga6, Irgb6 and the three GMS proteins.  
In this model, GMS proteins negatively regulate self-activating GKS proteins by 
formation of GDP-dependent G-domain-G-domain interactions at endomembranes in 
absence of infection, thus preventing nucleotide exchange and premature activation. 
Upon infection with avirulent strains of Toxoplasma gondii, the inhibition by the GMS 
proteins is released and the GKS proteins translocate to the membrane of most but not all 
parasitophorous vacuoles, where they form GTP-bound, homo- and heterooligomers via 
the same G-domain-G-domain interface, promoting vacuolar destruction. The presence 
of GTP-bound, active GKS proteins at the PVM promotes the further accumulation of 
these proteins due to activating heteromeric interactions. It is not clear what triggers the 
translocation to the vacuole and how the IRG proteins get there, but microtubules are not 
involved (Khaminets unpublished data). The simplest possibility is diffusion from the 
GDP-bound, cytosolic pool of the GKS GTPases followed by spontaneous activation on 
the PV membrane that is not efficiently protected by GMS proteins. A specific pathogen 
derived activation signal could, however, also be involved. Furthermore, the GKS 
proteins could travel to the vacuole in dimeric complexes with the GMS proteins, 
possibly explaining their presence at the vacuole. The absence of the GDI-like activity of 
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the GMS proteins, as is the case in ectopic expression of GKS proteins in cells not 
induced with IFNγ, results in premature activation and GTP-dependent oligomerisation 
of GKS proteins on endomembranes, thus hindering or even preventing translocation to 
the parasitophorous vacuole upon infection (not depicted in the model). Virulent 
Toxoplasma strains possess a virulence mechanism effectively preventing the 
accumulation of IRG proteins on most but not all parasitophorous vacuoles.  
 
Figure 58 Model of IRG function in uninfected and infected cells. Regulatory interactions of IRG 
proteins governing the resting localisation in uninfected cells and the translocation to the PVM of avirulent 
but not virulent T. gondii strains (see text for details). Red ellipse: GTP-bound self-activating GKS 
proteins, green ellipse: GDP-bound self-activating GKS proteins, yellow ellipse: GMS proteins bound to 
GDP at the endomembranes and in unknown nucleotide status at the Toxoplasma gondii PVM 
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V. Appendix 
 
V.1. Purification of recombinant Irga6(S83N) and (K82A) protein 
Purification of recombinant Irga6(S83N) and Irga6(K82A) protein by glutathione Sepharose affinity 
and size exclusion chromatography. (A-B) Coomassie stained SDS-PAGE gel of fractions eluted from a 
glutathione Sepharose affinity column (C-F) Size exclusion chromatography of Irga6(K82A) and 
Irga6(S83N) protein containing fractions (1-3) from (A) and (B) respectively. Fractions A14-B3 were 
pooled and used for biochemical analyses (C-D) Coomassie stained SDS-PAGE gel of eluted fractions. (E-
F) Elution profiles. For purification details see material and method section. (mAU: milli-absorbance unit). 
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V.2. Expression vectors 
Plasmid maps of expression vectors. (A) Mammalian Mifepristone-inducible expression vectors of the 
GeneSwitch system (Invitrogen). (B) Mammalian expression vector used for transient transfection studies. 
(C) Bacterial expression vector used for generation of recombinant IRG protein. (D) Yeast expression 
vectors used for the yeast two-hybrid assay. (For details see material and methods section; hPRD-LBD: 
human progesterone receptor Ligand binding domain, TK: thymidine kinase, hCMV: human 
cytomegalovirus, pA/PolyA: polyadenylation signal, UAS: upstream activating sequences, Amp: 
ampicillin resistance gene, ori: bacterial origin of replication, T: transcription termination, P: promoter, 
AD. activation domain, BD: DNA binding domain, 2µ:  yeast origin of replication; BGH: bovine growth 
hormone; SV40: Simianes Virus 40; TATA: TATA box; E1b: adenovirus E1b protein; ISV8: intron-8 
polythymidine sequence; EM7: E. coli EM7 promoter; f1: bacteriophage f1; pUC: plasmid University of 
California; LEU2: 3-isopropylmalate dehydrogenase gene, TRP1: N-(5 -phosphoribosyl)-anthranilate 
isomerase gene, involved in leucine and tryptophan biosynthesis respectively) 
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V.3. DNA sequence of the expressed murine IRGs  
Open reading frames of the mouse IRGs expressed using the vectors depicted above (V.2, see chapter 
II.1.6 for cloning strategy). A Kozak sequence (underlined) was introduced before the start codons and the 
sequences were flanked by SalI sites (in capitals) (GTCGACcaccatg....stopGTCGAC) (Kozak 1987).  
Irgc ORF 
atggcaacttccaggttgcccgccgtgcctgaggagaccaccatcctcatggccaaggaagagctggaggccctgcgcactgcttttga
gtctggcgacatccctcaagccgcctctcgccttcgggagctgctggccaactcagagaccacccggctggaagtgggcgtcacgggtg
agtcgggagccggcaagtcctccctcatcaatgccctacgcggcctgggggccgaggatcctggcgcagctctcactggggtcgtggag
accaccatgcagccttcgccctacccgcacccgcagtttcccgacgtgaccctgtgggacctgccgggggccggttctccaggctgctc
agcagacaagtatctgaagcaggtggatttcggccgctatgacttcttcttgctcgtctccccccgtcgctgtggcgccgtggagtccc
gcctcgcttctgagatcctgcgccaggggaagaagttttactttgtgcgcaccaaggtggacgaggatctggcggccacccgcagccag
aggccctcgggtttcagcgaggctgcagtcctccaggagatccgagatcactgcacggagcggctgcgggtagcgggtgtgaatgatcc
ccgcatcttcctggtgtccaacctgtcgccaacccgctatgacttcccgatgctcgtgaccacctgggagcacgacctgcccgcccacc
gtcgccacgccggtctgctgtccctgcctgacatctcgctggaggctctgcagaagaagaaggacatgctacaagagcaggtgcttaag
actgccttggtatctggtgtcatccaggccctgccggtccccggactggcagccgcctacgacgacgccttgcttatccgctcactgcg
gggctaccaccgcagcttcggcctagacgacgactcgctggccaagctggccgagcaggtgggcaaacaggcaggggacctgcgctccg
tcatccgctcccccctggccaacgaggtctcaccagagactgtcctgagactctactcgcagtcctcagatggtgccatgcgggtggcc
cgtgcctttgagaggggcatccctgttttcggcacgctggtggccgggggtatcagcttcggcacggtctacaccatgctccagggctg
tctcaatgagatggctgaggacgcccaacgcgtccgcatcaaagccctggaggaagatgagccccaggggggtgaggtgagcttggagg
cggctggtgacaatttagtggaaaagcggagcactggggaaggaaccagcgaggaagccccgctgtccacccgcaggaagctcggcctc
ctcctcaagtatattcttgacagctggaagaggcgcgacttgtcagaagacaaataa 
Irgm3 ORF 
atggatttagtcacaaagttgccacaaaatatctggaagacttttacacttttcataaacatggcaaattatctcaagcgcctcatcag
cccgtggtctaaatctatgactgctggtgagtcactttattccagccagaactcatcctctccagaagtcattgaagatattggtaagg
cggtgacagagggaaatttacagaaagtgataggtatagtcaaagatgaaattcagagtaagtcaagatacagagtaaagattgctgtg
actggggactctggcaatggcatgtcatctttcatcaatgcccttaggttcattggacatgaggaggaggagtcagctcccactggggt
ggtgaggaccactaagaaaccagcctgctactcctctgactcccactttccctatgtggagctgtgggacctgcctggcttaggggcca
cagcccagagtgtggagagctacctggaggagatgcagatcagcacatttgaccttatcatcatcgtagcttctgagcagttcagctca
aatcatgtgaagctggccataaccatgcagaggatgagaaagaggttctatgtcgtctggaccaagctggacagggacctcagcacaag
taccttccctgaaccccagctactgcagagtatccaaaggaatatccgggagaatctccagcaggctcaggtgagggacccccccctat
tcctgatatcctgttttagcccgtcttttcacgacttcccagagcttagaaacacactgcaaaaagacatcttcagcatcaggtacaga
gatcccttagagatcatttctcaagtctgcgacaagtgcatcagcaataaggcgttctctctgaaggaagatcagatgctcatgaaaga
cctggaggcagctgtcagctccgaggatgacactgccaacctggagaggggtctccagacctaccagaagctctttggtgtggatgatg
ggtcacttcagcaggtagctcggagtacagggagactggagatgggctccagggctctgcagttccaggacttgatcaagatggacagg
agactggagctgatgatgtgttttgccgtgaacaagttcctcaggcttctcgaaagctcatggtggtatggcttgtggaacgtcgtcac
ccgctacttcagacaccagaggcacaagctcgtcattgaaatagtggctgagaacaccaagacctccctgaggaaagctctaaaggact
ctgtcctccctcccgaaattcactga 
Irga6 ORF 
atgggtcagctgttctcttcacctaagagtgatgagaataatgatttgccctccagctttactggttattttaagaaatttaatacggg
aagaaaaatcatttctcaagagatcctcaatttgattgaattaaggatgagaaaagggaatattcagttgacaaactctgcaatcagtg
atgcattaaaagaaatcgatagtagtgtgctcaatgttgctgtcaccggggagacgggatcagggaagtccagcttcatcaataccctg
agaggcattgggaatgaagaagaaggtgcagctaaaactggggtggtggaggtaaccatggaaagacatccatacaaacaccccaatat
acccaatgtggttttttgggacctgcctgggattggaagcacaaatttcccaccaaacacttacctggagaaaatgaagttctatgagt
acgatttcttcattattatttcggccacacgcttcaagaaaaatgatatagacattgccaaagcaatcagcatgatgaagaaggaattc
tacttcgtgagaaccaaggtggactctgacataacaaatgaagcagatggcaaacctcaaacctttgacaaagaaaaggtcctgcagga
catccgccttaactgtgtgaacacctttagggagaatggcattgctgagccaccaatcttcctgctctctaacaaaaatgtttgtcact
atgacttccccgtcctgatggacaagctgataagtgacctccctatctacaagagacacaattttatggtctccttacccaatatcaca
gattcagtcattgaaaagaagcggcaatttctgaagcagaggatttggctggaaggatttgctgctgacctagtgaatatcatcccttc
tctgacctttctcttggacagtgatttggagactctgaagaaaagcatgaaattctaccgcactgtgtttggagtggatgaaacatctt
tgcagagattagctagggactgggaaatagaggtggatcaggtggaggccatgataaaatctcctgctgtgttcaaacctacagatgaa
gaaacaatacaagaaaggctttcaagatatattcaggagttctgtttggctaatgggtacttacttcctaaaaatagttttcttaaaga
aatattttacctgaaatattatttccttgacatggtgactgaggatgctaaaactcttcttaaagagatatgtttaagaaactag 
Irgd ORF 
atggatcagttcatctcagccttcctgaagggtgcttcagaaaatagtttccaacaattagctaaggagtttctgcctcagtactctgc
attaatcagtaaggcaggaggcatgctctctccagaaaccctcactggtattcacaaagccctccaggagggaaatctctctgatgtca
tgatccagattcagaaagcaattagtgctgcagagaatgctatcctggaggtggctgtgatcgggcagtctgggactggcaagtccagt
tttataaatgcccttcgagggctgggccacgaagcagatgaatccgctgatgttgggactgtggagaccactatgtgtaaaacccccta
tcaacatccaaaatatcccaaagtgatcttctgggacctgcctgggactgggacacccaatttccacgcagacgcttatctagaccaag
tgggatttgccaactatgacttcttcatcatcatttcttcttcccgcttcagcctcaatgatgctctcctggctcagaaaataaaggat
gctgggaagaagttctactttgttagaaccaaggtggatagtgacttatataatgaacagaaagccaaacccatagctttcaagaagga
gaaagtccttcagcagattcgagactactgtgtgactaatctcatcaaaactggggtgactgaaccatgcatcttcctgatctccaact
tggatctgggtgcgtttgatttccccaagctggaggagactctgctaaaggagctccctgggcacaagcgtcatatgtttgccctgctc
ttgcccaatatctcggatgcttccattgagctaaagaaacattttcttcgggagaagatctggctggaggccttgaagtcagcagctgt
gagcttcatccccttcatgactttctttaagggctttgatttgcctgaacaagaacagtgcttgaaggattaccgaagctattttggct
tggatgatcaatcgattaaagagattgctgaaaaattgggcgcacccttggcagacatcaagggggaacttaagtgcttggatttctgg
tcccttgtaaaggataacagcataatagcgcaagctacgagtgctgctgaagctttttgtgctgtgaaaggaggccctgaatcttctgc
cttccaggctttaaaagtctattataggcgcacacagttccttaacatagtggttgacgatgctaaacatctcttgagaaagatagaaa
cagtaaatgttgcctag 
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Irgm1 ORF 
atgaaaccatcacacagttcctgcgaggctgctccactactccccaacatggcagagacccattatgctcccctgagctcagccttccc
ctttgtcacgtcataccaaacaggctccagcaggttacctgaggtcagtaggagcaccgaaagagctttaagagaaggaaaactactgg
aactggtctacggaatcaaggagactgtggcaacattgtcccagattccagtgagcatctttgtgactggggactctggcaatggcatg
tcatctttcatcaatgcacttcgagtcatcggccatgatgaagatgcctcggctcccactggggtggtgaggaccacgaagacgcggac
tgagtactcttcatcccactttcccaatgtggtgctgtgggacttacctggattgggggccacagcccaaaccgtagaggactatgtgg
aagagatgaaatttagcacatgtgacttattcatcatcattgcctctgagcagttcagctcgaatcatgtgaagctgtccaaaattatc
cagagcatgggaaagaggttctatattgtctggaccaagctggacagggacctcagcaccagtgtcctatcagaggtccggctcctaca
gaatatccaggagaatatccgagagaatctgcagaaggagaaagtgaagtacccccccgtgttcctggtatccagtctagaccctttac
tatatgacttcccgaagcttagggacacacttcataaagatctctccaacatcaggtgctgtgaacccttaaagaccctttatggcact
tatgagaagatcgttggtgataaagtagcagtctggaagcagagaatagccaacgagtccttgaagaattctctcggtgtcagagatga
tgacaacatgggcgagtgtctgaaagtgtaccgactgatatttggtgtagatgacgaatcagttcagcaggtagcccagagtatgggga
cagtagtcatggagtacaaggacaacatgaagtcccaaaacttttatactctccgcagagaggactggaaactgaggctgatgacatgt
gcaattgtgaatgcattcttccgtttgttgagatttctcccatgcgtatgctgctgtttaagacgcttgagacataaacgcatgctttt
cttagttgcccaggacaccaagaacatcctagagaaaatcctgagggactccatcttccctccgcagatctag 
Irgb ORF 
atggcttgggcctccagctttgatgcattctttaagaattttaaaagggaaagcaaaatcatctctgaatatgacatcaccttgattat
gacttacatagaggaaaataagctacagaaagctgtttctgtaattgaaaaggtactgagagacatcgagagtgctcctctgcacatag
ctgtgacaggggaaacaggcgcagggaagtccactttcatcaataccctgaggggggtggggcatgaagaaaaaggtgcagcccccact
ggcgcaatagagacaaccatgaagagaactccatacccacacccaaagcttcccaacgtgacaatatgggacctgcctggcattgggac
cactaacttcacaccacaaaactatctgacagaaatgaagtttggtgagtatgacttcttcattatcatctcagctacacgtttcaaag
aaaatgatgcacaactggccaaagccattgcacagatggggatgaatttctactttgtcagaaccaagatagacagcgacttagataat
gaacagaagtttaagcctaagagtttcaataaggaggaagtcctcaagaatattaaggattactgctctaatcatcttcaggagtctct
cgacagtgagcctccagtcttcctagtctctaacgttgatatatcgaagtatgacttcccaaagctggaaactaaactcctacaggatc
tcccagcccacaagcgtcacgtattctcactgtctttgcaaagtcttactgaggccaccattaactacaagagagattccctgaagcaa
aaagtcttcctagaagccatgaaggctggagcattagccaccattccacttggtggcatgatcagtgatatcttagagaatctggatga
aacattcaatctctacaggtcttactttgggctggatgatgcttcactggaaaacattgcccaggatttgaacatgtctgtggatgact
tcaaggtacaccttcgatttccccatttgtttgcagaacacaatgatgagtccttagaagacaagctatttaaatatatcaaacacatt
tcttcagttactggtgggccagtcgctgcagtcacttactatcgcatggcttattatttgcagaatctctttcttgatactgcagccaa
tgatgccatagctcttctgaatagtaaagcactttttgagaagaaggtgggaccatatatatctgagccccccgagtactgggaagctt
ga 
 
V.4. Abbreviation of species names 
List of abbreviations of species names used in the phylogenetic analyses. 
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V.5. Sequence sources of mouse and human IRG genes 
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APPENDIX 
V.6. Nucleotide alignment of mouse Irga6 and Irga6* (C57BL/6) 
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V.7. Protein and nucleotide alignment of mouse Irgb3 and Irgb4 
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V.8. Alignment of mammalian IRGC proteins 
Alignment of mammalian IRGC proteins. Black shading: 80% conserved, grey shading: 40% conserved, 
red boxes: nucleotide-binding motifs 
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V.9. Alignment of mammalian IRGQ proteins 
Alignment of mammalian IRGQ proteins. Blue: position where splicing occurs, black: 80% conserved, 
grey: 40% conserved, red: GTPase motifs. Note that the IRGQ proteins from different species contain 
insertion of variable length between G4 and G5 motif. 
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V.10. Alignment of orang-utan IRGM sequences (Pongo pygmaeus) 
Alignment of IRGM sequences from orang-utan (Pongo pygmaeus). Note that the IRGM4-9 sequences 
are disrupted by frame shifts and/or premature stop codons. Black shading: 70% conserved, grey shading: 
40% conserved; * premature stop codon; red highlighting: position of frame shifts. Red boxes mark the 
GTPase motifs. The alignment was used to generate a consensus sequence (see appendix V.13). 
 
 
V.11. Alignment of Takifugu rubripes IRG proteins. 
Alignment of Takifugu rubripes (TR) IRG proteins. Blue: position of intron, black: 90% conserved, 
grey: 50% conserved, red: GTPase motifs 
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V.12. Alignment of Takifugu rubripes IRG proteins. 
Alignment of Tetraodon nigroviridis (TN) IRG proteins. Blue: position of intron, black: 85% conserved, 
grey: 50% conserved, red: GTPase motifs. 
 
V.13. IRG protein sequences 
The position of introns is indicate by yellow highlighting 
>MM_Irgq 
MPLPQGDVTALFLGPPGSGKSALIAALCGKNVDTVEIPDGRQDSGVPSLRAAAPGLFLGELSCPPAAPGPWAAEANLLVLVLPGSEGSE
EPLTPALGEAARAALARGTPLLAVRNLRPGDSQNAAKARDETAALLNSAGLGAAPLFVPPADCSSSDRCEELERLQVVLRTQAEALQRL
LPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRAGLERLGSARLDLAVAGTTNVGLVLDMLLGLDPGDPGAAPASAPTGPTPYPAP
ERPNVVLWTVPLGPTATSPAVTPHPTHYDALILVTPGAPTEENWAQVRSLVSPDAPLVGVRTDGQGEDPPEVLEEEKAQNASDGNSGDA
RSEGKKAGIGDSGCTAARSPEDELWEVLEEAPPPVFPMRPGGLPGLGTWLQHALPTAQAGALLLALPPASPRAARRKAAALRAGAWRPA
LLASLAAAAAPVPGLGWACDVALLRGQLAEWRRALGLEPAAVARRERALGLAPGVLATRTRFPGPVTRAEVEARLGSWAGEGTAGGAAL
SALSFLWPTGGAAATGGLGYRAAHGVLLQALDEMLADAEAVLGPPEPNQ* 
>MM_Irgc 
MATSRLPAVPEETTILMAKEELEALRTAFESGDIPQAASRLRELLANSETTRLEVGVTGESGAGKSSLINALRGLGAEDPGAALTGVVE
TTMQPSPYPHPQFPDVTLWDLPGAGSPGCSADKYLKQVDFGRYDFFLLVSPRRCGAVESRLASEILRQGKKFYFVRTKVDEDLAATRSQ
RPSGFSEAAVLQEIRDHCTERLRVAGVNDPRIFLVSNLSPTRYDFPMLVTTWEHDLPAHRRHAGLLSLPDISLEALQKKKDMLQEQVLK
TALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSPLANEVSPETVLRLYSQSSDGAMRVA
RAFERGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEDEPQGGEVSLEAAGDNLVEKRSTGEGTSEEAPLSTRRKLGL
LLKYILDSWKRRDLSEDK* 
>MM_Irga1 
MGQLFSLLKNKCQFLVSSVAEYFKKFKKIVIIILQEVTTSIELDMKKENFQEANSAICDALKEIDSSLVNVAVTGETGSGKSSFINTLR
GIGHEEEGAAKTGVVEATMERHPYKHPNMPNVVFWDLPGIGSTKFPPKTYLEKMKFYEYDFFIIISATCFKKNDIDLAKAISMMKKEFY
FVRTKVDTDLRNEEDFKPQTFDKEKVLQDIRLNCVNTFKENGIAEPPIFLISNENVCHYDFPVLMDKLISDLPDYKRHNFMLSLPNITD
SVIETKRQSLKQRHWLQGFAGVLLSYLH* 
 153
APPENDIX 
>MM_Irga2 
MGQLFSSRRSEDQDLSSSFIEYLKECEKGINIIPHEIITSIEINMKKGNIQEVNSTVRDMLREIDNTPLNVALTGETGSGKSSFINTLR
GIGHEEGGAAHTGVTDKTKERHPYEHPKMPNVVFWDLPGTGSEDFQPKTYLEKMKFYEYDFFIIISATRFKKNDIDLAKAIGIMKKEFY
FVRTQVDSDLRNEEDFKPQTFDREKVLQDIRLNCVNTFRENGIAEPPIFLISNKNVCHYDFPVLMDKLISDLPVFKRQNFMFSLPNITD
SVIEKKRNFLRWKTWLEGFADGLLSFFLESDLETLEKSMKFYRTVFGVDDASLQRLARAWEIDQVDQVRAMIKSPAVFTPTDEETIQER
LSRYNQEFCLANGYLLPKNHCREILYLKLYFLDMVTEDAKTLLKEICLRN* 
>MM_Irga3 
MGQLFSHIPKDEDKGNLESSFTEYFRNYKQETKIISEETTRSIELCLKRGDFQRANSVISDALKNIDNTPINIAVTGESGAGKSSLINA
LREVKAEEESAAEVGVTETTMKVSSYKHPKVKNLTLWDLPGIGTMKFQPKDYLEKVEFKKYDFFIIVSSSRFTKLELDLAKATRIMKKN
YYFVRSKVDCDLDNEKKSKPRNFNRENTLNQVRNSYLDTFRESKIDEPQVFLISNHDLSDYDFPVLMDTLLKDLPAEKRQNFLLSLPNI
TEAAIQKKYNSTKQIIWLQATKDGLLATVPVVGILKDLDKERLKKRLDYYRDLFGVDDESLMFMAKDAQVPVELLIKNLKSPNLLKCKE
ETLEELLLNCVEKFASANGGLLAAGLYFRKTYYLQFHFLDTVAEDAKVLLKAAQTHFAHSF* 
>MM_Irga4 
MGQLLSDTSKTEDNEDLVSSFNEYFKNIKTEKIISQETIDLIKLYLNKGNIHGANSLISDALRNIDNAPINIAVTGESGAGKSSLINAL
IGIGPEEEGAAEVGVIETTMKRTSYKHPKIETLTLWDLPGIGTQKFPPKTYLEEVKFKEYDFFIIVSATRFTKLELDLAKAITNMKKNY
YFVRTKVDIDVENERKSKPRTFEREKALKQIQSYSVKIFNDNNMAVPPIFLISNYDLSDYDFPFLVDTLIKELHVQKRHNFMLSLPNFT
DQAIDRKYKATQQFIWLEAFKIGVVAIFPVLGNLRNKDMKKIKNTLNYYQKIFGVDDESLELVAKDFQVPVEQVKKTMKTPHLLKKYRE
ETFRNDFKKLVSTFGRLLAVGLYFPAIYYLQLHILDTVTEDAKVLLRWKYSKPRSNSTYP 
>MM_Irga5_pseudo 
MGQLFSGTSKSEALCSSFTEYFQKFKVENKIISQEISTLIELYLTLGDVQQANNAITYALR*LARTPQNVALIGESGRGKYSFINVFRG
LDMKRKMATVGVVETTMNRTPYRNPNIPNVIIWDLPGIGTTNFPPKHYLKKMQFYVMYDFFIIVSATCFRKNDIDLSKAVVMIKKDFLL
RTRTKEDIDIENENE* 
>MM_Irga6 
MGQLFSSPKSDENNDLPSSFTGYFKKFNTGRKIISQEILNLIELRMRKGNIQLTNSAISDALKEIDSSVLNVAVTGETGSGKSSFINTL
RGIGNEEEGAAKTGVVEVTMERHPYKHPNIPNVVFWDLPGIGSTNFPPNTYLEKMKFYEYDFFIIISATRFKKNDIDIAKAISMMKKEF
YFVRTKVDSDITNEADGKPQTFDKEKVLQDIRLNCVNTFRENGIAEPPIFLLSNKNVCHYDFPVLMDKLISDLPIYKRHNFMVSLPNIT
DSVIEKKRQFLKQRIWLEGFAADLVNIIPSLTFLLDSDLETLKKSMKFYRTVFGVDETSLQRLARDWEIEVDQVEAMIKSPAVFKPTDE
ETIQERLSRYIQEFCLANGYLLPKNSFLKEIFYLKYYFLDMVTEDAKTLLKEICLRN* 
>MM_Irga7 
MDQLLSDTSKNEDNDDLVSSFNAYFKNIKTENKIISQETIDLIELHLNKGNIHGANSLIREALKNIDNAPINIAVTGESGVGKSSFINA
LIGTGPEEEGAAEVGVIETTMKRNFYKHPKIETLTLWDLPGIGTQKFPPKTYLEEVKFKEYDFFIIVSSTRFTKHELDLAKAIGIMKKN
YYFVRTKVDIDLENERKSKPRTFDREKTLKQIQSYAMNTFSDNNMAIPPIFMVSNYDLSKYDFPVMMDTLIKDLHAEKRHNFMLSLPGI
TEAAIDRKHKATQQIVWLEAFNVGLLANFPVTGILGDNDVKKLEKSLNYYRKIFGVDDESLELVAKDFQVPVEQVKEIMKSPHLLKTNG
KETLGEKLLKYLEKFETATGGLLAVGLYFRKTYYLQLHFLDTVTEDAKVLLRWKYSKPRSNSTYP* 
>MM_Irga8 
MGQLFSNMPKDEDKGNLESSFTEYFRNYKQETKIISEETTRSIELCLKKGDIQRANSIISDALKNIDNAPINIAVTGESGAGKSSLINA
LREIKAEEESAAEVGVTETTMKVYSYKHPKVKNLTLWDLPGIGTKKFPPKTYLETVEFKKYDFFIIVSAIRFTNHEIELAKAIRIMKKN
YYFVRSKVDFDLYNEEKSKPRNFNRENTLNQVRNYYLDTFRESKIDEPQVFLISNHDLSDYDFPVLMDTLLKDLPAEKRHNFLLSLPNI
TEAAIQKKYNSPKQYIWLQAMEDGLLATVPAVGILKDLDKERLKRSLDYYRDLFGVDDESLMFMAKDAQVPFELLKIKLKSPYLLELEE
ETLGGLILNCVEKFASANGGLLATGLYFRKTYYLQFHFLDTVAEDAKVLLKEAY* 
>MM_Irgb1 
QHPPLNTATCQTSTGRTSQITAQLLEFNFKNFFKNFKKESKILSEETITLIESHLENKNLKEALTVISHALRNIDKAPLNIAVTGETGT
GKSSFINALRGISSEEKDAAPTGVIETTMKRTPYPHPKLPNVTIWDLPGIGSTNFPPQNYLTEMKFGEYDFFIIISATRFKEIDAHLAK
AIAKMNIKFYFVRTKIDQDISNEQRSKPKSFNRDSVLKKIKDECLGLLQKVLSSQPPIFLVSNFDVSDFDFPKLETTLLKELPAHKRHL
FMMSLHSVTETTIARKRDFLRQKIWLEALKAGLWATIPLGGLVRDKMQKLEETLTLYRSYFGLDEASLENIAKDFNVSVNEIKAHLRSL
QLLTKNNDMSFKEKLLKYIEYISCVTGGPLASGLYFSKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLSDLPEYWETGMEL* 
>MM_Irgb2 
MGQTSSSTSPPKEDPPLTFQVKTKVLSQELIASIESSLEDGNLQETVSAISSALGDIEKVPLNIAVMGETGAGKSSLINALQGVGDDEE
GAAASTGVVHTTTERTPYTYTKFPSVTLWDLPSIGSTAFQPHDYLKKIEFEEYDFFIIVSAIRIKQSDIELAKAIVQMNRGLYFVRTKT
DSDLENEKLCNPMRFNRENILKSIRICLSSNLKERFQQEPPVFLVSNFDVSDFDFPKLESTLLSQLPAYKHQIFMSTLQVVINAIVDRK
RDMLKQKIWKESIMPRAWATIPSRGLTQKDMEMLQQTLNDYRSSFGLNEASLENIAEDLNVTLEELKANIKSPHLFSDEPDTSLTEKLL
KYIGNPYFSKVFHLQNYFIDTVASDAKIILSKEELFTEQVSSFNSKASPYREESVGKVFPVSPGSTFLFHFFEMFQSDSDKLCHVHVLL
LLTSWGLSGETVT* 
>MM_Irgb3 
QHPPLHTATCQPSSSRPSPLMAQLLVFSFENFFKNFKKESKILSEETITLIESHLEDKNLQGALSEISHALSNIDKAPLNIAVTGETGT
GKSSFINALRGVRDEEEGAAPTGVVETTMKRTPYPHPKLPNVTIWDLPGIGSTTFPPQNYLTEMKFGEYDFFIIISATRFKEIDAHLAK
TIEKMNTKFYFVRTKIDQDVSNEQRSKPRSFNRDSVLKKIRDDCSGHLQKALSSQPPVFLVSNFDVSDFDFPKLETTLLRELPSHKRHL
FMMSLHSVTETAIARKRDFLRQKIWLEALKAGLWATIPLGGLVRNKMQKLEETLTLYRSYFGLDEASLENIAKDFNVSVNEIKAHLRFL
QLFTKNNDMSFKEKLLKYIEYISCVTGGPLASGLYFRKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLSDLPEYWETGMEL* 
>Mouse_Irgb4 
QHPPLHTATCQPSSSRPSRLTAQLLVFSFENFFKNFKKESKILSEETITLIESHLEDKNLQGALSEISHALSNIDKAPLNIAVTGETGT
GKSSFINALRGVRDEEEGAAPTGVVETTMKRTPYPHPKLPNVTIWDLPGIGSTTFPPQNYLTEMKFGEYDFFIIISATCFKEIDAHLAK
TIEKMNTKFYFVRTKIDQDVSNEQRSKPRSFNRDSVLKKIRDDCSGHLQKALSSQPPVFLVSNFDVSDFDFPKLETTLLRELPAHKRHL
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FMMSLHSVTETAIARKRDFLRQKIWLEALKAGVWATIPLGGLVRNKMQKLEETLTLYRSYFGLDEASLENIAKDFNVSVNEIKAHLRSL
QLLTKNNDMSFKEKLLKYIEYISCVTGGPLASGLYFRKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLSDLPEYWETGMEL* 
>MM_Irgb5 
MGQTSSSTPPPKEDPDLTSSFGTNLQNFKMKTKILSQELIAFIESSLEDGNLQETVSAISSALGGIEKAPLNIAVMGETGAGKSSLINA
LQGVGDDEEGAAASTGVVHTTTERTPYTYTKFPSVTLWDLPGIGSTAFQPHDYLKKIEFEEYDFFIIVSSGRFKHNDAELAKAIVQMNR
SFYFVRTHTDLDLMVVKRSNPRRFNRENTLKQIRHTISSMLKEVTHQEPPVFLVSNFDVSDFDFPKLESTLLSQLPAYKHHMFMLTLPI
VTDSTIDRKRDMLKQKVWKESTMPRAWATIPSLGLTQKDMEMLQQTLNDYRSSFGLDEASLENIAEDLNVTLEELKANIKSPHLLSDEP
DTSLTEKLLKYIGNPYFSKVFHLQNYFIDTVASDVKIILSKEELFTEQVSSFNSKASLYREESVGKVFPVGPGSTFLFHFIEMFQSDSD
ELCHVHVLLLLTSGGLSSETVT* 
>MM_Irgb6 
MAWASSFDAFFKNFKRESKIISEYDITLIMTYIEENKLQKAVSVIEKVLRDIESAPLHIAVTGETGAGKSTFINTLRGVGHEEKGAAPT
GAIETTMKRTPYPHPKLPNVTIWDLPGIGTTNFTPQNYLTEMKFGEYDFFIIISATRFKENDAQLAKAIAQMGMNFYFVRTKIDSDLDN
EQKFKPKSFNKEEVLKNIKDYCSNHLQESLDSEPPVFLVSNVDISKYDFPKLETKLLQDLPAHKRHVFSLSLQSLTEATINYKRDSLKQ
KVFLEAMKAGALATIPLGGMISDILENLDETFNLYRSYFGLDDASLENIAQDLNMSVDDFKVHLRFPHLFAEHNDESLEDKLFKYIKHI
SSVTGGPVAAVTYYRMAYYLQNLFLDTAANDAIALLNSKALFEKKVGPYISEPPEYWEA* 
>MM_Irgb7_pseudo 
PFWFVPPLGTIDICQDWVKLPLLHPLQRRILLLTFQMKTKILSQELITFIELYLEDGNL*ETVSAISSALGDIEKVPLNIAVMGETGAG
KSSLINALQGTGADEDGVTAPVGVVYTTIEKKSYPYAKFPSAILWELPAIGFHHFQPHDYLKKIKFEEYDFIIVSAGRIKHSDVELAKA
IVQMNRGLYFNRTKTDIDLKNEKLYNPMRFNRENTLKSLQICISSNLKECFHQEPPVFLVSNFDVSDFDFPKLESTLLSQLPAYKHQIF
MRTLQVVINAIVDWKRDMLKQKVWKESTTPRAWATIPSLGLTQKDMEMLQQTLNDYRSSFGLDEASLKNIAEDLNVTLEELKANIKSPH
LLSDEPDTSLTEKLLKYIGNPYFSKVFHLQNYFIDTVASDVKIILSKEELFTEQVSSFNSKASPYREESVGEVFPVGPGSTFLFHFFEM
FQSDSDKLCHVHVLLLLTSWGLSGETVT 
>MM_Irgb8 
QHPPLHTATCQPSSSRPSPLMAQLLVISFENFFKNFKKESKILSEETITLIESHLEDKNLQGALSEISHALSNIDKAPLNIAVTGETGT
GKSSFINALRGVRGEEEGAAPTGVVETTMKRTPYPHPKLPNVTIWDLPGIGSTNFQPQNYLTEMKFGEYDFFIIISATRFKEIDAHLAK
AIAKMNTKFYFVRTKIDQDVSNEQRSKPKSFNRDSVLKKIRDDCSGHLQKVLSSQPPVFLVSNFDVSDFDFPKLENTLLRELPAHKRHL
FMMSLHSVTETAIDRKRDFLRQRIWLEALKAGVWTTIPLGGLVRDKMQKLEETLTLYRSYFGLDEASLENIAKDFNVSVNEIKAHLRSL
QLLTKNNDMSFKEKLLKYIEYISCVTGGPLASGLYFRKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLSDLPEYWETGMEL* 
>MM_Irgb9 
MGQTSSSTLPPKDDPDFIASFGTNLQNFKMKTKILSQELIAFIESSLEDGNLRETVSAISSALGGIEKAPLNIAVMGETGAGKSSLINA
LQGVGDDEEGAAASTGVVHTTTERTPYTYTKFPSVTLWDLPGIGSTAFQPHDYLKKIEFEEYDFFIIVSSGRFKHNDAELAKAIVQMNR
SFYFVRTHTDLDLMVVKLSDPRKFNKENILEQIRNSISNILKEVTHQEPPVFLVSNFDVSDFDFPNLESTLLSQLPAYKHHMFMLTLPI
VTDSTIDRKRDMLKQKIWKESIMPRAWATIPSRGLTQKDMEMLQQTLNDYRSSFGLDEASLENIAEDLNVTLEELKANIKSPHLLSDEP
DTSLTEKLLKYIGNPYFSKVFHLQNYFIDTVASDVKIILSKEELFTEQVSSFNSKASPYWEESVGKVFPVGPGSTFLFHFFEMFQSDSD
KLCHVHVLLLLTSWGLSGETVT* 
>MM_Irgb10 
MGQSSSKPDAKAHNMASSLTEFFKNFKMESKIISKETIDSIQSCIQEGDIQKVISIINAALTDIEKAPLNIAVTGETGAGKSTFINALR
GIGHEESESAESGAVETTKDRKKYTHPKFPNVTIWDLPGVGTTNFKPEEYLKKMKFQEYDFFLIISSARFRDNEAQLAEAIKKMKKKFY
FVRTKIDSDLWNEKKAKPSSYNREKILEVIRSDCVKNLQNANAASTRVFLVSSFEVAQFDFPSLESTLLEELPAHKRHIFVQCLPTITE
PAIDRRRDVLKQTIWLEALKAGASATIPMMSFFNDDIEEFEKILSHYRACFGLDDESLENMAKEWSMSVEELESTIKSPHLLSSEPNES
VADKLVKTMEKIFAVTGGFVATGLYFRKSYYMQNYFLDTVTEDAKVLLKKKVFLQDSVDSE* 
>MM_Irgd 
MDQFISAFLKGASENSFQQLAKEFLPQYSALISKAGGMLSPETLTGIHKALQEGNLSDVMIQIQKAISAAENAILEVAVIGQSGTGKSS
FINALRGLGHEADESADVGTVETTMCKTPYQHPKYPKVIFWDLPGTGTPNFHADAYLDQVGFANYDFFIIISSSRFSLNDALLAQKIKD
AGKKFYFVRTKVDSDLYNEQKAKPIAFKKEKVLQQIRDYCVTNLIKTGVTEPCIFLISNLDLGAFDFPKLEETLLKELPGHKRHMFALL
LPNISDASIELKKHFLREKIWLEALKSAAVSFIPFMTFFKGFDLPEQEQCLKDYRSYFGLDDQSIKEIAEKLGAPLADIKGELKCLDFW
SLVKDNSIIAQATSAAEAFCAVKGGPESSAFQALKVYYRRTQFLNIVVDDAKHLLRKIETVNVA* 
>MM_Irgm1 
MKPSHSSCEAAPLLPNMAETHYAPLSSAFPFVTSYQTGSSRLPEVSRSTERALREGKLLELVYGIKETVATLSQIPVSIFVTGDSGNGM
SSFINALRVIGHDEDASAPTGVVRTTKTRTEYSSSHFPNVVLWDLPGLGATAQTVEDYVEEMKFSTCDLFIIIASEQFSSNHVKLSKII
QSMGKRFYIVWTKLDRDLSTSVLSEVRLLQNIQENIRENLQKEKVKYPPVFLVSSLDPLLYDFPKLRDTLHKDLSNIRCCEPLKTLYGT
YEKIVGDKVAVWKQRIANESLKNSLGVRDDDNMGECLKVYRLIFGVDDESVQQVAQSMGTVVMEYKDNMKSQNFYTLRREDWKLRLMTC
AIVNAFFRLLRFLPCVCCCLRRLRHKRMLFLVAQDTKNILEKILRDSIFPPQI* 
>MM_Irgm2 
MEEAVESPEVKEFEYFSDAVFIPKDGNTLSVGVIKRIETAVKEGEVVKVVSIVKEIIQNVSRNKIKIAVTGDSGNGMSSFINALRLIGH
EEKDSAPTGVVRTTQKPTCYFSSHFPYVELWDLPGLGATAQSVESYLEEMQISIYDLIIIVASEQFSLNHVKLAITMQRMRKRFYVVWT
KLDRDLSTSTFPEPQLLQSIQRNIRDSLQKEKVKEHPMFLVSVFKPESHDFPKLRETLQKDLPVIKYHGLVETLYQVCEKTVNERVESI
KKSIDEDNLHTEFGISDPGNAIEIRKAFQKTFGLDDISLHLVALEMKNKHFNTSMESQETQRYQQDDWVLARLYRTGTRVGSIGFDYMK
CCFTSHHSRCKQQKDILDETAAKAKEVLLKILRLSIPHP* 
>MM_Irgm3 
MDLVTKLPQNIWKTFTLFINMANYLKRLISPWSKSMTAGESLYSSQNSSSPEVIEDIGKAVTEGNLQKVIGIVKDEIQSKSRYRVKIAV
TGDSGNGMSSFINALRFIGHEEEDSAPTGVVRTTKKPACYSSDSHFPYVELWDLPGLGATAQSVESYLEEMQISTFDLIIIVASEQFSS
NHVKLAITMQRMRKRFYVVWTKLDRDLSTSTFPEPQLLQSIQRNIRENLQQAQVRDPPLFLISCFSPSFHDFPELRNTLQKDIFSIRYR
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DPLEIISQVCDKCISNKAFSLKEDQMLMKDLEAAVSSEDDTANLERGLQTYQKLFGVDDGSLQQVARSTGRLEMGSRALQFQDLIKMDR
RLELMMCFAVNKFLRLLESSWWYGLWNVVTRYFRHQRHKLVIEIVAENTKTSLRKALKDSVLPPEIH* 
>RN_Irgq 
MPLPQGDVTALFLGPPGSGKSALIAALCGKNVDAVEIPDGRPDSGVPSLRAAAPGLFLGELSCPPAAPGPWAAEANLLVLVLPGSEGSE
EPLTPALGEAARAALARGTPLLAVRNLRPGDSQNAAQARDETAALLDSAGLGAAPLFVLPADCSSSDGCEELERLQVVLRTQAEALQRL
LPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRAGLERLGSARVDLAVAGTTNVGLVLDMLLGLEPGDAGAAPASAPTEPTPYPAP
ERPNVVLWTVPLGPTATSPAVTPHPTHYDALILVTPGAPTEENWAQVRSLVSPDAPLVGVRTDGQGEDPPEVLEEEKAGNARDGNSGDA
RSEGKKPGIGDSGCSAVRSPEDEQWEVLEEAPPPVFPLRPGGLPGLGTWLQRALPTAQAGALLLALPPASPRAARRKAAALRAGAWRPA
LLASLAAAAAPVPGLGWACDVALLRGQLAEWRRALGIEPAAVARRERALGLAPGVLATRTRFPGPVTRAEVEARLGSWAGEGTAGGAAL
GALSFLWPAGGAAATGGLGYRAAHGVLLQALDEMLADAEAVLGPPEHNQ* 
>RN_Irgc 
MATSRLPAVPEEETTILMAKEELEALRTAFESGDIPQAASRLRELLATTETTRLEVGVTGESGAGKSSLINALRGVGAEDPGAALTGVV
ETTMQPSPYPHPQFPDVTLWDLPGAGSPGCSADKYLKEVDFGRYDFFLLVSPRRCGAVETRLASEILRQGKKFYFVRTKVDEDLAATRN
QRPSGFSEAAVLQEIRDHCAERLRAAGLSDPRIFLVSNLSPNRYDFPMLVTTWEHDLPAHRRHAGLLSLPDISLEALQKKKDMLQEQVL
KTALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSPLANEVSPETVLRLYSQSSDGAMRV
ARAFERGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEDETQGEVSLEAAGDNAVEKRSSGEGTSEEAPLSTRRKLGL
LLKYILDSWKRRDLSEDK* 
>RN_Irgm1 
MPETSTHNAPLNLSFPSVPSYQIGCSSLPEISRSTERALKEGKLPELVYGVKETVATLSQIPVSIFVTGDSGNGMSSFINALRIIGHEE
DASAPTGVVRTTQTRAEYSSSHFPNVVLWDLPGLGATAQTVENYIEEMKFSTCDLFIIVASEQFSSNHVKLAKIIQSMGKRFYVIWTKL
DRDLSTSVLSEVRLIQNIQENIRENLQKEGVKEVPIFLVSNLDPLLHDFPELRNTLQTDLSNIRCCEPLKTLYVIYEKIIGDKVANWNQ
IIANGRLKSSLGVRDDDDMGECLKRYRLIFGIDDESLQQIAHGMGTVVMEYKANIKSQDFHTLRRADWKLRLMTCTTVNALFCLFKFLP
CLCHCFKRMRHKRMLLLVAKDTKNILKKILMDAVSPPQI* 
>RN_Irgm2 
MEEAVGLPEDKQFACLSDAVFISKDNSILSVEVIKSIQAAVAGGNGVEVVSIVKEIVQKVSRTTMKIAVTGDSGNGMSSFVNALRLIGH
EEEDSAPTGVVRTTQKPACYSSSHFPYVELWDLPGIGTTAQSMESYLDEMQFSAYDLIIIIASEQFSSNHVKLAEAMQRMRKKFYVVWT
KLDRDISTSTFPEPQLLQSIQKNIRENLQKGKVKEPPIFLVSIMKPLLHDFERLRETLRKDLSDIKYHGLLETLYQICENTINERVESI
KKIIDENNLQREFGILTPDNLTETRKVFQEIFGVDDQSLSQVSRSMEKPDTHYKASIESQEIQGYQQDGWPLVWLHRPVIQFFSTGLDR
VPCCFYSPHHRYTQQKGVLDETAGKTKNFLWKILKDSISHLQKT* 
>RN_Irgm3 
MAKPLKPPLFKSITAGESSYSSQNSSSPEVIEKVGKAVAEGDLQKVIYTVKEEMQSKSRYTVKIAVTGDSGNGMSSFVNALRLIGHEEE
DSAPTGVVRTTQKPACYSSFHFPYVELWDLPGTGVTAQSMESYLDEMQFSAYDLIIIIASEQFSSNHVKLAEAMQRMRKRFYVVWTKLD
RDISTSTFPEPQLLQSIQKNIRENLQKAQVRDPPIFLVSCFSPSFHDFLDLRETLRKDIHNIRYRDPLETLSQVCDKCINNKALSLKED
LMFTKHLEAAVSPPYDIADLERSLDTYQKLFGVDNESLRRVAQSTGRPEMSTRALQFQDLIKMDRRLRLMMCFVVNILLRVLGSPWWFG
LWDVVTRYFRHQRQKRIIEIVAKNTKTSLRRALEDYTLPPEILCEGSGVPSSGIQAASGSFCIEP* 
>RN_Irgd 
MDQFITAFLKGASEKNFQQLAMEFLPQYSALISKSGGMLSPETLSAIHYALQEGRLSDVMNQIQEAISAAENAVLEVAVIGESGTGKSS
FINALRGLGHEEAESADVGTVETTMYKTPYQHPKYPNVIFWDLPGTGTPNFHTDTYLDRVGFANYDFFIIISSSRFSVNDALLAQKIKD
AGKKFYFVRTKVDSDLYSEERTRPRTFRKEQVLQRIRDYCLSNLTDIGVSEPRIFLISNFDLDAFDFPKLEETLLKELPGHKRHMFALL
LPNISDASIELKKHFLQEKICLEALKSGAMSFIPFMPFISGFDLPQQEQCLKDYRSYFGLDDKSIEEIAERLETPLEDIKGQLKCLDFW
SFVKDDSIIARARSAGEAFCSVKGGLGSSVVQALKVYYMRTQFLNVVVEDAKHLLRKMETVNIA* 
>RN_Irga5 
MGQLFSGTAKSEALYSSFSEYFKKFKAENKIISQETITLIELYLILEDLPQANNEITSALRKLANTPLNVAVIGESGTGKSSFINVFRG
VGHEDETAAPIGVVETTMRRTPYRHPNIPNVVIWDLPGIGTTNFPPKDYLEKMKFCEYDFFIIISATRFRKNDIDLAKAVSMMKKDFYF
VRTKMDIDLENEMECKDTFSRETFLKHIRSHCVTMFKKNNLHVPPIFLISNRNVSDYDFPILKAMLQNKLSTHTYHNIMVSLPNITEAA
IERKHTFIQQFIWLEAFKDGVLMTIPVVDTLKDSDVEKLKMSLNHYRVLFGVDDATLQFMAKDSQVPVEQLRKIIKSPYLLETKKRKAL
EGMLLKYMEKSASANGGLLATGLYFRKSFYLQLLFLDTVAEDAKVLLRETHSRN* 
>RN_Irga11 
MGQLFSLTTNEQGEDLPSSFAKYFKKFKTGHKIISEEIITSVELSMTKGNIQMANSAISEAFREIDSTPLNVAVTGESGAGKSSFINAL
RGIGHEEEGAAEIGVVETTMWRHKYQHPSMPNVVIWDLPGIGTTNFPPKTYLEKMKFYEYDFFIIISATRFKKNDIDLAKAISMMKKDF
YFVRTKVDSDLRNEENTKPRSFDREKVLQNIRLNCVKHFKENGMDEPPIFLISNIDLSDYDFPILMDKLISDLPVYKRHTFMLSLPNIT
DSTIEMKRQCLKQRIWLEAFAADLLRILPSLTFLLDSDLETLKKCLKFYRTVFGVDDAALQSLAKDWQMPLVELEAMMKSPIVFKPTDE
ETIHERLSRYYHDYCSANGHLFTDDRDLREISYLKYYFLDIVTEDAKTLLKEICVRNKLVSN* 
>RN_Irga12 
MGQWFSSKNEQHQDLASSFKEYFKKFKTGHKIISEEIITSVELSMTKGNIQMANSTISEALRDIDGTPLNVAVTGESGAGKSSFINALR
GIGHEEEGAAEIGVVETTAERWPYKHPSMPNVVIWDLPGIGTTNFPPKTYLEKMKFYEYDFFIIISATRFKKTDTDLAKAISMMKKDFY
FVRTKVDSDLRNEENTKPRSFDREKVLQNIRLNCVKHFKENGMDEPPIFLISNIDLSDYDFPILMDKLISDLPVYKRHTFMLSLPNITD
STIEMKRQCLKQRIWLEAFAADLLRILPSLTFLLDSDLETLKKCLKFYRTVFGVDDAALQSLAKDWQMPLVELEAMMKSPIVFKPTDEE
TIHERLSRYYHDYCSANGHLFTDDRDLREISYLKYYFLDIVTEDAKTLLKEICVRNKLVSN* 
>RN_Irga13 
MGQWFSSKNEQHQDLASSFKEYFKKFKTGHKIISEEIITSVELSMTKGNIQMANSAISEALREIDGTPLNVAVTGESGAGKSSFINALR
GIGHEEEGAAKIGVVETTAERWPYKHPSMPNVVIWDLPGIGTTTFPTKTYLEKMKFYEYDFFIIISATRFKKNDIDLAKAISMMKKDFY
FVRTKIDSDLRNEEEFKPRSFDREKVLQNIRFNCVKHFKENGIDEPPIFLISNRNLSDYDFPILMDKLISDLPVYKRHTFMLSLPNITD
 156
APPENDIX 
SAIEKKRQSLKQKIWLEAFAADLLSIIPSLTFLLDSDLETLKKCLKFYRTVFGVDDAALQSLAKDWQMPLVELEAKMKSPIVFKPTDEE
TIHERLSRYYRDFCLANGYLVTQNLYLREIFYLKFYFLDIVTEDSKTLLKEICLRNKLVSN* 
>RN_Irga14p 
MGQLFSDTSKNEDNEGDLVSSFKAYFKKLIQKQKSFLQKLSIxIELHLSKGDFLGANDLISDALKNIDNIPINIAVTGESGAGKSSFIN
ALIGIRPEEEGAAAVGVVETTMKRTPYQHPKIKTLTLWDLPGIGTQKFPPKTYLEKVKFKEYDFFIIASATRFTKLELDLAIAIRILKK
NYYFVRTKVDIDLNHALLTEKRPxQIRSYSVNTFSNNYMDVPQIFLISNYDLSDYDFPILVDTLNKNLPAQKRYNFMLSLPKITEAAID
RKHKASQQFIWLEAFKVGILATFPVVGILRDNDVEKLTESLNHYRQLFGVDDESLELMARDFQVPVGQLKEKIKSPHLLKTNREETLGK
KLLKYLEKFASANGGLLATGLYFRKTFYLQLHFLDTVAEDAKVLLQWTYSKQ* 
>RN_Irga15 
MGQLFSDTSKSEDNGGDLVSSSNAYFKKINTKTKIISPETIRLIELHLSKGNILGASDLISDALKNIESIPINIAVTGESGAGKSSFIN
ALRGIRPEEEGAAEVGVVETTMERTPYQHPKIKTLTLWDLPGIGTQKFPPKTYLEKVKFEEYDFFIIASATRFTKLELDLAKAIRIMKK
NYYFVRTKVDFDLENEKRSKPRTFDREKTLKKIRGCTMKTFRENNMDVPQIFLISSYNLSDYDFPVLMDTLIKDIPAQKRYNFMLSLPK
ITEAAIDRKHKAMQEFVWLEAFKTGALATIPALGILRDNDVEKLRQKLNNYRQLFGVDDESLEFMAKDFQVPVAQLKEILKSPHLLKTD
REETLQDKLLKYLEIFASANGGLLATGLYFRKTYYLQLHFLDTVAEDAKVLLQWKYSKH* 
>RN_Irga16p 
MKTGNLESSLQICFTAYFRKYKPETKIISEEITRLTELCLKRGDLQGANSVISDALKNIDIAPINIAVTGVSGAGKSSLINALREVKDE
GEGAAEVGVAESTMKTDSYEQPQNxKSLTLWDLPGIETQKFQQKKIIWKKxEFKKYDFFIIVSSIQIAKHEVDLAKAIGIMKKNYYVVR
TKVDSDLERGEIHRPHSFNRENTLNQI*GDCLDTSRDNEIDEPQLFLISDHNLSDYDFPVLMDTLIKDLPAEKRHNFLPSLPNITEAAI
QTKKYNSTKQFIWLEAMKDGVLATVPVVGILNDLDMEGLxRYRDLLGAEDESLAFLAKDAQVPLTYxEKRKLKSPYLLEIKKEEALxSI
ALELFGEIYFSxINDGFLATGLYFGKTYFLQTYFLDTVTEEPKVLLKEAYSKNIAQTQLAHSCRQLRDQRVNSRESLDKFML* 
>RN_Irgb10  
MGQSSSKPDAKAHNMASSFNEFFKSFKMESKILSEETINSIQSCVQEGDIQKGISIINAALADIEKAPLNIAVTGETGAGKSTFINALR
GVGHEESESAKIGAVETTMDKFPKFPNVTIWDLPGVGTCNFKPEEYLKKLRFQEYDFFLIISATRFRENDAQLAKAIKKMKKNFYFVRT
KIDSDLWNQKKCKPKSYNKEKILEEIRKDCVEKLQNARVASARVFLVSSVEVAQFDFPELESTLLEELPAHKRHVFMQCLPSITERAID
RRRDALRQKIWLEALKYGASATIPMMCFFNDDIEELEKILTHYRGSFGLDDESLKNMASEWSMSVEELKSFINSPHLLSCEMNESVSDK
MVKIMEKIFAVTGGLIATGLYFRKSYYMQNYFLDTVSEDAKILLKKKVFLQGSEDSE* 
>RN_Irgb13 
QHPPGHTATCKSSSSRSSPLTAQLLSLGLKIFFKSFKKESKILSEETVTLIESHLEDKNLQGALSTISHALRNIDKAPLNIAVTGETGA
GKSSFINALRGVRDDEECAAPTGVVEKTKERTPYPHPKLANVTIWDLPGIGSTTFPPQNYLAEMKFGEYDFFVIISATRFKETDAHLAK
AIAKMNTKFYFVRTKIDQDLRNEEKSKPKVFNRDGVLKKIRDDCSQHLQKDLSSEPPIFLVSNFDVSDFDFPKLETTLLSELPAHKRHI
FMLSLHNVTETAIDRKRDFLKQKIWLEALKAGAWTTIPFGGLVHDKKQTLEDTLNLYRSYFGLDEASLEKIANNFNVSVDEIKAHIKSL
HLLTENKDMSFGEKLLKYIEYISSFTGGPLASGLYFRKTYYWKSLFIDTVASDAKALLNKEAFLSEKPGLRVSDHTEYWEAGMEL* 
>RN_Irgb14 
MGQTSSSTTPPKEDPDLTSSFGTNLQNFEMKTKILSQELITFIESSLEGGNLRETVSAISDALSDIEKAPLNIAVIGETGAGKSSLINA
LQGVGADKEGTAAPTGVVHTTSERTPYTYTKFPCVTLWDLPGIGSPAFQPHDYLKKIKFEEYDFFIIVSSGRFKHNDAELAKAIVQMNR
SFYFVRTHIDLDLMVVKLSAPKRFDKENILEEILNSISSILKEVTYQEPPVFLVSNFNVSDFDFRKLETTLLEELPAYKRHIFMLTLPT
VTESTIDRKRDMLKQKIWKESIMPRAWASIPFRGLTQNDIEMLEQTLNDYRSSFGLDEASLENIAGDLNVTLEELKANIKSPHLLSYEP
DISLRDKLLKYISHPYFSKVFHLQNYFIDAVASDVKLILSKEELLTNKVRSFNSNVSRQLF* 
>CP_IRGC 
XXGKKFYFVRTKVDEDLAATRTQRPSGFSEATVLHEIRDHCAERLRAVGVSDPRIFLVSNLSPTRYDFPTLVSTWEHDLPAHRRHAGLL
SLPDISLEALQKKKDMLQEQVLKTALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSPLA
NEVSPETVLRLYSQSSDGAMRVARAFERGIPVFGTLVAGGISFGTVYTMLQGCLNELAEDAQRVRIKALEEDEPQPEISLEAAGDNSVE
KRVTGEAGGEEGQLTTRRKLGLLLKYVLESWKKRDLEEK* 
>CP_IRGQ 
FVLPADCNRSDGCEELERLRAALRSQAEALQRFLPPAQDGFEVLGAAELEAVREAFETGARRLHXXXGTTTRGCWDSGRIAALSPEDET
WEVLEEAPPPIFPLHLSGLPGLCEWLQRALPSAQAGALLLALPPASPRAARKKVAALRAGAWRPALLASLAAAAAPVPGLGWACDVALL
RGQLAEWRRALGPRTCIAGAARARLGLGSWRAGCSCTLPRPRDTRxEVETRLGAWAGEGTAGGAALGALSFLWPAGGAAATGGLGYRAA
HGVLLQALDEMQADAEAVLAPGEPAQ* 
>CP_GMS1 
MENEPLSIAVTGESGAGMSTFINALRGTWDEEEGVAPTGPMATTLQATAYTLQSARGTLWDLPGLGRPNFPLQEYLKEIPDCDLFFIIF
ATRLKCNDIELAKAIAQIKKKVYFIQTKIDNALVSCQKARPLTFDKDKVLQEIRNCGLAQLQEARVVADKIFLVSSLDVCAYDFPELQS
TLVRDLPAHKRHAFMQRLSSVTEAAVNGKRDSLKQKIWLEALKAGAWAAVPLVGLFSDSERKKLEDTLSLYRSHFGVDDESLEKMAQDL
HVSLEDLKANLQSPDLLSAESDESFWEKTKQMVEMVLLVTGGPIATGLQFTKTFYLQNYFLDIVASDVKALLAKEDLFSASVGSAGLQK
EGN* 
>CP_GMS2 
MEEDLVSHRTPLSASFTSGVSYHRDGGVPLEVSRDLEKAVKEGQLLEVVAIARKVVEMASRAPVSLAVMGDSGNGMSSFVNALRGIGHE
DAASAPTGVVRTTLTPARYTSPSFPNVFLWDLPGMGASDQSLDHYLRELQHSQYDLFLLIASEQFSLHHVRLAKTIQGMGKRFYVIWTK
VDRDLSTTPLSRGLLLRNIQENILETLQKEGVHKPPIFLVSSLDPDLHDFPDLRKKLRIDIFNIRCSGPLEAMSYACKETINEKVASLK
TRVLQNCPEDTLGSCGADDLEQYLRVYRGCFGIDDDSLLQVAWSTGRVVSEYRTLLRSQDLCGLRRADCRLRLATCSVMKMLLRLLRWV
PWLGPRAVRWFAQVTHKRMLHLVAQDTKGILKKILEDSTCPA* 
>CP_GMS2b 
MEEDLVSHRTPLSASFTSGVSYHRGGGVPLEVSRDLEKAVKEGQLLEVVAIARKVVEMASRATVSLAVTGDSGNGMSSFVNALRGIGHE
DVASAPTGVVRTTLTPARYTSPSFPEVFLWDLPGMGASDQSLEHYLRELQHSQYDLFLLIASEQFSLHHVRLAKTIQGMGKRFYVIWTK
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VDRDLSTTPLSRGLLLRNIQENILETLLKEGVHKPPIFLVSSLDPDLHDFPDLRKELRIDIFNIRCSGPLEAMSCACKETINEKVASLK
TRVLQNCPEDTLGSCGADDLEHYLRVYRGCFGIDDDSLLQVAWSTGRVVSEYRTLLRSQDLCGLRRADCRLRLXXX 
>CP_GKS1 
XSGRAT*RLQWIYEEILSGAKNAALEVAVIGASGTGKSSFINALRGLGHEEEGAAEVGVVETTMEKTPYKHPQYPNVTFWDLPGTGTPT
FTPDTYLEAVGFATFDFFIIISSSRFTCSDGLLAQKIQEAGKNFYFVRSKVDCDLDNERRAKPKSFQRERVLQEIRDYCLANLRNMGVT
DPPIFLVSNFELHGFDFPGLQRTLLGELPAHKRQVFALMLPALSDASIELKRSILKEKIWLEALKLAAVAFIPFGSIFKGFDLPEQEQC
LQLYQKYFGLDDESIEEIAKKLHTSVQDIKGELRCLDSSALLQDDSKAAMAMYCAEKFCSVTGGPISSTMHFVKAYSIRLKILDAVAQD
AKVLLHKTLRAPF*QNEVEALCPAS 
>CP_GKS2 
MRHFLCLPASPPPCILAPALSPPLWLPLHLCFLLQVLFLSCLSCLKSCQKSLVVLRPVLLFGCCFPVTLFSLLFTDLPESAAMDALISD
FLKNLTQKNFQQLAADFMSQSAAFISTAGGVIPPGTLSKIEVVLKEGNLRAAVDIIEEILSEVENAALEVAVIGESGTGKSSFINALRG
LGHEEEGAAEVGVVETTMKKTPYKHPKYPNVTFWDLPGTGTPTFTPDTYLEAVGFATFDCFIIISSSRFTCNDALLARKIQEAGKNFYF
VRSKVDCDFDNERRAKPQSFKRERVLQLIRDYCLANLYDIGVPDPRIFLVSNFELHDFDFPDLQRTLLGELPAHKRQAFAVMLPTLSDA
CIELKRGFLKEKIWLEAVKSSALAFIPLMPIFKGFDLSEQEACLKLYRKYFGLDDKSIAETAMKLGTSVQDIKGYTRCLDFWALVKDDS
TAAKAMRCAESFCSVNGGVTSVVAQFLKACFLRSKFLDTVADDAKLLLRKTINAHI* 
>CP_GKS3 
MGQASSSSTNPDTGENGDLASSFDEYFKNITMETKILTNKDQDMIKLYLQQGDVQKAASVINAVLKDIENAPLSIAVTGEGGSGKSTLI
NALRGVAHEDEGAAATGLTETTTEGTEYRHPKFPNVSIWDLPGVGTTKFSPEKYLKKVNFADYDLFLIVSCTRFKNNDAHLAKAIAKMK
KKFYFVRTKIDIDLSNEERAKPRNFNKEKLLEKMRNDIVTQLKAAGVSAAQIFLISSLDVGDYDFPEMERTLLRDLPAHKRHVFRMSLP
SLTEPAINQKTDSLKQKIWLEALKVGATATVPLVGLFSDSERKKLEDTLGLYRSHFGLDDESLEKMPQDXXXXX 
>CP_GKS4 
MRHFLCLPASPPPCILAPALSPPLWLPLHLCFVLHVLFLSCLSCLKSCQKSLEVLRPVLLFGCCFPVTLFSLLFTDLPESAAMDALISD
FLKNLTQKNFQQLAADFMSQSAAFISNAGGVIPPETLSKIEAVLKEGNLRAAVDIIEEILSEAKNAALEVAVIGGSGTGKSSFINALRG
LGHEEEGAAEVGVVEITKKKTPYKHPKYPNVTFWDLPGTGTPTFTPDTYLEAVGFATFDCFIIISSSRFTCNDALLAGKIQEAGKNFYF
VRSKVDSDLYNERRGKPQSFQRERVLQLIRDNCLANLYDIGVPDPRIFLVSNFELHDFDFPGLQRTLLGELPAHKRQAFAVMLPTLSDA
CIELKRGFLKQKIWLDAVKSSALAFIPFMPILKGFDLSEQEACLKLYRKYFGLDDKSIAETAMKLGTSVQDIKGYTRCLDFWALVKDDS
TAAKAMRCAESFCSVNGGVTSVVAQFLKACFLRSKFLDTVADDAKLLLHKIINAHI* 
>CP_GKS5 
MDALISDFMKNLTQKNFQQLAADFMSQSAAFISNAGGVIKPETLSKIEAVLKEGNLRAAVDIIEEILSEAKNAALEVAVIGGSGTGKSS
FINALRGLGHEDEGAAATGLTETTTEGTEYRHPKFPNVSIWDLPGVGTTKFSPEKYLKKVNFADYDLFLIGSCTRFKNNDAHLAKAIAK
MKKKFYFVRTKIDIDLSNEERAKPRNFNKEKLLEKMRNDIVTQLKAAGVSAAQIFLISSFDVGDYDFPEMERTLLRDLPAHKRHVFRMS
LPSLTEPAINQKTDSLKQKIWLEALKVGATATVPLVGLFSDSERKKLEDTLGLYRSHFGLDDESLERWPRICTCPWRTSRQTFXXX 
>CP_GKS6 
MGQASSSSTNPATGENGDLASSFDEYFKNITMETKILTNKDQDMIKLYLQQGDVQKAASVINAVLKDIENAPLSIAVTGEGGSGKSTLI
NALRGVAHEDEGAAATGLTETTTEGTEYRHPKFPNVSIWDLPGVGTTKFSPEKYLKKVNFADYDLFLIVSCTRFKNNDAHLAKAIAKMK
KKFYFVRTKIDIDLSNEERAKPRNFNKEKLLEKLRNDIVTQLKAVGVSAAQIFLISSFDVGDYDFPEMEKTLLRDLPAHKRHVFRMSLP
SLTEPAIXXXESFSEKMMQIVQTVLSVTGGPIATGLYFTKAFYIHNYFLDTVANDANVLLNKEDLFGASAGSVEGYQE* 
>CP_GKS7 
XEAFSVGNLQAVVDAIQEILSAAENAVLEVAVIGESGTGKSSFINALRGLGHEEEGAAKGGVVETTMKKTPYKHPQYPNVTFWDLPGVG
TPTFTPDTYLEAVGFATFDCFIIISSSRFTCNDALLARKIQEAGKSFYFVRSKVDS*LYNERRGKPQSFQRERVLQLIRDNCLANLYDI
GVPDPRIFLVSNFELHDFDFPGLQRTLLGELPAHKRQAFAVMLPTLSDACIELKRGFLKQKIWLDAVKSSALAFIPFMPILKGFDLSEQ
EACLKLYRKYFGLDDKSIAETAMKLGTSVQDIKGYTRCLDFWAPGEG* 
>ST_Irgq 
MLPPRGDVTALFLGPPGSGKSSLIAALCDKNVETVEIPEGRPDSGIPSLRAAGPGLFLGELSCPPAVPGPWAAEANVLVLVLPGHEGNG
ELLDPALAEAARAALARGTPLLAVRNLRHGDSQNDARTQTAALLNSAGLGAATLFVLPAECCSSDCWEELERLRVALRSQAEALQRLLP
PAQDGFEVLGAAELEAVREAFETGGLEAALSWVRSGLERLGSARLDLAVTGTTDIGLVLNMLLGLDPNDPGAVPASVPTVPTPFPAPER
PNVVLWTVPLGPMGTSPAAAPHPTHYDGLILVTLGAPTEKDWAQVRSLVVPDGPLVCVRTDGEGEDPESLEEEKLKPRDADLQKKGEGG
LENAPSDPKEKPGTGSQKAGGEDSEKAGSEGAGFKKPGSGDSGGTGALSPEDETWEVLEEAPPPVFPLRPGGLPALCEWLQRGLPPAQA
GALLLALPPTSPGAARRKAAALRAGAWRPALLASLAAAAAPVPGLGWACDVALLRGQLAEWRRALGLEPxALARRERALGLAPGELAAR
THFPGPVTRAEVEARLGAWAGEGTAGGAALGALSFLWPAGGAAATGGLGYRAAHGVLLQALEEMQADAEAVLAPPEPTQ* 
>ST_IRGC 
MATSKLPSAPGEEETTILMAKEELEALRTAFESGDIPQAASRLRELLAASESTRLEVGVTGESGAGKSSLINALRGLGAEDPRAALTGV
VETTMQPSPYPHPQFPDVTLWDLPGTGTPNFLPDTYLETVGFTSYDFFIIISSSRFSFNDALLAQKIKEEGKKFYFVRTKVDSDLYNEE
VTKPKSFKRERVLQQIRDNCLANLSNIGVPEPCIFLVSNFNLDNFDFPRLQETLLKDLPAHKRHIFALLLPTFSEASIEIKRDFLKEKI
WLDAVKSASLAFVPFMPIIYGFDLPEQEKCLEGLPTTFWS* 
>ST_GKS1 
MGQASSSTTPNKEAQDFTFSCDKFFKTFKMESKILSPETIASIQSHLDEGNIQKTVSAINDALKNIQNAPLNIAVTGESGAGKSTFINA
LRGVGHEEKDAAATGVVETTMERTRYQHPKLPNVIIWDLPGIGTTNFQPRKYLKKMMFGEYDFFIIISSTRFKENDAHLAKAIAKMNKQ
FYFVRTKIDSDIYNQKICTPKSFNRDKLLQKIRDDCLKHLKDNNINGAQVFLVSSVHVSDYDFPNLETTLLKELPAHKRYIFMQCLPSV
TEAAIDRKRDSLKQMVWLEALKAGASATIPMMGLINDNDIQKLKETLTLYRSYFGLDDASLENMAKDFQVSMQELKANIKSPHLLSVDR
DESLGEKILTYIEKVCSVTGGFLATGLYFRKVFYLQTYFLDTVVSDAKVLLKREVLFTDSEISEQSFKNGVSEAESP* 
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APPENDIX 
>ST_GMS1 
MSHNFCASLSVTILTPCNSISVGYSTLINMAEAPLSPNTMFSSSHTSVMLDHKCSSILSTDIIRDIEKAWKEGKLLEVVSVVRKTETVS
RMPVSIAVTGESGNGMSSFINALRRLKHEDEDSAPIGVVKTTQTRGSYSSFHFPNVVLWDLPGMDTTAQSLENYLNEMQFSQYDLFIII
ASEQFSMNHVKLAKAIQGMGKRFYVVWTKLDRDFSTSALLNEKILQNIQEKIKENLQNEGVKEPPIFLVSNFDPSLHDFPKLRNTLRID
ISKIRYHSAQKIILSICEDIINENVTSLLNKIDTGGFQDVLGIQDPNNLGDCLKSYRFFFGVDDKSLKQVAQSIGKSVEEYTNIVKSQD
AQTYHQESSTLSWIGNITVFYFCIGLSYIPYYGNSVAKYLNYMEQRRLLESVAKDTKTILRKVLEDFINLDEVH* 
>OO_GIS 
MAEFSRSPPTLLSASLTSVMSHQDWGVLSKDEAVKIEKDLEDGNLLKVVSDMRRPLELVSQMPVNIAVTGESGNGISTFINALREIGHE
EEASAPTGVVTTTETRAAYSSPLFPKAVLWDLPGTGVATDTLQEYHVAMQFSQYDLFIIIASQQFSMNHVMLAKTIADMGKKFYIVWTK
LDLDLSSSTLPGCELQQTIKNHIMRSLQKQRVCEPPIFLVSSLKPSSYNFPGLRDTLQTGLSQVRCDGPLQTPHACL* 
>OO_GKS1 
MGASFSAELSKECQDLESSFKDYIRNFREENKILSQETILSIKSRLSRGDIQGAHSIISGILENIDKIPLNIAVTGESGSGKSSLVNSL
RGVGHEEEDAAPTGVEETTIMRTPYKHPKFPNVTIWDLPGIGTTNFQPKDYLEKVKFGEYDFFIIVSATRFKKNDLDLAKVIKAMKKNF
YFVRTKVDLDLQNEQEFKPTTYVRDKVLEEIRNKSLKEFKDNNIETQIFLISNKNLSEFDFPILMETLLKDLPAQKRHAFTLSLPNITE
AAIDRKRDSLKQIVWLEAFKAGISAIVPAVGIIKDNDVKKLKASLHQYQFHFGVDDTSLQSLAKDLQVPVEELKAIIKSPYLFDTEKEE
TTGEMALKFLEISSSVAFPPLAAGLYFMKVFYLQFHFLDIVTSDAKVLLKKS* 
>EE_GKS2 
MxSGSQLWQVFKVICTENKILSQESIGLxSVRICRRANIQDTASVIRYALSDIEKAPIDIAVTGETRAGNFSFINALRGVSPEEEGAAE
TGVVKTTVERVPYKHPKFPSVTVWDLPGIGTTRFPPHNYLQEMKFQEYDIFFIISAKHFTPNDTQLCVAIKKMRKNFYFVRTNVDSDLD
KERVRKCRPLSPEEKKHVLQKIKTDCVTNLQKTKVTNSPVFLVSSFEVSGYDFPDLQTTLLRELPAYKRHIFMLSLPAVVEATMDRKSN
SLKQKIWLDALKIRVPDPIPxAVSYFSPEEVDSLRETLTLYRSYFQLDDASLEQVAKDLHVSIGELKANLKXXX 
>EE_GKS1 
MGQSFSMPSRTMNHDLASSFGDF*KNFKTESNIISQETIALIQSHLLxGNIQKATSVISGALSDIEKAPIDIAVTGETGAGKSSFINTP
WGVGPEEEGAAEIGVVETTVERVPYKHSKLPRVTLWDLPSIGTTCFPPHNYLQEMKF*ECDFFLIVCGTHFKHSDAQLATAIRNMKKNF
CFVPMKVDSELLGSQKAQLSMFNEEETLQKMCFECVRQLEQAQVKESQVILVSSYDLGDYDFPKPEATLLxGLDRESLDSMAKNLHVPE
EMLERNLQSLHLLSIKNHKSLGEQLLRLLEIISSISGGPVADGLCFRKFYLQCYFLYTMVKDAKCFLNKEEIIKHSETLKRACQSCGVG
VRMWKMRQLASDVFSGVACHWPGKRVTFQAGP* 
>EE_GKS3 
MGQSCSTPPSDTKNYDLASSFGKFFKDICTENKILSQETIALIQSHLSEGNIQDTASVIRDALSDIEKGPIDxSVTGETxGAGKSVIIN
GVRGVRPEKIVPAETGGGEDNVDGKSQAKNP*S*NVVSLRPRLNLRPIFRPPAY*LXX 
>EE_Irgq 
RRLLPxAQDGFEVLGAAELEAVREAFETGGLEAALSWVRAGLERLGSARLDVAVAGTADLGLVLNVLLGLDPGEPGAGPAALPAEPTAF
PAPERPNVVLWTVPLGPAGSAATPHPAHYDALILVTPGAPADKDWARVRPLVLPGAPLVCVRTDGEGEDPEWLQEEEEAEKPEQEGFGG
VEKASGEGREERGPGAQAAGGEKAGCTVAGSPEDETWEVLEEALPPAFPLRPAGLPGLCAWLQRALPANQAKALLLALPPxxxPGSAEA
CDVALLRGQLAEWRRALGLETAALARRERALGLAPGELAARTRFPGPVTRAEVEGRLGAWAGEGTAGGAALGALSFLWPAGGAAATGGL
GYRAAHGVLLQALDEMLADAEAVLAPP 
>SA_GKS1 
SKVLKSLDECQALMETFEVGSLPAVAAKLQATLQALENVQLDIGITGSPGSGKSTLVNALRGLGDEDMDSAQTSVVETKVAPTPYPHRQ
YLNVVIWDLPGIGPASFQADKYLQQVLQKPYDLLLLLSAGCFPDSLAQLARRLGERGTHFCLVRSKVDVDVAASRSRRPSTFSEDAVLS
QIRNDCAKRLEGEGDRLLGGGGAECRVAQDGTGERGGPQVGIPVMAESNSQGPGASPLLLRFFFLGFFFLSHIRRCFWLYAQELLLVLL
GSIQVGRTPVQCLTCCTICSGLSEAFLLFFLF*GLGDVVLQQSSGRSGGHSW* 
>SA_IRGC 
MATSKLPAVPGEEGTTILMGKEELEALRSAFEAGDLPQAASRLRELLASSYTLRLEEGMTGYFFLCNSTRLYGLKRLRAEDKALALAA*
xxxxxxxxxxxxxQFPDVTL*DLLGAGTPRCPADKYLKQVDFSRYDFFLLVSPRRCGAVETRLASEILRQGKKFYFVRTKVDEDLAATR
SQRPSVFSEGLVLQEIREHCVERLRAAGVAEPRIFLVSNLSPSRYDFPLLMSTWEHDLPAHRRHAGLLSLPDISLEALQKKKDMLQEQV
LKTALVSGVIQALPVPGLAAAYDDALLVRSLRGYHRSFGLDDDSLARLAEQVGKQAGDLRSVIRSPLAVEVNPETVLRLYARSSDGAMR
VARAFERGVPVFGTLVASGISFGTVYAMLQGCLNEMAEDAQRVRIKALEEDEAPSEVSLEAGGDVGVEKHGLGESGSEDAPLSTRRKLG
LLLKYILDSWKKRDLSEEK* 
>SA_IRGQ 
ALARGTPLLAVRNLRPGEAQNELQVREQTETLLASAGLEAAALFVLPADCGGRDDCEELERLRAALESRAEALQRLLPPAQDGFEVLGA
AELEAVREAFETGGLEAALSWVRAGLERLGSARLDVAVAGTSGVNLVLDVLLGLDPDDPGAAPASEPFGAHIIPGPERPNVVFWAVPLG
PTSTATASHPAHYDALILVTPEAPAEKDWAPVRPLVLPDAPLACVRTDGKGENPESLEEGKVEKPASESLENSGGGGLEKGGGEGAEAC
VPGSQKAGVASGQQVGMAMKKSGSEDTDCPAVVSPEDEAWEVLEEAPPPVFPLRPGGLPELCEWLQRVLPAAQAGALLLALPPASPSAA
QKKAAALRAGAWRPALLASLAAAAAPVPGLGWACDVALLRGQLAEWRRALGLEPAALARRERALGLAPQDLREFPPFPAP*HAPRWSTA
RPLGQARARQGARHWAASPFSDPRGAQRPQAALGFRAAHGVLLQALEEMLADAEAVLAPPGSPAVRMLGPAGV* 
>ET_IRGQ 
MPPPRGDVTALFLGPPGTGKSALIAALCDKDVETLEPPEGPSDSRVPSLRAAGPGLFLGELSCPPAVPGPWAAEANVLVLVLPGPEGNG
EVLAPALGEAARAALARGTPLLAVRTLRAGSSQDEGQAREQTAALLDCAGLGAVALFVVPTDRSGSPAGEELERLRAAVQSQAEALQRL
LPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRAGLERLGSARVDLAVAGAAHLGLVLDLLLGLDPGDPRAAPASAPADPTPYPAP
ERPNVVLWTVPLDPACAAVxTPQPTHFDAVILVTPGTPTEKDWAQARALVXXXXXGMMEKPSGGEGIENRAAGASVAGSDDGLPQIGAG
TASGTSISEDETWEVLEEAQPPVFPLRQAGLPGLCAWLRRALPPGQAGALLLALPPSSPSAARTKAAALGAGAWRPALLASLAAAAAPI
PGLGWACDVALLRGQLAEWRRGLGLEPAALVRRERALGLTPGELASRAHFPGPVTRAEVEARLGAWAGEGRAGGAALGGAVLPVAGGRR
CGHWWPGLPGRRMASCCRS* 
 159
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>ET_IRGC 
MATSRSQAGPGEEETTILMAKEELEALRTAFESGDLPQAASRLRELLAASEATRLEVGVTGESGAGKSSLINALRGLGAEDPGAALTGV
VETTMQPSPYPHPQFPDVTLWDLPGAGSPGCSADKYLKQVDFGRYDFFLLVSPRRCGAVESRLAAEILRQGKKFYFVRTKVDEDLAATR
SQRPSAFSEAAVLQENPRALHRAPAPPPAWAEPRIFLVVQTCRXXX 
>ET_GKS1 
MGQLFSSDTDETENLASSMKTYFTNFNMINKIISEETIKLITSKLEAGHTDSMGVIINSVLKKVTNATLNIAVTGESGSGKSSFINALR
GVKPGDEQSADTGVVETTMEPTKYQHPKFPTVIFWDLPGIGTTSFPPQEYLKKVKFGEYDFFIIISSTRFKDTDVQLAKAIKDLGKHFY
FVRSKIDIDLQSEQKQKPKTFDQEKFLEQIRNNCLQDFRQIKMEKPPIFLISSDEVFEYDVPILMNTILNDLSTQKRHIFMLSLPNVTE
EVIESKRDSLKQKVWLEAFKNALWATLPFGITSDYDKKKVENSLNEYRALFGVDDASLQKLATYSKVPVEQLKSVIESPRLLAKEKMNQ
HQKDFYNGWKNSVQXXX 
>ET_GKS2 
MGQSSSKTPADPKNQNWASSVDEFVKDFKMESQMFSPETIDFIKSNLETGNMQGAVSVISNVMKEIENATIHIAVTGESGSGKSSFINA
LRGVGHEDLDAAACGVVETTMERKPYRHPKIPHVTLWDLPGIGTTTFQPQEYLKKMNFNEYDFFIIVCAQRFKLNDSQLATVIRKMKKN
FYLVRTKVDHDVYNQRRAQPKNFCKDKTLQMIREDCLRNLRAIGVNDAGVFLISSFEVSDYDFPKLETTLLEELPAYKRHIFTQCLPCV
TDAAIERRKDYLRQKIGLEALQCGALATIPVMGCISDSDVQQLEATLTFL* 
>ET_GKS3 
MGQSSSNTPADPKNKTWASSVEEFFKDFKIESQMLSSEMIKLIKSNIEKGDVQGTANVISAAMKEIENAAVNIAVTGESGSGKSSFINA
LRGVGHEDLDAAACGVVETTMERKSYCHAKIPNVTLWDLPGIGTTKFQPQEYLKKVNFNEYDFFIIICATRFKEYDSQLATVIKKMKKN
FYFVRSKVDSDLKNQRRAQPKNFCKDKTLQMIREDCLRNLRAIGVNDARVFLISSFEVSDYDSQSWRPPFWRSFQLINVTSSRNAFLVL
RMLPLNG*KDYLRQKIWLEALKCGALATIPVMGYISDSDVEQLKATLTFYRSYFGLDDASLEHIAKDLHLSVEELKANLKSPDLLSVAK
DDDLLADKLWKMLEKLCFIGGGLLATGLYFRKTFYLQIHFLDTVVDDAKFLLQKAVIKEQH* 
>ET_GKS4 
MDQFILSFITKNNFQQLSSEFLSYYFTIISKAGGILSQETLSDIQAALQKGNLEDIVKKIQGALVQAENAPLDVAVTGQSGTGKSSFIN
ALRGLSHEEEGTALVGIVETTMEKTPYQHPKYPKVTFWDLPGTGTPNFCADTYLEKMGFTNYDFFIIISSTRFTYNDALLAQKIKSMGK
NFYFVRTKVDNDLYNENISKPTSFNEKKVLQQIRDXXXKVERHVLNLSAQ* 
>ET_GLS 
MSLLFLLLQVTPLFCNMAAYPLSPEDLSSVSSGLFETGATSIEKDVMDGNLPNVIAKAKKTWKNMNNNVTLNIAVTGASGNGLSTFINA
LRNVGHDEETSAPTGVVRTTFTRASYSASCFPNVVLWDLPGMGASAQSLENYMAEMHFSQYDFVIIVASEQFSMNHAVLAKTIQKLGKK
FYIVWNKLDMDLSKNVLSKEKAVKMIREYILETLWMEQVNEPPIFLVSSFDLSLHGFRELKQTLKKDLLLIRYQDPLQNLLHTCEAIIN
DKQTFLQKKVDTLSFQDIHGIEDPDNSEACLKVYKVHFGVDDESILRVAQIMESDVLDYTANMKSQDLQTLSNVDWLIYCMNFNTTSYL
STIFSYIPVFGVPITNYIRWTKHRYFLEVVAKDTKTILRKILKDSIN* 
>ET_GMS1 
XPQ*ILFLTGDSGNGMSTFMSALRGIGHEEEDSAPTGVVKTTYTHASYSSLHFPNTLLWDLPGMETTPQNLEKYIMEMEFSRYDLFIII
ASEQFSMNHVMLAKTIKSMRKKFYIVWTKLDTDLSTSVLGEEQLLKNRRVNILENLQKVQVCEPPLFMVSSLDPLFYDFPKLRDTLQKD
LIHIRCHGPLQKLSDTCEKILNDKVVTLQEKIDAHSFQDIWDPDDLMECLAAYQLLFGMNDESIQQVAQKMGTATMEYTALMKSQNPWT
FSRIDCKMACLTCRVFQAFLNALRCIPLLGNPITNYFRRMKHKHILQIVAKDSKVILRKILKDSTIPG* 
>ML_IRGC 
MATSKCPGEEETTILMAKEELEALRTAFESGDIPQAASRLRELLASSESTRLEVGVTGESGAGKSSLINALRGLGAEDPGAALTGVVET
TMQPSSYPHPQFPDVTLWDLPGAGCPGCPADKYLKQVDFGRYDFFLLVSPRRCGAVEARLASEILRQGKKFYFVRTKVDEDLAATRSQR
PSGFSESMVLQEIRDHCTERLRAAGVTDPRIFLVSNLWPVRYDFPLLLSTWEHDLPAHRRHAGLLSLPDISLEALQRKGDMLQEQVLKT
ALVxxxGDLRSVIRSPLANAxDSPETVLRLYSQSFDGAMRVARAFERGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALE
EAEESQPEVSLDAAGDNGVEKCGVGEGGGEEAPLSTRRKLGLLLKYILDSWKKRDLEEK* 
>ML_GKS1 
MANQIFQFNISELSKDTGALKETFEAGNLPAVAAKLQATLHSLEDVRLDIGVTGAIGSGKSTFVNAIRGLGDEDPKSAGTGVVEMTVEP
TPYPHPKYFNIIIWDLPGIDAPTFQADEYLQRVLVDRYDFFIIITPDSFTARHAQLARGLRQQGKAFYFVRSKVDVDLAASSSRRPSTF
SEQRVLRQILGDCWQRWKVECPLWGARG* 
>ML_IRGQ 
RLLPPAQDGFEVLGAAELEAVREAFEKGGLEAALSWVRAGLERLGSARLDLAIAGTADTGFVLDMLLGLDTGDPGAVPASAPTGPTPYP
APERPNVVLWTIPLGSATTAAAPHPTHYDALILVTPGAPTEEDWAQVRPLVLPDAPLVCVRIDGEGEDPESPEEEEKAEKPSRESLEDA
EGGGLEEARSEGRDKRGAGSQKAGSESSQQAGGNAKPSGSGDSERAAAWSPEDETWEVLEEALPPVFPLRRGGLPGLCEWLQRALPPAQ
AGALLLDGATHVPACSPNQG 
>CF_IRGQ 
MPPPRGDVTALFLGPPGCGKSALIAALCDGNVETIEIPEGRPDSGIPSLRALGPGLFLGELSCPPAAPGPWAAEANVLVLVLPGPEGNG
EPLAPALGEAARAALARGTPLLAVRNLRPGESQDEAQARDQTAALLNGAGLGAAALFVLPADCGRRDGCKELERLRVALRSQAEVLQRL
LPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRAGLERLGSARLDLAVAGNADVSLVLNVLLGLDPGDPDAEPVFMPAGPTPHPAP
ERPNVVLWHVPLGSAGTAAATPHPTHYDALILVTPGAPTEKDWAQVRPFVLPDAPLVGVRTDGEGEDPEYLEEEDEAEKEKPSCESLEN
TGGEGVKNARSEGREKRGPGLQKGSEEDSEKAGSGEGSEKAGSESVPPVGGGGKKSGSGDAERAAALSPEDETWEVLEEAPPPVFPLRP
GGLPGLCEWLRRALPPAQAGALLLALPPASPHGARMKAAALRAGAWRPALLASLAAAAAPVPGLGWACDVALLRGQLAEWRRALGLEPA
ALARRERALGLTPGELAERTHFPGPVTRAEVEARLGAWAGEGTAGGAALGALSFLWPAGGAAATGGLGYRAAHGVLLQALSEMQADAEA
VLAPHVPAQ* 
 
 
 160
APPENDIX 
>CF_IRGC 
MATSKLRAVPGEEETTILMAKEELEALRSAFESGDIPQAASRLRELLASSQSIRLEVGVTGESGAGKSSLINALRGVGAEDPGAALTGV
VETTMQPSPYPHPQFPDVTLWDLPGAGSPGCPADKYLKQVDFGRYDFFLLVSPRRCGAVETRLASEILRQGKKFYFVRTKVDEDLAATR
TQRPSGFSEAAVLQEIRDHCAERLRVAGMTDPRIFLVSNLSPARYDFPLLMSTWEHDLPAHRRHAGLLSLPDISLEALQKKKDMLQEQV
LKTALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSPLANEVSPETVLRLYSQSSDGAMR
VARAFEKGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEDEPQSEVSLEAAGDNGVEKRGSGEGGCEEAPLSARRKLG
LLLKYILDSWKKRDLSEEK* 
>CF_C-like 
MASRVFQSNFTWSKILELWRDTSALKGAFEVGDLPTVATKLQATLHLPENARLDTGITGGTGSGKSTFVNAIRGLGDEDPRSAYTGVVE
MSVDPTPYAHPKYPNVVIWDLLGIDTPTFQAKKYLQQVLLDRYDFLLLITLESFTAHHTQLACEILQQGKRFYFIRSKVDVDMRPHAAG
APAPFQRKEHSARPGRTVGNGWKVSLGSGRWKRVGALGVVDSGGMARPFPFLFQLRPTVGKGSSKVTLRD* 
>CF_Qgene 
YNSGITCGSREYSSVYGCIQESGTRMYSFINAL*GHIHEEKNSATVGIFKTTMKKPPYQHPKDPSMTFWDLPGTGTPNFLLHTYLKMVG
FANYDFFIIVSSSWYNFNDVLLNQNFRELGKKFHFDRTKVDNDLYNEGKNKARSLKRERMLQQI*DSCLTTLSNIRVHEPGNFLVSKFD
LDDFDFPILEETLLKDLPVHKCYIFVILLPNLGEASIEMERTLFKERIWLDSLKSLAFTSIPFMACFSDFD*SQQEKCLNVYENYFGLD
EKSVKGIVRKLVMSVEEIKSFIKSLHFWLLLKNNCIAAKAMKCTEGHCFMNGSLSSNLFQLLKIYFLHLKFMNKVIDDARIFLHKISES
ISLRRCQTHSSETN* 
>CF_IRGB11 
MGQSPPSTPSNRNGGDLASSFDKFFKEFKLDSKIISQETISTIQSHLEKGDLQSAFSAINDALRDIDNAPLNIAVTGESGTGKSSFINA
LRGMGHDEEGAAPTGPVETTFLRKAYKHPKFPNVTFWDLPGIGTTSFQPQDYLEKMVFREYDFFIIICATRFKINDVQLATAIKKMKKN
FYFVRSKVDSDLYNLKRIKPREFNKDEILQKIRNDCVKHLMEANMSDAQVFLVSSFELSDYDFQSLETTLLRELPSHKRHIFMQYLPIV
TEATIDRKRDCLRQKVWLEAIKAGASASIPLVGYISDNDVETLKDTLTLYRSYFGLDDISLKTIAKDLNVSVEKLKANLMFPHLLSVEK
YDEPLGEKLLKYVEKFCSVSGGPIAAGIYFRKIYYLKNYFLDTVVSDAKVLLKKEEIFKDPVDSEQTYLHTNVGNENGKSDTSSS* 
>CF_IRGB12 
MGQSSSTPSHKTGGDLASSFGKFFKDFKLESKILSQEAITSIEKSLKEGNLQKAVSDINKALKDIDNAPLSIAVTGESGTGKSSFINAL
RGVGHDEEGAAPIGAVETTFDRTEYKHRKFPNVTLWDLPGVGTTTFHPQEYLEKMKFREYDFFIIISSTRFTINDAQLATAIRKMKKNF
YFVRSKVDSDLYNLKRTKPSDFNKDEILLKIRNDCITQLQNVKVCDPQVFLVSNLDLSSYDFQSLETTLLKELPAHKRHIFMQYLPNIT
ESAIDRKRDSLRQKVWLEAVKAGASATIPFMGLINDNEVEKLEETLHLYRSYFGLDDASLETIAKDLNVSVEKLKANLTSPHLLSVEKE
DESLGEKLLRYVEKFCSVSGGLIATGVYFRKIFYLQNYFLEAVVSDAKVLLNKEEIFKETVGSGQAYLLQDVGIENRKSDATSS* 
>CF_GKS1 
MGQSSSTSSHIKGDDLASSFGKFFKDFKIESQILSQETITLIKTHLKEGDLQKAASAISDALRDIDNAPLNIAVTGEPGTGKSSFINAL
RGMEHDEEGAAPTGLVETTLERISYKHPKFPMxTSWDLPGMMTTTFQPQMYLKKMKFCEYDVFIIISFTRFKISDMHLAAAIKKMKKNF
YFVRTKVDNDLYNIKMSKPSTFNKDEVLQGIRNDCVTQLQNANMSDTQVFLISSLDLFSYDFQSLETTLLKKLPAYKCHIFMQYLPNVT
EAAIDQKRDSVRQKVWLEAIKAGATATIPFMGLIGDKDVEKLGETLTLYRSYFGLDDASLETMAKDLNVSMEKLKANLKSPHLLTVEKE
DESLGKKLLRYVEKFCSVSGGLIATGLYFRKIFYLQNYFLETVASDAKVILNKEEIFKESLGSGKAYLLQDVGIENGKSDTTNS* 
>CF_IRGD 
MDKFMCDFLVGKNFQQLAINFIPHYTTLVNKAGGIIASENLDRIQAALKEAKLKDVADIIEESLVAAENAPLDVAVIGESGTGKSSFIN
ALRGLSYEEEGSASVGVVETTMKKTPYQHPKYPKVTFWDLPGTGTPNFHPHEYLEMVEFATYDFFIIISSSRFSLNDALLAQNIKEIGK
KFYFVRTKVDNDLYNEEKSKPMSFKRERVLQQIRDNCLANLSNIGVPEPCIFLVSNFDLDDFDFPRLEETLLKELPVHKRHIFALLLPN
LSYTSIEMKRAFFKEKIWLDALKSSALSFIPFMACFNGFDFPQQEKCLNLYQSHFGLDEKSVKGIAEKLDMSVEEIKSFTKSLDFWLLV
KDDSIAEKAMKCVECYCSVNGGLPSTIFQFFKIYFLHLKFINTVADDAKILLHKTLEILSHRR* 
>CF_IRGM4 
MAQPTQSLHTPSPTSFTSTVPYHKGGSILSESGAMNIEKALGEGKLLDMVSVVRETLETASSVPVSIAVTGDSGNGMSTFINALRKIGH
NEEDSAPTGVVRTTQIPTCYSFSDIPNVELWDLPGTGAATQNLETYLEEMQFSKYDLFIIIASEQFSMNLVKLVKSIQGQGKRFYIVWT
KLDRDLSTCVLSEEQLLRNIRENIRETLHKEGVCEPIIFLVSSFNPFLHDFPELRKSLHRDISNIGYRGHLENLTHTCEKVINGKVTTL
QGQIGSKSFQDILGIQNANDLGEFLNAYHRLFGVDDDSLQEVAQSMGKPKEEYKAIMKSQDLHTALAWDWALSWMNCNAASYLYSVLSY
IPILGTTGIHYLKWWSQGHLLEIVAEDTKTILKKILEDAII* 
>CF_IRGM5 
MTQPNHSLHIPLSTSFTSIVPYNMGWTVLPKATATNIEKALGDGKLLEVVSMIRETLETVSSAPVSIAVTGDSGNGMSSFINALREIGH
DEKDSAPTGVVRTTQVPTCYSSSHFPYMELWDLPGTGTGTQSLENYLEKIHFSQYDLFIIIASEQFSMNLVKLVKAIQRQGKRFYIVWT
KLDRDLSTRVLPEEQVLQNIWENIQETLQKVGVCEPIIFLVSSFEPLLHDFPELRDALNRDISDIRYCGPLENLSDTCEKIINDKVTSF
QEQIGSKTFQDILGIQDEDDLGQCLIAYHLFFGVDDKSLQQMAQSMGKPMEEYRAIMKSQDVHTVLTGDWALSCMNCKTASYLYSILSY
IPFLGDTVINYLRVWKHRHFLEIVAKDTRSIVKKILTDSII* 
>CF_IRGM6 
LHCFFPLLQVTPLLSDVTQPTHSLHTPLLTSSNYDMPYNMGWSSLSKETAINIEKALGGRKLLEVVPMVRETLERASSVPLRIAVTGDS
GNGMSSFINALRGIGHDEEDSAPTGVVKTTQIPTCYSYPHFPNVELWDLPGTGAGTQSLENYLEEMKFSWYDLFIIIASEQFSMNLVKL
AKAIQVLGKRFYIVWTKLDRDLSTSALLKERLLQNIQENIQENLQKERVFEPIIFLVSSFEPLLHDFPELRNTLNRDISDIRYCGPLKN
LSHTYEKVISDKVTMFRGKIASKSFDTLGIWNADDLGECLIAYHLFFGVDDESLQQIAQSMGKPMEEYRAIMKSRDLHTIIRGDWAVSC
MNCNTSSCLYTILRYIPLLGDFIINFLRKWKHRRLLEIVAEDTRTILKKILKDSII* 
>CF_GKS2pseudo 
MGQSSSTTSCHMVDGGLDSRVGKFFRELKLGSQIVPQEAINLIQSHLxRRGTFRKWFMISDALRKIENTSLNFAVIGESGAGKSSFINA
xKGMGQEVEVAATKLVETTLKRVKYxTQILSQCDIVKPIWHRDHYLFTTEYLKKMKYWEYNFFIIISSTCFTINDVQLATAIRKMKKNI
YFV*TKVDSDLHNKNxSQRKNFNKGKILQMICNGYVKHLMEANMSDAQIFVFSFELLxNYDFQSLEITLLxGKSQPTNLTSSCNITKSA
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APPENDIX 
IDQKRDSLRQKIWLEAMKVGATATIP*GCCLISDNKVEKLVDTLHLYRSYFGLDNAFLxNMAKDFHVPVETLKANLMSPHLLSIEKEDE
SLEEKPLRYVEKICSVSGGLIATGLYFRKIFYLQNYFLDTVVNDVKVLLLKKDFLRILRALGKPICI* 
>FC_IRGC 
MATSRLPAVPGEEETTILMAKEELEALRTAFESGDIPQAASRLRELLASSDSTRLEVGVTGESGAGKSSLINALRGLGAEDPGAALTGV
VETTVQPSPYPHPQLPDVTLWDLPGAGAPGCPADRYLKQVDFCRYDFFLLVSARRCGAVETRLASEILGQGKKFYFVRTKVDEDLAATR
AQRPSGFSEATVLQEIRDHCAERLRAAGVADPRIFLVSNLSPARYDFPLLVSTWEHDLPAHRRHAGLLSLPDISLEALQKKKDMLQEQV
LKTALVSGVIQALPVPGLAAAYDDALLLRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSPLANEVSPETVLRLYSQSSDGAMR
VARAFERGIPVFGTLVAGGISFGAVYTMLQGCLNEMAEDAQRVRIKALEEDEPRPSVSLEAAGDNGVEKRVSGEGTCEEAPLSTRRKLG
LLLKYILDSWKKRDLLEDK* 
>FC_C_like 
MAGRVLQSSLSQSKILELWRDTSALMGAFEAGGLAAVAARLQATLHSLENARLDIGITGGTGSGKSTFVNAIRGLGDEDPNSACTGVVE
MTVDPTPYPHPKYPNIVIWDLPGIGTSRFRTGRYLQRVLLERYDFFIIITSDSFTAHHAQLACEILQRGKRFYLVRSKVDVDIAASRSR
RPSTFSEERVLRQIREDCGRRLRGEVQALERRNRAVLLSSAAEGLKDPKVFLLSMFELGKYDFHLLEELMVKELESHKQHAFLLAVPNV
SKPILEKKAASLRQHIWLVATVACGVNPSPVPGVREVACDLYVLISSLEGYRRSLGLDEDSLVRLAEQRGQPLHKILEVVQGWKTKVTE
ALVVELLGQASRDASAFTQELLGVPILGALATCGISFATIYQMLRTALDEVVKDAQRVLTQAFLDDSDHELPDKCNQ* 
>FC_IRGQ 
MPPPRGDVTALFLGPPGSGKSALIAALCDRNVETIEIPEGRPYSGIPSLRAAGPGLFLGELSCPPAAPGPWAVEAIVLVLVLPDP*GNG
EPLASVLFESAWSALFRGTLLFFVRXXXXXRLLPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRAGLERLGSARLDLAVAGTANV
SLVLNTLLGLDPGDPDAEPVFMPAGPTPYPAPERPNVVLWNVPLGSAGIAAAPHPTQYDALILVTPGAPTEKDWAHVRPLVLPDAPLVC
VRTDGEGEDPEYPEEEGKAEKPSSESLENAGGGELKNARGEGREKRGAGLQKGSGEGSEKAGSGEGSEKAGSESLPRVGGGAKKSGSGD
SERAAALSPEDETWEVLEEAPPPVFPLRPGGLPGLCEWLRRALPPAQAGALLLALPPASPHGARMKAAALRAGAWRPALLASLAAAAAP
IPGLGWACDLALLRGQLAEWREGAGARTRGAGSTRARAGPGPWXX 
>HS_IRGC 
MATSKLPVVPGEEENTILMAKERLEALRTAFESGDLPQAASHLQELLASTESIRLEVGVTGESGAGKSSLINALRGLEAEDPGAALTGV
METTMQPSPYPHPQFPDVTLWDLPGAGSPGCPADKYLKQVDFSRYDFFLLVSPRRCGAVETRLAAEILCQGKKFYFVRTKVDEDLAATR
TQRPSGFREAAVLQEIRDHCAERLREAGVADPRIFLVSNLSPARYDFPTLVSTWEHDLPSHRRHAGLLSLPDISLEALQKKKAMLQEQV
LKTALVLGVIQALPVPGLAAAYDDALLIHSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSPLANEVSPETVLRLYSQSSDGAMR
VARAFERGIPVFGTLVAGGISFGAVYTMLQGCLNEMAEDAQRVRIKALEDDEPQPEVSLEVASDNGVEKGGSGEGGGEEAPLSTCRKLG
LLLKYILDSWKKHDSEEK* 
>HS_IRGQ 
MPPPQGDVTALFLGPPGLGKSALIAALCDKDVETLEAPEGRPDSGVPSLRAAGPGLFLGELSCPPAAPGPWAAEANVLVLVLPGPEGNG
EPLAPALGEAALAALARGTPLLAVRNLRPGDSQTAAQARDQTAALLNSAGLGAADLFVLPANCGSSDGCEELERLRAALQSQAEALRRL
LPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRSGLERLGSARLDLAVAGKADVGLVVDMLLGLDPGDPGAAPASVPTAPTPFPAP
ERPNVVLWTVPLGHTGTATTAAAASHPTHYDALILVTPGAPTEKDWAQVQALLLPDAPLVCVRTDGEGEDPECLGEGKMENPKGESLKN
AGGGGLENALSKGREKCSAGSQKAGSGEGPGKAGSEGLQQVVGMKKSGGGDSERAAALSPEDETWEVLEEAPPPVFPLRPGGLPGLCEW
LRRALPPAQAGALLLALPPASPSAARTKAAALRAGAWRPALLASLAAAAAPLPGLGWACDVALLRGQLAEWRRGLGLEPTALARRERAL
GLASGELAARAHFPGPVTRAEVEARLGAWAGEGTAGGAALGALSFLWPAGGAAATGGLGYRAAHGVLLQALDEMRADAEAVLAPPEPAQ
* 
>HS_IRGM 
MEAMNVEKASADGNLPEVISNIKETLKIVSRTPVNITMAGDSGNGMSTFISALRNTGHEGKASPPTELVKATQRCASYFSSHFSNVVLW
DLPGTGSATTTLENYLMEMQFNRYDFIMVASAQFSMNHVMLAKTAEDMGKKFYIVWTKLDMDLSTGALPEVQLLQIRENVLENLQKERV
CEY* 
>PT_IRGC 
MATSKLPVVPGEEENTILMAKERLEALRTAFESGDLPQAASHLQELLASTESIRLEVGVTGESGAGKSSLINALRGLEAEDPGAALTGV
METTMQPSPYPHPQFPDVTLWDLPGAGSPGCPADKYLKQVDFSRYDFFLLVSPRRCGAVETRLAAEILCQGKKFYFVRTKVDEDLAATR
TQRPSGFREAAVLQEIRDHCAERLREAGVADPRIFLVSNLSPARYDFPTLVSTWEHDLPSHRRHAGLLSLPDISLEALQKKKAMLQEQV
LKTALVLGVIQALPVPGLAAAYDDALLIHSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSPLANEVSPETVLRLYSQSSDGAMR
VARAFERGIPVFGTLVAGGISFGAVYTMLQGCLNEMAEDAQRVRIKALEDDEPQPEVSLEVASDNGVEKGGSGEGGGEEAPLSTCRKLG
LLLKYILDSWKKHDSEEK* 
>PT_IRGM 
MEAMNVEKASADGNLPEVISNIKETLKIVSRTPVNITTAGHSGNGMSTFISALRNTGHEGKASPPTGLVKATQRCASYFSSHFSNVVLW
DLPGTGSATKTLENYLMEMQFNRYDFIMVASAQFSMNHVMLAKTAEDMGKKFYIVWTKLDLDLSTGALPEVQLLQIRENVLENLQKERV
CEF* 
>PT_IRGQ 
MPPPQGDVTALFLGPPGLGKSALIAALCDKDVETLEAPEGRPDSGVPSLRAAGPGLFLGELSCPPAAPGPWAAEANVLVLVLPGPEGNG
EPLAPALGEAALAALSRGTPLLAVRNLRPGDSQTAAQARDQTAALLNSAGLGAADLFVLPANCGSSDGCEELERLRAALQSQAEALRRL
LPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRSGLERLGSARLDLAVAGKADVGLVVDMLLGLDPGDPGAAPASVPTAPTPFPAP
ERPNVVLWTVPLGHTGTATTAAAASHPTHYDALILVTPGAPTEKDWAQVQALLLPDAPLVCVRTDGEGEDPECLGEGKMEKPKGESLKN
AGGGGLENALSKGREKCSAGSQKAGSGEGPGKAGSEGLQQVVGMKKSGGGDSERAAALSPEDETWEVLEEAPPPVFPLRPGGLPGLCEW
LRRALPPAQAGALLLALPPASPSAARTKAAALRAGAWRPALLASLAAAAAPLPGLGWACDVALLRGQLAEWRRGLGLEPTALARRERAL
GLASGELAARAHFPGPVTRAEVEARLGTWAGEGTAGGAALGALSFLWPAGGAAATGGLGYRAAHGVLLQALDEMRADAEAVLAPPEPAQ
* 
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APPENDIX 
>MN_IRGM 
TEATNVEKALVGGNLPEVASAINDTLKIVSRTPVNIAMAGDSGSGMNTFISAL*NTGHEGKPSPPTGLVKATQRCAPYLSSHFPNMVLW
DLPGTGSATKTLENYLMEMQFNQYDFIMVASAQFSMNHVMLAKTTEDMGKKFYIVWTKLDMDLSTGALPEVQLLRIRENVLENLQKEQV
CEH* 
>MN_IRGC 
MATSKLPVVPGEEETTILMAKERLEALRTAFESGDLPQAASHLQELLASTESTRLEVGVTGESGAGKSSLINALRGLGAEDPGAALTGV
VETTMQPSSYPHPQFPDVTLWDLPGAGSPGCPADKYLKQVDFSRYDFFLLVSPRRCGAVETRLAAEILCQGKKFYFVRTKVDEDLAATR
SQRPSGFREAAVLQEIRDHCAERLREAGVAEPRIFLVSNLSPARYDFPTLVSTWEHDLPAHRRHAGLLSLPDISLEALQKKKAMLQEQV
LKTALVLGVIQALPVPGLAAAYDDALLIHSLRGYHRSFGLDEDSLAKLAEQVGKQAGDLRSVIRSPLANEVSPETVLRLYSQSSDGAMR
VARAFERGIPVFGTLVAGGISFGAVYTMLQGCLNEMAEDAQRVRIKALEEDESQPEVGLEAAGDNGVEKGGSGEGGSEEAPLSTRRKLG
LLLKYILDSWKKHDSEEK* 
>MN_IRGQ 
MPPPQGDVTALFLGPPGLGKSALIAALCDKDVETLEAPEGRPDSGVPSLRAAGPGLFLGELSCPPATPGPWAAEANVLVLVLPGPEGNG
EPLAAALGEAARAALARGTPLLAVRNLRPGDSQTAAQARDQTAALLNSAGLGAADLFVLPANCGSSDGCEELERLRAALQSQAEALRRL
LPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRSGLERLGSARLDLAVAGKADVGLVVDMLLGLDPGDPGAAPASAPTGPTPFPAP
ERPNVVLWTVPLGPTGTATTAAAASHPTHYDALILVTPGAPTEKDWAQVQALVLPDAPLVCVRTDGEGEDPEYLGEGKMEKPNGESLKN
AGGGGLENALSKGREKCSAGSQKAGSGEGPEKAGSEGLQQVVGMKKSGGGDSERAAVLSPEDETWEVLEEAPPPVFPLRPGGLPGLCEW
LRQALPPAQAGALLLALPPASPSAARTKAAALRAGAWRPALLASLAAAAAPLPGLGWACDVALLRGQLAEWRRGLGLEPAALARRERAL
GLAPGELAARAHFPGPVTRAEVEARLGAWAGEGTAGGAALGALSFLWPAGGAAATGGLGYRAAHGVLLQALDEMRADAEAVLAPPESAQ
* 
>PP_IRGM_consensus 
MEAMSVEKASADGNLPEVISDIKETLKIVSRTPVNITMAGDSGNGMSTFISALRNTGHEGKASPRTGLVKTTQRCASYFSSHFSNVVLW
DLPGTGSATKTLENYLMEMQFNQCDFIMVASAQFSMNQVMLAKTAEDMGKKFYIVWTKLDMDLSTGALPEVQLLQIRENVLENLQKERV
CEH* 
>CJ_IRGC_consensus 
MAASKLPAVPGKEETTVLMAKEELEALRTAFESGDIPQAASRLRELLASTHSTRLEVGVTGESGAGKSSLINALRGLGAEDPGAALTGV
IETTMQTSPYPHPQFPDVTLWDLPGAGCPGCPADKYLKQVDFSRYDFFLLVSSRRCGAVETRLAAEILYQGKKFYFVRTKVDEDLAATR
TQRPSGFSEAAVLQEIRDHCAERLRAAGVAEPRIFLVSNLSPARYDFPMLVSTWEHDLPAHRRHAGLLSLPDISLEALRKKKAMLQEQV
LKTALVSGVMQALPVPGLAAAYDDALLVRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSPLANELSPETILRLYSQSSDGAMR
VARAFERGIPVFGTLVAGGISFGAVYTMLQGCLNEMAEDAQRVRIKALEEDKPQPEVSLETAGDNSMEKGGSGEGDGEESPLSARRKLG
LLLKYILDSWKKYSRKR 
>CJ_GMS1 
MNVERASADGDLPEVVSAIKESLKIVFRTPVNIAMAGDSGNSISTFISALQIAGHEAKASPPTGLVKATQRCASYFSSRFPNVVLWDLP
GAGSATKTLENYLMEM*FNQYDFIMVASAQFSMNHVILAKTIEDMGKKFYIVWTKLDMDLSTGALPEVQLL*IRENVLESLQREQVCEL
PIFMASSLEPLLHDFPKLRDTLQKTHPN* 
>CJ_IRGQ_consensus 
MPPPQGDVTALFLGPPGLGKSALITALCDKDVETLEAPEGRPDSGVPSLRAAGPGLFLGELSCPPAAPGPWAAEANLLVLVLPGPEGNG
EPLAPALGEAARAALARGTPLLAVRNLRPGDSQNATEARDQTAALLNSAGLGAADLFVLPANCGSCDGCEELERLRVALQSQAEALRRL
LPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRSGLERLGSARLDLAVAGKADVGLVLDMLLGLDPGDPGAAPASVPMGPTPFPAP
ERPNVVLWTVPLDPAGTATTPAATSHSSHYDALILVTPGAPTEKDWAQVQALVLPDAPLVCVRTDGEGEDPECVGEGKMEKPSGESLKN
AGGGGLENALSKGREKYSTGSQKAGSREGSGKAGSEGLQQVVGMKKSGGGDSERAAALSPEDEMWEVLEEAPPPVFPLRPGGLPGLCEW
MRRVLPPAQAGALLLALPPASPSAARTKAAALRAGAWRPALLASLAAAAAPLPGLGWACDIALLRGQLAEWRRGLGLEPAALARRERAL
GLAPGELAARARFPGPVTRAEVEARLGAWAGEGTAGGAALGALSFLWPAGGAAATGGLGYRAAHGVLLHALDEMLADAEAVLAPPESAQ
* 
>OG_IRGC 
MATSKLRSVPREEETTILMAKEELEALRTAFESGDIPQAASRLRELLASSDSTRLEVGVTGESGAGKSSLINALRGLGAEDPGAALTGV
VETTIQPSPYPHPQFSDVTLWDLPGAGSPGCPADKYLKQVDFSRYDFFLLVSPRRCGAVESRLATEILRQGKKFYFVRTKVDEDLAATR
TQSPSGYSELAVLQEIRDHCALxRLRAAGVSDPRIFLVSNLSPTRYDFPVLVSTWEHDLPAHRRHACLLSLPDISLEALQKKKDMLQEQ
VLKTALVSGVIQALPVPGLAAAYDDALLVRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSLLDNEVSPETVLRLYSQSSYGAM
RVARAFEKGIPVFGTLVAGGISFGTVYTMLQGCLNELAEDAQRVRIKALRRRSPSQRTA* 
>OG_GKS1 
MGQHSSAASHDDQDLASSCNAYFKNFKMENKIISQETIDLMELHLKKGDIQGANSVINDALKEIDNVPLSIAVIGECGVGKSSLINALR
GVGNGDQDLAPTGVVGTTRERSPYKHPKFPNVTFWDLPAIGTSNYQQKDYLEKVKFGEYDFFIIVSAVCFKKNDIDLAQMIQIMKKNFY
FVRTKVDLDLEAEQVFKKTAFDREKVLQQIRNDYLNIFKQNKINEPPIFLISNRDLSEYDFPILIDTLIKDLPIQKHHIFMLSLPNVTE
AAIESKRDSLKQMIWLDALKAGALAPLRMVGITSNRDVEKLKTSLNQYRVLFGVDDASLERLAKDLQVPVKQLKATLKSPSLLQNKKEE
SIGEMLLKYLERVCSADGFLASGISFGKTYYLQLHFLNTVTEDAKVLLKETFKKRVESGTCGSKE* 
>OG_IRGQ 
MPLPQGDVTALFLGPPGSGKSALISALCDKDIETLETHEGRPDSGVPSLRAAGPGLFLGELSCPPAAPGPWAAEANVLVLVLPGSDGNG
EPLAPALGEAARAALARGTPLLAVRILRPGDSQNDTQARDQTAALLDSARLGSAALYVVPADCSSSESCEELERLRTALQSQAETLQRL
LPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRAGIERLGSARLDLAVAGAADMGLVPETCCLDLDPGDPRCCACFGAHWGPLPFP
APERPNVVLWAVPLAPVGTTTVASHPAHYDALILVTPGVPTEKDWAQVRALVPPDAPLACVRTDGEGEDPESLEEESTVEKPNSKSFEN
AGRGDAENALTEGRERCGTGSQKAGSGEGSEKSGSENVQHIVNWRQEIRQWGFRAGxxxxxPVPGLGWACDVALLRGQLAEWRRAMGLE
PGALARRERALGLAPGELAARTHFPGPVTRSEVEARLSAWAGEGTAGGAALGALSFLWPAGGAAATGGLGYRAAHGVLLQALEEMLADA
EAVLEPPEPAQ* 
 163
APPENDIX 
>MU_GKS1 
MDQFSSATSHDGEHQDLASSFSAYFNNFRVGSKIISKETTVSIESHLRNGNIVAAHSVIEDALKEIDNATLNIAVTGESGAGKSSFINA
LRELGPEDEGAAPTGVVETTMERIPYKHPKFPRVTLWDLPGIGSTNFQPKDYLQKVQLVEYDFFIIVSATRFKNNDIQLAKVIKSMKKN
FYFVRSKVDCDLRNEQESKPKSFNKEKVLQQMRNNCLRIFNENKIDEAPVFLISNRELSKYDFPILIDTLSKDLPAQKHHIFMLSLPNI
TDAAIESKRNSLEQHIWLEAFRDALMAGVPIISIFSDSEEEKLKEILNNYQVLFGVDDESLQHLAKHLQVPVEQLKAGLKSPGLLKKKK
ELTGNTLKGVMKKLFSVFGGVIRGVYYFGKIYYLRFNFLDTVANDAKVLLKETYSRKV* 
>MU_GKS2 
MGQLFSATSHDEQHQDLASSFTAYFKNFSVGSNIISQEAAESIKSHLTKGNIQAANSVISAALKEIDNAPLSIAVTGESGTGKSSFINA
LRGLGPEDEGAAPTGAVETTMERKPYTHPKFPCVTLWDLPGIGTMNFQPKDYLRKVNFVEYDFFIIVSATRFKDNDIELAKMIKTMKKN
FYFVRSKVDIDLRNEQESKPKSFTEEGVLQQIRNNCRYIFKENKIDEAPVFLISNRDLSAYDFPILIDTLLKDLPAEKHHIFSAFPAQ 
>MU_IRGC 
MATSKLPSVPREEETTILMAKEELEALRSAFESGDIPQAASRLRELLASSESAGLEVGVTxGESGAGKSSLINALRGLGAEDPGAALTG
VVETTMQPSPYPHPQFPDVTLWDLPGAGTPGCPADKYLKQVDFSRYDFFLLVSPRRCGAIESRLASEILRQGKKFYFVRTKVDEDLAAT
RTQRPSGYSEVIVLQEIRDHCVDRLRAAGVADPRVFLVSNLSPSRYDLPLLMSTWEHDLPAHRRHAGLLSLPDISLEALQKKKDMLQEQ
VLKTALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDEDSLAKLAEQVGKQAGDLRAVMRSPLANEVSPEAVLRLYSQSSYGAM
RVARAFEKGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEDESQAEVGLEAAGDGGVEKRGSGEGGGEEAPVSVRRKL
GLLLKYILDSWKKRDLEEK* 
MU_GKS4 
GLKAGLKAGLEAGLEAGLEAVLEAGLKATVKAVVKAAVNAAVPILDIFCDGEVEKLKEILSNYRVLFGVDDESLQRLAKDLQVPVEQLK
AGLISPGLLEKKAKSIEYILLTNLENFIPSNIFLLRGAFTFSKIYYLQLQFLDTVADDAKVLLKETYSTKKKLDFPIN* 
>MU_GKS5 
PAEKPHIFLLSLISITDAAIEGKRDSM*QILCLEALKAAAWATLPMVGIISDRDVEKLKGILNDYRVFFGVDDKSLKHLANDLQVPVVQ
LKARLKSPGLLEMKEESTGEMLLRYAENFSSATGGPLAAGLYFRKNYYLQFHFLDTVVNDAKVLLKEIYSRKV* 
>MU_GKS6_corrected  
MHPFIPAILSGKSFQSLAIDFVSPYSTLTSKTRGILALQTLTGIEETLKNGKVRDMVDKIEESLAEAENDSLHVAVTGQSGTGKSSVMN
ALRGLSHEGKGSACVGAVETTMKKVPYQHPKYPNVTFCDLPKTGTPSFLPDTSLEMVGLLTTYNFFILISSSWFSLNDALLAQKIKEMG
KKFYFIRSKVDNDLYNEKKPRSFRKERVLQQI*GNCLANLSDTGEPELCVFSVSDSDLDDFDFPRLEETLLKELPAHKCQTFVLQVPNW
SDTSTEMKREMLKEKIWLF* 
>MU_GMS1 
MLSQMTLMHPPNSPALLPLQVPPLLTDVTAFPLSPHTPLSASLTAVLPQCKDWSMLSKVEALSIEKAIAGGNLPELVSAVRETVKMVSR
TPVNVAVTGDSGNGMSSFINALRNIGHEEEASAPVGVLKTTQTHACYLSPHFPNVVLWDLPGTVSAAQSLENYATEMQFSRYDFFIIIA
SEQFSMNHVMLAKTVEDMGKQFYIVWTKLDMDLNTSALPKGQLRQIIRENILENLQKQRVCEPPIFLVSSFDPLSYDFPKLRDSLQMDL
MKNRRHELLQNLSHTCERAVNDKVSFLQKKIATESLQDACGISDADDLAACLKAYQLLFGVDDESLWQVAQRVGRTFADYTNITKSCDV
QGLSTRNWKLTCMTCTVFRAFLGLLRCIPWLGNLTIHYFRRKKQRCLLEIVAEDTKAILRKVLEDSIIPQ* 
>MU_GMS2 
MLSQMILMHPVPPHSPALLPLQVPPLLADVTAFPLPPHTPLSASLTAVLPQCKDWSMLSKAEATYINKAIADRNLPELVSAVRETVKMA
FRTPVNVAVTGNSGNGMSSFINALRNIGHEEEASAPVGVLKTTQTRACYLSPHFPNVELWDLPGTECAAQSLENYATEMQFSRYDFFII
IASEQFSMNHVMLAQTMENMRKKFYVVWTKLDIDLNTSALPEGQLRQIIRENILENLQKQQVCEPPIFLVSSFDPLSYDFPKLRDSLQM
DLMRIRCDELLQNLSHTCERAVNDKVSFLQKKISTESLQDACGISDADDLAACLKAYQLLFGVDDESLWQVAQRVGRTFADYTNIMKSH
DVEGLSTRNWKLTCMTCTVFRAFLGLLRCIPWLGNLIIGYFRGKKQRCLLEIVAEDTKAIIRKVLEDSIIPQ* 
>MU_GMS3 
MNIEKALADGNLPEVVSAIRESLKMASRTPVNVALTGNSGNDMSSFINPLRNIGHEEEASVPVAVLKTTQTRACYLSPHFPNVVLWDLP
GTECAAQSLENYSMEMQFSRYDFFIIIVSDSSA*NHVILAKTM*DMRKQFYVVWTKLDMDLNTSALPEGQLLQIIRENILENLQKQRVC
GPPIFLVSSFDPLSYDFPKLRDSLQMDLMKNRYHELLQNLSHMCERAVNDKVSFLQKKIATESLQDACGISDADDLAVCLKAYQLLFGV
DDESLWQVAQRVGRTFADYMSIMKSCDVQGLSTRNWKLTCMTCTVFRSFLGLLRCIPWLGNLIIRYFRQKKQRCLLEIVAEDTKAILRK
VLEDSIIPQ* 
>MU_GMS4 
MLSQMILMHPVPPHSPALLPLQVPPLLADVTAFPLSPHTLLSASLTAVLPQCKDWGMLSRVEAMSIEKAVAGGNLPELVSAVRETAKVA
FRTPVNVAVTGDSGNGMSSFINALRNVGHEEEASAPVGVLKTTQTRACYLSPHFPNVELWDLPGTECAAQSLENYATEMQFSRYDFFII
IASEQFNTNHVMLAKAVEDMGKQFYIVWTKLAMDLNTSALPEGQLQQIIRKNILENLQKKRVCDTPIFLVSSFDHLSYNFPKLRDIL* 
>MU_GMS5 
MLSKAEATYINKAIADRNLPELVSAIRESSKMASRTPVNVAVTGNSGNGMSSFINALRNIGHEEEASAPVGVLKTTQTRACYLSPHFPN
VELWDLPGT 
>MU_GMS6 
MNIEKAVAGGNLPEGVSAIRETVEIVSRTPVNVAVTGDSGNGMSSFINALQNIGHEGEDSAPHFQCPFLDGVV* 
>MU_IRGQ 
RLLPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRAGLERLGSARLDLAVAGTADMGLVLNVLLGLDPGEAGAVPASVPTKPTPFP
APERPNVVLWTVPLGPAGTTTVASHPTHYDALILVTPGAPTEKDRAQVRALMPPDAPLVCVRQTVRARIRSLWKKRTRWRRPAARARRV
HSARKGRSAALEGRKQAVGKALRKLSAGVCSRLSLAQRSQAVGTQIRQQH*IPEDESWEVLEESLPPVFPLRASGLPGLCEWLQRALPP
AQAGALLLALPPASISAARKKAAALRAGAWRPALLASLAAAAAPVPGLGWACDVALLRGQLAEWRRAMGLEPGVLARRERALGLAPGEL
AARAHFPGPVTRAEVEARLGAWAGEGTAGGAALGALSFLWPAGGAAATGGLGYRAAHGVLLQALEEMLADAEAVLAPPEPTQ* 
 164
APPENDIX 
>LA_IRGC 
MATSKSQVVPGEETTILMAKEELEALRTAFESGDLPQAASRLRELLASSECTRLEVGVTGESGAGKSSLINALRGLGAEDPGAALTGVV
ETTMQPSPYPHPQFPDVTLWDLPGAGSPGCSADKYLKQVDFGRYDFFLLVSPRRCGAVESRLASEILRQGKKFYFVRTKVDEDLAATRT
QRPSGYSEAAVLQEIRDHCVERLRAAGMSDPRIFLVSNLSPARYDFPLLMSTWEHDLPAHRRHAGLLSLPDISLEALQKKKDMLQEQVL
KTALVSGVIQALPVPGLAAAYDDALLVRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSPLANEVSPETVLRLYSQSSDGAMRV
ARAFEKGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEDEPQPQLSLEAAGDSGVEKRGSGEGGSEEAPLSARRKLGL
LLKYILDSWKKRDLSEEK* 
>LA_IRGQ 
MPLPRGDVTALFLGPPGSGKSALVAALCDKDVETLEPLEERPDSGVPSLRAAGPGLFLGELSCPPAAPGPWAAEANVLVLVLPGPEGNG
ESLAPALGEAARAALARGTPLLAVRTLGPRDSQNEAQARDQTATLLDSAGLRAVALFVLPADCSGSEGHEELERLRAALQSQAEALQRL
LPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRAGLERLGSARLDLAVAGTADVGLVLDSLLGLDPGDSGAAPASAPAEPTPYPAP
ERPNVVFWTVPLGHAGTAAAPHPTHYDAVILVTSGAPTEKDWAQVRALVPPDAPVICVRTDGEGEEPKSLEEEEMVEKLSGESLENADS
EGREKCGTGSQKAGSGESEKSNNGFQQVAGAESGSGDSXXXLSEWRRALGLEPAALARRERALGLAPGELGARAHFPGPVTRAEVEARL
GAWAGEGTAGGAALGALSFLWPAGGAAATGGLGYRAAHGVLLQALDEMQADAQAVLALPAPTQ 
>LA_GKS1 
MGHILSSTSYNEEHQNLASSMNAYFMNFKVENKIISEETINLITFNLEKGYIDSVGTVIDDVLKEIDSAPLNIAVTGESGVGKSSFINA
LRGVGYEGEGAAPTDVVETTMKATPYKHPRFPNVTLWDLPGIGTTNFPPQDYLRKVKFDEYDFFIIISATRFKENDAQLAKAIKGMKKN
FYFVRTKVDIDLRNERKCKPKNFKRGEILQKIRNNCLVSFRQLKMDEPQIFLVSTHDISKYDFPILIDTLLKDLPAQKRHMFMLSLPNV
TKEAIERKRGSLGQKIWLEALKAGAWATLPMVGIFNDNDIKKLEASLKEYRVLFGVDDITLPKFG* 
>LA_GKS#2 
XKVTFWDLPGSRTPNFLPETYLETVEFAKYDFFIIISSTRFTYSDALLAQKIKNDGKKFYFVRTKVDNDLYNEERSKPKSFKKERVLQQ
IRDHCLANLSHIGVPEPCIFLVSNFDLADFDFPRLEETLLMELPSHKRHTFALLIPCLSDSAIEMKRDFFKGKIWLDALSTAALALIPF
MPFIYGFDTPEQEKCLGLYRSHFGLDDKSIKEIAQKLGTPEQEIRSSIKSLDFQSLVKDDEIVAKAKKCVESYCSLKGGLPSSVFQFVK
VYLLRLKFLNTVADDAKIILQKTLEG* 
>LA_GKS3_p 
SSNLASLTTGRDQDLQHIGKITITKWRTTTQYWESWPNQVDIYFWGTQFNYDSAPLNIAMTWESGAGKSSFIKALRGVEYEEEHAAPTG
VVQTTVKATPYKYSQFPxLTFWDLPGIGTTNFQPQNHLWKVKFGEYDFFIVISATCFRKNDAHLAKAIKYMKKNFYFIRTKVDINLQNE
QKSKPKNFEREKALLQIQNNCLLRFRQIKMxEPQILVSSNDVSKYD*DLSAQKWHVFMFSLPNVTEEAIGRKRDSLRQKIWLKALKAGA
WATWPMVGILKDNDVKNLEASLQEYQVLFGVDDITLQNLAGNLQVPVEQLQAIIESPNLLEKKKDESIGERLLKYVKFCLANGGLLATG
LYFRKNFHLQLHFLNMMTNDAKTLLKITFSEKRLSSH* 
>LA_GMS1 
MKAQKDLENGNLLRSGLCCNAKLVRRVSTTGVNIAVTGESGNGMSTFINALRGIGHEEEASAPTGVVRTTQTPASYSCSHFPNVVLWDL
PGMGATSQSLKDYVVEMEFNQYDLFIIVASEHFSMNHVTLAKTIEEMGKKFYIVWTKLDMDLSTTIFTEEQLLKSIREHILENLQMMLV
CKSPIFLISSFEPLRHDFPKLRATLQVDISDIRCHGPLQDLFHTCEKIINDKATCLQEKIATDSFQNTPAIRDADGLAECLKAYQFSFG
VNDKSLQQVAQRMGKESLEYTAITMSQDVQALSRADWKLMCLTCRVMKAFLFLLSYIPSFSSPIVQCIRRMQHKRILMIVVEDTKTVLR
KVLKDSSISG* 
>LA_GMS2 
MAILTALLFLPLCRVTPLLTDMAEYSGSAHDPVSASFPSVVPYCTGWSISPEAGAMDIEKALADGNLLEVVSVVKNTLKTASRTPVKIA
VTGDFGNGMSSFINALRGIGHEEEASAPTGVVRTTQTPASYLSSNFPNVELWDQPGMGRSHRAWRAMCWKWGLASTNSSSSLHPNSST* 
>BT_IRGC 
MATSKLPAVSGEEETTILMAKEELEALRTAFESGDIPQAASRLRELLASSDCTRLEVGVTGESGAGKSSLINALRGLGAEDPDAALTGV
VETTIEPSPYPHPQFPDVTLWDLPGAGSPGCSADKYLKQVDFGRYDFFLLVSPRRCGAVETRLASEILRQGKKFYFVRTKVDEDLAATR
MQRPSGFSEGAVLHEIREHCVERLRGAGVHDPRVFLVSNLSPARYDFPLLMSTWERDLPAHRRHAGLLSLPDISLEALQKKKDMLQEQV
LKTALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSPLANEVSPETVLRLYSQSSDGAMR
VARAFEKGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEEEDTQPDVSLEAAGDNGVEKRGSGEGSMEEAPLSTRRKL
GLLLKYILDSWKKRDLAEDK* 
>BT_GKS1_D 
MDPLLLNVIKKNDSKQLASEFLSGYKTLVSEVGGILSQVSLTRILKGFEKGQPKDVADEIQRALQSAENARQNVAVIGQSGSGKSSFIN
VLRGIGHEGAGSASVGVVPTTRKKTPYPHPKYPNVTFWDLPGTGTPESLPNPYQEVVGDDNYDYFIIISSSRFSSNDAFLAQKIQEKGK
KFYFVRTKVDSDLYNESKSKPRSFNKETVLQQIRDNCLINLSKIVSEPTVFLVSNFKSKEFDFPKLQETLLQDLPAEKRYTALLLLPNL
SESFIQLKRATIKEKLWLTAFRAAILAFIPLTPFCCGFELSEHERDLKQYQSHFGLDEESVSQIAQNLGTSEQEIYSLMKSTDFNSLVK
DDSIIANVKKCAEFVFSVTGLLQSSVFQFYKVYFLHLKFIDTVAEDAKRVLAKIEEMRSGRMK* 
>BT_IRGQ 
MPPPRGDVTVLFLGPPGSGKSALIAALCDRDVETVEIPDGRPDSGLPSLRAAGPGLFLGELSCPPAEPGPWAAEANVLVLVLPGPEGNE
EPLAPALGEAARAALARGTPLLAVRNLRPEESQNEAQARDQTAALLDSAGLGAAALFVPRTDCLSTDGCEELERLRAALRSQAEALQRL
LPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRAGLERLGSARLDLAVAGRADVGLVLNVLLGLDPEDPGAVPAAAPAGPTPYPTP
ERPNVVLWSVPLSSADTTVAPYPTTHYDALILVTPGAPTEKDWAQVRPLVLPDTPLVCVRTDGEGEDPESLEEEEKAEKSGSESLENAD
GEGTKKSGSGDSERAAALSPEDETWEVLEEAPPPVFPLQPGGLPGLCEWLRRALPPAQAGALLLALPPASPRAARTKAAALRAGAWRPA
LLASLAAAAAPVPGLGWACDLALLRGQLAEWRRALGLEPAALARRERALGLAPLKGXXXXXEGEXRXGXLSGEGTAGGAALGALSFLWP
AGGAAATGGLGYRAAHGVLLQALDEMCADAEAVLAPQVPAQ 
>BT_GKS2 
GRWDILSQLCCLSSSPEDGELGVRQPMASEVFQSCLSQCKILELSKDTRALKEAFEAGDLPAVAAKLQSTLHSLENVRLDVGVTGGMGS
GKTTFVNAIRGLGDEDPNSACTGVVEMTVDPTPYPHPKYPSVVFWDLPGVGTPAFRADKYFQRVQLFRYDFFLIITSESFTTDLAELAL
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EILRRGKHFYCVRSKVDVDIAASRSRRPSSFSEERVLNQIRDDCAQRLEAQGLRDPKVFLLSMFELGKYDFHLLEESMVRDLESHKRHA
FLVALPNVSKP 
>SS_Irgc 
MATSKLPAVPGEEETTILMAKEELEALRTAFESGDIPQAASRLKQLLASSEGGRLEVGVTGESGAGKSSLINALRGLGAEDPGAALTGV
VETTMTPSPYPHPQLPDVTLWDLPGAGSPGCSADKYLKQVDFGRYDFFLLVSPRRCGAVETRLASEILRQGKKFYFVRTKVDEDLAASR
TQRPSGFSEAAVLQEIREHCAERLRAAGVSDPRIFLVSNLSPARYDFPLLVSTWEHDLPAHWRHAGLLSLPDISLEALQKKKDMLQEQV
LKTALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSPLANEVSPETVLRLYSQSSDGAMR
VARAFEKGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEDEPQPPVSLEAAGDNGVEKRGSREGSCEEAPLSARRKLG
LLLKYILDSWKKRDLSEDK* 
>SS_C_like 
MASEAFPSGLSQSKMLELLGDTRALKEAFEAGDLPAVAAMLQSTLHSLENVRLDIGVTGGTGSGKSTFVNAIRGLGDEDPTSACTGVVE
MTMAPTPYLHPKYPNVIIWDLPGIGAPAFQADKYVQRVLLDRYDFLLLLTSESFTAHHARLAREILQQGKRFYCVR 
>EC_IRGC 
MATSKLPAVPREEETTILMAKEELEALRTAFESGDIPQAASRLRELLASSESTRLEVGVTGESGAGKSSLINALRGLGAEDPGAALTGV
VETTMHPSPYPHPQFPDVTLWDLPGAGSPGCPADKYLKQVDFGRYDFFLLVSPRRCGAVETRLASEILRQGKKFYFVRTKVDEDLAATR
TQRPSGFSEAAVLQEIREHCAERLRVAGVTDPRIFLVSNLSPVRYDFPLLVSTWEHDLPAHRRHAGLLSLPDISLEALQKKKDMLQEQV
LKTALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRSPLASELSPETVLRLYSRSSDGAMR
VARAFEKGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEDEPQSEVSLEAAGDNGVEKRASGEGVSEEAPLSARRKLG
LLLKYILESWKKRDLSEEK* 
>EC_IRGQ 
MPPPRGDVTALFLGPPGSGKSPLIAALCDKDVEMVEIPDGRPDSGIPSLRAAGPGLFLGELSCPPAAPGPWAAEADVLVLVLPGPEGNG
EPLAPALAEAARAALARGTPLLAVRNLRPGDSQNEAQARDQTAALLASAGLGAAALFVLPADFGSRDGCEELERLRAALRSQAEALQRL
LPPAQDGFEVLGAAELEAVREAFETGGLEAVLSWVRAGLERLGSARLDLAVAGTADVGLVLDMLLGLDAGDPGAVPATAPAEPTPYPAP
ERPNVVFWTVPLGSAGTVAAPHPTHYDALILVTSGAPTEKDWAQVRPLVLPDAPLVCVRTDGEGEDPESLEEEEQAEKPSGQSLENAGG
GGLENASSEGGEKLGPGSQKAGNGEGSEKAGRESSQEGWRRREEIGRWGLGAGEPP* 
>EC_C_like 
NKAFGARPGIWLPSSAEGCGEERAAQFEILPYLSCQWSSGPGDGEPGPGSPWQAVFQRSLSQARVSELLRDTGALKEAFEAGSLPAVAA
TLQATLHLLENVRPDIGIPGGTGSGKVTFVNAIWGLGDEDPNSACKGMVGMTVDPTPYPHPKYPNVIIWDLPGIGTPTFQADxYLQWAL
LDHYDFIIIMVTSEHFTANQARLTCEILQ*GKRPYFIRSKVDVDVAAxEHRHPVPSLGRVRSARSGTTVGSTQWVRRRLWGGWVGGPLR
DCPPLPLHLLVEAWSGKRGRPKSHCTTELGPTVTEVYSCHFLRAGTSQxVEGLRDPRVFLLCVIDLSKDDFHLLQESVEKELESHKRHA
FLVAPPSTSKPVLAKEASPLGHIWLVATVACGVNLSPMLGAQDMGCDLHMLIHSLEGCRHSFGLDDCPVKRAERTGRPLHKIWEAVQGQ
EPKVSQALVVKLLGQAPGDASAFTRKHLNVPVLGTLAACGTSFTTIYWMLSLSLDAAVKDAQDMLTQAFFNNSDHKLPEKPHHNPSPEP
RPAGGGSEELGGSRLYLSPGQVVSGDGKKETQAPAVLD* 
>DN_GKS1 
MDQSSSSKRSPTKHNDYNDLASSFDKFFKTTHIESQIISQETITLIKSQLKEGNIQGAVSAINDALIDIENAPMSIAVTGETGTGKSSF
INALRGLRHQGKGAAPVGVTETTTERESYQHPKFPNVTIWDLPGIGCTNFPPKEYLKKMKFLEYDFFIIISATRFRDHDAQLATAIEKM
RKKFYFVRAKIDSDLQNDRKCNPSTFNKERTLEKIRDDCHEKLLQAKIRVPQVFLISSFDVSDYDFPNLETTLLRELPAHKRYIFMLSL
PCVTEATIDRRRESLKQKVWLEALKAGISATMPLVGCISDSDVEMLEDTLNLYRSYFGLDNVSLENMAEDLDISIEQIKAIIKSPHLLS
VKKENESLGEKLLKCMEKTFSVIGTPIASGLYFRKTFYLHSHFLDTVANDAKALLNKEEIFISKVHSM* 
>DN_GMS1 
MTDMADSPVSPQSPLPANFNSMPPQIEALSIEKAWSDDEWxQRVISMFRETLRSVPCTPANIAVTGASGNGMSSFINALQGIGHEEAAS
APTGVVRPTQTNASYSSSCFPNVLLWYLPGMGATTQSLESYLLEMKFNQYDLFIIIAPEEFSMNHVRFAKTIEDIGKKFYVV*TKLDRD
LSMSxRSAPAEYPRKYPGKSPEGLGLxEPPIFLVSNLDPSLHDFPKLRDTL*KDFSHSRCDGLLQNLFHTCKKIINDKVTFLKEKISTR
SFQDTLDSPDAVNLEECFKFYRWYFGVDDESL* 
>DN_GKS2 
MEQLPSATPSDNFGSSFDEFPKNFKTENKILSEDNITLIKSYVERGNILKVISIIRDAMKDIENAPLSIAVIGEIGVGKSSFTNALMGF
GPEEKCAAKTGPAETTKERAPYKSLKFRNVTLWDLPGIGSTDFQSVQKYLKKMKFEEYDFFIIISAARFKETDAQLAKAIGEMRKTFYV
VRTKVDSDLQNEKKSKPNIFNKETILQKIRENYKENLHKAKVKAPQIFLVSNIDVSNYDFPQLKTTLLHELPTHKYHKLINFVSSFTEP
IIDQKRDSLKQKVWQDAWALKFFTQPFMIFISDNDVKELEEILSHYRACFGLDDVSLTDMAKYFRVSVKELKAHIKSPSLLSVEDEDKP
LRTKLLECIEKVCSNGGLLENALPFRRAYCLHIYFIDTVASDAKTLLRNVNLLVKKVPMSNNSGY* 
>DN_GKS3 
MGQLCFSKHSH*KPNGLASSFDKFFKxLHRKIISQETIIFIQLQLKKGDIQGAVSSISDTSTDIENAPKSIVVPGEAGMKxSFINAVRK
AELERKGVAPIRVVKTTCKTASSQHLMFPNVTFxWDLPGIGTTNF*AKQFLKKVKFGKYDFFIIISATHFKENDAQLATARTRKNEEKF
YFVQTKTDLDLQDEKKKMCKPSSFNKDRILQNIQNHCQENLQKVNVREPQVFLVSSTDVSDYxFPKMNTTLLEEFPAHKHYIFMLSLTS
FT*ATIDRKESLKQKVWLETLKAGASATILFMDFINDSDMEILEETLYSSYFGLDDVSPRNYGKGFGHFSGLKTCIKSLHFLSEE*R*V
LRGKTVKRWAKVCSVTGRPIATDLYFRKTLYLQYHFLDTVASDAKSLLKKEELFISKVDSMQV* 
>DN_GKS4 
QQLASNFVPYYSTLISKGGSMLSQETLTGIKKALK*GKLKVMIDMIQKSLHETENSPLDVAVIGESGxGKSSFINAL*GLSHEEESSAG
VGVVESTREKIPYQHPKYPNVTFWDLPGTGTPDFLPETYLGKVGFANYDFFIIISSSWFEYNDALLAQKIKEIGKHFYFVRTKVHSDLY
NEEKTKPSSLYKERVLQKTQDKCLANLNVIGVPAPCIFLISNFDLGDFDFPSLEETLLKEIPAHKCQPFVLLLPSLSEAAIELKRDFLK
EKIWLDALKSAALDFMPFMAIISGFDLPKQEKCLDLH*SYFGLDDKSVNEIAQYLDISMQEIKSSTKSLNF*LLVKDDSIVAKVMKCAE
LYCSVNGGLPSTIFQFFKTYFLHLKFLNTVADDAKFILHKTLESSLRE* 
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>DN_IRGC_K5 
MAGARSPGPREEETTILMAKEELEALRTAFESGDIPQAASRLRELLASSESTRLEVGVTGESGAGKSSLINALRGLGAEDAGAALTGVV
ETTMNPSPYPHPQFPDVTLWDLPGAGAPGCPADKYLKQVDFGRYDFFLLVSPRRCGAVEARLAAEILRQGKKFYFVRTKVDEDLAATRS
QRPSGFSEAAVLREIRDHCAEGLRRAGLAEPRIFLVSNLSPARYDFPLLVSTWEHDLPAHRRHAGLLSLPDISLEXXX 
>DN_IRGQ 
MPSPRGDVTALFLGLLGSGKSALITALCDKDVETLGARRTESGVXXXARAALVRETPLLAVRTIHAGESQNEAQARDQAETLLDSAGLG
AATLFVLPANCSSSDGCEELERLRVALESQAEALQRLLPPAQDGFEVLGAAELEAVREAFETGGLEAALSWVRAGLERLGSARLDVAVA
GTADLGLVLDALLGLDPGDQGAAPASAPAEPTPYPAPERPNVVLWTVPLSPADTAAAPNPTNYDAVILVTPGVPVEKDWAQVRALVPPN
APLVCVRTDGEGEDPEPLEEEGKAEKSSGEGLENARSGKRGVGQQTTGSGEGSEKAGSESWQLIGAGAKKSGGGDAERTAASSPEDETW
EVLEESPPQVFPLRPGGLAGLCEWLRQALPSAQAGALLLALPPTSPRAARTKAAALRAGAWRPALLASLAAAAAPVPGLGWACDVALLR
GQLAEWRRAMGLEPAALARRERALGLPPGELAARTHFPGPVTRAEVEARLGAWAGEGTAGGAALGALSFLWPAGGAAATGGLGYRAAHG
VLLQALDEMLADAEAVLAPQAASQ 
>MD_Irgc 
CGPGPSKKGIPVFGDTSGGRHLLGTVYTMLQGCLNEMAEDAQRVRIKAMEEEVAAPDARLDVASSGPGLEKRGAGEGGGEDAPLSARRK
LGLLLKYILESWKKRDVVEEK* 
>MD_C_like 
MAAPKETFEEGTIPVASGKLRATLQDLENVRLDIAVTGGSGSGKSTFVNVIRGLGDEDQGSAKTGVVEIITDPTPYPHPKFPNVIIWDL
PGVETPLMEANKYLDKLLPSRYDFFLIMVSERFTTSHAQLACAIQDQGKPFYFVRSKVDIDMAASRQRRPTTFSEEGVLCEIRAKCCTE
LEDEGVMDPEVFLLSMFELGKYDFQLLIEIIEKDMDAQKHHAFLVALPNVSQAILEKKQATLKQHIWLVATVACSSNPQPVPGVRGVAC
DLSQLLRSLDTYRRSFGLDSTSLCKLAQQTGQPLRVMQSAILGPSSEVTEAQVIQLLAEATQGPTGVFAKELSSVPVLGVVASCGYSFA
VVYQMLRTYLTGAAKNAQRVMKRAFHSSL* 
>MD_GKS1_D 
MEHSLSSLSLKEKPNALASSIVNNYETETGGRGFLPQENITLLKSVLKEGRLEEAVAIIKEKIEDMDKALLNIAITGESGTGKSTFINA
FRGTSHEGDDAANTGVVETTTEIIPYEHPKFPNVKLWDLPGIGTPNFQPKLYLEQVNFNSYDFFFIVSSTRFRDNDANLAQEIRKMGKK
FYFVRTKIDSDLDNERKAKPRSFKEENVLQQIQENCLQNLRKVGIEDPQVFLISNFELASFDFPKLQDILVEELPAHKRHVFLLSLPNI
SEAAINQKKAALQDKIWLKALKSGLRSTVPFVGIIKEDSIAKLQKTLKNYQSLFGVDDASLRKIAQKSNRSLEDLKKLIKSPDLLTVKK
DESLSEKLVKYAEVVFSVSGGLCATGLYYRKIYNIQLHFLNTVADDAKILLSKIWEPPAKER* 
>MD_GKS2 
METSDTALHDANIQSLASNFMPGYRMISSTDGSLLTKDTLTWIQSALEEGRLGEVASRIQETLEASENIPLNIAVTGESGSGKSTFINA
I*GIGHEEKDSASTGVVETTKEATPYKHPKYPNVNFWDLPGIGIPDFHPETYLNKVNIDQYDFFIIFSASRFTVNHVKLVQEIRKMKKK
FYFVRSMVDKDLENERKAKPSTFSQEKVLQIIRDYCLKYFNDECMSEAPVFLVSNFDLSVYDFPKLEETLIKDLPACKRHAFLLALPDV
SKAVIDRKKAALRERIWLQALKTGALATIPVAGFFLNDLVTLNNHLKHYRKVFGMDDESLLQVARRLGRPVEEIKVPLKSLDLEALIKE
ESTIELLLKLVEGFCSANGIILSAGFHFGKTYYTQLLFLNTVADDAKILLQKNLGVPF* 
>OA_IRGC 
XLAGEVLRQGKRFYFVRTKVDEDLAASRSQRPSGYCEGAVLQEIRDHCSERLRLAGVAEPRVFLVSNLAPARFDFPLLVSTWERELPAH
RRHAGLLSLPDVSLRALQEKKDALQDQVLKAALVSGVIQALPVPGLAAAYDDALLVRSLRGYHRSFGLDDDSLARLAEQVGKPAGDLRA
VIRSPLAAEVSSDAVLRLYSQASSGAMRVARAFERGVPVFGTLVAGGISFGTIYTMLQGCLNEMAEDARRVRVKALEDASGEREPGAGP
DEEAGADQDPDAWALDLEGRGLGGAGGEGRGDPPLTMRRKLGLMLKYLLEAWKRKDVVDDK* 
>OA_GKS1 
MEPQASRPSGNQVPPLNPDAIREFTAALGSGNVPNVARKLMEAVKMAAYAKLNVAVTGEPGAGKSTFINAMRQLGDEDPGAAATGVVDT
TRDPTPYPHPKYPNITLWDLPGIGSPEFRAEGYLARVASDRYDFFILLASQRFTYNLAQLACAIQQQGKKFYLVRCKVDVDLEASRRRR
PSSFDPEQVLAEIRRDCQDQLSRQGLSGPRVFALSNFNRGLYDFPLLEETLEKELPGHKRQAFLLARPNDSLEVLEKKKAALEEQIWKL
ALAACTVNSVPVPGLPGLPAACEVAILTDSLSDYCRSFGLERETLEELARELGLPQEEVQGLIRSPLAQDITRGLVLQLLASASQSAQL
LFQYFRQAVPTFGTLAAAGLSFAAIYLTLRTFLQHVAEDARRIVLLAQRKRGQRDGEPPRRAPPAPPEPRGSAEALPPAASPPPPAPLP
GPSKSPS* 
>OA_GKS2 
MAAKAKPPTGPGASSGQGPEEKNFLQLSAEELGALREAFEDGNLSAAARKLQDTLQSLENVRLDVAVTGETGSGKSTFVNAIRGLGDEE
PGSAETGVVETTLDPTPYPHPKYPNVTIWDLPGIGTPAFQASRYLERVQFGRYDFFILIASERFTAHHAQLACEIQRLGKRFYFIRSKV
DVDLAASRQRRPATFSEEGVLNEIRTHCRDRLRAEGVAEPRVFLLSTF*LGKYDFHLLGETLERELEGHKRHALLLALPNVSRQILDKK
RASLHQHIWLISAISCGLDPVPVPKVPGLLLRPLTAGTGPTWLLSELRVGMSTTXXX 
>OA_GKS4 
MASRTGSRATSPGGEDDGSILLNKEELEALRSAFEAGDLPQAASKLRELLAPAEPGQLHVGVTGESGAGKSSLINALRGLGAEDPGAAR
TGVIETTVQPAPYPHPQLPGLTLWDMAGAGTPGCPADRYLXXX 
>OA_GKS5 
RKRFWDHFGAERSQEHLNITVMGESGAGKSTIINALWGVGHEEEGSALTGVVTTKEPTCYQHPNLDMNYWDPPGIGTPNFQPGSYLEKV
AFHRYDFFILVASERFTSNHALLAREIGKMGKRFYFVRAKVDMDLENCRIRKPRSHNEDRILWEI* 
>OA_GKS6 
IIASEPFKSSSVDLAREIQRMEKKFYFVRTMTVEDPASAKEGKPGSSNEESLPQLIRDDCLESLKKGSVSHPRVFLISSFDMGLYDFGD
LEDTLVRELPAHQRHTLRLALPSVTEEAIEKKKLTLQEKIGLEATKECLRAPFSGIFSPNNREELEKCLPHYRSLLGVDDASLAKLAER
EGREVRDLKAALKSYDMETVLKNSDALPSLVNSVKEKIKTSLSCVSFFGNLLSTIAISRTQIYTLQWHALDTVAEDAKLLLKKTQSTG* 
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>AC_GKS1 
MKVKKSHVIFACFFTFRSRLDQMAAAPQEAAQNHQVNFEEYDIITEEDIEEIKDALEGGRMAEAASKIMENLQALENARLDIAVTGESG
SGKSSFINAIRGLGDEEEGSAPTGVVETTREPTPYPHPKHPNVTMWDLPGIGTPDFQSSTYLEQVNFSRYDFFFLIASERFKANHAMLA
NEIKKQGKHFYFVRSKVDADLEASKKRRPRSYNEEMVLTKIRENCQDCLKKEGVDDPHVFLLSSWELSKYDFMLLEKTLERELPNHKRH
AFLLALPNISLEILQKKKETLQKQIWKLATISCGVAAVPIPGLSVTCDVALLIKSLSTYRKNFGLDEESLIKLAEKVDKPVEEIKEAIK
SPLTKEISKDLVVKMLTKAGGGALMFMEYLASTVPIFGSMAAGGISFGTTYYMLWSFLNEVAGDAQNVLIKAFESDV* 
>AC_GKS2 
MASAPQEAVQNHQVNFEEYHIIAEKDIKVIKDALEGGRMSDAVSKIMENLQNIENARLDIAVTGECGSGKSSFINAIRGLGDEEEGSAP
TGVVETTREPIPYPHPKHPNVTMWDLPGIGTPDFQSSTYLKQVNFSRYDFFFLIASERFKANHAMLANKIKKQGKHFYFVRSKVDADLE
ASKKRRPRSYNEEMVLTKIRENCQDCLKKEGVDDPHVFLLSSWELSKYDFMLLEKTLERELPNHKRHAFLLALPNISIEILKKKKKVLQ
KQIWKLATISCVVATVPIPGLSITCDIALLIKSMSTYRKDFGLDEESLIQLAEKVGKPVEEIKEVIKSPLVKKISKDLVIKLLTKAGGG
ALMVLGYFVSMVPIFGSLAAGGISFGTTYYMLKKFIDELAEDAQNVLIKVSESGV* 
>AC_GKS3 
MSFCPLSLYSRTATMEIQEVDLREMGSLIQSRVILEVSNQVQSLLESVETTTLEIAVTGESGAGKSTFINALLGLNDGDPRAAPTGVTE
TTFSPMPYEHPRLPRVHIWDLPGTGTPRFQAETYLQQVGFERYDFFIIIASERFRENHVKLARAVAAMGKRFYFVRSKIDLDLQASRQR
RPTRFEEVHVLREIEADCIRQLKKEGLDSPKVFLISSFELHRFDFQCLEDTLAEELEGHKRHVLLLSFPSVTTEAVQKKKASLRRNIWK
KALMACFFSALPGLPFHLNIPMLLKTLDSYRRSFGLDDDSLGALALTTSKNPSQLKNQVSSTLARDLSENAVHVILSQAATYGKVAARL
LKDRVPFLDNLVAGGISFVAAYYLLHTALDNFAKDAERVLLAAYDLEDEFQKSVFYPPEPGFIFD* 
>AC_GKS4 
MGIALTKSLVKEELQRFKAAKEEGNIEDVKAKIMKDMELLNNTTLHIAITGDSGSGKSSLVNALREMTDEEKDSAPTGEIEMTKDKQSY
KHPKFPQVTLWDLPGIGTPNFKADEYLKQVNFRQYDFFIIASGERFTENDVKLACEIKEMKKKFYYVRTKMDVSISNNKKRKNFSEEKT
LQEIRNYCIQRLRGTGEHSPRVFLISRWHLNNYEFPLLVKALEEDLDALKRHVLIMALPTFSKEVIKKKENAMSDLIWKLSLLSCTVGA
IPIPGLSLACDIGILVSTMRKIFNCFGLDAESLRRLGERVGKPVDELKSARKKFQGVDTLTKEFVIDYLQKSVAWITVSTVELVLDFVP
VVGSVVGGGASFVTTYYMLKNFLSDAVEDAQNVLAKVCEKKE* 
>AC_GKS5 
MFLLLLRSNEPPKGSFLRSAISRTILKLDLENLTLALEKEDISDVVAKTQQQLDFLTNATLDIAITGRSGAGKSSLVNALRGMSDYDEG
SAETGVIQTTMEIKGYPHPTFPKVTLWDLPGIGTPEFKAKEYLRKVNFSKYDFFIIVSAGRFTTNDITLAHEIQKMKKQFYYVRTKIDI
NIDSEKRKQNFNEHETLEKIRNDCSENLKKAEGSSSRVFLVSRSDLSLYDFPSLHGTLEEDLDDLKRHAFIMASPTFSGEMVKKKKKSL
ESLIWMLALVSCFVGAVPVPGLSLACDISILMGAMVHFCKVFGLDDNSLHVLAKRVGKPVEELRSAIKNTPLPHTITTDLVLSLLSKSL
LCATLTVIELVCDFVPVLGSIVGGASSFVCTFFMLRSFLQSVEVDAANVRAKATK* 
>AC_GKS6 
MRSISKTIISLPHAEEDLIRNLAEKLYETFNAVSIYEVARELERSLELWGKTELHIAVIGETGAGKSSFINAMRGLKPGDVGAAQVGVT
ATTSNPICYENPNDPNVKFWDLPGIGAPEFRPNDYLEKVNFHHYDFFIILCSKRFRDIHIDLAQIIDNEKKKFYFVRTKVDEDLTNMER
DYPRTFNEANVLQNIRDDCNRYFQVYIRSFIPQVFLLFSCNLERFDFYLLIERLEGDLPTLKKLKFVLNLPNMSSDIIQQKKQLLKGEL
WKVSLVSAFINAVPLPDFPVAFNASFLQKYMADMYKKFGLDGDSLALLAWHINKPVEELKAQIKSSQEEYISTDSIIKKCFNIVMTFVV
FWNKYFPLSVFTSLANVGLSFISTSRMLYKFLDQVAEDAERVSKEALKHVEYDINRPLNRT* 
>AC_GKS7 
MGGTNSHPSSIQELEDVTFNIAVIGETGTGKSSLVNALRGMKTDVEGGAAVTDVIQVLNEPTAYVHPEYSDITLWDLPGIGTNEFKSEE
YVKNIDLNKYDFFIIVSEIRFTEDDQRLVHAIQKIKRKFVYVRTKVDKSLESERENPNFSEEGILKKIRNHYCENLTKAGEPSPRVFVI
SRWHLEMYDFPCLVNALKDELADFKREVSRWSPEKKRKRLDR* 
>AC_GKS8 
MRSVLKTIISLPNAKEDLIQNIAEKLCETFNAVSIYEVAHELERSLELWEKTELHIAVIGETGAGKSSFINAMRGLKPGDVGAAQVGVT
ATTSNPICYESPNDPNVKFWDLPGIGAPEFRSNDYLEKVNFHRYDFFIILCSKRFRDIHIDLAQIIDNEKKKFYFVRTKVDEDLTNMER
DYPRTFNEANVLQNIRDECNRYFQVYMGSFIPQVFLLSSCKLERFDFYLLIERLEGDLPILKKLKFILNLPNVSSDIIQQKKQLLEGEL
WKVSLVTACINAVPLPDFPVAFNASFLQKYMADMYKKFGLDGDSLALLAWHINKPVEELKAQIKSSQEEYISTDSIIKKCFNIVMTFVV
FWNKYFPLSVVTSLANVGLSFTSTSRMLYKFLDQVAEDAERVSKEALKHVEYDINRPLNRT* 
>AC_GKS9 
MAMEDFKAAVYEGRLTDAVSNVVGKPLQYFSEVPLNISVAGEPGSGKSSFINAMLGLHAGDPGAAETGIQTTTVDVKAFPHPHLLRSFL
DLPERAAFLVRYFADDs*xRFDFSS*LVPSVSRTIHADLVNEIQGMSKKFYFVRSNIDLDLEASKRQRPSDYNEEKILLRIKDDCHEGL
RREGVANPQVFLVSSYETSRFDFPLLWEKLKSDLLGLRRKAFLLNLPSIYLPVLNNKKMAMKKQILTRALWLWIFAAIPIPGLSYFPAR
KVHSWCYRNFGLDDPSLTDLSQLVGKTAATFKAVMKPLSFTSVVLWGFAELVRAVVIIGDYNHHRHFPLYGYLLSGGISLLSTYLILKK
FVSNATDNTQRVLTEALVCEEKKSI* 
>AC_GKS10 
MSAKGTEAKVSLTEMQIRDLQRAFEKGSFSDLSDRLREAHSALENLRLDVAITGEPAVGKSTFINAFRDVSADDDDAAPTGGSAATTTT
ATTPEPRPYTHPKYADVRLWDLPSIGGPGFQPRDYLQQVEFSRYDLFLVLSSGRFSALHGRLARLLQKAQADVYFVRSRVDQDVEARRR
RREGPAGFSEAAALKEIREACLQDLAAAGVKSPKVSEPQGRPRGPPGPAPPHAERAGKS* 
>ATT_GKS1 
MTDCKLHIAITGESGSGKSSFVNSLRGLMDDDVDSAQTGVIEMTACPTPYQFSKNPDVLLWDLPGIGTPLFQPKSYFQQVKFHQYDVYI
IIASERFKSNHAMLARGIANMGKRFYFVRTKVDLDLRASKRKLKSVYNEAQILQTIRQNTVDCLLTEGLDASQVFLISNFELDRHDFPA
LLKALENDIPAHVLNASKSQWNRGCRLQ* 
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APPENDIX 
>XT_Q1 
VESTYCSCFRCPSYIGTWSPFNEPAFFSLPFAHRPLSLVQQGYEVIGDKEISELQSALERGGIPEMVRFIQNSLDTLLDTRIDFALEGG
DCSVRHSLLNALRGVPDEEDGSAHEKDPETPTEYPSLKYPKASLWDLPGLESQEFQVKDYLEHVNINHYDFIFLLLTHGTEATASFQSL
LSELKKTGKKVFLIQAYQEGEIQLEEESGQNEVFVLCPTNLPGPEFHRLLGNLEKQLSTHKSRAFMLSLPNLSTEVIQKKKDALAHEIW
KVALLSSLVACVPVPGVAIACDMSLLTARLDTYRQELGLDANSIASIAQQYGVSAATLTLEIHSPAGKGVTRKLVGKMLGSATGLGLEV
AGVILHRFPLLGPLATGGIAFHANYSVLSRCLEGMAEDAQRVLEKALKLTSTPMN* 
>XT_Q2 
MKSYAVYVPPHPFQVMETLGELSLSEEKTHPWGTEDPTPCLTEECCEFSVAVAGSPGVGKTVLIQALLGLTESHQHSNAASLHPTRPGG
PLLYIHPSHPGLSLWELPLEDGSPEKWISEADLLLLVTNGCFSPVHIDLARSALSQGKKLCLVRSQVDCDLHTLKRRMKEMFSREEALH
SLCTVTLQPFTHLIREGEIRLFLVSGYEPWKLDTAGLKAVIEETAALCGRYVYMGIWVSLFLEGAEQT* 
>XT_Q1+2 
CWQTVLIQALLGLTESHQHSNAASLHPTRPGGPLLYIHPSHPGLSLWELPLEDGSPEKWISEADLLLLVTNGCFSPVHIDLARSALSQG
KKLCLVRSQVDCDLHTLKRRMKEMFSREEALHSLCTVTLQPFTHLIREGEIRLFLVSGYEPWKLDTAGLKAVIEETAALCGRPLSLVQQ
GYEVIGDKEISELQSALERGGIPEMVRFIQNSLDTLLDTRIDFALEGGDCSVRHSLLNALRGVPDEEDGSAHEKDPETPTEYPSLKYPK
ASLWDLPGLESQEFQGK 
>DR_irge1 
MPEKEEDKNENLYIISSEFLDIMSNATDDPDSISEDMKEVIDAKPKEKTRKLKDKLTELENVTLNMAITGMTGAGKSSFVNALRGLRDD
DEGAASTGTTETTMKPNMYEHPFMPNVKIWDLPGIGSPKFRAKKYLKDVNFHMYDFFLIVTSERFRENDIELAKAINKSNKLFYFIRTK
IDNDVRAESNKRNFDERVLLDKIREDCKVNLLKLNISKIFLISSFHLERYDFQKLVNTLEEELPKNKRFALIQSLPVYSLETLTKKITY
FKKLIWLNAVGAGVGAFPPIPGVSLAVDYGIMKKFFKQVFMAFGLSNQALQVLSERVNKPVEVLNAAKTSRFKDGVTDRILIDMMSNPV
IAITKTLGTIMALLPGGALPAGGAAVASVHYLLNVGLKEMADDTRKVLVVSQLA 
>DR_irge2 
MKIQKQKQELSNSSKPDTHSHSTAKENVSLKSANTVQVEHIYEMPDVHLNSSAEYINEMECVIEQNKQLGNVTLHVAVTGSTGAGKSSF
INAIRGLTSDDENAAPTGVTETTLVPTMYRHPTMPNIELWDLPGTGSPKFKAKKYLKDVKLETFDFFIIISSERFKENDIMLANAIKER
KKLFYFLRSKIDNDIHAESHRKDFDEQKVLSHIRENCHRNLKDIDDPHAFLICSFELHKYDFQTFVDTLEKQLPDHKRDALILSLPIYS
SKILEEKIEIFMKQTWSAAVASGSVAVVPVPGLSMACDAAILLGFFTKCYYAFGLDEKSIDKLSVRVNNLSLKAIRRSPLVVAIGQKKL
TNKELSALTSKEAAVKFAWSMVPVVGSIKTAQMSYSTTLNLLRTGVQDLAETAS 
>DR_irge3 
METQDPAIAEAVQASGESTLEKATAKAKESFDQFMNVSLNIAVTGKTGSGKSSFINALRGLKDDDEGAAPTGVTETTMEPNMYEHPAMP
NVKIWDLPGIGSPNFKADKYLKDVKLKNYDFFIILNSERFMQNDVMLAKEIRKQKKNFYFVRSKIDNDISAEQRKKTFDEQRVLCTIRE
DCLKNLKQLGDPKVFLISSFDLEKYDFEELQNTLAEELPVHKRNALLQAWPVCSAASLEMKIKMFEGVIWAASLASAGIAVVPLPGLSA
ACDTGMVALFLTRCYFAFGLDDGSLARLSEKINKPLVGHLAKSKIASAIQEKALTRLQVSGTLVVLFSAEYVASLVPGVGSVAAAGLSF
GTTYYLLRSGLKELANVAREIRKEVLDSVR 
>DR_irge4 
MTDDSSADMNFSGALQRLGESDPNAAAVKAKEELDRLDSVTLNIAVTGEAGAGKSSFINALRDLSDEDENSAPTGLTETTKKATMYTHP
TKPNVRLWDLPGIGTPNFKANQYLKDVKFETYDFFIIISSERFKENDVYLAKEIQKKQKRFYFVRNKIDNDICSVANGKINEQQLLCAI
REDCYRNLKEVGNPKVFLISSFDLRKYDFNLVGTLESELSDQKGFALVQSVPVYSLAMLEKKKALLEKFIWLAALASSACTLVPNQFIS
LITDKAILIVYLIGCHYALGLNEKSLKQLSERTNKPVSLLKLAIKSPVSLAVLDRMRISPMAKPVKSLEDLLDSKNLAVNVQNTADAFR
NSHTNLTRALNEMIKDMRQVLQVAGLDE 
>DR_irge5 
KEEEDENENLYIVSSEFINIMSNATDDPDSISVDMKEVIDAKPNEKTTKLKDKLTELENVTLNMAITGMTGVGKSSFVNALRGLRDDDK
DAAFTGTTETTMKPNMYEHPFMPNVKIWDLPGIGSPKFRAKKYLKDVNFHMYDFFFIVTSERFRENDIELAKAIKKSNKLFYFIRTKID
NDVRAESYKRNFDEPMLLDKIREDCKVNLLKVRISKIFLISSFHLERYDFQKLVNTLEEELPKNKRFALIQSLPVYSLEALTKKITYFK
KLIWLNAVGAGVGAIAPIPGVSLAVEYVIMKKFFKQVFMAFGLSNQALEVLSGRVNKPVKVLKAAKTSRFKDGITEHILMDMISNPVIA
IAVTLGTIMALLPGGALPAGGTAVATVHYLLNVGLREMADDTRKVLAISQLA 
>DR_irge6 
MECVIEQNKQLGNVTLHVAVTGSTGAGKSSFINAVRGLTSDDENAAPTGVTETTLVPMMYKHPTMPNVELWDLPGTGSPKFKAKKYLKE
VKLETFDFFIIISSERFKENDIMLANAIKERKKLFYFLRSKIDNDIHAESHRKDFDEQKVLSHIREDCHRNLKDMDDPHVFLICSFELH
KYDFQTFVDTLEKQLPDHKRDALILSLPIYSSKILEEKIEIFMKQTWSAAVASGSVAVVPVPGLSMACDAAILLGFFIKCYYAFGLDEK
SIDKLSVRVNNPSLKAIRRSPLVVAIGQKKLTNKELSALTSKEAAVKFAWSMVPVVGSKKTAQMSYSTTLKLLRTGVQDLAETAREVLK
AAGVTGVY 
>DR_irgf1 
MATFEDYCVITQEDLDDIKDSISTQDLPSAVNTIKEYLKQQDLVELNIGVTGESGSGKSTFVNAFRGLGDEDEGSAETGPVETTMEPEV
YIHPKYHNVKVWDLPGIGTPNFKADEYLELVEFERYDFFIIIASDRFRECHTQLAKEIMRMGKKFYFVRSKIDASITAEKKKKNFDQKK
TLDSIRKDCINGLRKIGIEDPIVFLISGWELSKYDLNLLQDRMEKELPQHKRRVLMLALPNITLEINEKKKKALEENIRKVAFLSACVA
LFPLPGLSISADIAIIAEELRKYYSAFGLDDPSLQKLCERSGKTVEELKSLMKSPLHHGINPSSILTLLGAASVLISEDAVELLVSFIP
IIGSVVAGGLSYLTVSGMLKKALNEIAEDARNVLMASLETEV 
>DR_irgf2 
VDALEHLYEIKVEDKLKEIKEILYTQDLPTAFGTISNYFKETSLVLNIGVTGESGSGKSTFVNAFRGLGDEDEGSAKTSSVVTTAEPEV
YFHPKYENVKLWDLPGIGTPNFKADKYLELVEFERYDFFIIIASDRFRECHTQLAKGIMRMGKKFYFVRSKIDASITAEKKKKNFDQKK
TLDSIREDCENGLRKIGIEYPVVFLISGWDLGKYDLNLLQEMMEKEILKCKRILLKSALLNVKQEVIEQRKDTLKRNIERVTEQSVAIT
DVHLPGLSISVNVDIIAEELTKYYSEFGLDDQSLQKLCERSGKTIEELKSLMKSPLCYGINTSLIINLLEAEVPKIENEYFLSFMPFIG
TEIKKIKSSVAVSSMLKTALNVIAEDIRNVI 
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APPENDIX 
>DR_irgf3 
MDILEDYDIITQNDLEEIKESISTEDLPTAVSRIREYLRKQDLVELNVGVTGESGSGKSTFVNAFRGLGDEDEGSAETGVVETTMEPKA
YNHPKIQHVKVWDLPGIGTPNFKADEYLQQVEFERFDFFIIIASDRFKECHTHLAKEIMRMGKKFYFVRSKIDASITAEKRKKNFDLKK
TLDVIREDCVNGLRKIGIEDPVVFLISNFELGKYDLNLLEEKMEEELPQHKRRVLLLALPNITQEINEKKKEALGQNIGKVAILSACVA
AVPIPGLSVAVDLVIVKREIEIYYSTFGLDDPSLQMLCERSGKTIEEFKSLMKSPLRGGINPASLLSLVGAVSVVGAESTVEYILSLVP
ILGTVVAGGLSYLTVSTMLRRALNDIAEDARNVLNASLETEV 
>DR_irgf4 
MSNISQKVVLLFAEQEELVDLRKAISTQDLPTAINTIKECLRKQDLVELNIGVTGESGSGKSTFVNAFRGLGNEEKGSAETGFEETTME
PKDYIHPNFKNVRLWDLPGIGTPNFKAKDYLKLVKFERYDFFIIISSDRFKEHHSLLAEEIVRLRKTFYFVRSKIDQSIDSEKYKKTFD
QEKMLDNIRDKCKSELSKIVKDPAVFLISCNELNKYDFQLLQERMETELPLHKRRVLMLALPNVSLDVIKKKKEVLEKDIAKVAFISAT
VSAVPIPGLSVAVDVMIIKEETEKYFRGFNLDDESLQRLCDVSGKSLEEIKSLMKSPLKAGIGSYSILALLSSATLVLGGMSVLAAESA
LEYFLSTIPLIGSVAAAAMSYKTITLMLKKTLNDLAKDAETVFKALLETEV 
>DR_irgg1 
MFFSRLCMPAKVQEDHLGTIRDVFAGESPETIPHRLISLLEVFDRFKIDIAVTGDSGAGKSSLINAILGLKPDDKGAAQTGAIETTKQA
TMYQQSNLPHIRLWDLPGMGTPSFASKSYVKMMNFDLYDMFMVVISERVRENNMLLVDEIDKRKKPFYFIRTKIDNDVKSQRRKSKFSE
TQALEQMRQDCEKYLKEKKLDPHIFLVSTHDTHNYEFQKFISTFKDEVFKIRAEEFSGFLDKMLHGGWLKAR 
>DR_irgq1 
MLHGGWLKARYATQHVQQTEKLETEDITKLQNMYKSTGFGAAKVSAVLEALSHFQLDVAVLGETGSGVSTLVNALVGLENEESSGAGAS
ISNPALSPVYPDVRFWDISGIEAVMDYSVFEMKQAMKCYDFYIIIVSDWEKVRHVKLAKEVEKLRKHYLLVQTKVDSCLQTQGDLCCEE
TEILDGLRAQFTQELQREKLSEQQMFLINSQDRSAFDFVSLESALSSDLNTIRTSAFAYYIARTVKENL 
>DR_irgq2 
MADVIKGLNLLETLKESIEKNNISDIRDALEDMLISRINIAIAGERNAEKATFINSLRGLSQEDEGAAQNPPSAAPEELAVFTNPKHPD
FRLWDLPPISSDANFKPEDYIERFKATRYNAIILTSTDRPSANSVAVWKEVRSLQKETVYFVLLASVKDTEKSLEAKKAASLDVLKAEG
VPLPKVFLVQPSALEKLDFLTFLEVMRGDLPEIRAHALLLALPTFSSSLVTQKKDAFKALVWAAASLSGGVSAIPVPLVSSMVDATVGV
RILVKAQISLCLDDESLQRLARQRGLDPAKLKALRTCALSVEVSKSEVKRRLAEAEKDTSTATTRLVELAIPRQARSVSRSFTVMLQAL
NNAIDDMGADAEKVVAMVTGERQ 
>DR_irgq3 
MAIQCTHRICSYLTNSLFFRFVVSTALRSMKINQDDLDQISKLSQTRDFTDNPSKLQAILGALDHFRLDVGVLGETGCGSSSLINALLG
LKNSNETAALTGVTETTKEAVEYALPDSHNIRFWDLPGLGKIGDLNSLSANAFSSSEGQQVASVLALCDGYIHILVSPLRVRLRTIQLL
QQASSMGKECYLVISMVDLIEDKAVEEVRQWTEKVLSKLDIQQSLFLVSANYPETLDLAKLKGMLKAAIPSHKKVALARYVSKQLDEDV
FWKRSDSCKFM 
>TN_GKS1 
MADFPDMTEIKEALQSNNQALAVSKIKELLEKTANTTLNIGITGESGSGKSSFVNAFRGVDHRDEKAAPTGVVETTTVVKEYPHPSYPK
VSLWDLPGIGTTKFPADEYLKHVGFERFDFFIIISDTRFRENDVKLAKEIQKMGKKFYFVRSKVDNDLQNAQRSQRDFDANQTLSLIRE
NCKQGLLKEGVQAPQVFLLSNFELQRHDFHRLHETLERELPDHKKNVLLFAMPNVSLEIIEKKKEAFSSKIPHYAFVSAACAAVPVPGL
SVAVDGSLIAGVVQQYKTGFGLDIPSLQRLANSTGVPLEALTSVVRSPLGLNNINVQFILKILLHSASVAGSMVAEEGLRFVPLFGTMI
AATLSYKVTEKALQDFLNMLAEDAHNVFKRAVCSMNSSV* 
TN_GKS2 
MAEFLDKTEIKEALLNDNKDLDVAKIQEHLERTANIPLNIGITGESGSGKSSFVNAFRGVDHRDEKAAPTGVVETTTVVKEYPHPSYPK
VSLWDLPGIGTTKFPADEYLKHVEFERFDFFIIISDTRFRENDVKLAKEIQKMGKKFYFVRSKVDNDLQNAQRCQRDFDANQTLSLIRE
NCKQGLLREGVLAPQVFLLSNFEYQSHDFCCLCETLERELPQHKRDVLLFALANISLEIIEKKKEAFKSKIPQHAFLSAAHATRPVSEL
SVAVDADLIANVVQQYKTGFGLDRPSLQRLTDITGIPLARLTIISSHLTLQNVNADFVLSLMSQSSAISSLTEKKQIFGFIPFFGTLLA
QKLSYKISTIALLSFLDMLTVDAKDVYTKVKMYHSGKK* 
TN_GKS3 
MFASCVGLIMADFLGTTEIKEALQNNNQALAVSKIKELLEKTANTTLNIGITGESGSGKSSFVNAFRGVDHRDEKAAPTGVVETTTVVK
EYPHPSYPKVSLWDLPGIGTTKFPADEYLKHVGFERFDFFIIISDTRFRENDVKLAKEIQKMGKKFYFVRSKVDNDLQNAQRSQRDFDA
NQTLSLIRENCEQGLLKEGVQAPQVFLLSNFELQRHDFHHLHETLERELPDHKKNVLLFAMPNVSLEIIEKKKEAFSSKIPHYAFVSAA
CAAVPVPGLSVAVDGSLIAGVVQQYKTGFGLDIPSLQRLANSTGVSLEALTSVVRSPLGSNNINVQFILRLLFQSASVAGLMVAEEGLS
FLPIFGTMIAATLSYKVTEKALQDFLNMLAEDAHNVFKRALCCMNSSV* 
TN_GKS4 = irgf8 
MNIVKLLILHSCGQCSCFICNSFDLLEIFIQNVSCVFFATKILALCFRLIMADSSDFAEIKEALQNNNQALAAAKIKELLDNTSNTTLN
IGITGEAGSGKSSFVNAFRGVDDRDEKAAPVGVVETTAEVKEYPHPNYPNVSLWDLPGIGTTKFPADEYLKLVGFEKFDFFIIISETRF
RENDVKLAKEIQKMGKKFYFVRSKVDNDLQSEQRYQRDFDPEKTLSLIRENCKRGLLNAGLQAQVFLLSSFELQRYDFHLLYETLEREF
PEHQRDVLLVAMSNISLEINGKKKEAFKSKIPYWALVSSVGALVPVPGLSVAVDLSLIAGLVQQYKTGFGLGRPSLQRLADTTGVQLTD
LTSVIRSPLGLNIIDAELIVKALSELASVAGLMAAEEGLRFIPIFGTMIAGTLSYAATYNALSDFLKMLTEDAQNVFEKALRCMNSSV* 
TN_GKS5 = irgf7 
MNIVKLLILHSCGQCSCFICNSFGLLNIFIQNVSCVFFATKILVLCFRLIMADSSDIAEIKKALQNNDQALAVAKIKELLDKQSNIPLN
IGITGESGSGKSSFVNAFRGVHHRDENAAPVGVVETTTDVKEYPHPDYPNVSFWDLPGIGSTKFPADKYLKLVGFEKFDFFIIISATRF
RENDVKLAKEIQKMGKKFNFVRSKVDNDLLNAQRSQRDFDPEKTLSRIRENCEQGLLNAGVQAEVFLLSSFELQRYDFHRLHETLEREL
LEHQRDVLLVAMPNISLEIIEKKKEAFKSKIPYWALVSAAGALVPVPGLPVAVDLSLIAGVVQQYKTGFGLDTPSLQRLADSTGVHLTD
LTSVIRSPLVLNKINAQLIMKTLIQIETVAGSMAAEEGLRFIPIFGTMIAGNLSSVATYKALSNFLEMLTEDAQNVFKKALRCMNSSV* 
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APPENDIX 
>TN_GKS6 
MADSSDIVGIKEALQNNNQALAAAKIKELLDNQSNTPLKIGITGESGSGKSSFVNAFRGVDHRDEKEAAPVGVVETTAEVKEYPHPDYP
NVILWDLPGISSTKFPADDYLSRVGFEKFDFFIIISDTHFRENDVKLAKEIQKMGKKFYFVRSKVDNDLLNAQRRQRDFDPEQTLSHIR
DDCKQGLLNAGLQAQVFVLSNFYPQRYDFHRLHETLERELPEHQRDVLLVAMPNISLEIIEKKKEAFKSKIPYWALVSAAGALVPVPGL
SVAVDLSLIAGLVQQYKTGFGLDTPSLQRLANTTGVQLTDLTSVIRSPLGLNNINAQLIMKTITQIATVASLMAAKEGLRFIPIFGTMI
AGTLSYAVTYKALLDFLEMLTEDAQNVFKKVLPA* 
>TN_GKS8 
MADTTKIKDALQNNNQALAAAKIKELLDKQSNTPLNIGITGESGSGKSSFVNAFRGVDHKDEKEAAPEGVVETTEDVKEYPHPDYPKVS
LWDLSGIGSISWKLGATKFDFFIIISDTRFRENDVKLAKEIQKMGKKFYFLRSKVDNDLLNAQRSQRDFDPEQTLSHIRENCEQGLLNA
GVQAQVFLLSSFELQRYDFHRLHETLERELPEHKKDVLLVAMPNISLEIIEKKKKAFKSKIPY*ALVSAAGAVVPVPGLSVAVDVGLIA
RVVQQYKTGFGLDRPSLQRLADTTGVQLTDLTSVIRSPLGLKNINAQFIMKTLIHSASVASLMVAEEGLRLIPIFWNNDSRDSFLCSYS
KCSARFPQDVD*RCSECG*KGSPCMNSSV* 
TN_GKS9 
MADSSDIAEIKEALKNNNQALAAAKIKELLDNQSNIPLNIGITGETGSGKSSFVNAFRGVDHKDEKEAAPTEVVETTADVKEYPHPDYP
NVSLWDLPGIGTTKFQADKYLKLVGFEKFDFFIIISDARFRENDVKLAKKIKGDGGKSSTSYAPRLTTTCLSAQRSKRDFDPEQTLSLI
RENCKQGLLNAGVQAQVFLLSNFEFKCYDSHRLHETLERELPEHKKDVLLVAMPNFSLEIIEKKKEAFKSKIPYWALVSAAVALVPVPG
LSVAVDVGLITGLVQQYKTSFGLDRPSLKRLADATGVRLTDLTSVIQSPLSLNNINAQLIIKALNQTATDAXX 
TN_GKS10 
MADSSDIAEIKEALQNNNQALAAAKIKELLDKQSNATLNIGITGDSGSGKSSFVNAFRGVDHRDEKEAARVGVVETTAEPKEYPHPDYP
NVSLWDLPGIGTFKFPAKDYLKHVGFEKFDFFIIISATRFSENDVSLQKRSRRWAKSSSFVRSKVDNDLLNEQRCQRDFDPEKTLSRIR
DDCRQGLLNAGVQAQVFLLSNFELQRYDFHRLHETLERELPKHKRDVLLVAMPNISLEIIEKKKEAFKSKILHWALVSAAGALVPVPGL
SVAVDVGLIVGLVQQYKTGFGLDRPSLQRLADTTGVQLTDLTSVIQSQLGLNNINAQLIMKTLIHSTTVAGLMAAEEGLRLIPIFGTII
AGTLSSVATYKALSDFLEMLTKDAQNVFKKALCRMNSSV* 
TN_GKS11 
XXXVNAFRGVDHRDEKEAAPVDVVETTAEVKEYLHPNYPNVSLWDLPGIGSTNFPADEYLKLVGFEKFDFFIIISDTRFSENDVKLAKE
IQKMGKKFYFVRSKVDSDLLNEQRSQRDFDPEQTLSLLRENCEQGLLNAGLQAQVFLLSNFDPQHYDFHRLHETLERELPEHQRDVLFV
AMPNISQEIIEKKKEAFKSKIPYWALVSAAGAVVPVPGLSVAVDLSLIAVVVQKYKTGFGLDRPSLQRLADTTGVQLTDLTSVIRSPLG
LNNINAQLILKILIRSAKVAGLMAAEEDLRFIPIFGTMIAGTLLQLLIKLCQISSRCSLKILRMCLKRLSAA* 
>TN_GKS12  
MADSSDIAEIKEALQNNNQALAAAKIKELLDNQSNIPLNIAITGESGSGKSSFVNAFRGVDHKDEKAAPTDVVETTAEVIGYPHPNYPN
VILWDLPGIGTTKFPVDDYLKLVGFEKFDFFIIISDARFRENDVKLAKKITEMGKKFYFIRSKVDSDLLNAQRSKRDFDPEKTLSLIRE
NCKRGASQRRCAGSSFSAVNFYLSAXX 
>TN_GKS13 
DIILFIQNVSCVFFATKILALCLRLIMADSSDIVGIKEALQNNNQALAAAKIKELLDKQSNATLNIAITGDSGSGKSSFVNAFRGVDHK
DKKEAAPVGVVETTAKVEKYLHPNYPNVILWDLPGIGTFKFPADKYLKVVGFEKFDFFIIISATRFSENDVNLAKEIQKMGKKFYFVRS
KVDXXX 
>TR_irgf6 
MVNVCVCYITVGLSVGMISRLSDFYIVTVGFALCVQVIMADSLDTTEIKEALQNNNQALAVDKIKKLLERAANTPLNIGITGESGSGKS
SFVNAFRGVDHQDNQAAPTGVVETTTEVRAYPHPSYPNVTLWDLPGIGTTRFPADQYLKHVGFERFDFFIIISATRFRENDVKLAKEIQ
KMGKKFYFVRSKVDNDLQNAQRSQRNFDAEQTLALIRENCKEGLLKEGVQAPQVFLLSNFELRRHDFHRLHATLERELPEHKRDALLFA
MPNMSLEIIEKKKEAFKSKIPHYAFVSAACAAVPVPGLSVAVDGALIAGVVQQYKTGFGLDGPSLQRLADSTGVPLEDLTSVVRSPLSL
NTIDKAFILKLLLQSAAVAGLMLAEEGLKFIPLFGTLVASTLSYKVTEKALLDFLHMLAEDAQNVFKRALCCMNSSV* 
>TR_irgf5 
MVNVCVCYITVGLSVGMISRLSDFYIVTVGFALCVQVIMADSLDTTEIKEALQNNNQALAVDKIKKLLEKRANTPLNIGITGESGSGKS
SFVNAFRGVDHRDNQAAPTGVVETTTEVRAYPHPSYPNVTLWDLPGIGTTRFPADQYLKHVGFERFDFFIIISATRFRENDVKLAKEIQ
KMGKKFYFVRSKVDNDLQNAQRSQRNFDAEQTLALIRENCKEGLLKEGVQAPQVFLLSNFELRRHDFHRLHATLERELPEHKRDALLVS
LANMSLEIIKKKKEAFKSKIPHYAFVSAACAAVPLPGLSAAVDADLIAGVVQQYKTGFGLGRPSLQRLVAITGVPLVDLTIISSPLTLD
NINTDLVLNLMSQSSAISSLTETRESYSFIPLFGIPVARKLSYEITERALHNFLDMLTEDAQDVYNRVINHINS* 
>TR_GKS1 
MDNVCVCYITVGLSVGMISRLSDFYIVTVGFALCVQVIMADSLDTTEIKEALQNNNQALAVDKIKKLLERAANTPLNIGITGESGSGKS
SFVNAFRGVDHRDNQAAPTGVVETTTEVRAYPHPSYPNVTLWDLPGIGTTRFPADQYLKHVGFERFDFFIIISATRFRENDVKLAKEIQ
KMGKKFYFVRSKVDNDLQNAQRSQRNFDAEQTLALIRENCKEGLLKEGVQAPQVFLLSNFELRHHDFHRLHATLERELPEHKRDALLSA
MPNMSLEIIEKKKEAFKSKIPHCAFVSAACAVVPVPGLSAAVDADLIAGVVQQYKTGFALDGPSLQRLADSTGVPLEDLTSVVRSPLSL
NTIDKTFILKLLLQSAAVAGLMVAEEGLKFIPLFGTLVASTLSYKVTEKALLDVLHMLAEDAQNVFKRALCCMNSSV* 
>TR_GKS2 
XSSSSSQILALEENDVKLAKEIQKMGKKFYFVRSKVDNDLQNAQRSQRNFDAEQTLALIRENCEEGLLKEDVQAPQVFLLSNFDFRRHD
FHRLHATLERELPEHKRDALLVSLANMSLEIIEKKKEAFKSKIPHYAFVSAACAAVPLPGLSAAVDADLIAGVVQQYKTGFGLDRPSLQ
RLVAITVVPLVDLTIISSPLTLDNINTDLVLNLMSQSSAISSLTERRESYSFIPLFGIPVARKLSYEITERALHNFLDMLTEGCSGCV* 
>TR_GKS3 
MDNVCVCYITVGLSVGMISRLSDFYIVTVGFALCVQVIMADSLDTTEIKEALQNNNQALAVDKIKKLLERAANTPLNIGITGESGSGKS
SFVNAFRGVDHRDNQAAPTGVVETTTEVRAYPHPSYPNVTLWDLPGIGTTRFPADQYLKHVGFERFDFFIIISATRFRENDVKLAKEIQ
KMGKKFYFVRSKVDNDLQNAQRSQRNFDAEQTLALIRENCKEGLLKEGVQAPQVFLLSNFELQRHDFHRLHATLERELPEHKRDALLFA
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MPNMSLEIIEKKKEAXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXLQRLADSTGVLLEDLTSVVRSPLSLNTIDKTFILKLLLQSAAVAGLMLAEEG
LKFIPLFGTLVASTLSYKVTEKALLDFLHMLAEDAQNVFKRALCCMNSSV* 
>TR_GKS4 
MADFLDTTEIKEALQNNNQALAVDKIKKLLEMAANTPLNIGITGESGSGKSSFVNAFRGVDHRDDQAAPTGVVETTTEVRAYPHPSYPN
VTLWDLPGIGTTRFPADQYLKHVGFERFDFFIIISDTRFRENDVKLAKEIQKMGKKFYFVRSKVDNDLQNAQRSQRNFDAEQTLALIRE
NCEEGLLKEGVQAPQVFLLSNFDFRRHEFHRLHATLERELPEHKRDALLVSLANMSLKIIKKKKEAFKSKIPHYAFVSAACAAVPLPGL
SAAVDADLIARVVQQYKTGFGLDRPSLQRLVAITGVPLVDLTIISSPLTLDNINTDLVLNLMSQSSAISSLTERRESYSFIPLFGILVA
RKLSHEITERALHNFLDMLTEDAQDVYNRVINHINS* 
>TR_GKS5 
MADSLDTTEIKEALQNNNQALAVDKIKKLLERAANTPLNIGITGESGSGKSSFVNAFRGVDHRDNQAAPTGVVETTTEVRAYPHPSYPN
VTLWDLPGIGTTRFPADQYLKHVGFERFDFFIIISDTRFRENDVKLAKEIQKMGKKFYFVRSKVDSDLQNAQRSQRNFDAEQTLALIRE
NCKEGLLKEGVQAPQSSCCPTLSFGTMTSIASMRPWRENFQNTSGMLFCPPCPT* 
>TR_GKS7 
MVNVCVCYITVGLSVGMISRLSDFYIVTVGFASCVQVIMADFLDTTEIKEALQNNNQALAVDKIKKLLEKAANTPLNIGITGESGSGKS
SFVNAFRGVDHQDDQAAPTGVVETTTEVKAYTHPSYPNFKLWDLPGIGTTRFPADQYLKHVGFERFDFFIIISATRFSENDVKLAKEIL
NMGKKFYFVRSKVDNDLQNAQRSQRNFDAEQTLALIRENCKKGLLKEGVQAPQVFLLSNFELRRHDFHRLHETLERELPEHKRDALLFA
MPNMSLEIIKKKKEAFKSKIPHYAFVSAACAVVPLPGLSVAVDLALIVSVVQKYKTGFGLDRPSLQRLADSTGVPLEDLTSVVHSPLSL
NTINKTLIQKLLLQSAAIVALMAAEEGLKFIPLFGALVAAPLSYKVTEKALLDFLHVLAEDAQNVFKRALCCMNSPV* 
>TR_GKS8 
MDNVCVCYITVGLSVGMISRLSDFYIVTVGFALCVQVIMADSLDTTEIKEALQNNNQALAVDKIKKLLERAANTPLNIGITGESGSGKS
SFVNAFRGVDHRDDQAAPIGVVETTTEVGAYPHPSYPNVTLWDLPGIGTTRLTTICRMHKGVRETLMQSRLSHLFVKTATKGLLKEGVQ
APQVFLLSNFELQRHDFHRLHATLERELPEHKRDALLSAMPNMSLEIIEKKKEAFKSKIPHCAFVSAACAVVPVPGLSAAVDADLIAGV
VQQYKTGFALDGPSLQRLADSTGVPLEDLTSVVRSPLSLNTIDKTFILKLLLQSAAVAGLMVAEEGLKFIPLFGTLVASTLSYKVTEKA
LLDFLHMLAEDAQNVFKRALCCMNSSV* 
>AM_GKS1 
FGTREDDRLKGDTGARHRAADDINVSKTEEAREQRWPKVEVHIALTGDSGAGKSSFINAIRDLREDDEGAATVDVTQCTKEPTAYDHPA
FPNAKFWDLPGIGTPSYPDMETYTKKVELEKYDAFLIFTATRFTENSLKLAVKIKSMKRKFIFIRTKIDNSARAESRKQSFDEQGMLTK
IRCKCVERLGDLLSCEEDVFLISSHHPNKWDFSRLTEAIFDAVIMLQEQESLTLRVLQDLVITS* 
>LE_GKS1 
MAQSMLPKYFSDTEMRSLQTGYSNGDVVSAMLRIKRVEDSGNVPINIAVLGDGGAGKSTFINTMRGVRSGDQGAAPVGGYEASVNPVGY
PYPSLPNVQLWDLPGSNSLGFEMSRYLKQVQFESYDFYIIVSQSRFRESDGELSKKIQQQGKCFYYIRSKIDNDAFSMQMQGTDFGEGQ
RQIRQDCLKHFHRVSVEPPAIFLISGLEVTGYDFPKLQSALASDLPKIKSTAFRLAIPRMMQEIQRPRRQILMWCIILWAFLSGALGVL
RLLTLPLLTATLCTVSGWIYLRRQLGV 
>SqA_GKS1 
MAGVLSHLFYSTTDVKHLAATYRHGGMAALQSEIEAKAIQFKHVKLHVAVMGEAGAGKSSFINALRGLGVNDKGAAPTDVVECTKEVTP
YLHPTLPNVTYLDFPGIGTERFPIKKFLKQTNFSQFDFGIIVSDARFTDNDA 
>SqA_GKS2 
EGRRTILRDCVSNFQSVGVTPPAIFLISSFDLDKYDFPDIRSTLVSNLPSIKSNVFLLSLPKIMLEIIEPKVRMLKKRVWLMAVLAGAL
GAVPVPGLSFITGIVLTVAGLIYLQKQVGLNDKSLQSLASQXQxKPTSALKTEMNRRLPSKIPPVFTRVLLGIPIVACMIAGVNHSFSP
LTLSIFGTVSVLL 
>SqA_GKS3 
FSSVNKDLEDDLPTIKKSVFILALPNLTLEIVEKKRLELRKRVWMLATLSGAVGAVPVPGVSLAADIGIVIGGIIHFRKCLGLDDASLQ
RLANKAGKPVEDLKAVVKTPLVGEITPDLIARLSWGLAAVTISALEIALDIIPVVGSIFGAGSSFLMTYKLLSDALDDLAENAQRVVKA
AFGTDGDGLHQTSIQ*VNAVANILKGSNPERCRNSTLQYSLFAKLFPGILLIH 
>BF_GKS1 
KELQEMLSNLSAATGAARIKILKNIQEYAAENTEAWKNQKVNLGILGDPGAGKSTFINSIRGLKPKAPGAAKVGLRHTTTVVTGYPHPA
RPDNLIFVDFPGVLLKKGTGQARDFDIQQYLDEFGEKMQQCHVFLVFTSGHIQHNAVQIGMEARKMGKKVLFVRSQFDLDVGKRKKDDP
DYFTGKTKADLMEELRQDYIHVLKEVGWEGQVDPKDVFIISGVLENVLEGSWDIPKFRKAMIGNLSALQKMVVISTCRDFSKATIKERG
DIYREYVWAVAMAATAGTFVPFAGAASVPGK* 
>BF_GKS2 
SIRREIRILEMNEEEQGMLRNLAAAEGANKAEILKKIQEYAAEKVEAWKRQKVYVGIVGDPGAGKSTFINSIRGLSPTDDGAAEVGLTH
TTTTTTVYPHPERPDNLIFVDFPGVLLKKGTEEERDFDIQQYLAKFKGKMQQCHVFLVFSSGRIQHNAVQIGMKAREMGKKVLFVRSKF
DSDLPNMRKDKPQYFKDKTEADLMEELCQDYIKVLKEVGWKGEVNPRDVFIISGHLDYVLKGSWDIPKFRKAMIGNLSALQKMVVISTC
RDFSKATIKERGDIYREYVWAVAMAATAGTFVPFAGAASIPGK* 
>BF_GKS3 
MLRNLADPGSANKAEILKKIQEYAAEKVEAWKRQKVYVGIVGEPGAGKSTFINSIRGLKPKAPGAAEVGLGHTTSVVTEYPHPARPDNL
IFVDFPGVLLKKGTGQARDFDIQQYLNEFGEKMQECHVFLVFSSGRIQHNAVQIGMKARDMEKKVLFVRSQFDKDLADKQNDDPEYFDD
KTEADLMEELRQDYIKVLKKVGWEGEVNPREVFIISGRLKNVLEGSWDIPKFRKAMIEGLDALQKMIVINTCRDFSKATIKERGDVYRG
QVWWVAAAATAGTLVPYVGGAAVPGEKCHSHSGREREKF* 
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>BF_GKS4 
MNEEEQRMLKNLAAAGGANKAEILKEIQQYAAENMEAWKNQKVNIGIVGDPGAGKSTFINSIRGMKPKAPGAAGVGLTHTTTEAIDYPH
PERPNSLVFVDFPGVLLKKGTRGKRDFDIQQYLNEFGEKMQQCHVFLVFSSGRIQHNAVQIGMEAREMGKKVLFVRSQFDKDLEDKHND
DDEYFDDKTEADLMEELRHNYIKVLKDVGWEGEVNPRDVFIISGRLKHVMKGFWDIPTFRKTMIEELGTLHKMVVINTCRDYSTATIKE
RGDIYRSKVWTVAMAASTGSFVPYAGAAAIPGR* 
>BF_GKS5 
MDEEEQGMLRNLAAAGGANKAEILKKIQQYAAENMEAWKNQKVNIGIVGDPGAGKSTFINSIRGLKPTGLPVQRRWGLHTLPK*TTDYP
HPTRPDSLVFVDFPGVLLGRGSGDERDFDIQQYLAKFGEKMDQCHVFLVFSSGRIQHNAVQIGMKAREKGKKVLFVRSQFDKDLADKKN
DDPEYFDDKTEADLMEELRQDYINVLKRVGWEGEVNPREVFIISGRLRNVLEGSWDIPKFRKAMIDGLGALQKMVVINTCRDFSKATIK
ERGDIYRGKVWTVAMATTAGSFVPYAGAAAIPGR* 
>BF_GKS6 
MVCYIAVSCFQFDDLGPDERKQFRKFADKSVKDQTASEMLQALWEEVGQYIDQEAWMGQAYVRIGLVGLSGAGKSTFINSLRGLRPTDP
GAADVGVKETTTIPTEYPHPEHKHVILVDFPGNVFKLKEGLMTPVGFDTNEYIKKNGKKMEECNVFLVFTSGRVHDNAVWIAKKCKDMG
KKLLFVRSKFDSDVTNTQEDKPTYFKNGQDEGESHLLNEVKADFVSKLNEQGFGQVDEKDVFIIGGKYDKVQMGEWDTPLLKQAILKQL
DIQQQMLFITTCQDFSPTMARAKAQVYRSRAWKVALGTAPAGAIPFVGAGVTLGV* 
>BF_GKS7 
MIRDEDGDNTDFDKIAHRMTLKLQDSEHATVNIGIVGEAGAGKSTFINSFRGIKPGEEGAAEVSAFRHTTNDVTRYPVPDNQNIVLMDF
PGVIFRNTGTRLDMEEEFNTKSYLDLYGVEMEECDVFLVFVTCRVSNNIIWIAKEVGKMNKKVLFVRSKIDVDLANESRDNPRRFPEGT
SSTTIEVRRFVEELRKVTTNELERLSYAEVKETMVFVICGLPDDVASGTYDMTNLRKAIYNTLSPDKKGVLINGLVEFATDMVHEKAEY
LRSREVIAAAVANTVISATPIPGLGLALDIGTFFLLLCFLSFMSTAP* 
>BF_GKS8 
MLHERAADGGGNITAQEALDIAAASESEPDKVKIGIVGDAGAGKSTFINSFRGLSPDDVGAAKVSAFGHATTESESYDVPGKAVVLTDF
PGVLFKPKMEASSTDIDGTEKVIFNTSSYLDPNKAKMQECDFFLIFMPNRPGNNVVWIAKEVRKMGKRLLFVRSQADEDIERARHDNPK
DFPTNIDNQIAERRVMLKFKQSTKVTFEALGYGKVDEDDIFVICGLKEPVARGDYDMGALRIAMLNSLSTYKQGVLIKNIQDFSMATLM
KKGEVMRKIVWGVAAGAAAISAVPLPGIGVAMDMGKWLCIYTYMLDEVMLSSKLST* 
>BF_GKS9 
MGQAYVRIGIVGVSGAGKSTYINSFRGLRASDPGAAAVGVIETTTEAEEYRHPKHDHVILVDFPGALFKLEGGHRRSVTFDMKEYTRKF
EGKMKECNVLLVFTSVRVHDNAVWIAAKAREIGKKVLFVRSMLDVDIYNKQRDDPAYFTGGQEEGEKRLLQLHRQDYVTMLETMGYGRV
APEEVFIISGMLEHIQRGSWDAPALKEAMLKQLHIQQQILFITICQDFSPTMARAKAKIYKSRAWKVALRVAAAGVIPFAGGSINAGV* 
>BF_GKS10 
MRLKSKFTSVFFLLLNIASVLHVFCTFFLSHRRECPLEVDQLTISEKHLSQEELDELEMIRDEDGDNTDFEKIAHRMTLKLQDSEHATV
NIGIVGEAGAGKSTFINSFRGIKPGEEGAAEVSAFRHTTNEVTRYPVPDNQNIVLMDFPGVIFRNTGTRLDMEEEFNTKSYLDLYGSEM
EECDVFLVFVTCRVSNNIIWIAKEVGKMNKKVLFVRSKIDVDLANESRDNPRRFPEGTSSTTIEVRRFVEELRKVTTKELERLSYAEVK
ETMVFVICGLPDDVASGTYDMTNLRKAIYNTLSPDKKGVLINGLVEFATDMVHEKAEYLRSREVIVAAVANTVISATPIPGLGLALDIG
TLCSSLFFSFFMPTAP* 
>BF_GKS11 
LEEHMSQAEIDELKKACDGSDDFEDMAKRLTSTFQSAKYATVNIGIVGDAGAGKSTFINSFRGLRPKEEEAAEVSAIRHTTNKVTRYPV
PDNQNIVLLDFPGVIFRSTGTGVAEEFDTKSYLDLHGAEMKNCDLFLIFVTGRVSNNIIWIAKEARKMEKNVLFVRSKIDIDLANESRD
HPTRFPKGTSYTTLETQHFVEELRQATAEELKRLDYGEVKETRVFVISGVLECMAEGQYDMTNLRKTIYNSVSPDKKAVLITSLSDFAT
DMVHEKAKYLRTREAIVAAMCNAVISAAPVPGIGIVTDIGKVLNFSTFLTVACYLMILLLMIETY* 
>BF_GKS12 
MWVFFFLQYSVEIRRDDLGPEEQEIFRRFADQVQGVRGDLPPEEMLQMLRRELGTDDREDAWMGQAYVRIGIVGSSGAGKSTFINSFRG
LEASDPGAADVGTTETTRETAEYPHPEHDHVILVDFPGALFKLQEENWHPVTFNMEEYRVRFGGKMKECNVFLVFTSERVHDNAVWIAK
VAKDMGKKVLFVRSKFDRDLEDKQRDKRSYFAGGQKEGEERLLQEHREDYVTKLDTLGYGRVDIRDVFVISGILEHVQTGHWDAAALKE
AILKQLDIQQKMLLMTTTTDYSPTMVRVKAEIYRSRAWKVALTVAAGGLIPLAGTFINAGVYRILTDHLSAKVGRELESPWLRLDDFTF
QKYDKAAHFRRVLHCRYYGDDDGVVQERLWPLPDLGEKAG* 
>BF_GKS13 
MGQAYVRIGIVGSSGPGKSTFINSFRGLKAEDKGAAPVGTKETTKETAEYPHPEHDHVILVDFPGALFKLQGSDWQPVRFNMKEYTRKF
GDKMKECNVFLVFTSDRVHDNAVWIAAKAKEMKKKVLFVRSKFDRDLEDVRRDKPSFFAEKDGEERLLQEHRDDYVTKLGTLGYGRVDI
GDVFVISGILEHIEGGRWDAAALKEAILKQLDIQQKMLLMTTTTDYSPTMVRVKAEIYRSRAWKVALGVAAGGAIPWAGTFVNAGMYRI
RMDHLSKLVRQ* 
>BF_GKS14 
MFADKVKNANDQSSAEMIQTLHEEVGQHVDEEAWMGQAYVRIGIVGVTGAGKSTFINSFRGLEAGDPGAAAVDTIETTADTAEYPHPEH
DHVILVDFPGALFKLEDGGRRRSAKFDMKEYTRKFGEKMRECNVFLVFTSDRVHDNAVWIAAKAREIGKKVLFVRSKFDQDVANKRRDD
KTYFAGGQEEGEERLLQFHRQDYVTKLETMGYGRVAPEDVFIISGIVENIQRGRWDATAL 
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SUMMARY 
VII. Summary 
Members of the immunity-related (p47) GTPases (IRGs) are essential, interferon-
inducible resistance factors active against a broad spectrum of important intracellular 
bacterial and protozoal pathogens including Toxoplasma gondii. Despite the strong, 
partially overlapping but non-redundant susceptibility phenotypes of mice genetically 
deficient for individual members of the family, little is known about molecular 
mechanisms of function and regulation of the IRG resistance system.  
This study demonstrates that IRG GTPases function in a system of direct, 
nucleotide-dependent regulatory interactions between family members. Spontaneous 
GTP-dependent homo-oligomerisation of the GKS subfamily member Irga6 leads to the 
activation of GTPase function in vitro. In vivo, accumulation of activated, GTP-bound 
GKS proteins at the parasitophorous vacuolar membrane is associated with the IFN-
induced, cell autonomous destruction of avirulent Toxoplasma gondii. In contrast, direct 
GDP-dependent interactions of the unusual GMS subfamily members with the GKS 
proteins Irga6 and Irgb6 via the G-domains prevent premature activation of the resistance 
system in absence of infection. Lack of GMS GTPases results in spontaneous activation 
and aggregation of Irga6 and Irgb6 on endomembranes and hinders association with the 
parasitophorous vacuolar membrane upon infection with T. gondii. The three GMS 
GTPases are both necessary and sufficient to regulate Irga6 and Irgb6. No other 
interferon-inducible proteins are required for the regulation of the resting localisation of 
Irga6 and Irgb6 in the IFN-induced cell or for their infection-induced assembly on the 
membrane of the parasitophorous vacuole. Nucleotide binding is essential for the 
translocation from the resting localisation to the vacuole. Virulent Toxoplasma efficiently 
inhibited the recruitment of IRG proteins to the parasitophorous vacuole. These findings 
provide the first link between the enzymatic properties of IRG proteins as GTPases and 
their function in pathogen resistance. 
The IRG resistance GTPases are an ancient family that underwent extensive 
expansion and diversification as well as contraction in the euchordates – a feature 
characteristic for multigene families associated with pathogen resistance due to host-
pathogen coevolution. Despite its essential role in resistance to vacuolar pathogens in 
mice, the IRG resistance system as such is not conserved in higher primates. While all 
other groups of mammals possess multiple divergent IRG genes, humans and higher 
primates contain a largely reduced set of typically three genes. All of these genes lack 
IFN-inducible elements in their putative promoters and are either significantly truncated, 
drastically damaged in the nucleotide binding domain or show testis-specific expression 
paralleling sexual maturity. Consequently, mice and humans must deploy their immune 
resources against vacuolar pathogens in radically different ways. 
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ZUSAMMENFASSUNG 
VIII. Zusammenfassung 
Die Mitglieder der (p47) immun-verwandten GTPasen (‘immune-related GTPases’, 
IRGs) sind essentielle, Interferon-induzierbare Resistenzfaktoren und aktiv gegen ein 
breites Spektrum bedeutender, intrazellulärer Pathogene einschließlich Toxoplasma 
gondii. Obwohl Mäuse, die genetisch defizient für einzelne Mitglieder des IRG 
Resistenzsystems sind, ausgeprägte, teilweise überlappende aber nicht redundante 
Anfälligkeiten gegenüber Pathogenen aufweisen, ist wenig über die molekularen 
Mechanismen der Funktion und der Regulation des IRG Resistenzsystems bekannt. 
Diese Studie zeigt, dass die IRG GTPasen in einem System von direkten, 
Nukleotid-abhängigen Interaktionen zwischen Familienmitgliedern funktionieren. 
Spontane GTP-abhängige Oligomerisierung von Irga6, einem Mitglied der GKS 
Unterfamilie, führt zur Aktivierung der GTPase Funktion in vitro. Die Akkumulation von 
aktivierten, GTP-gebundenen GKS Proteinen an der Membran der parasitophoren 
Vakuole in vivo ist mit der IFN-induzierten, zellautonomen Zerstörung von avirulenten 
Toxoplasma gondii assoziiert. Direkte GDP-abhängige Interaktionen von Mitgliedern der 
ungewöhnlichen GMS Unterfamilie mit den GKS Proteinen mittels der G Domänen 
verhindert dagegen die verfrühte Aktivierung des Resistenzsystems in Abwesenheit von 
Infektion. Die Abwesenheit von GMS GTPasen resultiert in der spontanen Aktivierung 
und Aggregation von Irga6 und Irgb6 an Endomembranen und behindert die Assoziation 
mit der Membran der parasitophoren Vakuole im Zuge der Infektion mit T. gondii. Die 
drei GMS GTPasen sind sowohl notwendig als auch hinreichend für die Regulation von 
Irga6 und Irgb6. Keine anderen Interferon-induzierbaren Proteine sind für die Infektions-
induzierte Assemblierung an der Membran der parasitophoren Vakuole notwendig. Die 
Nukleotid-Bindung ist essentiell für den Transfer von der Ruhelokalisation zur Vakuole. 
Virulente Toxoplasmen inhibieren die Rekrutierung der IRG Proteine an die 
parasitophore Vakuole. Diese Ergebnisse stellen die erste Verbindung zwischen den 
enzymatischen Eigenschaften der IRG Proteine als GTPasen und ihrer Funktion in der 
Resistenz gegen Pathogene her.  
Die IRG Resistenz-GTPasen sind eine alte Familie die in den Euchordaten eine extensive 
Expansion, Diversifikation und Kontraktion durchlaufen hat – eine Eigenschaft, die 
aufgrund von Wirts-Pathogen-Koevolution charakteristisch für Pathogenresistenz-
assozierte Multigenfamilien ist. Trotz ihrer essentiellen Rolle in der Resistenz gegen 
vakuoläre Pathogene ist das IRG Resistenzsystem als solches in höheren Primaten nicht 
konserviert. Während alle anderen Gruppen von Säugetieren mehrere, divergente IRG 
Gene besitzen, haben Menschen und höhere Primaten einen stark reduzierten Satz von 
typischerweise drei Genen. Alle diese Gene besitzen keine Interferon-induzierbaren 
Elemente in ihren mutmaßlichen Promotoren und sind entweder verkürzt, stark 
beschädigt in ihrer Nukleotidbindungsdomäne oder zeigen eine Testis-spezifische 
Expression parallel zu sexuellen Reife. Deshalb müssen Mensch und Maus ihre 
Immunressourcen gegen vakuoläre Pathogene radikal unterschiedlich nutzen. 
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Genetics and Functional Genomics“ der Universität zu 
Köln 
Okt. 2001 – März 2002 Rotationsperioden in den Laboren von Prof. Dr. Martin 
Scheffner, Prof. Dr. Mats Paulsson und Prof. Dr. Jonathan 
Howard 
April 2002 Beginn der Arbeit am Promotionsthema am Institut für 
Genetik der Universität zu Köln in der Abteilung von Prof. 
Dr. Jonathan Howard zum Thema „Evolution and cellular 
resistance mechanisms of the immunity-related GTPases“ 
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